Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 C20140401_SF093_03 C20140401_SF093_03 TB483065.[MT7]-ASPLPNEAWVALR.2y6_1.heavy 784.439 / 715.425 3882.0 39.07357597351074 38 16 10 2 10 1.8691644771075244 53.49983975446986 0.08179855346679688 3 0.9653503406955157 6.610751457416163 3882.0 14.562539442875373 0.0 - - - - - - - 603.5714285714286 7 7 FBXL8 F-box and leucine-rich repeat protein 8 3 1 C20140401_SF093_03 C20140401_SF093_03 TB483065.[MT7]-ASPLPNEAWVALR.2y8_1.heavy 784.439 / 958.51 1941.0 39.07357597351074 38 16 10 2 10 1.8691644771075244 53.49983975446986 0.08179855346679688 3 0.9653503406955157 6.610751457416163 1941.0 2.6862385996859315 1.0 - - - - - - - 299.75 5 8 FBXL8 F-box and leucine-rich repeat protein 8 5 1 C20140401_SF093_03 C20140401_SF093_03 TB483065.[MT7]-ASPLPNEAWVALR.2y9_1.heavy 784.439 / 1055.56 40758.0 39.07357597351074 38 16 10 2 10 1.8691644771075244 53.49983975446986 0.08179855346679688 3 0.9653503406955157 6.610751457416163 40758.0 84.63136840655557 0.0 - - - - - - - 1272.2857142857142 81 7 FBXL8 F-box and leucine-rich repeat protein 8 7 1 C20140401_SF093_03 C20140401_SF093_03 TB483065.[MT7]-ASPLPNEAWVALR.2b4_1.heavy 784.439 / 513.315 19751.0 39.07357597351074 38 16 10 2 10 1.8691644771075244 53.49983975446986 0.08179855346679688 3 0.9653503406955157 6.610751457416163 19751.0 16.897931468250807 0.0 - - - - - - - 308.4 39 10 FBXL8 F-box and leucine-rich repeat protein 8 9 2 C20140401_SF093_03 C20140401_SF093_03 TB482995.[MT7]-AAIELLMVLAGR.2y8_1.heavy 700.924 / 872.539 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 11 2 C20140401_SF093_03 C20140401_SF093_03 TB482995.[MT7]-AAIELLMVLAGR.2b4_1.heavy 700.924 / 529.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 13 2 C20140401_SF093_03 C20140401_SF093_03 TB482995.[MT7]-AAIELLMVLAGR.2y9_1.heavy 700.924 / 1001.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 15 2 C20140401_SF093_03 C20140401_SF093_03 TB482995.[MT7]-AAIELLMVLAGR.2y11_1.heavy 700.924 / 1185.7 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 17 3 C20140401_SF093_03 C20140401_SF093_03 TB483120.[MT7]-VLGLQDTITAELVVIEDAAEPK[MT7].3b6_1.heavy 871.493 / 770.453 3553.0 53.56145095825195 38 13 10 7 8 1.4921105550847769 53.5111528110331 0.02459716796875 4 0.9103797196832109 4.091297938979471 3553.0 14.850281630040538 0.0 - - - - - - - 151.75 7 20 PALM paralemmin 19 3 C20140401_SF093_03 C20140401_SF093_03 TB483120.[MT7]-VLGLQDTITAELVVIEDAAEPK[MT7].3b4_1.heavy 871.493 / 527.367 3520.0 53.56145095825195 38 13 10 7 8 1.4921105550847769 53.5111528110331 0.02459716796875 4 0.9103797196832109 4.091297938979471 3520.0 0.6692015209125475 1.0 - - - - - - - 151.92592592592592 7 27 PALM paralemmin 21 3 C20140401_SF093_03 C20140401_SF093_03 TB483120.[MT7]-VLGLQDTITAELVVIEDAAEPK[MT7].3b5_1.heavy 871.493 / 655.426 2616.0 53.56145095825195 38 13 10 7 8 1.4921105550847769 53.5111528110331 0.02459716796875 4 0.9103797196832109 4.091297938979471 2616.0 7.19381443298969 1.0 - - - - - - - 169.27586206896552 5 29 PALM paralemmin 23 3 C20140401_SF093_03 C20140401_SF093_03 TB483120.[MT7]-VLGLQDTITAELVVIEDAAEPK[MT7].3b8_1.heavy 871.493 / 984.585 7363.0 53.56145095825195 38 13 10 7 8 1.4921105550847769 53.5111528110331 0.02459716796875 4 0.9103797196832109 4.091297938979471 7363.0 187.58327873734368 0.0 - - - - - - - 191.88888888888889 14 18 PALM paralemmin 25 4 C20140401_SF093_03 C20140401_SF093_03 TB483063.[MT7]-GIPEFWFTIFR.2y8_1.heavy 778.923 / 1145.58 19637.0 53.72740173339844 39 9 10 10 10 0.9822951451954979 71.7217169047426 0.0 3 0.8126119221706285 2.805199690903725 19637.0 89.8807960199005 0.0 - - - - - - - 137.11428571428573 39 35 NAP1L4 nucleosome assembly protein 1-like 4 27 4 C20140401_SF093_03 C20140401_SF093_03 TB483063.[MT7]-GIPEFWFTIFR.2y5_1.heavy 778.923 / 683.388 15487.0 53.72740173339844 39 9 10 10 10 0.9822951451954979 71.7217169047426 0.0 3 0.8126119221706285 2.805199690903725 15487.0 47.88091684434968 0.0 - - - - - - - 130.51282051282053 30 39 NAP1L4 nucleosome assembly protein 1-like 4 29 4 C20140401_SF093_03 C20140401_SF093_03 TB483063.[MT7]-GIPEFWFTIFR.2y9_1.heavy 778.923 / 1242.63 22806.0 53.72740173339844 39 9 10 10 10 0.9822951451954979 71.7217169047426 0.0 3 0.8126119221706285 2.805199690903725 22806.0 89.18547486033519 0.0 - - - - - - - 146.74285714285713 45 35 NAP1L4 nucleosome assembly protein 1-like 4 31 4 C20140401_SF093_03 C20140401_SF093_03 TB483063.[MT7]-GIPEFWFTIFR.2y7_1.heavy 778.923 / 1016.54 25908.0 53.72740173339844 39 9 10 10 10 0.9822951451954979 71.7217169047426 0.0 3 0.8126119221706285 2.805199690903725 25908.0 17.867586206896547 0.0 - - - - - - - 155.65714285714284 51 35 NAP1L4 nucleosome assembly protein 1-like 4 33 5 C20140401_SF093_03 C20140401_SF093_03 TB482791.[MT7]-ASPLPNEAWVALR.3y6_1.heavy 523.295 / 715.425 2475.0 39.10445022583008 42 17 10 5 10 3.74157687403302 26.726699294624055 0.04010009765625 3 0.9728553711581125 7.473655811770166 2475.0 15.290000000000001 0.0 - - - - - - - 225.3846153846154 4 13 FBXL8 F-box and leucine-rich repeat protein 8 35 5 C20140401_SF093_03 C20140401_SF093_03 TB482791.[MT7]-ASPLPNEAWVALR.3b4_1.heavy 523.295 / 513.315 8100.0 39.10445022583008 42 17 10 5 10 3.74157687403302 26.726699294624055 0.04010009765625 3 0.9728553711581125 7.473655811770166 8100.0 29.16 0.0 - - - - - - - 184.54545454545453 16 11 FBXL8 F-box and leucine-rich repeat protein 8 37 5 C20140401_SF093_03 C20140401_SF093_03 TB482791.[MT7]-ASPLPNEAWVALR.3y8_1.heavy 523.295 / 958.51 1013.0 39.10445022583008 42 17 10 5 10 3.74157687403302 26.726699294624055 0.04010009765625 3 0.9728553711581125 7.473655811770166 1013.0 17.57061946902655 0.0 - - - - - - - 193.14285714285714 2 7 FBXL8 F-box and leucine-rich repeat protein 8 39 5 C20140401_SF093_03 C20140401_SF093_03 TB482791.[MT7]-ASPLPNEAWVALR.3y5_1.heavy 523.295 / 644.388 6863.0 39.10445022583008 42 17 10 5 10 3.74157687403302 26.726699294624055 0.04010009765625 3 0.9728553711581125 7.473655811770166 6863.0 18.27954603174603 0.0 - - - - - - - 270.1 13 10 FBXL8 F-box and leucine-rich repeat protein 8 41 6 C20140401_SF093_03 C20140401_SF093_03 TB482991.[MT7]-IIELPFQNK[MT7].2b3_1.heavy 695.421 / 500.32 12429.0 39.57674980163574 39 13 10 6 10 1.013149186715556 63.708103674538336 0.039302825927734375 3 0.9158558232096035 4.224321458443439 12429.0 31.54883668743504 0.0 - - - - - - - 345.1111111111111 24 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 43 6 C20140401_SF093_03 C20140401_SF093_03 TB482991.[MT7]-IIELPFQNK[MT7].2y5_1.heavy 695.421 / 777.438 19609.0 39.57674980163574 39 13 10 6 10 1.013149186715556 63.708103674538336 0.039302825927734375 3 0.9158558232096035 4.224321458443439 19609.0 72.69803923914344 0.0 - - - - - - - 272.54545454545456 39 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 45 6 C20140401_SF093_03 C20140401_SF093_03 TB482991.[MT7]-IIELPFQNK[MT7].2b4_1.heavy 695.421 / 613.404 14787.0 39.57674980163574 39 13 10 6 10 1.013149186715556 63.708103674538336 0.039302825927734375 3 0.9158558232096035 4.224321458443439 14787.0 58.88741054973336 0.0 - - - - - - - 723.25 29 8 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 47 6 C20140401_SF093_03 C20140401_SF093_03 TB482991.[MT7]-IIELPFQNK[MT7].2y6_1.heavy 695.421 / 890.522 4607.0 39.57674980163574 39 13 10 6 10 1.013149186715556 63.708103674538336 0.039302825927734375 3 0.9158558232096035 4.224321458443439 4607.0 28.617027305063466 0.0 - - - - - - - 187.33333333333334 9 12 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 49 7 C20140401_SF093_03 C20140401_SF093_03 TB482990.[MT7]-LNIGDLQVTK[MT7].2y5_1.heavy 694.921 / 732.474 17277.0 35.35660171508789 48 18 10 10 10 5.691501048821901 17.570057378922783 0.0 3 0.9880342959799651 11.270916577107515 17277.0 65.2096 0.0 - - - - - - - 270.8333333333333 34 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 51 7 C20140401_SF093_03 C20140401_SF093_03 TB482990.[MT7]-LNIGDLQVTK[MT7].2y9_1.heavy 694.921 / 1131.65 9743.0 35.35660171508789 48 18 10 10 10 5.691501048821901 17.570057378922783 0.0 3 0.9880342959799651 11.270916577107515 9743.0 23.668638486925616 0.0 - - - - - - - 227.5 19 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 53 7 C20140401_SF093_03 C20140401_SF093_03 TB482990.[MT7]-LNIGDLQVTK[MT7].2b5_1.heavy 694.921 / 657.369 21694.0 35.35660171508789 48 18 10 10 10 5.691501048821901 17.570057378922783 0.0 3 0.9880342959799651 11.270916577107515 21694.0 51.24968588139483 0.0 - - - - - - - 260.0 43 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 55 7 C20140401_SF093_03 C20140401_SF093_03 TB482990.[MT7]-LNIGDLQVTK[MT7].2y7_1.heavy 694.921 / 904.522 24032.0 35.35660171508789 48 18 10 10 10 5.691501048821901 17.570057378922783 0.0 3 0.9880342959799651 11.270916577107515 24032.0 79.49046153846155 0.0 - - - - - - - 248.1818181818182 48 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 57 8 C20140401_SF093_03 C20140401_SF093_03 TB482992.[MT7]-IIELPFQNK[MT7].3y3_1.heavy 463.95 / 533.316 32865.0 39.56692409515381 37 11 10 6 10 1.2289336247394886 69.29644711802267 0.039302825927734375 3 0.8752983488293611 3.457851104553074 32865.0 120.88878135165211 0.0 - - - - - - - 228.0 65 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 59 8 C20140401_SF093_03 C20140401_SF093_03 TB482992.[MT7]-IIELPFQNK[MT7].3b4_1.heavy 463.95 / 613.404 55892.0 39.56692409515381 37 11 10 6 10 1.2289336247394886 69.29644711802267 0.039302825927734375 3 0.8752983488293611 3.457851104553074 55892.0 299.2432490198317 0.0 - - - - - - - 216.0 111 5 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 61 8 C20140401_SF093_03 C20140401_SF093_03 TB482992.[MT7]-IIELPFQNK[MT7].3y4_1.heavy 463.95 / 680.385 17622.0 39.56692409515381 37 11 10 6 10 1.2289336247394886 69.29644711802267 0.039302825927734375 3 0.8752983488293611 3.457851104553074 17622.0 194.98416666666665 0.0 - - - - - - - 216.0 35 6 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 63 8 C20140401_SF093_03 C20140401_SF093_03 TB482992.[MT7]-IIELPFQNK[MT7].3b3_1.heavy 463.95 / 500.32 37946.0 39.56692409515381 37 11 10 6 10 1.2289336247394886 69.29644711802267 0.039302825927734375 3 0.8752983488293611 3.457851104553074 37946.0 353.4949731119019 0.0 - - - - - - - 324.0 75 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 65 9 C20140401_SF093_03 C20140401_SF093_03 TB144495.[MT7]-DRLEFWC[CAM]TDVK[MT7].3y5_1.heavy 586.303 / 766.389 1834.0 35.5127010345459 43 18 10 5 10 5.296103810521015 18.881805111399864 0.04160308837890625 3 0.9867769303382287 10.720536099798537 1834.0 27.146 0.0 - - - - - - - 131.0 3 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 67 9 C20140401_SF093_03 C20140401_SF093_03 TB144495.[MT7]-DRLEFWC[CAM]TDVK[MT7].3b4_1.heavy 586.303 / 658.364 2227.0 35.5127010345459 43 18 10 5 10 5.296103810521015 18.881805111399864 0.04160308837890625 3 0.9867769303382287 10.720536099798537 2227.0 24.4715 0.0 - - - - - - - 180.125 4 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 69 9 C20140401_SF093_03 C20140401_SF093_03 TB144495.[MT7]-DRLEFWC[CAM]TDVK[MT7].3b5_1.heavy 586.303 / 805.432 2096.0 35.5127010345459 43 18 10 5 10 5.296103810521015 18.881805111399864 0.04160308837890625 3 0.9867769303382287 10.720536099798537 2096.0 12.8 0.0 - - - - - - - 163.75 4 4 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 71 9 C20140401_SF093_03 C20140401_SF093_03 TB144495.[MT7]-DRLEFWC[CAM]TDVK[MT7].3y4_1.heavy 586.303 / 606.358 2096.0 35.5127010345459 43 18 10 5 10 5.296103810521015 18.881805111399864 0.04160308837890625 3 0.9867769303382287 10.720536099798537 2096.0 30.08 0.0 - - - - - - - 218.33333333333334 4 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 73 10 C20140401_SF093_03 C20140401_SF093_03 TB482895.[MT7]-FAQDFLIRPIGEK[MT7].3b4_1.heavy 608.02 / 606.3 5649.0 38.62990188598633 46 16 10 10 10 1.7928972471422866 44.566484354886036 0.0 3 0.9604607692004331 6.18595564569172 5649.0 64.25737500000001 0.0 - - - - - - - 195.125 11 8 AS3MT arsenic (+3 oxidation state) methyltransferase 75 10 C20140401_SF093_03 C20140401_SF093_03 TB482895.[MT7]-FAQDFLIRPIGEK[MT7].3b5_1.heavy 608.02 / 753.369 1683.0 38.62990188598633 46 16 10 10 10 1.7928972471422866 44.566484354886036 0.0 3 0.9604607692004331 6.18595564569172 1683.0 28.05 0.0 - - - - - - - 120.0 3 2 AS3MT arsenic (+3 oxidation state) methyltransferase 77 10 C20140401_SF093_03 C20140401_SF093_03 TB482895.[MT7]-FAQDFLIRPIGEK[MT7].3y12_2.heavy 608.02 / 765.942 4567.0 38.62990188598633 46 16 10 10 10 1.7928972471422866 44.566484354886036 0.0 3 0.9604607692004331 6.18595564569172 4567.0 57.08749999999999 0.0 - - - - - - - 240.0 9 1 AS3MT arsenic (+3 oxidation state) methyltransferase 79 10 C20140401_SF093_03 C20140401_SF093_03 TB482895.[MT7]-FAQDFLIRPIGEK[MT7].3y5_1.heavy 608.02 / 687.416 3966.0 38.62990188598633 46 16 10 10 10 1.7928972471422866 44.566484354886036 0.0 3 0.9604607692004331 6.18595564569172 3966.0 20.32437673130194 0.0 - - - - - - - 253.77777777777777 7 9 AS3MT arsenic (+3 oxidation state) methyltransferase 81 11 C20140401_SF093_03 C20140401_SF093_03 TB482897.[MT7]-AELLEIIK[MT7].2y4_1.heavy 608.891 / 646.426 2556.0 40.370201110839844 41 13 10 10 8 1.2227188832410416 47.88506549288514 0.0 4 0.9252479067021203 4.4854649045375306 2556.0 14.667922656643546 0.0 - - - - - - - 241.36363636363637 5 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 83 11 C20140401_SF093_03 C20140401_SF093_03 TB482897.[MT7]-AELLEIIK[MT7].2b5_1.heavy 608.891 / 700.4 1573.0 40.370201110839844 41 13 10 10 8 1.2227188832410416 47.88506549288514 0.0 4 0.9252479067021203 4.4854649045375306 1573.0 6.796198705777503 1.0 - - - - - - - 215.0625 3 16 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 85 11 C20140401_SF093_03 C20140401_SF093_03 TB482897.[MT7]-AELLEIIK[MT7].2y5_1.heavy 608.891 / 759.51 1180.0 40.370201110839844 41 13 10 10 8 1.2227188832410416 47.88506549288514 0.0 4 0.9252479067021203 4.4854649045375306 1180.0 9.763451776649745 0.0 - - - - - - - 226.1 2 10 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 87 11 C20140401_SF093_03 C20140401_SF093_03 TB482897.[MT7]-AELLEIIK[MT7].2y3_1.heavy 608.891 / 517.383 1180.0 40.370201110839844 41 13 10 10 8 1.2227188832410416 47.88506549288514 0.0 4 0.9252479067021203 4.4854649045375306 1180.0 16.22759763803999 2.0 - - - - - - - 160.72727272727272 2 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 89 12 C20140401_SF093_03 C20140401_SF093_03 TB144297.[MT7]-LNIGDLQVTK[MT7].3y3_1.heavy 463.617 / 491.331 194489.0 35.35660171508789 47 17 10 10 10 3.9461029668484824 25.34145734161216 0.0 3 0.9755863176444013 7.882394790906395 194489.0 709.9218250950569 0.0 - - - - - - - 657.75 388 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 91 12 C20140401_SF093_03 C20140401_SF093_03 TB144297.[MT7]-LNIGDLQVTK[MT7].3b4_1.heavy 463.617 / 542.342 38819.0 35.35660171508789 47 17 10 10 10 3.9461029668484824 25.34145734161216 0.0 3 0.9755863176444013 7.882394790906395 38819.0 73.54764944275583 0.0 - - - - - - - 695.4285714285714 77 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 93 12 C20140401_SF093_03 C20140401_SF093_03 TB144297.[MT7]-LNIGDLQVTK[MT7].3b5_1.heavy 463.617 / 657.369 286602.0 35.35660171508789 47 17 10 10 10 3.9461029668484824 25.34145734161216 0.0 3 0.9755863176444013 7.882394790906395 286602.0 928.8182815103321 0.0 - - - - - - - 263.3333333333333 573 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 95 12 C20140401_SF093_03 C20140401_SF093_03 TB144297.[MT7]-LNIGDLQVTK[MT7].3b3_1.heavy 463.617 / 485.32 73559.0 35.35660171508789 47 17 10 10 10 3.9461029668484824 25.34145734161216 0.0 3 0.9755863176444013 7.882394790906395 73559.0 86.88011659376056 0.0 - - - - - - - 740.125 147 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 97 13 C20140401_SF093_03 C20140401_SF093_03 TB483129.[MT7]-EDAVEVLAIDNTSVR.3b6_1.heavy 592.315 / 787.395 4004.0 36.64670181274414 47 17 10 10 10 4.93505725908127 20.26318941203458 0.0 3 0.9771856243160244 8.155093039724887 4004.0 15.052218590704648 0.0 - - - - - - - 226.6 8 10 MUT methylmalonyl CoA mutase 99 13 C20140401_SF093_03 C20140401_SF093_03 TB483129.[MT7]-EDAVEVLAIDNTSVR.3b4_1.heavy 592.315 / 559.284 2002.0 36.64670181274414 47 17 10 10 10 4.93505725908127 20.26318941203458 0.0 3 0.9771856243160244 8.155093039724887 2002.0 2.0828131502288807 1.0 - - - - - - - 267.0 4 6 MUT methylmalonyl CoA mutase 101 13 C20140401_SF093_03 C20140401_SF093_03 TB483129.[MT7]-EDAVEVLAIDNTSVR.3b5_1.heavy 592.315 / 688.327 5873.0 36.64670181274414 47 17 10 10 10 4.93505725908127 20.26318941203458 0.0 3 0.9771856243160244 8.155093039724887 5873.0 19.846689655172415 0.0 - - - - - - - 222.22222222222223 11 9 MUT methylmalonyl CoA mutase 103 13 C20140401_SF093_03 C20140401_SF093_03 TB483129.[MT7]-EDAVEVLAIDNTSVR.3y5_1.heavy 592.315 / 576.31 2403.0 36.64670181274414 47 17 10 10 10 4.93505725908127 20.26318941203458 0.0 3 0.9771856243160244 8.155093039724887 2403.0 6.301619190404798 0.0 - - - - - - - 236.88888888888889 4 9 MUT methylmalonyl CoA mutase 105 14 C20140401_SF093_03 C20140401_SF093_03 TB144291.[MT7]-AAATAEEPDPK[MT7].3b6_1.heavy 463.248 / 659.348 20586.0 17.986299514770508 48 18 10 10 10 3.1437239257143745 25.438465162110276 0.0 3 0.9828442520703404 9.408809861903583 20586.0 128.2988321167883 0.0 - - - - - - - 197.68421052631578 41 19 NAP1L4 nucleosome assembly protein 1-like 4 107 14 C20140401_SF093_03 C20140401_SF093_03 TB144291.[MT7]-AAATAEEPDPK[MT7].3b5_1.heavy 463.248 / 530.305 21759.0 17.986299514770508 48 18 10 10 10 3.1437239257143745 25.438465162110276 0.0 3 0.9828442520703404 9.408809861903583 21759.0 68.12529756871037 0.0 - - - - - - - 659.625 43 8 NAP1L4 nucleosome assembly protein 1-like 4 109 14 C20140401_SF093_03 C20140401_SF093_03 TB144291.[MT7]-AAATAEEPDPK[MT7].3b3_1.heavy 463.248 / 358.221 22521.0 17.986299514770508 48 18 10 10 10 3.1437239257143745 25.438465162110276 0.0 3 0.9828442520703404 9.408809861903583 22521.0 40.094204545454545 0.0 - - - - - - - 735.7272727272727 45 11 NAP1L4 nucleosome assembly protein 1-like 4 111 14 C20140401_SF093_03 C20140401_SF093_03 TB144291.[MT7]-AAATAEEPDPK[MT7].3b7_1.heavy 463.248 / 788.391 4927.0 17.986299514770508 48 18 10 10 10 3.1437239257143745 25.438465162110276 0.0 3 0.9828442520703404 9.408809861903583 4927.0 90.2424558240173 0.0 - - - - - - - 136.93333333333334 9 15 NAP1L4 nucleosome assembly protein 1-like 4 113 15 C20140401_SF093_03 C20140401_SF093_03 TB482792.[MT7]-DLAGNEQR.2y6_1.heavy 523.771 / 674.322 1212.0 15.817349910736084 37 11 10 6 10 0.9042240979913422 73.72803579860465 0.03980064392089844 3 0.8718662353057498 3.4102036031570915 1212.0 35.416799999999995 0.0 - - - - - - - 100.7 2 10 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 115 15 C20140401_SF093_03 C20140401_SF093_03 TB482792.[MT7]-DLAGNEQR.2b5_1.heavy 523.771 / 615.322 555.0 15.817349910736084 37 11 10 6 10 0.9042240979913422 73.72803579860465 0.03980064392089844 3 0.8718662353057498 3.4102036031570915 555.0 5.852227722772278 0.0 - - - - - - - 0.0 1 0 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 117 15 C20140401_SF093_03 C20140401_SF093_03 TB482792.[MT7]-DLAGNEQR.2y5_1.heavy 523.771 / 603.284 1464.0 15.817349910736084 37 11 10 6 10 0.9042240979913422 73.72803579860465 0.03980064392089844 3 0.8718662353057498 3.4102036031570915 1464.0 13.559110877975215 0.0 - - - - - - - 138.5 2 8 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 119 15 C20140401_SF093_03 C20140401_SF093_03 TB482792.[MT7]-DLAGNEQR.2y7_1.heavy 523.771 / 787.406 909.0 15.817349910736084 37 11 10 6 10 0.9042240979913422 73.72803579860465 0.03980064392089844 3 0.8718662353057498 3.4102036031570915 909.0 13.879072847682119 0.0 - - - - - - - 0.0 1 0 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 121 16 C20140401_SF093_03 C20140401_SF093_03 TB483125.[MT7]-SIIGVIPYFPYSK[MT7].2y4_1.heavy 886.515 / 638.363 17244.0 45.38174915313721 39 13 10 6 10 2.126214979973231 37.3508283512814 0.036998748779296875 3 0.9014434655337098 3.898401090162091 17244.0 49.028627087198515 0.0 - - - - - - - 267.2352941176471 34 17 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 123 16 C20140401_SF093_03 C20140401_SF093_03 TB483125.[MT7]-SIIGVIPYFPYSK[MT7].2b4_1.heavy 886.515 / 515.331 23171.0 45.38174915313721 39 13 10 6 10 2.126214979973231 37.3508283512814 0.036998748779296875 3 0.9014434655337098 3.898401090162091 23171.0 50.647500499500495 0.0 - - - - - - - 731.5 46 10 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 125 16 C20140401_SF093_03 C20140401_SF093_03 TB483125.[MT7]-SIIGVIPYFPYSK[MT7].2b5_1.heavy 886.515 / 614.399 21016.0 45.38174915313721 39 13 10 6 10 2.126214979973231 37.3508283512814 0.036998748779296875 3 0.9014434655337098 3.898401090162091 21016.0 43.59825481707834 0.0 - - - - - - - 231.0 42 13 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 127 16 C20140401_SF093_03 C20140401_SF093_03 TB483125.[MT7]-SIIGVIPYFPYSK[MT7].2y7_1.heavy 886.515 / 1045.55 31254.0 45.38174915313721 39 13 10 6 10 2.126214979973231 37.3508283512814 0.036998748779296875 3 0.9014434655337098 3.898401090162091 31254.0 61.35275724275724 0.0 - - - - - - - 748.0 62 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 129 17 C20140401_SF093_03 C20140401_SF093_03 TB483131.[MT7]-AFWDVMDEIDEK[MT7].3y3_1.heavy 595.958 / 535.284 3408.0 45.824750900268555 40 14 10 6 10 2.307704276988526 43.333108577714526 0.039699554443359375 3 0.9434304404046333 5.1641884264677085 3408.0 60.281766233766234 0.0 - - - - - - - 123.8 6 10 FANCL Fanconi anemia, complementation group L 131 17 C20140401_SF093_03 C20140401_SF093_03 TB483131.[MT7]-AFWDVMDEIDEK[MT7].3b4_1.heavy 595.958 / 664.321 3795.0 45.824750900268555 40 14 10 6 10 2.307704276988526 43.333108577714526 0.039699554443359375 3 0.9434304404046333 5.1641884264677085 3795.0 17.138709677419353 0.0 - - - - - - - 128.88888888888889 7 9 FANCL Fanconi anemia, complementation group L 133 17 C20140401_SF093_03 C20140401_SF093_03 TB483131.[MT7]-AFWDVMDEIDEK[MT7].3b5_1.heavy 595.958 / 763.39 1239.0 45.824750900268555 40 14 10 6 10 2.307704276988526 43.333108577714526 0.039699554443359375 3 0.9434304404046333 5.1641884264677085 1239.0 19.679181818181817 0.0 - - - - - - - 165.85714285714286 2 7 FANCL Fanconi anemia, complementation group L 135 17 C20140401_SF093_03 C20140401_SF093_03 TB483131.[MT7]-AFWDVMDEIDEK[MT7].3b7_1.heavy 595.958 / 1009.46 775.0 45.824750900268555 40 14 10 6 10 2.307704276988526 43.333108577714526 0.039699554443359375 3 0.9434304404046333 5.1641884264677085 775.0 13.386363636363637 0.0 - - - - - - - 0.0 1 0 FANCL Fanconi anemia, complementation group L 137 18 C20140401_SF093_03 C20140401_SF093_03 TB483075.[MT7]-VTDLVQFLLFK[MT7].2b4_1.heavy 805.992 / 573.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 139 18 C20140401_SF093_03 C20140401_SF093_03 TB483075.[MT7]-VTDLVQFLLFK[MT7].2b6_1.heavy 805.992 / 800.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 141 18 C20140401_SF093_03 C20140401_SF093_03 TB483075.[MT7]-VTDLVQFLLFK[MT7].2y6_1.heavy 805.992 / 939.578 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 143 18 C20140401_SF093_03 C20140401_SF093_03 TB483075.[MT7]-VTDLVQFLLFK[MT7].2b5_1.heavy 805.992 / 672.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 145 19 C20140401_SF093_03 C20140401_SF093_03 TB483076.[MT7]-VTDLVQFLLFK[MT7].3b6_1.heavy 537.664 / 800.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 147 19 C20140401_SF093_03 C20140401_SF093_03 TB483076.[MT7]-VTDLVQFLLFK[MT7].3y3_1.heavy 537.664 / 551.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 149 19 C20140401_SF093_03 C20140401_SF093_03 TB483076.[MT7]-VTDLVQFLLFK[MT7].3b4_1.heavy 537.664 / 573.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 151 19 C20140401_SF093_03 C20140401_SF093_03 TB483076.[MT7]-VTDLVQFLLFK[MT7].3b5_1.heavy 537.664 / 672.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - MAGEA10 melanoma antigen family A, 10 153 20 C20140401_SF093_03 C20140401_SF093_03 TB483077.[MT7]-LVTANLITIQNK[MT7].3b6_1.heavy 539.338 / 756.474 10008.0 36.65760135650635 45 20 10 5 10 7.055167305350759 14.174008307947325 0.043598175048828125 3 0.9965283251718863 20.939539444645373 10008.0 24.635256333394256 0.0 - - - - - - - 233.25 20 4 AS3MT arsenic (+3 oxidation state) methyltransferase 155 20 C20140401_SF093_03 C20140401_SF093_03 TB483077.[MT7]-LVTANLITIQNK[MT7].3b4_1.heavy 539.338 / 529.347 9608.0 36.65760135650635 45 20 10 5 10 7.055167305350759 14.174008307947325 0.043598175048828125 3 0.9965283251718863 20.939539444645373 9608.0 22.559243823780996 1.0 - - - - - - - 266.55555555555554 24 9 AS3MT arsenic (+3 oxidation state) methyltransferase 157 20 C20140401_SF093_03 C20140401_SF093_03 TB483077.[MT7]-LVTANLITIQNK[MT7].3b5_1.heavy 539.338 / 643.39 26821.0 36.65760135650635 45 20 10 5 10 7.055167305350759 14.174008307947325 0.043598175048828125 3 0.9965283251718863 20.939539444645373 26821.0 99.85046441947566 0.0 - - - - - - - 266.6 53 5 AS3MT arsenic (+3 oxidation state) methyltransferase 159 20 C20140401_SF093_03 C20140401_SF093_03 TB483077.[MT7]-LVTANLITIQNK[MT7].3y5_1.heavy 539.338 / 747.448 10942.0 36.65760135650635 45 20 10 5 10 7.055167305350759 14.174008307947325 0.043598175048828125 3 0.9965283251718863 20.939539444645373 10942.0 90.98314135338346 0.0 - - - - - - - 228.57142857142858 21 7 AS3MT arsenic (+3 oxidation state) methyltransferase 161 21 C20140401_SF093_03 C20140401_SF093_03 TB483071.[MT7]-ILVVNAAYFVGK[MT7].2y4_1.heavy 791.484 / 594.373 6764.0 42.50675010681152 38 14 10 6 8 1.1271528764953616 52.622955705336764 0.036502838134765625 4 0.93345733149288 4.7574482557660165 6764.0 22.686708074534163 1.0 - - - - - - - 1288.3333333333333 18 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 163 21 C20140401_SF093_03 C20140401_SF093_03 TB483071.[MT7]-ILVVNAAYFVGK[MT7].2y8_1.heavy 791.484 / 1013.55 10709.0 42.50675010681152 38 14 10 6 8 1.1271528764953616 52.622955705336764 0.036502838134765625 4 0.93345733149288 4.7574482557660165 10709.0 24.413885887755896 0.0 - - - - - - - 719.0 21 14 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 165 21 C20140401_SF093_03 C20140401_SF093_03 TB483071.[MT7]-ILVVNAAYFVGK[MT7].2y9_1.heavy 791.484 / 1112.62 13689.0 42.50675010681152 38 14 10 6 8 1.1271528764953616 52.622955705336764 0.036502838134765625 4 0.93345733149288 4.7574482557660165 13689.0 35.28531055900621 0.0 - - - - - - - 377.5625 27 16 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 167 21 C20140401_SF093_03 C20140401_SF093_03 TB483071.[MT7]-ILVVNAAYFVGK[MT7].2y6_1.heavy 791.484 / 828.474 6361.0 42.50675010681152 38 14 10 6 8 1.1271528764953616 52.622955705336764 0.036502838134765625 4 0.93345733149288 4.7574482557660165 6361.0 29.042779156327544 0.0 - - - - - - - 254.52631578947367 12 19 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 169 22 C20140401_SF093_03 C20140401_SF093_03 TB144683.[MT7]-SC[CAM]PELHSLFLDNSTLVGSVGPGSVLELLEAC[CAM]PR.4y8_1.heavy 925.223 / 987.493 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 171 22 C20140401_SF093_03 C20140401_SF093_03 TB144683.[MT7]-SC[CAM]PELHSLFLDNSTLVGSVGPGSVLELLEAC[CAM]PR.4b4_1.heavy 925.223 / 618.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 173 22 C20140401_SF093_03 C20140401_SF093_03 TB144683.[MT7]-SC[CAM]PELHSLFLDNSTLVGSVGPGSVLELLEAC[CAM]PR.4b5_1.heavy 925.223 / 731.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 175 22 C20140401_SF093_03 C20140401_SF093_03 TB144683.[MT7]-SC[CAM]PELHSLFLDNSTLVGSVGPGSVLELLEAC[CAM]PR.4b9_2.heavy 925.223 / 608.301 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 177 23 C20140401_SF093_03 C20140401_SF093_03 TB483073.[MT7]-TVDISMILSEAIR.3y6_1.heavy 531.3 / 688.399 1737.0 49.04240036010742 44 14 10 10 10 6.574067937412613 15.211281804817714 0.0 3 0.9335892628264278 4.762225145254059 1737.0 34.739999999999995 0.0 - - - - - - - 133.66666666666666 3 3 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 179 23 C20140401_SF093_03 C20140401_SF093_03 TB483073.[MT7]-TVDISMILSEAIR.3b4_1.heavy 531.3 / 573.336 2271.0 49.04240036010742 44 14 10 10 10 6.574067937412613 15.211281804817714 0.0 3 0.9335892628264278 4.762225145254059 2271.0 28.211921194029852 0.0 - - - - - - - 167.125 4 8 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 181 23 C20140401_SF093_03 C20140401_SF093_03 TB483073.[MT7]-TVDISMILSEAIR.3b5_1.heavy 531.3 / 660.369 2338.0 49.04240036010742 44 14 10 10 10 6.574067937412613 15.211281804817714 0.0 3 0.9335892628264278 4.762225145254059 2338.0 33.15074626865672 0.0 - - - - - - - 200.66666666666666 4 3 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 183 23 C20140401_SF093_03 C20140401_SF093_03 TB483073.[MT7]-TVDISMILSEAIR.3y5_1.heavy 531.3 / 575.315 3874.0 49.04240036010742 44 14 10 10 10 6.574067937412613 15.211281804817714 0.0 3 0.9335892628264278 4.762225145254059 3874.0 3.7396128159960695 1.0 - - - - - - - 162.42857142857142 12 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 185 24 C20140401_SF093_03 C20140401_SF093_03 TB144485.[MT7]-ASPLPNEAWVALRR.3b6_1.heavy 575.329 / 724.411 655.0 35.48149871826172 46 16 10 10 10 3.4362457238670636 29.101527665915157 0.0 3 0.9625168787743311 6.35445804987209 655.0 1.2499999999999998 3.0 - - - - - - - 0.0 1 0 FBXL8 F-box and leucine-rich repeat protein 8 187 24 C20140401_SF093_03 C20140401_SF093_03 TB144485.[MT7]-ASPLPNEAWVALRR.3b4_1.heavy 575.329 / 513.315 3930.0 35.48149871826172 46 16 10 10 10 3.4362457238670636 29.101527665915157 0.0 3 0.9625168787743311 6.35445804987209 3930.0 11.52 0.0 - - - - - - - 187.14285714285714 7 7 FBXL8 F-box and leucine-rich repeat protein 8 189 24 C20140401_SF093_03 C20140401_SF093_03 TB144485.[MT7]-ASPLPNEAWVALRR.3y12_2.heavy 575.329 / 711.404 1965.0 35.48149871826172 46 16 10 10 10 3.4362457238670636 29.101527665915157 0.0 3 0.9625168787743311 6.35445804987209 1965.0 5.8125 1.0 - - - - - - - 240.16666666666666 4 6 FBXL8 F-box and leucine-rich repeat protein 8 191 24 C20140401_SF093_03 C20140401_SF093_03 TB144485.[MT7]-ASPLPNEAWVALRR.3y13_2.heavy 575.329 / 754.92 2096.0 35.48149871826172 46 16 10 10 10 3.4362457238670636 29.101527665915157 0.0 3 0.9625168787743311 6.35445804987209 2096.0 23.2 0.0 - - - - - - - 203.77777777777777 4 9 FBXL8 F-box and leucine-rich repeat protein 8 193 25 C20140401_SF093_03 C20140401_SF093_03 TB144481.[MT7]-SLNLSTEFISSTK[MT7].3y4_1.heavy 572.32 / 566.327 5762.0 36.56119918823242 45 15 10 10 10 2.742431546698415 36.463991278246844 0.0 3 0.9548637574128213 5.786986177646866 5762.0 18.64952671755725 0.0 - - - - - - - 314.4 11 5 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 195 25 C20140401_SF093_03 C20140401_SF093_03 TB144481.[MT7]-SLNLSTEFISSTK[MT7].3y12_2.heavy 572.32 / 742.41 393.0 36.56119918823242 45 15 10 10 10 2.742431546698415 36.463991278246844 0.0 3 0.9548637574128213 5.786986177646866 393.0 -0.15530997304582206 8.0 - - - - - - - 245.625 4 8 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 197 25 C20140401_SF093_03 C20140401_SF093_03 TB144481.[MT7]-SLNLSTEFISSTK[MT7].3y5_1.heavy 572.32 / 679.411 2619.0 36.56119918823242 45 15 10 10 10 2.742431546698415 36.463991278246844 0.0 3 0.9548637574128213 5.786986177646866 2619.0 18.12641221374046 0.0 - - - - - - - 205.85714285714286 5 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 199 25 C20140401_SF093_03 C20140401_SF093_03 TB144481.[MT7]-SLNLSTEFISSTK[MT7].3b7_1.heavy 572.32 / 889.475 2750.0 36.56119918823242 45 15 10 10 10 2.742431546698415 36.463991278246844 0.0 3 0.9548637574128213 5.786986177646866 2750.0 15.954198473282444 0.0 - - - - - - - 273.90909090909093 5 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 201 26 C20140401_SF093_03 C20140401_SF093_03 TB144281.[MT7]-VLQPAVPVAALR.2y9_1.heavy 689.439 / 893.557 152026.0 36.04280090332031 43 18 10 5 10 2.2409691587416876 33.47637587557276 0.04119873046875 3 0.9890492915910069 11.782681677545316 152026.0 1194.6768750896313 0.0 - - - - - - - 266.7142857142857 304 7 FBXL8 F-box and leucine-rich repeat protein 8 203 26 C20140401_SF093_03 C20140401_SF093_03 TB144281.[MT7]-VLQPAVPVAALR.2y6_1.heavy 689.439 / 626.398 23224.0 36.04280090332031 43 18 10 5 10 2.2409691587416876 33.47637587557276 0.04119873046875 3 0.9890492915910069 11.782681677545316 23224.0 92.20014981273408 0.0 - - - - - - - 266.6363636363636 46 11 FBXL8 F-box and leucine-rich repeat protein 8 205 26 C20140401_SF093_03 C20140401_SF093_03 TB144281.[MT7]-VLQPAVPVAALR.2y10_1.heavy 689.439 / 1021.62 41377.0 36.04280090332031 43 18 10 5 10 2.2409691587416876 33.47637587557276 0.04119873046875 3 0.9890492915910069 11.782681677545316 41377.0 247.03773670411985 0.0 - - - - - - - 255.66666666666666 82 12 FBXL8 F-box and leucine-rich repeat protein 8 207 26 C20140401_SF093_03 C20140401_SF093_03 TB144281.[MT7]-VLQPAVPVAALR.2y11_1.heavy 689.439 / 1134.7 33635.0 36.04280090332031 43 18 10 5 10 2.2409691587416876 33.47637587557276 0.04119873046875 3 0.9890492915910069 11.782681677545316 33635.0 165.81700498065572 0.0 - - - - - - - 242.36363636363637 67 11 FBXL8 F-box and leucine-rich repeat protein 8 209 27 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 561825.0 29.548099517822266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 561825.0 3759.4713960820536 0.0 - - - - - - - 302.57142857142856 1123 7 211 27 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 203543.0 29.548099517822266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 203543.0 825.7112475693764 0.0 - - - - - - - 722.75 407 8 213 27 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 219670.0 29.548099517822266 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 219670.0 986.42562716321 0.0 - - - - - - - 781.8 439 10 215 28 C20140401_SF093_03 C20140401_SF093_03 TB483134.[MT7]-EIQGFFNIPVDNLR.2b3_1.heavy 903.487 / 515.295 17330.0 44.93712615966797 43 17 10 6 10 8.372353362918066 11.944073030040672 0.0345001220703125 3 0.9738500650109323 7.615108492935655 17330.0 42.28851674641148 0.0 - - - - - - - 259.29411764705884 34 17 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 217 28 C20140401_SF093_03 C20140401_SF093_03 TB483134.[MT7]-EIQGFFNIPVDNLR.2y9_1.heavy 903.487 / 1087.59 18243.0 44.93712615966797 43 17 10 6 10 8.372353362918066 11.944073030040672 0.0345001220703125 3 0.9738500650109323 7.615108492935655 18243.0 52.00855263157894 0.0 - - - - - - - 335.29411764705884 36 17 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 219 28 C20140401_SF093_03 C20140401_SF093_03 TB483134.[MT7]-EIQGFFNIPVDNLR.2b4_1.heavy 903.487 / 572.316 8589.0 44.93712615966797 43 17 10 6 10 8.372353362918066 11.944073030040672 0.0345001220703125 3 0.9738500650109323 7.615108492935655 8589.0 7.034210526315789 1.0 - - - - - - - 662.2857142857143 17 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 221 28 C20140401_SF093_03 C20140401_SF093_03 TB483134.[MT7]-EIQGFFNIPVDNLR.2y6_1.heavy 903.487 / 713.394 27972.0 44.93712615966797 43 17 10 6 10 8.372353362918066 11.944073030040672 0.0345001220703125 3 0.9738500650109323 7.615108492935655 27972.0 45.30552631578947 0.0 - - - - - - - 234.9090909090909 55 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 223 29 C20140401_SF093_03 C20140401_SF093_03 TB483044.[MT7]-DVEDESTGLEK[MT7].2y4_1.heavy 755.38 / 590.363 1144.0 22.964600086212158 43 17 10 6 10 10.914934520005119 9.16175903911452 0.03880119323730469 3 0.9784552296421782 8.392833462540333 1144.0 8.97840465116279 0.0 - - - - - - - 156.57894736842104 2 19 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 225 29 C20140401_SF093_03 C20140401_SF093_03 TB483044.[MT7]-DVEDESTGLEK[MT7].2y8_1.heavy 755.38 / 1022.51 2460.0 22.964600086212158 43 17 10 6 10 10.914934520005119 9.16175903911452 0.03880119323730469 3 0.9784552296421782 8.392833462540333 2460.0 45.29691575878471 0.0 - - - - - - - 153.92307692307693 4 13 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 227 29 C20140401_SF093_03 C20140401_SF093_03 TB483044.[MT7]-DVEDESTGLEK[MT7].2b4_1.heavy 755.38 / 603.274 4577.0 22.964600086212158 43 17 10 6 10 10.914934520005119 9.16175903911452 0.03880119323730469 3 0.9784552296421782 8.392833462540333 4577.0 8.59517075416786 0.0 - - - - - - - 215.23529411764707 9 17 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 229 29 C20140401_SF093_03 C20140401_SF093_03 TB483044.[MT7]-DVEDESTGLEK[MT7].2y7_1.heavy 755.38 / 907.485 2060.0 22.964600086212158 43 17 10 6 10 10.914934520005119 9.16175903911452 0.03880119323730469 3 0.9784552296421782 8.392833462540333 2060.0 13.138027910953674 0.0 - - - - - - - 156.47368421052633 4 19 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 231 30 C20140401_SF093_03 C20140401_SF093_03 TB483041.[MT7]-GSDVASAQLPNFR.3b5_1.heavy 502.599 / 574.295 4116.0 31.348499298095703 45 15 10 10 10 2.4414079732993623 33.084393603559306 0.0 3 0.9513954703257054 5.5750536704089555 4116.0 10.448886236264794 0.0 - - - - - - - 309.0 8 12 C9orf114 chromosome 9 open reading frame 114 233 30 C20140401_SF093_03 C20140401_SF093_03 TB483041.[MT7]-GSDVASAQLPNFR.3y4_1.heavy 502.599 / 533.283 23973.0 31.348499298095703 45 15 10 10 10 2.4414079732993623 33.084393603559306 0.0 3 0.9513954703257054 5.5750536704089555 23973.0 41.44540204283657 0.0 - - - - - - - 1146.5714285714287 47 7 C9orf114 chromosome 9 open reading frame 114 235 30 C20140401_SF093_03 C20140401_SF093_03 TB483041.[MT7]-GSDVASAQLPNFR.3b8_1.heavy 502.599 / 860.423 1440.0 31.348499298095703 45 15 10 10 10 2.4414079732993623 33.084393603559306 0.0 3 0.9513954703257054 5.5750536704089555 1440.0 12.116504854368932 2.0 - - - - - - - 212.86666666666667 2 15 C9orf114 chromosome 9 open reading frame 114 237 30 C20140401_SF093_03 C20140401_SF093_03 TB483041.[MT7]-GSDVASAQLPNFR.3y5_1.heavy 502.599 / 646.367 4733.0 31.348499298095703 45 15 10 10 10 2.4414079732993623 33.084393603559306 0.0 3 0.9513954703257054 5.5750536704089555 4733.0 23.435242718446602 0.0 - - - - - - - 224.72727272727272 9 11 C9orf114 chromosome 9 open reading frame 114 239 31 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 302171.0 15.041299819946289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 302171.0 1391.1769959045037 0.0 - - - - - - - 252.0909090909091 604 11 241 31 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 374550.0 15.041299819946289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 374550.0 530.458560543973 0.0 - - - - - - - 241.22222222222223 749 9 243 31 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 249562.0 15.041299819946289 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 249562.0 399.0960443950234 0.0 - - - - - - - 284.3076923076923 499 13 245 32 C20140401_SF093_03 C20140401_SF093_03 TB482675.[MT7]-VLYNLFTK[MT7].3y3_1.heavy 429.263 / 539.331 48185.0 41.39889907836914 40 10 10 10 10 0.8520775525342988 78.24013960746032 0.0 3 0.840508918224819 3.048213520759237 48185.0 619.1744553411368 0.0 - - - - - - - 162.0 96 7 PARVB;PARVA parvin, beta;parvin, alpha 247 32 C20140401_SF093_03 C20140401_SF093_03 TB482675.[MT7]-VLYNLFTK[MT7].3b4_1.heavy 429.263 / 634.368 26711.0 41.39889907836914 40 10 10 10 10 0.8520775525342988 78.24013960746032 0.0 3 0.840508918224819 3.048213520759237 26711.0 328.42670944108096 0.0 - - - - - - - 174.25 53 4 PARVB;PARVA parvin, beta;parvin, alpha 249 32 C20140401_SF093_03 C20140401_SF093_03 TB482675.[MT7]-VLYNLFTK[MT7].3b5_1.heavy 429.263 / 747.452 7769.0 41.39889907836914 40 10 10 10 10 0.8520775525342988 78.24013960746032 0.0 3 0.840508918224819 3.048213520759237 7769.0 41.09528389117657 1.0 - - - - - - - 174.8 16 5 PARVB;PARVA parvin, beta;parvin, alpha 251 32 C20140401_SF093_03 C20140401_SF093_03 TB482675.[MT7]-VLYNLFTK[MT7].3b3_1.heavy 429.263 / 520.325 30640.0 41.39889907836914 40 10 10 10 10 0.8520775525342988 78.24013960746032 0.0 3 0.840508918224819 3.048213520759237 30640.0 198.53706686497955 0.0 - - - - - - - 211.0 61 12 PARVB;PARVA parvin, beta;parvin, alpha 253 33 C20140401_SF093_03 C20140401_SF093_03 TB144082.[MT7]-YVPQLLK[MT7].2y4_1.heavy 574.868 / 645.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 255 33 C20140401_SF093_03 C20140401_SF093_03 TB144082.[MT7]-YVPQLLK[MT7].2y5_1.heavy 574.868 / 742.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 257 33 C20140401_SF093_03 C20140401_SF093_03 TB144082.[MT7]-YVPQLLK[MT7].2y3_1.heavy 574.868 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 259 33 C20140401_SF093_03 C20140401_SF093_03 TB144082.[MT7]-YVPQLLK[MT7].2y6_1.heavy 574.868 / 841.563 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 261 34 C20140401_SF093_03 C20140401_SF093_03 TB144080.[MT7]-GQVEVAEK[MT7].2y6_1.heavy 574.332 / 818.474 804.0 18.848800659179688 50 20 10 10 10 7.330296891390898 13.642012251569986 0.0 3 0.9923033284230298 14.05827214874807 804.0 23.86610526315789 0.0 - - - - - - - 0.0 1 0 AS3MT arsenic (+3 oxidation state) methyltransferase 263 34 C20140401_SF093_03 C20140401_SF093_03 TB144080.[MT7]-GQVEVAEK[MT7].2y4_1.heavy 574.332 / 590.363 1034.0 18.848800659179688 50 20 10 10 10 7.330296891390898 13.642012251569986 0.0 3 0.9923033284230298 14.05827214874807 1034.0 20.534455324357406 0.0 - - - - - - - 165.66666666666666 2 9 AS3MT arsenic (+3 oxidation state) methyltransferase 265 34 C20140401_SF093_03 C20140401_SF093_03 TB144080.[MT7]-GQVEVAEK[MT7].2y5_1.heavy 574.332 / 719.406 1034.0 18.848800659179688 50 20 10 10 10 7.330296891390898 13.642012251569986 0.0 3 0.9923033284230298 14.05827214874807 1034.0 34.46666666666667 0.0 - - - - - - - 143.25 2 4 AS3MT arsenic (+3 oxidation state) methyltransferase 267 34 C20140401_SF093_03 C20140401_SF093_03 TB144080.[MT7]-GQVEVAEK[MT7].2b4_1.heavy 574.332 / 558.3 2356.0 18.848800659179688 50 20 10 10 10 7.330296891390898 13.642012251569986 0.0 3 0.9923033284230298 14.05827214874807 2356.0 18.5789353292406 0.0 - - - - - - - 134.0 4 9 AS3MT arsenic (+3 oxidation state) methyltransferase 269 35 C20140401_SF093_03 C20140401_SF093_03 TB483245.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].4y4_1.heavy 723.155 / 518.342 11197.0 51.15869903564453 46 16 10 10 10 2.3332662870271084 35.0306937083761 0.0 3 0.964863790425566 6.564550927777453 11197.0 16.6701784726993 0.0 - - - - - - - 703.1666666666666 22 12 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 271 35 C20140401_SF093_03 C20140401_SF093_03 TB483245.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].4b7_1.heavy 723.155 / 867.506 7140.0 51.15869903564453 46 16 10 10 10 2.3332662870271084 35.0306937083761 0.0 3 0.964863790425566 6.564550927777453 7140.0 41.74153846153846 0.0 - - - - - - - 223.53333333333333 14 15 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 273 35 C20140401_SF093_03 C20140401_SF093_03 TB483245.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].4y7_1.heavy 723.155 / 830.522 2001.0 51.15869903564453 46 16 10 10 10 2.3332662870271084 35.0306937083761 0.0 3 0.964863790425566 6.564550927777453 2001.0 17.39862849002849 0.0 - - - - - - - 202.8125 4 16 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 275 35 C20140401_SF093_03 C20140401_SF093_03 TB483245.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].4b6_1.heavy 723.155 / 754.422 15633.0 51.15869903564453 46 16 10 10 10 2.3332662870271084 35.0306937083761 0.0 3 0.964863790425566 6.564550927777453 15633.0 62.062093515722154 0.0 - - - - - - - 241.6 31 15 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 277 36 C20140401_SF093_03 C20140401_SF093_03 TB483047.[MT7]-ILGVGPDDPDLVR.2y5_1.heavy 755.423 / 599.351 150654.0 36.390098571777344 46 16 10 10 10 2.946126804668483 33.94287029381705 0.0 3 0.9642737501706298 6.509792192309766 150654.0 135.48275409836066 0.0 - - - - - - - 267.0 301 2 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 279 36 C20140401_SF093_03 C20140401_SF093_03 TB483047.[MT7]-ILGVGPDDPDLVR.2y9_1.heavy 755.423 / 983.479 79264.0 36.390098571777344 46 16 10 10 10 2.946126804668483 33.94287029381705 0.0 3 0.9642737501706298 6.509792192309766 79264.0 66.12581123794239 0.0 - - - - - - - 199.75 158 4 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 281 36 C20140401_SF093_03 C20140401_SF093_03 TB483047.[MT7]-ILGVGPDDPDLVR.2y6_1.heavy 755.423 / 714.378 17080.0 36.390098571777344 46 16 10 10 10 2.946126804668483 33.94287029381705 0.0 3 0.9642737501706298 6.509792192309766 17080.0 31.421130747265334 0.0 - - - - - - - 650.625 34 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 283 36 C20140401_SF093_03 C20140401_SF093_03 TB483047.[MT7]-ILGVGPDDPDLVR.2y11_1.heavy 755.423 / 1139.57 24286.0 36.390098571777344 46 16 10 10 10 2.946126804668483 33.94287029381705 0.0 3 0.9642737501706298 6.509792192309766 24286.0 88.0026404494382 0.0 - - - - - - - 253.3 48 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 285 37 C20140401_SF093_03 C20140401_SF093_03 TB143907.[MT7]-FVSATFR.2y4_1.heavy 486.275 / 494.272 8147.0 30.670900344848633 42 17 10 5 10 5.7369078056016685 17.43099303467233 0.041400909423828125 3 0.9756715342632352 7.896244346394018 8147.0 24.562271650174164 0.0 - - - - - - - 669.2857142857143 16 7 AS3MT arsenic (+3 oxidation state) methyltransferase 287 37 C20140401_SF093_03 C20140401_SF093_03 TB143907.[MT7]-FVSATFR.2y5_1.heavy 486.275 / 581.304 51634.0 30.670900344848633 42 17 10 5 10 5.7369078056016685 17.43099303467233 0.041400909423828125 3 0.9756715342632352 7.896244346394018 51634.0 182.467671555214 0.0 - - - - - - - 305.8 103 5 AS3MT arsenic (+3 oxidation state) methyltransferase 289 37 C20140401_SF093_03 C20140401_SF093_03 TB143907.[MT7]-FVSATFR.2b4_1.heavy 486.275 / 549.315 8758.0 30.670900344848633 42 17 10 5 10 5.7369078056016685 17.43099303467233 0.041400909423828125 3 0.9756715342632352 7.896244346394018 8758.0 37.542212277958214 0.0 - - - - - - - 756.7142857142857 17 7 AS3MT arsenic (+3 oxidation state) methyltransferase 291 37 C20140401_SF093_03 C20140401_SF093_03 TB143907.[MT7]-FVSATFR.2y6_1.heavy 486.275 / 680.373 51736.0 30.670900344848633 42 17 10 5 10 5.7369078056016685 17.43099303467233 0.041400909423828125 3 0.9756715342632352 7.896244346394018 51736.0 140.98491824460328 0.0 - - - - - - - 260.44444444444446 103 9 AS3MT arsenic (+3 oxidation state) methyltransferase 293 38 C20140401_SF093_03 C20140401_SF093_03 TB143799.[MT7]-SPASAK[MT7].2y4_1.heavy 424.758 / 520.321 2525.0 13.480124711990356 41 15 10 6 10 3.241411515837272 30.850757304775456 0.039099693298339844 3 0.9525958502500547 5.645773719728904 2525.0 8.179577464788734 0.0 - - - - - - - 212.65 5 20 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 295 38 C20140401_SF093_03 C20140401_SF093_03 TB143799.[MT7]-SPASAK[MT7].2y5_1.heavy 424.758 / 617.374 18188.0 13.480124711990356 41 15 10 6 10 3.241411515837272 30.850757304775456 0.039099693298339844 3 0.9525958502500547 5.645773719728904 18188.0 99.82482428355958 0.0 - - - - - - - 219.0 36 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 297 38 C20140401_SF093_03 C20140401_SF093_03 TB143799.[MT7]-SPASAK[MT7].2y3_1.heavy 424.758 / 449.284 3036.0 13.480124711990356 41 15 10 6 10 3.241411515837272 30.850757304775456 0.039099693298339844 3 0.9525958502500547 5.645773719728904 3036.0 22.514701099952177 0.0 - - - - - - - 216.1904761904762 6 21 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 299 38 C20140401_SF093_03 C20140401_SF093_03 TB143799.[MT7]-SPASAK[MT7].2b5_1.heavy 424.758 / 558.3 511.0 13.480124711990356 41 15 10 6 10 3.241411515837272 30.850757304775456 0.039099693298339844 3 0.9525958502500547 5.645773719728904 511.0 1.2308943089430895 20.0 - - - - - - - 660.8571428571429 6 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 301 39 C20140401_SF093_03 C20140401_SF093_03 TB483149.[MT7]-IFVMATHGLLSSDAPR.3y7_1.heavy 620.337 / 745.384 1493.0 39.46100044250488 39 13 10 6 10 1.96694937351265 50.84014939409261 0.037197113037109375 3 0.9059470533194242 3.9921974559794853 1493.0 12.333478260869565 0.0 - - - - - - - 262.57142857142856 2 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 303 39 C20140401_SF093_03 C20140401_SF093_03 TB483149.[MT7]-IFVMATHGLLSSDAPR.3b4_1.heavy 620.337 / 635.371 1263.0 39.46100044250488 39 13 10 6 10 1.96694937351265 50.84014939409261 0.037197113037109375 3 0.9059470533194242 3.9921974559794853 1263.0 9.335217391304347 1.0 - - - - - - - 188.92857142857142 2 14 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 305 39 C20140401_SF093_03 C20140401_SF093_03 TB483149.[MT7]-IFVMATHGLLSSDAPR.3b3_1.heavy 620.337 / 504.33 1723.0 39.46100044250488 39 13 10 6 10 1.96694937351265 50.84014939409261 0.037197113037109375 3 0.9059470533194242 3.9921974559794853 1723.0 9.963434782608694 0.0 - - - - - - - 208.4375 3 16 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 307 39 C20140401_SF093_03 C20140401_SF093_03 TB483149.[MT7]-IFVMATHGLLSSDAPR.3y9_1.heavy 620.337 / 915.489 5283.0 39.46100044250488 39 13 10 6 10 1.96694937351265 50.84014939409261 0.037197113037109375 3 0.9059470533194242 3.9921974559794853 5283.0 50.083660699062236 0.0 - - - - - - - 252.8 10 10 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 309 40 C20140401_SF093_03 C20140401_SF093_03 TB144084.[MT7]-GSIDEVDK[MT7].2y4_1.heavy 575.813 / 634.353 1429.0 20.692550659179688 42 16 10 6 10 2.2716019791351485 34.14620977507797 0.03459930419921875 3 0.9689068952703829 6.980693304179693 1429.0 32.72289915966387 0.0 - - - - - - - 161.0 2 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 311 40 C20140401_SF093_03 C20140401_SF093_03 TB144084.[MT7]-GSIDEVDK[MT7].2b5_1.heavy 575.813 / 646.316 714.0 20.692550659179688 42 16 10 6 10 2.2716019791351485 34.14620977507797 0.03459930419921875 3 0.9689068952703829 6.980693304179693 714.0 11.115530726256985 0.0 - - - - - - - 0.0 1 0 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 313 40 C20140401_SF093_03 C20140401_SF093_03 TB144084.[MT7]-GSIDEVDK[MT7].2y5_1.heavy 575.813 / 749.38 655.0 20.692550659179688 42 16 10 6 10 2.2716019791351485 34.14620977507797 0.03459930419921875 3 0.9689068952703829 6.980693304179693 655.0 10.698333333333332 1.0 - - - - - - - 0.0 1 0 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 315 40 C20140401_SF093_03 C20140401_SF093_03 TB144084.[MT7]-GSIDEVDK[MT7].2b4_1.heavy 575.813 / 517.274 2619.0 20.692550659179688 42 16 10 6 10 2.2716019791351485 34.14620977507797 0.03459930419921875 3 0.9689068952703829 6.980693304179693 2619.0 75.078 0.0 - - - - - - - 162.54545454545453 5 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 317 41 C20140401_SF093_03 C20140401_SF093_03 TB143795.[MT7]-TINVVR.2y4_1.heavy 423.27 / 487.299 26908.0 23.06160068511963 39 13 10 6 10 1.2796073801247934 53.657967241634395 0.038799285888671875 3 0.9276694041251197 4.5608752681947635 26908.0 50.17679079643774 0.0 - - - - - - - 768.0 53 14 MECR mitochondrial trans-2-enoyl-CoA reductase 319 41 C20140401_SF093_03 C20140401_SF093_03 TB143795.[MT7]-TINVVR.2b3_1.heavy 423.27 / 473.284 36201.0 23.06160068511963 39 13 10 6 10 1.2796073801247934 53.657967241634395 0.038799285888671875 3 0.9276694041251197 4.5608752681947635 36201.0 81.049534372502 0.0 - - - - - - - 378.0 72 5 MECR mitochondrial trans-2-enoyl-CoA reductase 321 41 C20140401_SF093_03 C20140401_SF093_03 TB143795.[MT7]-TINVVR.2y5_1.heavy 423.27 / 600.383 64243.0 23.06160068511963 39 13 10 6 10 1.2796073801247934 53.657967241634395 0.038799285888671875 3 0.9276694041251197 4.5608752681947635 64243.0 205.1433305234425 0.0 - - - - - - - 709.0 128 8 MECR mitochondrial trans-2-enoyl-CoA reductase 323 41 C20140401_SF093_03 C20140401_SF093_03 TB143795.[MT7]-TINVVR.2b4_1.heavy 423.27 / 572.352 52573.0 23.06160068511963 39 13 10 6 10 1.2796073801247934 53.657967241634395 0.038799285888671875 3 0.9276694041251197 4.5608752681947635 52573.0 91.26800228833152 0.0 - - - - - - - 751.0 105 10 MECR mitochondrial trans-2-enoyl-CoA reductase 325 42 C20140401_SF093_03 C20140401_SF093_03 TB483049.[MT7]-ALLSGYFMQIAR.2y8_1.heavy 757.419 / 985.492 5624.0 45.0838508605957 23 13 0 6 4 2.4538118974855907 40.75292001904038 0.0345001220703125 7 0.9248872361840442 4.474544669130231 5624.0 19.733333333333334 0.0 - - - - - - - 281.6470588235294 11 17 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 327 42 C20140401_SF093_03 C20140401_SF093_03 TB483049.[MT7]-ALLSGYFMQIAR.2y10_1.heavy 757.419 / 1185.61 1900.0 45.0838508605957 23 13 0 6 4 2.4538118974855907 40.75292001904038 0.0345001220703125 7 0.9248872361840442 4.474544669130231 1900.0 6.232142857142858 5.0 - - - - - - - 261.77777777777777 131 18 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 329 42 C20140401_SF093_03 C20140401_SF093_03 TB483049.[MT7]-ALLSGYFMQIAR.2b5_1.heavy 757.419 / 586.368 2052.0 45.0838508605957 23 13 0 6 4 2.4538118974855907 40.75292001904038 0.0345001220703125 7 0.9248872361840442 4.474544669130231 2052.0 6.264 7.0 - - - - - - - 714.4 142 10 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 331 42 C20140401_SF093_03 C20140401_SF093_03 TB483049.[MT7]-ALLSGYFMQIAR.2y9_1.heavy 757.419 / 1072.52 11248.0 45.0838508605957 23 13 0 6 4 2.4538118974855907 40.75292001904038 0.0345001220703125 7 0.9248872361840442 4.474544669130231 11248.0 26.64 0.0 - - - - - - - 616.4444444444445 22 9 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 333 43 C20140401_SF093_03 C20140401_SF093_03 TB483052.[MT7]-LC[CAM]DAVAVLLNMR.3b6_1.heavy 506.947 / 774.394 1256.0 50.63274955749512 34 8 10 6 10 5.705992060337933 17.52543623309521 0.03459930419921875 3 0.7896743864614207 2.642363462477722 1256.0 29.516 0.0 - - - - - - - 139.66666666666666 2 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 335 43 C20140401_SF093_03 C20140401_SF093_03 TB483052.[MT7]-LC[CAM]DAVAVLLNMR.3y5_1.heavy 506.947 / 646.37 1615.0 50.63274955749512 34 8 10 6 10 5.705992060337933 17.52543623309521 0.03459930419921875 3 0.7896743864614207 2.642363462477722 1615.0 18.841666666666665 0.0 - - - - - - - 90.0 3 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 337 43 C20140401_SF093_03 C20140401_SF093_03 TB483052.[MT7]-LC[CAM]DAVAVLLNMR.3b4_1.heavy 506.947 / 604.288 778.0 50.63274955749512 34 8 10 6 10 5.705992060337933 17.52543623309521 0.03459930419921875 3 0.7896743864614207 2.642363462477722 778.0 -3.8900000000000006 0.0 - - - - - - - 0.0 1 0 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 339 43 C20140401_SF093_03 C20140401_SF093_03 TB483052.[MT7]-LC[CAM]DAVAVLLNMR.3b5_1.heavy 506.947 / 703.357 1555.0 50.63274955749512 34 8 10 6 10 5.705992060337933 17.52543623309521 0.03459930419921875 3 0.7896743864614207 2.642363462477722 1555.0 22.288333333333334 0.0 - - - - - - - 229.5 3 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 341 44 C20140401_SF093_03 C20140401_SF093_03 TB482888.[MT7]-MLLEVALK[MT7].2y4_1.heavy 602.883 / 574.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 343 44 C20140401_SF093_03 C20140401_SF093_03 TB482888.[MT7]-MLLEVALK[MT7].2y5_1.heavy 602.883 / 703.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 345 44 C20140401_SF093_03 C20140401_SF093_03 TB482888.[MT7]-MLLEVALK[MT7].2b4_1.heavy 602.883 / 631.36 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 347 44 C20140401_SF093_03 C20140401_SF093_03 TB482888.[MT7]-MLLEVALK[MT7].2b6_1.heavy 602.883 / 801.466 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 349 45 C20140401_SF093_03 C20140401_SF093_03 TB483252.[MT7]-ITLIPLNEVFQVSQEGAGNNLILQSINK[MT7].4b8_1.heavy 835.973 / 1038.63 7101.0 51.93560028076172 50 20 10 10 10 71.21451506195879 1.4042081156207686 0.0 3 0.9993086969209619 46.93567866182261 7101.0 55.42801158301158 0.0 - - - - - - - 214.55555555555554 14 18 ART3 ADP-ribosyltransferase 3 351 45 C20140401_SF093_03 C20140401_SF093_03 TB483252.[MT7]-ITLIPLNEVFQVSQEGAGNNLILQSINK[MT7].4y4_1.heavy 835.973 / 605.374 11583.0 51.93560028076172 50 20 10 10 10 71.21451506195879 1.4042081156207686 0.0 3 0.9993086969209619 46.93567866182261 11583.0 29.168379066166406 1.0 - - - - - - - 329.64285714285717 23 14 ART3 ADP-ribosyltransferase 3 353 45 C20140401_SF093_03 C20140401_SF093_03 TB483252.[MT7]-ITLIPLNEVFQVSQEGAGNNLILQSINK[MT7].4b4_1.heavy 835.973 / 585.409 33196.0 51.93560028076172 50 20 10 10 10 71.21451506195879 1.4042081156207686 0.0 3 0.9993086969209619 46.93567866182261 33196.0 122.98772904091214 0.0 - - - - - - - 749.6666666666666 66 9 ART3 ADP-ribosyltransferase 3 355 45 C20140401_SF093_03 C20140401_SF093_03 TB483252.[MT7]-ITLIPLNEVFQVSQEGAGNNLILQSINK[MT7].4y6_1.heavy 835.973 / 846.516 11006.0 51.93560028076172 50 20 10 10 10 71.21451506195879 1.4042081156207686 0.0 3 0.9993086969209619 46.93567866182261 11006.0 85.8271184718553 0.0 - - - - - - - 269.26666666666665 22 15 ART3 ADP-ribosyltransferase 3 357 46 C20140401_SF093_03 C20140401_SF093_03 TB483253.[MT7]-K[MT7]LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK[MT7].4y4_1.heavy 901.245 / 574.404 3123.0 50.26959991455078 42 12 10 10 10 1.3937831165624235 65.27064703307266 0.0 3 0.8958542523899587 3.790515996102327 3123.0 26.298947368421054 0.0 - - - - - - - 169.61111111111111 6 18 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 359 46 C20140401_SF093_03 C20140401_SF093_03 TB483253.[MT7]-K[MT7]LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK[MT7].4b4_1.heavy 901.245 / 853.529 930.0 50.26959991455078 42 12 10 10 10 1.3937831165624235 65.27064703307266 0.0 3 0.8958542523899587 3.790515996102327 930.0 8.88045112781955 0.0 - - - - - - - 0.0 1 0 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 361 46 C20140401_SF093_03 C20140401_SF093_03 TB483253.[MT7]-K[MT7]LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK[MT7].4b5_1.heavy 901.245 / 981.587 797.0 50.26959991455078 42 12 10 10 10 1.3937831165624235 65.27064703307266 0.0 3 0.8958542523899587 3.790515996102327 797.0 0.7989974937343359 2.0 - - - - - - - 0.0 1 0 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 363 46 C20140401_SF093_03 C20140401_SF093_03 TB483253.[MT7]-K[MT7]LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK[MT7].4b9_2.heavy 901.245 / 718.934 4253.0 50.26959991455078 42 12 10 10 10 1.3937831165624235 65.27064703307266 0.0 3 0.8958542523899587 3.790515996102327 4253.0 72.07521986785144 0.0 - - - - - - - 169.0 8 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 365 47 C20140401_SF093_03 C20140401_SF093_03 TB482884.[MT7]-AVLLLQEK[MT7].2y4_1.heavy 601.392 / 661.4 2894.0 34.29909896850586 33 13 0 10 10 1.2045470176150561 47.925496721386 0.0 3 0.9261580206060391 4.513374193907628 2894.0 28.20414828489381 0.0 - - - - - - - 167.83333333333334 5 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 367 47 C20140401_SF093_03 C20140401_SF093_03 TB482884.[MT7]-AVLLLQEK[MT7].2y5_1.heavy 601.392 / 774.484 1761.0 34.29909896850586 33 13 0 10 10 1.2045470176150561 47.925496721386 0.0 3 0.9261580206060391 4.513374193907628 1761.0 12.857873041108336 4.0 - - - - - - - 126.0 5 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 369 47 C20140401_SF093_03 C20140401_SF093_03 TB482884.[MT7]-AVLLLQEK[MT7].2b4_1.heavy 601.392 / 541.383 3271.0 34.29909896850586 33 13 0 10 10 1.2045470176150561 47.925496721386 0.0 3 0.9261580206060391 4.513374193907628 3271.0 37.38285714285714 0.0 - - - - - - - 157.41666666666666 6 12 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 371 47 C20140401_SF093_03 C20140401_SF093_03 TB482884.[MT7]-AVLLLQEK[MT7].2y6_1.heavy 601.392 / 887.568 N/A 34.29909896850586 33 13 0 10 10 1.2045470176150561 47.925496721386 0.0 3 0.9261580206060391 4.513374193907628 3397.0 6.746753473593258 3.0 - - - - - - - 251.71428571428572 103 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 373 48 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 119456.0 17.886600494384766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 119456.0 1033.8132061220433 0.0 - - - - - - - 149.0 238 13 375 48 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 70372.0 17.886600494384766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 70372.0 699.6635738421785 0.0 - - - - - - - 208.55555555555554 140 9 377 48 C20140401_SF093_03 C20140401_SF093_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 80693.0 17.886600494384766 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 80693.0 1823.8685058744222 0.0 - - - - - - - 224.91666666666666 161 12 379 49 C20140401_SF093_03 C20140401_SF093_03 TB144093.[MT7]-TLHELLER.3y3_1.heavy 385.56 / 417.246 N/A 29.947900772094727 38 18 2 10 8 4.253282370768977 23.511253493832903 0.0 4 0.9846675417356153 9.954054347080126 36097.0 36.09073773013773 1.0 - - - - - - - 372.875 72 8 SASH3 SAM and SH3 domain containing 3 381 49 C20140401_SF093_03 C20140401_SF093_03 TB144093.[MT7]-TLHELLER.3b3_1.heavy 385.56 / 496.3 16646.0 29.947900772094727 38 18 2 10 8 4.253282370768977 23.511253493832903 0.0 4 0.9846675417356153 9.954054347080126 16646.0 100.503478624289 0.0 - - - - - - - 303.5 33 14 SASH3 SAM and SH3 domain containing 3 383 49 C20140401_SF093_03 C20140401_SF093_03 TB144093.[MT7]-TLHELLER.3y4_1.heavy 385.56 / 530.33 36640.0 29.947900772094727 38 18 2 10 8 4.253282370768977 23.511253493832903 0.0 4 0.9846675417356153 9.954054347080126 36640.0 189.6891009251325 1.0 - - - - - - - 243.53846153846155 175 13 SASH3 SAM and SH3 domain containing 3 385 49 C20140401_SF093_03 C20140401_SF093_03 TB144093.[MT7]-TLHELLER.3y5_1.heavy 385.56 / 659.372 19451.0 29.947900772094727 38 18 2 10 8 4.253282370768977 23.511253493832903 0.0 4 0.9846675417356153 9.954054347080126 19451.0 83.82198895027625 0.0 - - - - - - - 248.625 38 8 SASH3 SAM and SH3 domain containing 3 387 50 C20140401_SF093_03 C20140401_SF093_03 TB348591.[MT7]-LFTWNILK[MT7].2y3_1.heavy 661.907 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC35F2 solute carrier family 35, member F2 389 50 C20140401_SF093_03 C20140401_SF093_03 TB348591.[MT7]-LFTWNILK[MT7].2y6_1.heavy 661.907 / 918.553 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC35F2 solute carrier family 35, member F2 391 50 C20140401_SF093_03 C20140401_SF093_03 TB348591.[MT7]-LFTWNILK[MT7].2b5_1.heavy 661.907 / 806.432 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC35F2 solute carrier family 35, member F2 393 50 C20140401_SF093_03 C20140401_SF093_03 TB348591.[MT7]-LFTWNILK[MT7].2y7_1.heavy 661.907 / 1065.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - SLC35F2 solute carrier family 35, member F2 395 51 C20140401_SF093_03 C20140401_SF093_03 TB483254.[MT7]-TEAVFSEEALIQVPSDIPLQSAATLGVNPC[CAM]TAYR.4b7_1.heavy 948.737 / 908.448 2490.0 46.905799865722656 48 18 10 10 10 4.927652552355298 20.293638591097995 0.0 3 0.98648142157954 10.602453749469257 2490.0 35.7161157604376 0.0 - - - - - - - 225.23076923076923 4 13 MECR mitochondrial trans-2-enoyl-CoA reductase 397 51 C20140401_SF093_03 C20140401_SF093_03 TB483254.[MT7]-TEAVFSEEALIQVPSDIPLQSAATLGVNPC[CAM]TAYR.4b4_1.heavy 948.737 / 545.305 5273.0 46.905799865722656 48 18 10 10 10 4.927652552355298 20.293638591097995 0.0 3 0.98648142157954 10.602453749469257 5273.0 32.50479452054795 1.0 - - - - - - - 166.27272727272728 10 11 MECR mitochondrial trans-2-enoyl-CoA reductase 399 51 C20140401_SF093_03 C20140401_SF093_03 TB483254.[MT7]-TEAVFSEEALIQVPSDIPLQSAATLGVNPC[CAM]TAYR.4b5_1.heavy 948.737 / 692.374 3003.0 46.905799865722656 48 18 10 10 10 4.927652552355298 20.293638591097995 0.0 3 0.98648142157954 10.602453749469257 3003.0 42.86951330122961 0.0 - - - - - - - 178.88888888888889 6 9 MECR mitochondrial trans-2-enoyl-CoA reductase 401 51 C20140401_SF093_03 C20140401_SF093_03 TB483254.[MT7]-TEAVFSEEALIQVPSDIPLQSAATLGVNPC[CAM]TAYR.4b9_1.heavy 948.737 / 1108.53 5273.0 46.905799865722656 48 18 10 10 10 4.927652552355298 20.293638591097995 0.0 3 0.98648142157954 10.602453749469257 5273.0 22.29040909090909 1.0 - - - - - - - 204.8 10 10 MECR mitochondrial trans-2-enoyl-CoA reductase 403 52 C20140401_SF093_03 C20140401_SF093_03 TB483057.[MT7]-SIATDVLLGLLK[MT7].2y4_1.heavy 765.989 / 574.404 22985.0 50.80065059661865 41 15 10 6 10 2.6058686933405486 38.374918987881436 0.033397674560546875 3 0.9505257477060961 5.525425802527442 22985.0 80.0077191030415 0.0 - - - - - - - 723.8571428571429 45 7 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 405 52 C20140401_SF093_03 C20140401_SF093_03 TB483057.[MT7]-SIATDVLLGLLK[MT7].2b6_1.heavy 765.989 / 731.406 13555.0 50.80065059661865 41 15 10 6 10 2.6058686933405486 38.374918987881436 0.033397674560546875 3 0.9505257477060961 5.525425802527442 13555.0 130.6884662063193 0.0 - - - - - - - 231.71428571428572 27 14 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 407 52 C20140401_SF093_03 C20140401_SF093_03 TB483057.[MT7]-SIATDVLLGLLK[MT7].2b7_1.heavy 765.989 / 844.49 10903.0 50.80065059661865 41 15 10 6 10 2.6058686933405486 38.374918987881436 0.033397674560546875 3 0.9505257477060961 5.525425802527442 10903.0 35.79293969615342 0.0 - - - - - - - 255.57142857142858 21 21 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 409 52 C20140401_SF093_03 C20140401_SF093_03 TB483057.[MT7]-SIATDVLLGLLK[MT7].2b5_1.heavy 765.989 / 632.337 24341.0 50.80065059661865 41 15 10 6 10 2.6058686933405486 38.374918987881436 0.033397674560546875 3 0.9505257477060961 5.525425802527442 24341.0 93.29734382566588 0.0 - - - - - - - 251.73333333333332 48 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 411 53 C20140401_SF093_03 C20140401_SF093_03 TB483157.[MT7]-AAIELLMVLAGRAPGLR.3b6_1.heavy 632.384 / 755.478 1304.0 52.329599380493164 39 13 10 6 10 1.4685646436425075 49.689498212016815 0.036197662353515625 3 0.9192010787289402 4.3121223059713465 1304.0 34.76464 0.0 - - - - - - - 178.85714285714286 2 7 FBXL8 F-box and leucine-rich repeat protein 8 413 53 C20140401_SF093_03 C20140401_SF093_03 TB483157.[MT7]-AAIELLMVLAGRAPGLR.3b4_1.heavy 632.384 / 529.31 1304.0 52.329599380493164 39 13 10 6 10 1.4685646436425075 49.689498212016815 0.036197662353515625 3 0.9192010787289402 4.3121223059713465 1304.0 14.973293532338309 0.0 - - - - - - - 123.23076923076923 2 13 FBXL8 F-box and leucine-rich repeat protein 8 415 53 C20140401_SF093_03 C20140401_SF093_03 TB483157.[MT7]-AAIELLMVLAGRAPGLR.3b5_1.heavy 632.384 / 642.394 1053.0 52.329599380493164 39 13 10 6 10 1.4685646436425075 49.689498212016815 0.036197662353515625 3 0.9192010787289402 4.3121223059713465 1053.0 1.6780876494023904 0.0 - - - - - - - 107.28571428571429 2 14 FBXL8 F-box and leucine-rich repeat protein 8 417 53 C20140401_SF093_03 C20140401_SF093_03 TB483157.[MT7]-AAIELLMVLAGRAPGLR.3y16_2.heavy 632.384 / 840.503 1755.0 52.329599380493164 39 13 10 6 10 1.4685646436425075 49.689498212016815 0.036197662353515625 3 0.9192010787289402 4.3121223059713465 1755.0 46.4022 0.0 - - - - - - - 100.0 3 7 FBXL8 F-box and leucine-rich repeat protein 8 419 54 C20140401_SF093_03 C20140401_SF093_03 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 101316.0 37.70159912109375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 101316.0 1048.3922803412695 0.0 - - - - - - - 285.1666666666667 202 6 421 54 C20140401_SF093_03 C20140401_SF093_03 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 71617.0 37.70159912109375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 71617.0 124.5662972823034 0.0 - - - - - - - 224.0 143 6 423 54 C20140401_SF093_03 C20140401_SF093_03 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 94838.0 37.70159912109375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 94838.0 430.3890625922892 0.0 - - - - - - - 258.0 189 9 425 55 C20140401_SF093_03 C20140401_SF093_03 TB144259.[MT7]-DLPVSEQQER.2y8_1.heavy 672.847 / 972.474 37903.0 21.91900062561035 50 20 10 10 10 4.472530586110771 22.35870679354216 0.0 3 0.9926279003740036 14.36480071824333 37903.0 390.45659748522957 0.0 - - - - - - - 162.66666666666666 75 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 427 55 C20140401_SF093_03 C20140401_SF093_03 TB144259.[MT7]-DLPVSEQQER.2y9_1.heavy 672.847 / 1085.56 12117.0 21.91900062561035 50 20 10 10 10 4.472530586110771 22.35870679354216 0.0 3 0.9926279003740036 14.36480071824333 12117.0 294.6344210526315 0.0 - - - - - - - 191.25 24 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 429 55 C20140401_SF093_03 C20140401_SF093_03 TB144259.[MT7]-DLPVSEQQER.2y6_1.heavy 672.847 / 776.353 4996.0 21.91900062561035 50 20 10 10 10 4.472530586110771 22.35870679354216 0.0 3 0.9926279003740036 14.36480071824333 4996.0 114.37191350469197 0.0 - - - - - - - 146.66666666666666 9 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 431 55 C20140401_SF093_03 C20140401_SF093_03 TB144259.[MT7]-DLPVSEQQER.2y7_1.heavy 672.847 / 875.422 4250.0 21.91900062561035 50 20 10 10 10 4.472530586110771 22.35870679354216 0.0 3 0.9926279003740036 14.36480071824333 4250.0 45.84668989547039 0.0 - - - - - - - 126.2 8 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 433 56 C20140401_SF093_03 C20140401_SF093_03 TB482906.[MT7]-TILSGY[MT7]HR.3y3_1.heavy 412.243 / 619.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 435 56 C20140401_SF093_03 C20140401_SF093_03 TB482906.[MT7]-TILSGY[MT7]HR.3y6_1.heavy 412.243 / 876.481 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 437 56 C20140401_SF093_03 C20140401_SF093_03 TB482906.[MT7]-TILSGY[MT7]HR.3b4_2.heavy 412.243 / 280.182 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 439 56 C20140401_SF093_03 C20140401_SF093_03 TB482906.[MT7]-TILSGY[MT7]HR.3y5_1.heavy 412.243 / 763.397 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 441 57 C20140401_SF093_03 C20140401_SF093_03 TB482753.[MT7]-TVYEGFISAQGR.3y6_1.heavy 491.26 / 631.352 25410.0 33.35710144042969 50 20 10 10 10 10.812889747179973 9.248221552067545 0.0 3 0.996729803124335 21.57530762697128 25410.0 137.6375 0.0 - - - - - - - 275.5 50 8 FANCL Fanconi anemia, complementation group L 443 57 C20140401_SF093_03 C20140401_SF093_03 TB482753.[MT7]-TVYEGFISAQGR.3b5_1.heavy 491.26 / 694.353 64395.0 33.35710144042969 50 20 10 10 10 10.812889747179973 9.248221552067545 0.0 3 0.996729803124335 21.57530762697128 64395.0 188.18883620689655 0.0 - - - - - - - 270.6666666666667 128 9 FANCL Fanconi anemia, complementation group L 445 57 C20140401_SF093_03 C20140401_SF093_03 TB482753.[MT7]-TVYEGFISAQGR.3b3_1.heavy 491.26 / 508.289 18448.0 33.35710144042969 50 20 10 10 10 10.812889747179973 9.248221552067545 0.0 3 0.996729803124335 21.57530762697128 18448.0 35.915287356321834 0.0 - - - - - - - 247.46666666666667 36 15 FANCL Fanconi anemia, complementation group L 447 57 C20140401_SF093_03 C20140401_SF093_03 TB482753.[MT7]-TVYEGFISAQGR.3y5_1.heavy 491.26 / 518.268 102220.0 33.35710144042969 50 20 10 10 10 10.812889747179973 9.248221552067545 0.0 3 0.996729803124335 21.57530762697128 102220.0 204.18822660098522 0.0 - - - - - - - 324.8 204 5 FANCL Fanconi anemia, complementation group L 449 58 C20140401_SF093_03 C20140401_SF093_03 TB143924.[MT7]-TINMLVR.2y5_1.heavy 495.798 / 632.355 5562.0 32.358649253845215 39 16 10 3 10 2.0382485810793343 34.869811768699975 0.07179641723632812 3 0.9675386054541729 6.831198595140343 5562.0 46.39363286264442 0.0 - - - - - - - 227.42857142857142 11 14 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 451 58 C20140401_SF093_03 C20140401_SF093_03 TB143924.[MT7]-TINMLVR.2b4_1.heavy 495.798 / 604.325 5448.0 32.358649253845215 39 16 10 3 10 2.0382485810793343 34.869811768699975 0.07179641723632812 3 0.9675386054541729 6.831198595140343 5448.0 1.6322896281800392 1.0 - - - - - - - 265.0 10 15 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 453 58 C20140401_SF093_03 C20140401_SF093_03 TB143924.[MT7]-TINMLVR.2y6_1.heavy 495.798 / 745.439 5108.0 32.358649253845215 39 16 10 3 10 2.0382485810793343 34.869811768699975 0.07179641723632812 3 0.9675386054541729 6.831198595140343 5108.0 13.569468500411878 0.0 - - - - - - - 259.7142857142857 10 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 455 58 C20140401_SF093_03 C20140401_SF093_03 TB143924.[MT7]-TINMLVR.2b5_1.heavy 495.798 / 717.409 3178.0 32.358649253845215 39 16 10 3 10 2.0382485810793343 34.869811768699975 0.07179641723632812 3 0.9675386054541729 6.831198595140343 3178.0 10.426549295774647 0.0 - - - - - - - 227.3125 6 16 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 457 59 C20140401_SF093_03 C20140401_SF093_03 TB143821.[MT7]-GAVEGAAR.2y5_1.heavy 437.747 / 503.257 10106.0 14.270400047302246 44 14 10 10 10 7.066422499693997 14.151432355527906 0.0 3 0.9353426890092906 4.827088718031314 10106.0 25.787170111287757 0.0 - - - - - - - 232.28571428571428 20 21 PALM paralemmin 459 59 C20140401_SF093_03 C20140401_SF093_03 TB143821.[MT7]-GAVEGAAR.2b6_1.heavy 437.747 / 629.338 11176.0 14.270400047302246 44 14 10 10 10 7.066422499693997 14.151432355527906 0.0 3 0.9353426890092906 4.827088718031314 11176.0 54.78431372549019 0.0 - - - - - - - 268.14285714285717 22 21 PALM paralemmin 461 59 C20140401_SF093_03 C20140401_SF093_03 TB143821.[MT7]-GAVEGAAR.2b5_1.heavy 437.747 / 558.3 7014.0 14.270400047302246 44 14 10 10 10 7.066422499693997 14.151432355527906 0.0 3 0.9353426890092906 4.827088718031314 7014.0 15.92602495543672 1.0 - - - - - - - 246.125 15 24 PALM paralemmin 463 59 C20140401_SF093_03 C20140401_SF093_03 TB143821.[MT7]-GAVEGAAR.2y7_1.heavy 437.747 / 673.363 9313.0 14.270400047302246 44 14 10 10 10 7.066422499693997 14.151432355527906 0.0 3 0.9353426890092906 4.827088718031314 9313.0 48.23402698907003 0.0 - - - - - - - 167.54545454545453 18 22 PALM paralemmin 465 60 C20140401_SF093_03 C20140401_SF093_03 TB144655.[MT7]-ETIEDVEEMLNNLPGVTSVHSR.3b5_1.heavy 871.77 / 732.353 4116.0 47.1609001159668 42 12 10 10 10 1.2426679729757486 65.32671904175305 0.0 3 0.8893357113447323 3.675104721417333 4116.0 19.822390317700453 0.0 - - - - - - - 207.2941176470588 8 17 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 467 60 C20140401_SF093_03 C20140401_SF093_03 TB144655.[MT7]-ETIEDVEEMLNNLPGVTSVHSR.3b8_1.heavy 871.77 / 1089.51 6762.0 47.1609001159668 42 12 10 10 10 1.2426679729757486 65.32671904175305 0.0 3 0.8893357113447323 3.675104721417333 6762.0 18.823116490166417 0.0 - - - - - - - 237.15384615384616 13 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 469 60 C20140401_SF093_03 C20140401_SF093_03 TB144655.[MT7]-ETIEDVEEMLNNLPGVTSVHSR.3b7_1.heavy 871.77 / 960.464 2866.0 47.1609001159668 42 12 10 10 10 1.2426679729757486 65.32671904175305 0.0 3 0.8893357113447323 3.675104721417333 2866.0 3.4119047619047618 0.0 - - - - - - - 215.6875 5 16 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 471 60 C20140401_SF093_03 C20140401_SF093_03 TB144655.[MT7]-ETIEDVEEMLNNLPGVTSVHSR.3y9_1.heavy 871.77 / 939.501 20579.0 47.1609001159668 42 12 10 10 10 1.2426679729757486 65.32671904175305 0.0 3 0.8893357113447323 3.675104721417333 20579.0 75.52859976528987 0.0 - - - - - - - 282.38461538461536 41 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 473 61 C20140401_SF093_03 C20140401_SF093_03 TB144394.[MT7]-LSAAEDPLVQSLR.2b6_1.heavy 771.934 / 731.369 6457.0 37.132598876953125 44 16 10 10 8 4.692759113035115 21.309425348986952 0.0 4 0.9652127341581774 6.597586931289074 6457.0 12.76001360566871 0.0 - - - - - - - 295.85714285714283 12 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 475 61 C20140401_SF093_03 C20140401_SF093_03 TB144394.[MT7]-LSAAEDPLVQSLR.2y10_1.heavy 771.934 / 1127.61 2071.0 37.132598876953125 44 16 10 10 8 4.692759113035115 21.309425348986952 0.0 4 0.9652127341581774 6.597586931289074 2071.0 5.391376596076439 2.0 - - - - - - - 713.5714285714286 4 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 477 61 C20140401_SF093_03 C20140401_SF093_03 TB144394.[MT7]-LSAAEDPLVQSLR.2b5_1.heavy 771.934 / 616.342 2558.0 37.132598876953125 44 16 10 10 8 4.692759113035115 21.309425348986952 0.0 4 0.9652127341581774 6.597586931289074 2558.0 3.0887924970691674 1.0 - - - - - - - 311.1111111111111 7 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 479 61 C20140401_SF093_03 C20140401_SF093_03 TB144394.[MT7]-LSAAEDPLVQSLR.2y7_1.heavy 771.934 / 812.499 10721.0 37.132598876953125 44 16 10 10 8 4.692759113035115 21.309425348986952 0.0 4 0.9652127341581774 6.597586931289074 10721.0 48.67046305307868 0.0 - - - - - - - 298.90909090909093 21 11 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 481 62 C20140401_SF093_03 C20140401_SF093_03 TB144503.[MT7]-SIIGVIPYFPYSK[MT7].3y3_1.heavy 591.346 / 541.31 4163.0 45.38174915313721 39 13 10 6 10 0.9879363629690038 58.02396370650082 0.036998748779296875 3 0.9201519703235197 4.338076557123638 4163.0 50.55071428571428 0.0 - - - - - - - 154.0 8 9 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 483 62 C20140401_SF093_03 C20140401_SF093_03 TB144503.[MT7]-SIIGVIPYFPYSK[MT7].3b4_1.heavy 591.346 / 515.331 6553.0 45.38174915313721 39 13 10 6 10 0.9879363629690038 58.02396370650082 0.036998748779296875 3 0.9201519703235197 4.338076557123638 6553.0 81.76259144049563 0.0 - - - - - - - 136.23076923076923 13 13 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 485 62 C20140401_SF093_03 C20140401_SF093_03 TB144503.[MT7]-SIIGVIPYFPYSK[MT7].3b5_1.heavy 591.346 / 614.399 14262.0 45.38174915313721 39 13 10 6 10 0.9879363629690038 58.02396370650082 0.036998748779296875 3 0.9201519703235197 4.338076557123638 14262.0 92.23994805194803 0.0 - - - - - - - 179.66666666666666 28 12 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 487 62 C20140401_SF093_03 C20140401_SF093_03 TB144503.[MT7]-SIIGVIPYFPYSK[MT7].3y4_1.heavy 591.346 / 638.363 11101.0 45.38174915313721 39 13 10 6 10 0.9879363629690038 58.02396370650082 0.036998748779296875 3 0.9201519703235197 4.338076557123638 11101.0 77.85116883116882 0.0 - - - - - - - 165.07142857142858 22 14 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 489 63 C20140401_SF093_03 C20140401_SF093_03 TB144652.[MT7]-YSFMENLLQNQIVIVSGDAK[MT7].3b6_1.heavy 853.124 / 916.399 4509.0 49.549598693847656 39 12 9 10 8 0.9676623019285091 60.26144837494219 0.0 4 0.8925196343910499 3.730172845300631 4509.0 20.968018134715027 1.0 - - - - - - - 192.93333333333334 22 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 491 63 C20140401_SF093_03 C20140401_SF093_03 TB144652.[MT7]-YSFMENLLQNQIVIVSGDAK[MT7].3b5_1.heavy 853.124 / 802.356 3156.0 49.549598693847656 39 12 9 10 8 0.9676623019285091 60.26144837494219 0.0 4 0.8925196343910499 3.730172845300631 3156.0 14.691745993493193 0.0 - - - - - - - 202.85 6 20 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 493 63 C20140401_SF093_03 C20140401_SF093_03 TB144652.[MT7]-YSFMENLLQNQIVIVSGDAK[MT7].3y8_1.heavy 853.124 / 932.553 5862.0 49.549598693847656 39 12 9 10 8 0.9676623019285091 60.26144837494219 0.0 4 0.8925196343910499 3.730172845300631 5862.0 11.92786768868138 0.0 - - - - - - - 219.0 11 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 495 63 C20140401_SF093_03 C20140401_SF093_03 TB144652.[MT7]-YSFMENLLQNQIVIVSGDAK[MT7].3b7_1.heavy 853.124 / 1029.48 8825.0 49.549598693847656 39 12 9 10 8 0.9676623019285091 60.26144837494219 0.0 4 0.8925196343910499 3.730172845300631 8825.0 44.508452576055966 0.0 - - - - - - - 289.8333333333333 17 18 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 497 64 C20140401_SF093_03 C20140401_SF093_03 TB144395.[MT7]-GRPLAEESEQER.3b6_1.heavy 515.598 / 768.448 1132.0 17.064899444580078 43 13 10 10 10 2.1364130002112867 46.80742908328597 0.0 3 0.9151643788617728 4.206821092477443 1132.0 16.56528379772962 0.0 - - - - - - - 107.11111111111111 2 9 C2orf18 chromosome 2 open reading frame 18 499 64 C20140401_SF093_03 C20140401_SF093_03 TB144395.[MT7]-GRPLAEESEQER.3y6_1.heavy 515.598 / 777.337 2263.0 17.064899444580078 43 13 10 10 10 2.1364130002112867 46.80742908328597 0.0 3 0.9151643788617728 4.206821092477443 2263.0 34.305126533147025 0.0 - - - - - - - 141.5 4 6 C2orf18 chromosome 2 open reading frame 18 501 64 C20140401_SF093_03 C20140401_SF093_03 TB144395.[MT7]-GRPLAEESEQER.3y8_1.heavy 515.598 / 977.417 1132.0 17.064899444580078 43 13 10 10 10 2.1364130002112867 46.80742908328597 0.0 3 0.9151643788617728 4.206821092477443 1132.0 29.86733053873622 0.0 - - - - - - - 113.33333333333333 2 3 C2orf18 chromosome 2 open reading frame 18 503 64 C20140401_SF093_03 C20140401_SF093_03 TB144395.[MT7]-GRPLAEESEQER.3y5_1.heavy 515.598 / 648.295 6054.0 17.064899444580078 43 13 10 10 10 2.1364130002112867 46.80742908328597 0.0 3 0.9151643788617728 4.206821092477443 6054.0 96.38182300884957 0.0 - - - - - - - 113.3076923076923 12 13 C2orf18 chromosome 2 open reading frame 18 505 65 C20140401_SF093_03 C20140401_SF093_03 TB144658.[MT7]-GRPYTLSVALPGSILDNAQSPELR.3b9_1.heavy 900.16 / 1089.62 5763.0 41.13585090637207 42 16 10 6 10 4.660418758979604 17.137580562306468 0.038898468017578125 3 0.9689148328652712 6.981589178436719 5763.0 12.44584806515584 0.0 - - - - - - - 230.4 11 10 C9orf114 chromosome 9 open reading frame 114 507 65 C20140401_SF093_03 C20140401_SF093_03 TB144658.[MT7]-GRPYTLSVALPGSILDNAQSPELR.3b10_1.heavy 900.16 / 1202.7 4255.0 41.13585090637207 42 16 10 6 10 4.660418758979604 17.137580562306468 0.038898468017578125 3 0.9689148328652712 6.981589178436719 4255.0 8.528668171557563 1.0 - - - - - - - 228.0 8 14 C9orf114 chromosome 9 open reading frame 114 509 65 C20140401_SF093_03 C20140401_SF093_03 TB144658.[MT7]-GRPYTLSVALPGSILDNAQSPELR.3y8_1.heavy 900.16 / 914.469 3280.0 41.13585090637207 42 16 10 6 10 4.660418758979604 17.137580562306468 0.038898468017578125 3 0.9689148328652712 6.981589178436719 3280.0 7.773639964402074 0.0 - - - - - - - 206.86666666666667 6 15 C9orf114 chromosome 9 open reading frame 114 511 65 C20140401_SF093_03 C20140401_SF093_03 TB144658.[MT7]-GRPYTLSVALPGSILDNAQSPELR.3y10_1.heavy 900.16 / 1142.58 3901.0 41.13585090637207 42 16 10 6 10 4.660418758979604 17.137580562306468 0.038898468017578125 3 0.9689148328652712 6.981589178436719 3901.0 16.87951494119915 0.0 - - - - - - - 696.8571428571429 7 7 C9orf114 chromosome 9 open reading frame 114 513 66 C20140401_SF093_03 C20140401_SF093_03 TB144657.[MT7]-C[CAM]LAALTEC[CAM]AASGDGNILALAVDASR.3b4_1.heavy 888.446 / 560.298 7533.0 47.80987548828125 44 18 10 6 10 51.48678142185533 1.942246091878479 0.0399017333984375 3 0.9885893831134024 11.542343030183597 7533.0 42.69231723303418 0.0 - - - - - - - 248.3684210526316 15 19 MUT methylmalonyl CoA mutase 515 66 C20140401_SF093_03 C20140401_SF093_03 TB144657.[MT7]-C[CAM]LAALTEC[CAM]AASGDGNILALAVDASR.3b5_1.heavy 888.446 / 673.382 4787.0 47.80987548828125 44 18 10 6 10 51.48678142185533 1.942246091878479 0.0399017333984375 3 0.9885893831134024 11.542343030183597 4787.0 15.939649501720677 0.0 - - - - - - - 197.13333333333333 9 15 MUT methylmalonyl CoA mutase 517 66 C20140401_SF093_03 C20140401_SF093_03 TB144657.[MT7]-C[CAM]LAALTEC[CAM]AASGDGNILALAVDASR.3y8_1.heavy 888.446 / 802.442 1056.0 47.80987548828125 44 18 10 6 10 51.48678142185533 1.942246091878479 0.0399017333984375 3 0.9885893831134024 11.542343030183597 1056.0 3.537098646034816 2.0 - - - - - - - 183.0 7 15 MUT methylmalonyl CoA mutase 519 66 C20140401_SF093_03 C20140401_SF093_03 TB144657.[MT7]-C[CAM]LAALTEC[CAM]AASGDGNILALAVDASR.3y9_1.heavy 888.446 / 915.526 4154.0 47.80987548828125 44 18 10 6 10 51.48678142185533 1.942246091878479 0.0399017333984375 3 0.9885893831134024 11.542343030183597 4154.0 3.7407551522332327 1.0 - - - - - - - 248.73333333333332 8 15 MUT methylmalonyl CoA mutase 521 67 C20140401_SF093_03 C20140401_SF093_03 TB144397.[MT7]-EFLTIYEDVK[MT7].2b3_1.heavy 772.926 / 534.304 16568.0 40.370201110839844 44 14 10 10 10 6.004229528071731 16.654926253646266 0.0 3 0.9425405242650953 5.1236535094898 16568.0 30.433375438265116 0.0 - - - - - - - 750.0 33 8 CD244 CD244 molecule, natural killer cell receptor 2B4 523 67 C20140401_SF093_03 C20140401_SF093_03 TB144397.[MT7]-EFLTIYEDVK[MT7].2y5_1.heavy 772.926 / 797.416 15521.0 40.370201110839844 44 14 10 10 10 6.004229528071731 16.654926253646266 0.0 3 0.9425405242650953 5.1236535094898 15521.0 43.049250374812594 0.0 - - - - - - - 231.0 31 14 CD244 CD244 molecule, natural killer cell receptor 2B4 525 67 C20140401_SF093_03 C20140401_SF093_03 TB144397.[MT7]-EFLTIYEDVK[MT7].2y7_2.heavy 772.926 / 506.278 4475.0 40.370201110839844 44 14 10 10 10 6.004229528071731 16.654926253646266 0.0 3 0.9425405242650953 5.1236535094898 4475.0 8.776430668589676 0.0 - - - - - - - 723.7 8 10 CD244 CD244 molecule, natural killer cell receptor 2B4 527 67 C20140401_SF093_03 C20140401_SF093_03 TB144397.[MT7]-EFLTIYEDVK[MT7].2y7_1.heavy 772.926 / 1011.55 16663.0 40.370201110839844 44 14 10 10 10 6.004229528071731 16.654926253646266 0.0 3 0.9425405242650953 5.1236535094898 16663.0 67.81208567186545 0.0 - - - - - - - 733.3 33 10 CD244 CD244 molecule, natural killer cell receptor 2B4 529 68 C20140401_SF093_03 C20140401_SF093_03 TB482650.[MT7]-AQNPAR.2y4_1.heavy 400.728 / 457.252 7839.0 13.56980037689209 41 11 10 10 10 0.5215859353898894 100.12784998649572 0.0 3 0.8776001150229754 3.490914137146788 7839.0 19.69263516639242 0.0 - - - - - - - 277.8333333333333 15 18 CD244 CD244 molecule, natural killer cell receptor 2B4 531 68 C20140401_SF093_03 C20140401_SF093_03 TB482650.[MT7]-AQNPAR.2b3_1.heavy 400.728 / 458.248 15424.0 13.56980037689209 41 11 10 10 10 0.5215859353898894 100.12784998649572 0.0 3 0.8776001150229754 3.490914137146788 15424.0 33.88444665166447 0.0 - - - - - - - 283.44444444444446 30 18 CD244 CD244 molecule, natural killer cell receptor 2B4 533 68 C20140401_SF093_03 C20140401_SF093_03 TB482650.[MT7]-AQNPAR.2y5_1.heavy 400.728 / 585.31 659.0 13.56980037689209 41 11 10 10 10 0.5215859353898894 100.12784998649572 0.0 3 0.8776001150229754 3.490914137146788 659.0 3.713552076393515 0.0 - - - - - - - 0.0 1 0 CD244 CD244 molecule, natural killer cell receptor 2B4 535 68 C20140401_SF093_03 C20140401_SF093_03 TB482650.[MT7]-AQNPAR.2b5_1.heavy 400.728 / 626.338 372.0 13.56980037689209 41 11 10 10 10 0.5215859353898894 100.12784998649572 0.0 3 0.8776001150229754 3.490914137146788 372.0 3.0437053662517854 2.0 - - - - - - - 171.64 2 25 CD244 CD244 molecule, natural killer cell receptor 2B4 537 69 C20140401_SF093_03 C20140401_SF093_03 TB348664.[MT7]-DVEDESTGLEK[MT7].3y3_1.heavy 503.922 / 533.341 6050.0 22.974300384521484 43 13 10 10 10 2.162672359684576 46.23908913072016 0.0 3 0.9248409423238076 4.47314867239754 6050.0 9.045061728395062 0.0 - - - - - - - 284.72727272727275 12 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 539 69 C20140401_SF093_03 C20140401_SF093_03 TB348664.[MT7]-DVEDESTGLEK[MT7].3b4_1.heavy 503.922 / 603.274 11236.0 22.974300384521484 43 13 10 10 10 2.162672359684576 46.23908913072016 0.0 3 0.9248409423238076 4.47314867239754 11236.0 22.818558156819023 0.0 - - - - - - - 729.0 22 10 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 541 69 C20140401_SF093_03 C20140401_SF093_03 TB348664.[MT7]-DVEDESTGLEK[MT7].3b5_1.heavy 503.922 / 732.317 4483.0 22.974300384521484 43 13 10 10 10 2.162672359684576 46.23908913072016 0.0 3 0.9248409423238076 4.47314867239754 4483.0 10.607921810699589 0.0 - - - - - - - 234.0 8 21 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 543 69 C20140401_SF093_03 C20140401_SF093_03 TB348664.[MT7]-DVEDESTGLEK[MT7].3y4_1.heavy 503.922 / 590.363 9021.0 22.974300384521484 43 13 10 10 10 2.162672359684576 46.23908913072016 0.0 3 0.9248409423238076 4.47314867239754 9021.0 21.603320707070708 0.0 - - - - - - - 726.0 18 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 545 70 C20140401_SF093_03 C20140401_SF093_03 TB483222.[MT7]-NVDMLSELVQEYDEPILK[MT7].3b4_1.heavy 808.425 / 604.288 8969.0 48.7495002746582 44 14 10 10 10 1.4968045663307734 47.172601468317325 0.0 3 0.9444450784758867 5.211583535908104 8969.0 26.672516339869283 0.0 - - - - - - - 645.6 17 10 NAP1L4 nucleosome assembly protein 1-like 4 547 70 C20140401_SF093_03 C20140401_SF093_03 TB483222.[MT7]-NVDMLSELVQEYDEPILK[MT7].3b5_1.heavy 808.425 / 717.372 7271.0 48.7495002746582 44 14 10 10 10 1.4968045663307734 47.172601468317325 0.0 3 0.9444450784758867 5.211583535908104 7271.0 22.072678571428572 0.0 - - - - - - - 280.5 14 16 NAP1L4 nucleosome assembly protein 1-like 4 549 70 C20140401_SF093_03 C20140401_SF093_03 TB483222.[MT7]-NVDMLSELVQEYDEPILK[MT7].3y4_1.heavy 808.425 / 614.436 15017.0 48.7495002746582 44 14 10 10 10 1.4968045663307734 47.172601468317325 0.0 3 0.9444450784758867 5.211583535908104 15017.0 34.64478357743705 0.0 - - - - - - - 272.0 30 14 NAP1L4 nucleosome assembly protein 1-like 4 551 70 C20140401_SF093_03 C20140401_SF093_03 TB483222.[MT7]-NVDMLSELVQEYDEPILK[MT7].3b7_1.heavy 808.425 / 933.447 11212.0 48.7495002746582 44 14 10 10 10 1.4968045663307734 47.172601468317325 0.0 3 0.9444450784758867 5.211583535908104 11212.0 83.54039215686274 0.0 - - - - - - - 204.0 22 16 NAP1L4 nucleosome assembly protein 1-like 4 553 71 C20140401_SF093_03 C20140401_SF093_03 TB144255.[MT7]-GFWLSQWK[MT7].2b3_1.heavy 670.374 / 535.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 555 71 C20140401_SF093_03 C20140401_SF093_03 TB144255.[MT7]-GFWLSQWK[MT7].2y4_1.heavy 670.374 / 692.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 557 71 C20140401_SF093_03 C20140401_SF093_03 TB144255.[MT7]-GFWLSQWK[MT7].2y5_1.heavy 670.374 / 805.469 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 559 71 C20140401_SF093_03 C20140401_SF093_03 TB144255.[MT7]-GFWLSQWK[MT7].2b4_1.heavy 670.374 / 648.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 561 72 C20140401_SF093_03 C20140401_SF093_03 TB144507.[MT7]-DAFDTLFDHAPDK[MT7].3y3_1.heavy 593.965 / 503.295 5830.0 38.25157356262207 42 17 10 5 10 5.459145709755407 18.317884393761755 0.04489898681640625 3 0.9779839060318972 8.302181239162692 5830.0 29.306690755701425 0.0 - - - - - - - 189.625 11 8 PARVB;PARVA parvin, beta;parvin, alpha 563 72 C20140401_SF093_03 C20140401_SF093_03 TB144507.[MT7]-DAFDTLFDHAPDK[MT7].3b4_1.heavy 593.965 / 593.269 3032.0 38.25157356262207 42 17 10 5 10 5.459145709755407 18.317884393761755 0.04489898681640625 3 0.9779839060318972 8.302181239162692 3032.0 6.806372448121616 0.0 - - - - - - - 699.5714285714286 6 7 PARVB;PARVA parvin, beta;parvin, alpha 565 72 C20140401_SF093_03 C20140401_SF093_03 TB144507.[MT7]-DAFDTLFDHAPDK[MT7].3b5_1.heavy 593.965 / 694.316 1283.0 38.25157356262207 42 17 10 5 10 5.459145709755407 18.317884393761755 0.04489898681640625 3 0.9779839060318972 8.302181239162692 1283.0 4.920987124463519 1.0 - - - - - - - 155.66666666666666 2 3 PARVB;PARVA parvin, beta;parvin, alpha 567 72 C20140401_SF093_03 C20140401_SF093_03 TB144507.[MT7]-DAFDTLFDHAPDK[MT7].3b8_1.heavy 593.965 / 1069.5 1399.0 38.25157356262207 42 17 10 5 10 5.459145709755407 18.317884393761755 0.04489898681640625 3 0.9779839060318972 8.302181239162692 1399.0 12.257157776128837 0.0 - - - - - - - 117.0 2 3 PARVB;PARVA parvin, beta;parvin, alpha 569 73 C20140401_SF093_03 C20140401_SF093_03 TB144389.[MT7]-SIATDVLLGLLK[MT7].3b6_1.heavy 510.995 / 731.406 37815.0 50.817349433898926 35 9 10 6 10 0.7030706492175709 81.54755030093551 0.033397674560546875 3 0.8183186289940223 2.850369932765768 37815.0 832.9124792703151 0.0 - - - - - - - 142.83333333333334 75 6 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 571 73 C20140401_SF093_03 C20140401_SF093_03 TB144389.[MT7]-SIATDVLLGLLK[MT7].3b5_1.heavy 510.995 / 632.337 24318.0 50.817349433898926 35 9 10 6 10 0.7030706492175709 81.54755030093551 0.033397674560546875 3 0.8183186289940223 2.850369932765768 24318.0 340.9065420560748 0.0 - - - - - - - 134.1 48 10 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 573 73 C20140401_SF093_03 C20140401_SF093_03 TB144389.[MT7]-SIATDVLLGLLK[MT7].3y4_1.heavy 510.995 / 574.404 56723.0 50.817349433898926 35 9 10 6 10 0.7030706492175709 81.54755030093551 0.033397674560546875 3 0.8183186289940223 2.850369932765768 56723.0 687.7337369228622 0.0 - - - - - - - 164.33333333333334 113 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 575 73 C20140401_SF093_03 C20140401_SF093_03 TB144389.[MT7]-SIATDVLLGLLK[MT7].3b7_1.heavy 510.995 / 844.49 10820.0 50.817349433898926 35 9 10 6 10 0.7030706492175709 81.54755030093551 0.033397674560546875 3 0.8183186289940223 2.850369932765768 10820.0 49.549532710280374 0.0 - - - - - - - 148.88888888888889 21 9 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 577 74 C20140401_SF093_03 C20140401_SF093_03 TB144514.[MT7]-EIQGFFNIPVDNLR.3y6_1.heavy 602.66 / 713.394 30948.0 44.94575119018555 44 18 10 6 10 5.4362206501783135 18.39513265465409 0.0345001220703125 3 0.9885408896250283 11.517847536377731 30948.0 212.1566842105263 0.0 - - - - - - - 228.0 61 12 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 579 74 C20140401_SF093_03 C20140401_SF093_03 TB144514.[MT7]-EIQGFFNIPVDNLR.3b4_1.heavy 602.66 / 572.316 8668.0 44.94575119018555 44 18 10 6 10 5.4362206501783135 18.39513265465409 0.0345001220703125 3 0.9885408896250283 11.517847536377731 8668.0 149.5990350877193 0.0 - - - - - - - 157.84615384615384 17 13 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 581 74 C20140401_SF093_03 C20140401_SF093_03 TB144514.[MT7]-EIQGFFNIPVDNLR.3b5_1.heavy 602.66 / 719.385 9049.0 44.94575119018555 44 18 10 6 10 5.4362206501783135 18.39513265465409 0.0345001220703125 3 0.9885408896250283 11.517847536377731 9049.0 92.47442982456141 0.0 - - - - - - - 168.28571428571428 18 14 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 583 74 C20140401_SF093_03 C20140401_SF093_03 TB144514.[MT7]-EIQGFFNIPVDNLR.3b3_1.heavy 602.66 / 515.295 4790.0 44.94575119018555 44 18 10 6 10 5.4362206501783135 18.39513265465409 0.0345001220703125 3 0.9885408896250283 11.517847536377731 4790.0 42.01754385964912 0.0 - - - - - - - 167.2 9 15 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 585 75 C20140401_SF093_03 C20140401_SF093_03 TB143914.[MT7]-QAVC[CAM]EAR.2y4_1.heavy 489.251 / 535.229 3254.0 14.361900091171265 44 18 10 6 10 4.20885234109936 23.759446018930618 0.03040027618408203 3 0.9845985602427191 9.93168031285656 3254.0 38.60677966101695 0.0 - - - - - - - 129.89473684210526 6 19 FBLIM1 filamin binding LIM protein 1 587 75 C20140401_SF093_03 C20140401_SF093_03 TB143914.[MT7]-QAVC[CAM]EAR.2y5_1.heavy 489.251 / 634.298 3215.0 14.361900091171265 44 18 10 6 10 4.20885234109936 23.759446018930618 0.03040027618408203 3 0.9845985602427191 9.93168031285656 3215.0 100.57179487179486 0.0 - - - - - - - 78.2 6 15 FBLIM1 filamin binding LIM protein 1 589 75 C20140401_SF093_03 C20140401_SF093_03 TB143914.[MT7]-QAVC[CAM]EAR.2y6_1.heavy 489.251 / 705.335 13095.0 14.361900091171265 44 18 10 6 10 4.20885234109936 23.759446018930618 0.03040027618408203 3 0.9845985602427191 9.93168031285656 13095.0 181.17833594976454 0.0 - - - - - - - 142.21052631578948 26 19 FBLIM1 filamin binding LIM protein 1 591 75 C20140401_SF093_03 C20140401_SF093_03 TB143914.[MT7]-QAVC[CAM]EAR.2b5_1.heavy 489.251 / 732.347 5254.0 14.361900091171265 44 18 10 6 10 4.20885234109936 23.759446018930618 0.03040027618408203 3 0.9845985602427191 9.93168031285656 5254.0 64.94702694850004 0.0 - - - - - - - 106.0 10 17 FBLIM1 filamin binding LIM protein 1 593 76 C20140401_SF093_03 C20140401_SF093_03 TB482765.[MT7]-NAVIVAK[MT7].2y4_1.heavy 501.831 / 574.404 11539.0 22.696300506591797 46 20 10 6 10 4.691224576344449 21.31639583068589 0.037200927734375 3 0.9920254115393762 13.810811473945716 11539.0 85.4935 0.0 - - - - - - - 193.94736842105263 23 19 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 595 76 C20140401_SF093_03 C20140401_SF093_03 TB482765.[MT7]-NAVIVAK[MT7].2y5_1.heavy 501.831 / 673.473 3187.0 22.696300506591797 46 20 10 6 10 4.691224576344449 21.31639583068589 0.037200927734375 3 0.9920254115393762 13.810811473945716 3187.0 25.496000000000002 0.0 - - - - - - - 196.42857142857142 6 21 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 597 76 C20140401_SF093_03 C20140401_SF093_03 TB482765.[MT7]-NAVIVAK[MT7].2b4_1.heavy 501.831 / 542.342 6814.0 22.696300506591797 46 20 10 6 10 4.691224576344449 21.31639583068589 0.037200927734375 3 0.9920254115393762 13.810811473945716 6814.0 17.808292594822397 1.0 - - - - - - - 211.31578947368422 13 19 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 599 76 C20140401_SF093_03 C20140401_SF093_03 TB482765.[MT7]-NAVIVAK[MT7].2y6_1.heavy 501.831 / 744.51 3572.0 22.696300506591797 46 20 10 6 10 4.691224576344449 21.31639583068589 0.037200927734375 3 0.9920254115393762 13.810811473945716 3572.0 47.24781818181819 0.0 - - - - - - - 135.66666666666666 7 15 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 601 77 C20140401_SF093_03 C20140401_SF093_03 TB143811.[MT7]-VIGDC[CAM]R.2b3_1.heavy 432.23 / 414.283 N/A 18.88559913635254 45 15 10 10 10 2.9925282695415705 25.20125326840264 0.0 3 0.9594880400612219 6.110736443456815 15134.0 0.7504151683404046 5.0 - - - - - - - 6209.5 139 2 AS3MT arsenic (+3 oxidation state) methyltransferase 603 77 C20140401_SF093_03 C20140401_SF093_03 TB143811.[MT7]-VIGDC[CAM]R.2y4_1.heavy 432.23 / 507.198 25415.0 18.88559913635254 45 15 10 10 10 2.9925282695415705 25.20125326840264 0.0 3 0.9594880400612219 6.110736443456815 25415.0 41.82821619950536 0.0 - - - - - - - 718.8888888888889 50 9 AS3MT arsenic (+3 oxidation state) methyltransferase 605 77 C20140401_SF093_03 C20140401_SF093_03 TB143811.[MT7]-VIGDC[CAM]R.2y5_1.heavy 432.23 / 620.282 72953.0 18.88559913635254 45 15 10 10 10 2.9925282695415705 25.20125326840264 0.0 3 0.9594880400612219 6.110736443456815 72953.0 165.51226783146413 0.0 - - - - - - - 294.09090909090907 145 11 AS3MT arsenic (+3 oxidation state) methyltransferase 607 77 C20140401_SF093_03 C20140401_SF093_03 TB143811.[MT7]-VIGDC[CAM]R.2b4_1.heavy 432.23 / 529.31 123263.0 18.88559913635254 45 15 10 10 10 2.9925282695415705 25.20125326840264 0.0 3 0.9594880400612219 6.110736443456815 123263.0 159.42677769193347 0.0 - - - - - - - 269.5 246 6 AS3MT arsenic (+3 oxidation state) methyltransferase 609 78 C20140401_SF093_03 C20140401_SF093_03 TB144516.[MT7]-AAASAELNAALEELAAR.3y7_1.heavy 605.662 / 801.446 5504.0 44.378150939941406 43 17 10 6 10 3.528283356278608 28.34239484253701 0.0364990234375 3 0.9735398176594956 7.5701354080964505 5504.0 47.43381585887593 0.0 - - - - - - - 201.0 11 6 FBXL8 F-box and leucine-rich repeat protein 8 611 78 C20140401_SF093_03 C20140401_SF093_03 TB144516.[MT7]-AAASAELNAALEELAAR.3y6_1.heavy 605.662 / 688.362 7389.0 44.378150939941406 43 17 10 6 10 3.528283356278608 28.34239484253701 0.0364990234375 3 0.9735398176594956 7.5701354080964505 7389.0 186.39983999999998 0.0 - - - - - - - 96.57142857142857 14 7 FBXL8 F-box and leucine-rich repeat protein 8 613 78 C20140401_SF093_03 C20140401_SF093_03 TB144516.[MT7]-AAASAELNAALEELAAR.3b6_1.heavy 605.662 / 645.332 9877.0 44.378150939941406 43 17 10 6 10 3.528283356278608 28.34239484253701 0.0364990234375 3 0.9735398176594956 7.5701354080964505 9877.0 31.787983496969424 0.0 - - - - - - - 205.45454545454547 19 11 FBXL8 F-box and leucine-rich repeat protein 8 615 78 C20140401_SF093_03 C20140401_SF093_03 TB144516.[MT7]-AAASAELNAALEELAAR.3b5_1.heavy 605.662 / 516.29 2639.0 44.378150939941406 43 17 10 6 10 3.528283356278608 28.34239484253701 0.0364990234375 3 0.9735398176594956 7.5701354080964505 2639.0 22.719867549668876 0.0 - - - - - - - 125.58333333333333 5 12 FBXL8 F-box and leucine-rich repeat protein 8 617 79 C20140401_SF093_03 C20140401_SF093_03 TB144515.[MT7]-RVASSVFITLAPPRR.4y5_1.heavy 454.277 / 596.363 10820.0 32.927799224853516 38 8 10 10 10 0.9081807427811628 65.12478805064697 0.0 3 0.7863895639918362 2.6211893258034826 10820.0 21.755780251688407 0.0 - - - - - - - 228.0 21 8 FBLIM1 filamin binding LIM protein 1 619 79 C20140401_SF093_03 C20140401_SF093_03 TB144515.[MT7]-RVASSVFITLAPPRR.4y4_1.heavy 454.277 / 525.326 24600.0 32.927799224853516 38 8 10 10 10 0.9081807427811628 65.12478805064697 0.0 3 0.7863895639918362 2.6211893258034826 24600.0 110.73196881091617 0.0 - - - - - - - 313.5 49 4 FBLIM1 filamin binding LIM protein 1 621 79 C20140401_SF093_03 C20140401_SF093_03 TB144515.[MT7]-RVASSVFITLAPPRR.4b7_1.heavy 454.277 / 891.517 6036.0 32.927799224853516 38 8 10 10 10 0.9081807427811628 65.12478805064697 0.0 3 0.7863895639918362 2.6211893258034826 6036.0 24.103068505817987 0.0 - - - - - - - 239.4 12 10 FBLIM1 filamin binding LIM protein 1 623 79 C20140401_SF093_03 C20140401_SF093_03 TB144515.[MT7]-RVASSVFITLAPPRR.4y9_2.heavy 454.277 / 535.827 39634.0 32.927799224853516 38 8 10 10 10 0.9081807427811628 65.12478805064697 0.0 3 0.7863895639918362 2.6211893258034826 39634.0 86.93913021868786 0.0 - - - - - - - 358.2857142857143 79 7 FBLIM1 filamin binding LIM protein 1 625 80 C20140401_SF093_03 C20140401_SF093_03 TB144643.[MT7]-TAWGQQPDLAANEAQLLRK[MT7].3y6_1.heavy 800.108 / 872.58 4269.0 35.16525077819824 42 17 10 5 10 3.455100707444725 28.942716426334385 0.042499542236328125 3 0.9757397732337673 7.90738716492011 4269.0 18.577363272698324 0.0 - - - - - - - 280.1666666666667 8 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 627 80 C20140401_SF093_03 C20140401_SF093_03 TB144643.[MT7]-TAWGQQPDLAANEAQLLRK[MT7].3b6_1.heavy 800.108 / 816.412 10479.0 35.16525077819824 42 17 10 5 10 3.455100707444725 28.942716426334385 0.042499542236328125 3 0.9757397732337673 7.90738716492011 10479.0 41.469667191768536 0.0 - - - - - - - 215.55555555555554 20 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 629 80 C20140401_SF093_03 C20140401_SF093_03 TB144643.[MT7]-TAWGQQPDLAANEAQLLRK[MT7].3b5_1.heavy 800.108 / 688.354 10349.0 35.16525077819824 42 17 10 5 10 3.455100707444725 28.942716426334385 0.042499542236328125 3 0.9757397732337673 7.90738716492011 10349.0 18.796983631443492 0.0 - - - - - - - 323.5 20 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 631 80 C20140401_SF093_03 C20140401_SF093_03 TB144643.[MT7]-TAWGQQPDLAANEAQLLRK[MT7].3y9_1.heavy 800.108 / 1186.7 6080.0 35.16525077819824 42 17 10 5 10 3.455100707444725 28.942716426334385 0.042499542236328125 3 0.9757397732337673 7.90738716492011 6080.0 15.195398269570898 0.0 - - - - - - - 630.5 12 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 633 81 C20140401_SF093_03 C20140401_SF093_03 TB143912.[MT7]-LGEAGIK[MT7].2y4_1.heavy 488.307 / 532.357 4482.0 24.04680061340332 45 17 10 10 8 2.4896379580479375 31.385580098119974 0.0 4 0.976658844911271 8.06218602570917 4482.0 15.967619047619046 1.0 - - - - - - - 316.2857142857143 8 21 AS3MT arsenic (+3 oxidation state) methyltransferase 635 81 C20140401_SF093_03 C20140401_SF093_03 TB143912.[MT7]-LGEAGIK[MT7].2b4_1.heavy 488.307 / 515.295 2862.0 24.04680061340332 45 17 10 10 8 2.4896379580479375 31.385580098119974 0.0 4 0.976658844911271 8.06218602570917 2862.0 4.756410256410256 0.0 - - - - - - - 345.0 5 18 AS3MT arsenic (+3 oxidation state) methyltransferase 637 81 C20140401_SF093_03 C20140401_SF093_03 TB143912.[MT7]-LGEAGIK[MT7].2y6_1.heavy 488.307 / 718.422 N/A 24.04680061340332 45 17 10 10 8 2.4896379580479375 31.385580098119974 0.0 4 0.976658844911271 8.06218602570917 17440.0 20.115759099162318 1.0 - - - - - - - 691.2 51 10 AS3MT arsenic (+3 oxidation state) methyltransferase 639 81 C20140401_SF093_03 C20140401_SF093_03 TB143912.[MT7]-LGEAGIK[MT7].2b5_1.heavy 488.307 / 572.316 2268.0 24.04680061340332 45 17 10 10 8 2.4896379580479375 31.385580098119974 0.0 4 0.976658844911271 8.06218602570917 2268.0 3.298909090909091 2.0 - - - - - - - 668.25 4 8 AS3MT arsenic (+3 oxidation state) methyltransferase 641 82 C20140401_SF093_03 C20140401_SF093_03 TB144385.[MT7]-TQIFLPMNFK[MT7].3y3_1.heavy 509.626 / 552.326 2802.0 42.0786018371582 50 20 10 10 10 7.181200417859295 13.92524845168015 0.0 3 0.9943520330218859 16.413895971035267 2802.0 36.69729490022173 0.0 - - - - - - - 228.88888888888889 5 9 ART3 ADP-ribosyltransferase 3 643 82 C20140401_SF093_03 C20140401_SF093_03 TB144385.[MT7]-TQIFLPMNFK[MT7].3y5_1.heavy 509.626 / 780.419 1731.0 42.0786018371582 50 20 10 10 10 7.181200417859295 13.92524845168015 0.0 3 0.9943520330218859 16.413895971035267 1731.0 20.457272727272724 0.0 - - - - - - - 233.5 3 6 ART3 ADP-ribosyltransferase 3 645 82 C20140401_SF093_03 C20140401_SF093_03 TB144385.[MT7]-TQIFLPMNFK[MT7].3b4_1.heavy 509.626 / 634.368 2802.0 42.0786018371582 50 20 10 10 10 7.181200417859295 13.92524845168015 0.0 3 0.9943520330218859 16.413895971035267 2802.0 49.617973392461195 0.0 - - - - - - - 123.41666666666667 5 12 ART3 ADP-ribosyltransferase 3 647 82 C20140401_SF093_03 C20140401_SF093_03 TB144385.[MT7]-TQIFLPMNFK[MT7].3y4_1.heavy 509.626 / 683.367 1648.0 42.0786018371582 50 20 10 10 10 7.181200417859295 13.92524845168015 0.0 3 0.9943520330218859 16.413895971035267 1648.0 9.488484848484848 0.0 - - - - - - - 189.5 3 10 ART3 ADP-ribosyltransferase 3 649 83 C20140401_SF093_03 C20140401_SF093_03 TB348671.[MT7]-LC[CAM]DAVAVLLNMR.2y8_1.heavy 759.916 / 915.544 2068.0 50.63274955749512 40 14 10 6 10 2.2162808439920973 40.35043158224564 0.03459930419921875 3 0.9411436071719093 5.061882974957261 2068.0 5.331960093116062 1.0 - - - - - - - 229.61111111111111 4 18 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 651 83 C20140401_SF093_03 C20140401_SF093_03 TB348671.[MT7]-LC[CAM]DAVAVLLNMR.2y5_1.heavy 759.916 / 646.37 2261.0 50.63274955749512 40 14 10 6 10 2.2162808439920973 40.35043158224564 0.03459930419921875 3 0.9411436071719093 5.061882974957261 2261.0 2.1533333333333338 1.0 - - - - - - - 254.7058823529412 4 17 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 653 83 C20140401_SF093_03 C20140401_SF093_03 TB348671.[MT7]-LC[CAM]DAVAVLLNMR.2b4_1.heavy 759.916 / 604.288 5556.0 50.63274955749512 40 14 10 6 10 2.2162808439920973 40.35043158224564 0.03459930419921875 3 0.9411436071719093 5.061882974957261 5556.0 10.68082229102167 0.0 - - - - - - - 753.6666666666666 11 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 655 83 C20140401_SF093_03 C20140401_SF093_03 TB348671.[MT7]-LC[CAM]DAVAVLLNMR.2b6_1.heavy 759.916 / 774.394 2391.0 50.63274955749512 40 14 10 6 10 2.2162808439920973 40.35043158224564 0.03459930419921875 3 0.9411436071719093 5.061882974957261 2391.0 5.83264326734534 0.0 - - - - - - - 206.0 4 16 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 657 84 C20140401_SF093_03 C20140401_SF093_03 TB348806.[MT7]-LGIAVIHGEAQDAESDLVDGR.3b6_1.heavy 770.4 / 711.489 24071.0 37.321800231933594 47 17 10 10 10 3.349909867243645 29.851549433561765 0.0 3 0.9736954825303988 7.592601094869506 24071.0 49.58089823010957 0.0 - - - - - - - 718.0 48 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 659 84 C20140401_SF093_03 C20140401_SF093_03 TB348806.[MT7]-LGIAVIHGEAQDAESDLVDGR.3b5_1.heavy 770.4 / 598.404 29361.0 37.321800231933594 47 17 10 10 10 3.349909867243645 29.851549433561765 0.0 3 0.9736954825303988 7.592601094869506 29361.0 39.129499054820414 0.0 - - - - - - - 628.125 58 8 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 661 84 C20140401_SF093_03 C20140401_SF093_03 TB348806.[MT7]-LGIAVIHGEAQDAESDLVDGR.3y5_1.heavy 770.4 / 559.32 12036.0 37.321800231933594 47 17 10 10 10 3.349909867243645 29.851549433561765 0.0 3 0.9736954825303988 7.592601094869506 12036.0 22.029667661080303 0.0 - - - - - - - 248.125 24 8 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 663 84 C20140401_SF093_03 C20140401_SF093_03 TB348806.[MT7]-LGIAVIHGEAQDAESDLVDGR.3y9_1.heavy 770.4 / 961.458 16136.0 37.321800231933594 47 17 10 10 10 3.349909867243645 29.851549433561765 0.0 3 0.9736954825303988 7.592601094869506 16136.0 30.47450285303038 0.0 - - - - - - - 208.0 32 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 665 85 C20140401_SF093_03 C20140401_SF093_03 TB483235.[MT7]-GRPYTLSVALPGSILDNAQSPELR.4y5_1.heavy 675.372 / 601.33 4398.0 41.13585090637207 36 10 10 6 10 0.8963064018626659 66.31695382557513 0.038898468017578125 3 0.8448525817883468 3.091777371565087 4398.0 10.22981675908296 1.0 - - - - - - - 329.22222222222223 8 9 C9orf114 chromosome 9 open reading frame 114 667 85 C20140401_SF093_03 C20140401_SF093_03 TB483235.[MT7]-GRPYTLSVALPGSILDNAQSPELR.4b7_1.heavy 675.372 / 919.512 1338.0 41.13585090637207 36 10 10 6 10 0.8963064018626659 66.31695382557513 0.038898468017578125 3 0.8448525817883468 3.091777371565087 1338.0 3.6020942408376966 1.0 - - - - - - - 270.8888888888889 2 18 C9orf114 chromosome 9 open reading frame 114 669 85 C20140401_SF093_03 C20140401_SF093_03 TB483235.[MT7]-GRPYTLSVALPGSILDNAQSPELR.4b9_1.heavy 675.372 / 1089.62 2772.0 41.13585090637207 36 10 10 6 10 0.8963064018626659 66.31695382557513 0.038898468017578125 3 0.8448525817883468 3.091777371565087 2772.0 13.642303664921466 1.0 - - - - - - - 198.14285714285714 5 14 C9orf114 chromosome 9 open reading frame 114 671 85 C20140401_SF093_03 C20140401_SF093_03 TB483235.[MT7]-GRPYTLSVALPGSILDNAQSPELR.4b9_2.heavy 675.372 / 545.312 8413.0 41.13585090637207 36 10 10 6 10 0.8963064018626659 66.31695382557513 0.038898468017578125 3 0.8448525817883468 3.091777371565087 8413.0 17.07649897830106 0.0 - - - - - - - 278.1818181818182 16 11 C9orf114 chromosome 9 open reading frame 114 673 86 C20140401_SF093_03 C20140401_SF093_03 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 138182.0 34.49879837036133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 138182.0 534.7739861042726 0.0 - - - - - - - 250.5 276 2 675 86 C20140401_SF093_03 C20140401_SF093_03 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 26935.0 34.49879837036133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 26935.0 107.98953517063043 0.0 - - - - - - - 232.71428571428572 53 7 677 86 C20140401_SF093_03 C20140401_SF093_03 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 38836.0 34.49879837036133 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 38836.0 88.14994286921281 0.0 - - - - - - - 292.3333333333333 77 6 679 87 C20140401_SF093_03 C20140401_SF093_03 TB348572.[MT7]-RDVAVAEEVR.2b8_1.heavy 644.36 / 1014.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 681 87 C20140401_SF093_03 C20140401_SF093_03 TB348572.[MT7]-RDVAVAEEVR.2y8_1.heavy 644.36 / 872.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 683 87 C20140401_SF093_03 C20140401_SF093_03 TB348572.[MT7]-RDVAVAEEVR.2y9_1.heavy 644.36 / 987.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 685 87 C20140401_SF093_03 C20140401_SF093_03 TB348572.[MT7]-RDVAVAEEVR.2b6_1.heavy 644.36 / 756.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 687 88 C20140401_SF093_03 C20140401_SF093_03 TB144517.[MT7]-VQTATFQVFVFDK[MT7].3y3_1.heavy 606.673 / 553.31 5600.0 43.17397499084473 41 17 10 6 8 4.1364784706272575 24.175153022091266 0.03150177001953125 4 0.978617102693688 8.424655873712506 5600.0 32.393569131832805 0.0 - - - - - - - 176.72727272727272 11 11 CD244 CD244 molecule, natural killer cell receptor 2B4 689 88 C20140401_SF093_03 C20140401_SF093_03 TB144517.[MT7]-VQTATFQVFVFDK[MT7].3b4_1.heavy 606.673 / 544.321 2022.0 43.17397499084473 41 17 10 6 8 4.1364784706272575 24.175153022091266 0.03150177001953125 4 0.978617102693688 8.424655873712506 2022.0 27.572273101630703 0.0 - - - - - - - 189.07142857142858 4 14 CD244 CD244 molecule, natural killer cell receptor 2B4 691 88 C20140401_SF093_03 C20140401_SF093_03 TB144517.[MT7]-VQTATFQVFVFDK[MT7].3b5_1.heavy 606.673 / 645.369 2178.0 43.17397499084473 41 17 10 6 8 4.1364784706272575 24.175153022091266 0.03150177001953125 4 0.978617102693688 8.424655873712506 2178.0 24.572307692307692 2.0 - - - - - - - 227.0 11 12 CD244 CD244 molecule, natural killer cell receptor 2B4 693 88 C20140401_SF093_03 C20140401_SF093_03 TB144517.[MT7]-VQTATFQVFVFDK[MT7].3b7_1.heavy 606.673 / 920.496 2178.0 43.17397499084473 41 17 10 6 8 4.1364784706272575 24.175153022091266 0.03150177001953125 4 0.978617102693688 8.424655873712506 2178.0 9.49404001514769 0.0 - - - - - - - 184.0 4 11 CD244 CD244 molecule, natural killer cell receptor 2B4 695 89 C20140401_SF093_03 C20140401_SF093_03 TB348678.[MT7]-GRPLAEESEQER.2y5_1.heavy 772.893 / 648.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - C2orf18 chromosome 2 open reading frame 18 697 89 C20140401_SF093_03 C20140401_SF093_03 TB348678.[MT7]-GRPLAEESEQER.2b6_1.heavy 772.893 / 768.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - C2orf18 chromosome 2 open reading frame 18 699 89 C20140401_SF093_03 C20140401_SF093_03 TB348678.[MT7]-GRPLAEESEQER.2y10_1.heavy 772.893 / 1187.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - C2orf18 chromosome 2 open reading frame 18 701 89 C20140401_SF093_03 C20140401_SF093_03 TB348678.[MT7]-GRPLAEESEQER.2b10_2.heavy 772.893 / 621.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - C2orf18 chromosome 2 open reading frame 18 703 90 C20140401_SF093_03 C20140401_SF093_03 TB144117.[MT7]-FSQLYPER.2y4_1.heavy 592.315 / 564.278 N/A 30.27120018005371 48 18 10 10 10 3.8007910175938004 26.310312652577217 0.0 3 0.9896811215205985 12.138693888123653 1799.0 1.1481904740900297 7.0 - - - - - - - 379.0 3 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 705 90 C20140401_SF093_03 C20140401_SF093_03 TB144117.[MT7]-FSQLYPER.2y5_1.heavy 592.315 / 677.362 568.0 30.27120018005371 48 18 10 10 10 3.8007910175938004 26.310312652577217 0.0 3 0.9896811215205985 12.138693888123653 568.0 0.021474309228460997 2.0 - - - - - - - 0.0 1 0 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 707 90 C20140401_SF093_03 C20140401_SF093_03 TB144117.[MT7]-FSQLYPER.2b4_1.heavy 592.315 / 620.352 2273.0 30.27120018005371 48 18 10 10 10 3.8007910175938004 26.310312652577217 0.0 3 0.9896811215205985 12.138693888123653 2273.0 26.504292068198666 0.0 - - - - - - - 168.55555555555554 4 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 709 90 C20140401_SF093_03 C20140401_SF093_03 TB144117.[MT7]-FSQLYPER.2y7_1.heavy 592.315 / 892.452 4356.0 30.27120018005371 48 18 10 10 10 3.8007910175938004 26.310312652577217 0.0 3 0.9896811215205985 12.138693888123653 4356.0 64.77108771929824 0.0 - - - - - - - 123.2 8 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 711 91 C20140401_SF093_03 C20140401_SF093_03 TB144118.[MT7]-LEELYTK[MT7].2y4_1.heavy 592.344 / 668.41 1464.0 30.375 29 14 2 5 8 2.5385639015126915 31.44029554223395 0.04180145263671875 4 0.936247049010199 4.861580436718307 1464.0 0.17490396927016644 2.0 - - - - - - - 276.5833333333333 2 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 713 91 C20140401_SF093_03 C20140401_SF093_03 TB144118.[MT7]-LEELYTK[MT7].2b3_1.heavy 592.344 / 516.279 4099.0 30.375 29 14 2 5 8 2.5385639015126915 31.44029554223395 0.04180145263671875 4 0.936247049010199 4.861580436718307 4099.0 51.35098836804346 0.0 - - - - - - - 257.45454545454544 8 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 715 91 C20140401_SF093_03 C20140401_SF093_03 TB144118.[MT7]-LEELYTK[MT7].2y3_1.heavy 592.344 / 555.326 4684.0 30.375 29 14 2 5 8 2.5385639015126915 31.44029554223395 0.04180145263671875 4 0.936247049010199 4.861580436718307 4684.0 53.58362889182977 0.0 - - - - - - - 227.75 9 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 717 91 C20140401_SF093_03 C20140401_SF093_03 TB144118.[MT7]-LEELYTK[MT7].2y6_1.heavy 592.344 / 926.495 4001.0 30.375 29 14 2 5 8 2.5385639015126915 31.44029554223395 0.04180145263671875 4 0.936247049010199 4.861580436718307 4001.0 38.57374358974359 1.0 - - - - - - - 256.25 21 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 719 92 C20140401_SF093_03 C20140401_SF093_03 TB144113.[MT7]-ELAVEAMK[MT7].2y4_1.heavy 589.838 / 622.335 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 721 92 C20140401_SF093_03 C20140401_SF093_03 TB144113.[MT7]-ELAVEAMK[MT7].2y5_1.heavy 589.838 / 721.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 723 92 C20140401_SF093_03 C20140401_SF093_03 TB144113.[MT7]-ELAVEAMK[MT7].2y6_1.heavy 589.838 / 792.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 725 92 C20140401_SF093_03 C20140401_SF093_03 TB144113.[MT7]-ELAVEAMK[MT7].2y7_1.heavy 589.838 / 905.525 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 727 93 C20140401_SF093_03 C20140401_SF093_03 TB144116.[MT7]-QDEESEFR.2b3_1.heavy 592.271 / 517.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 729 93 C20140401_SF093_03 C20140401_SF093_03 TB144116.[MT7]-QDEESEFR.2b4_1.heavy 592.271 / 646.28 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 731 93 C20140401_SF093_03 C20140401_SF093_03 TB144116.[MT7]-QDEESEFR.2y6_1.heavy 592.271 / 796.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 733 93 C20140401_SF093_03 C20140401_SF093_03 TB144116.[MT7]-QDEESEFR.2y7_1.heavy 592.271 / 911.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 735 94 C20140401_SF093_03 C20140401_SF093_03 TB348543.[MT7]-FDIIVFGK[MT7].2y4_1.heavy 613.873 / 594.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 737 94 C20140401_SF093_03 C20140401_SF093_03 TB348543.[MT7]-FDIIVFGK[MT7].2b3_1.heavy 613.873 / 520.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 739 94 C20140401_SF093_03 C20140401_SF093_03 TB348543.[MT7]-FDIIVFGK[MT7].2y5_1.heavy 613.873 / 707.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 741 94 C20140401_SF093_03 C20140401_SF093_03 TB348543.[MT7]-FDIIVFGK[MT7].2b4_1.heavy 613.873 / 633.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 743 95 C20140401_SF093_03 C20140401_SF093_03 TB144376.[MT7]-GLGSSPDLELLLR.2y8_1.heavy 757.439 / 968.578 6119.0 43.66390037536621 38 13 10 7 8 1.2790705220497434 45.11471485032132 0.029201507568359375 4 0.9205689852596768 4.349604874424889 6119.0 0.6260383172138063 1.0 - - - - - - - 301.29411764705884 12 17 SLC35C2 solute carrier family 35, member C2 745 95 C20140401_SF093_03 C20140401_SF093_03 TB144376.[MT7]-GLGSSPDLELLLR.2y9_1.heavy 757.439 / 1055.61 3442.0 43.66390037536621 38 13 10 7 8 1.2790705220497434 45.11471485032132 0.029201507568359375 4 0.9205689852596768 4.349604874424889 3442.0 5.249237472766884 0.0 - - - - - - - 332.6 6 20 SLC35C2 solute carrier family 35, member C2 747 95 C20140401_SF093_03 C20140401_SF093_03 TB144376.[MT7]-GLGSSPDLELLLR.2y6_1.heavy 757.439 / 756.498 2830.0 43.66390037536621 38 13 10 7 8 1.2790705220497434 45.11471485032132 0.029201507568359375 4 0.9205689852596768 4.349604874424889 2830.0 0.035374169111632436 3.0 - - - - - - - 650.0 7 8 SLC35C2 solute carrier family 35, member C2 749 95 C20140401_SF093_03 C20140401_SF093_03 TB144376.[MT7]-GLGSSPDLELLLR.2y11_1.heavy 757.439 / 1199.66 2295.0 43.66390037536621 38 13 10 7 8 1.2790705220497434 45.11471485032132 0.029201507568359375 4 0.9205689852596768 4.349604874424889 2295.0 7.75 0.0 - - - - - - - 239.2173913043478 4 23 SLC35C2 solute carrier family 35, member C2 751 96 C20140401_SF093_03 C20140401_SF093_03 TB348541.[MT7]-LLC[CAM]SWQLR.2y6_1.heavy 610.341 / 849.404 2574.0 38.72420120239258 50 20 10 10 10 58.99368363868592 1.695096726159063 0.0 2 0.9995623952534258 58.99368420012274 2574.0 45.75744642857143 0.0 - - - - - - - 186.66666666666666 5 6 FANCL Fanconi anemia, complementation group L 753 96 C20140401_SF093_03 C20140401_SF093_03 TB348541.[MT7]-LLC[CAM]SWQLR.2y4_1.heavy 610.341 / 602.341 N/A 38.72420120239258 50 20 10 10 10 58.99368363868592 1.695096726159063 0.0 2 0.9995623952534258 58.99368420012274 783.0 8.333357142857142 0.0 - - - - - - - 0.0 1 0 FANCL Fanconi anemia, complementation group L 755 96 C20140401_SF093_03 C20140401_SF093_03 TB348541.[MT7]-LLC[CAM]SWQLR.2y5_1.heavy 610.341 / 689.373 N/A 38.72420120239258 50 20 10 10 10 58.99368363868592 1.695096726159063 0.0 2 0.9995623952534258 58.99368420012274 783.0 5.751321428571428 0.0 - - - - - - - 0.0 1 0 FANCL Fanconi anemia, complementation group L 757 96 C20140401_SF093_03 C20140401_SF093_03 TB348541.[MT7]-LLC[CAM]SWQLR.2y7_1.heavy 610.341 / 962.488 7945.0 38.72420120239258 50 20 10 10 10 58.99368363868592 1.695096726159063 0.0 2 0.9995623952534258 58.99368420012274 7945.0 43.13280850893997 0.0 - - - - - - - 201.6 15 5 FANCL Fanconi anemia, complementation group L 759 97 C20140401_SF093_03 C20140401_SF093_03 TB348680.[MT7]-RLEEEEAAAEK[MT7].2y4_1.heavy 781.917 / 562.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 761 97 C20140401_SF093_03 C20140401_SF093_03 TB348680.[MT7]-RLEEEEAAAEK[MT7].2y5_1.heavy 781.917 / 633.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 763 97 C20140401_SF093_03 C20140401_SF093_03 TB348680.[MT7]-RLEEEEAAAEK[MT7].2b4_1.heavy 781.917 / 672.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 765 97 C20140401_SF093_03 C20140401_SF093_03 TB348680.[MT7]-RLEEEEAAAEK[MT7].2b9_1.heavy 781.917 / 1143.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 767 98 C20140401_SF093_03 C20140401_SF093_03 TB483207.[MT7]-LLHQQQPLHPEWAALAK[MT7].4y4_1.heavy 567.827 / 546.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 769 98 C20140401_SF093_03 C20140401_SF093_03 TB483207.[MT7]-LLHQQQPLHPEWAALAK[MT7].4b4_1.heavy 567.827 / 636.395 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 771 98 C20140401_SF093_03 C20140401_SF093_03 TB483207.[MT7]-LLHQQQPLHPEWAALAK[MT7].4b6_1.heavy 567.827 / 892.512 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 773 98 C20140401_SF093_03 C20140401_SF093_03 TB483207.[MT7]-LLHQQQPLHPEWAALAK[MT7].4b3_1.heavy 567.827 / 508.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 775 99 C20140401_SF093_03 C20140401_SF093_03 TB482774.[MT7]-FSFIVK[MT7].2y4_1.heavy 514.823 / 650.436 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 777 99 C20140401_SF093_03 C20140401_SF093_03 TB482774.[MT7]-FSFIVK[MT7].2b3_1.heavy 514.823 / 526.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 779 99 C20140401_SF093_03 C20140401_SF093_03 TB482774.[MT7]-FSFIVK[MT7].2y5_1.heavy 514.823 / 737.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 781 99 C20140401_SF093_03 C20140401_SF093_03 TB482774.[MT7]-FSFIVK[MT7].2y3_1.heavy 514.823 / 503.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 783 100 C20140401_SF093_03 C20140401_SF093_03 TB144674.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].3b9_1.heavy 963.871 / 1101.61 2923.0 51.15869903564453 44 14 10 10 10 1.6291963700764462 50.55212914190609 0.0 3 0.9383355216522528 4.944102426661885 2923.0 29.395064593486502 0.0 - - - - - - - 185.5909090909091 5 22 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 785 100 C20140401_SF093_03 C20140401_SF093_03 TB144674.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].3b6_1.heavy 963.871 / 754.422 3247.0 51.15869903564453 44 14 10 10 10 1.6291963700764462 50.55212914190609 0.0 3 0.9383355216522528 4.944102426661885 3247.0 35.06776110146365 0.0 - - - - - - - 123.66666666666667 6 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 787 100 C20140401_SF093_03 C20140401_SF093_03 TB144674.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].3y5_1.heavy 963.871 / 646.4 1438.0 51.15869903564453 44 14 10 10 10 1.6291963700764462 50.55212914190609 0.0 3 0.9383355216522528 4.944102426661885 1438.0 15.406059910692136 1.0 - - - - - - - 107.0625 2 16 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 789 100 C20140401_SF093_03 C20140401_SF093_03 TB144674.[MT7]-EPLGNVLFSPIC[CAM]LSTSLSLAQVGAK[MT7].3b7_1.heavy 963.871 / 867.506 2180.0 51.15869903564453 44 14 10 10 10 1.6291963700764462 50.55212914190609 0.0 3 0.9383355216522528 4.944102426661885 2180.0 44.303225806451614 0.0 - - - - - - - 123.75 4 12 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 791 101 C20140401_SF093_03 C20140401_SF093_03 TB483108.[MT7]-DC[CAM]YVLSQLVGEK[MT7].3b4_1.heavy 566.971 / 682.299 4275.0 38.365299224853516 38 13 10 5 10 3.7246921365831147 26.847856502775567 0.0467987060546875 3 0.9010411789418435 3.89033380100998 4275.0 53.88655462184874 0.0 - - - - - - - 148.5 8 4 AS3MT arsenic (+3 oxidation state) methyltransferase 793 101 C20140401_SF093_03 C20140401_SF093_03 TB483108.[MT7]-DC[CAM]YVLSQLVGEK[MT7].3b5_1.heavy 566.971 / 795.383 1781.0 38.365299224853516 38 13 10 5 10 3.7246921365831147 26.847856502775567 0.0467987060546875 3 0.9010411789418435 3.89033380100998 1781.0 17.95966386554622 0.0 - - - - - - - 148.5 3 4 AS3MT arsenic (+3 oxidation state) methyltransferase 795 101 C20140401_SF093_03 C20140401_SF093_03 TB483108.[MT7]-DC[CAM]YVLSQLVGEK[MT7].3y4_1.heavy 566.971 / 576.347 3800.0 38.365299224853516 38 13 10 5 10 3.7246921365831147 26.847856502775567 0.0467987060546875 3 0.9010411789418435 3.89033380100998 3800.0 38.89411764705882 0.0 - - - - - - - 213.8 7 5 AS3MT arsenic (+3 oxidation state) methyltransferase 797 101 C20140401_SF093_03 C20140401_SF093_03 TB483108.[MT7]-DC[CAM]YVLSQLVGEK[MT7].3b3_1.heavy 566.971 / 583.23 1544.0 38.365299224853516 38 13 10 5 10 3.7246921365831147 26.847856502775567 0.0467987060546875 3 0.9010411789418435 3.89033380100998 1544.0 -0.35918597902312877 2.0 - - - - - - - 169.57142857142858 3 7 AS3MT arsenic (+3 oxidation state) methyltransferase 799 102 C20140401_SF093_03 C20140401_SF093_03 TB482779.[MT7]-VVSSQDPR.2b6_1.heavy 516.284 / 760.396 15272.0 16.444100379943848 41 18 10 5 8 1.3711165370632006 41.74079125298268 0.04120063781738281 4 0.9812451081890453 8.997544017709034 15272.0 74.00823536167525 0.0 - - - - - - - 181.4 30 10 C9orf114 chromosome 9 open reading frame 114 801 102 C20140401_SF093_03 C20140401_SF093_03 TB482779.[MT7]-VVSSQDPR.2y6_1.heavy 516.284 / 689.321 694.0 16.444100379943848 41 18 10 5 8 1.3711165370632006 41.74079125298268 0.04120063781738281 4 0.9812451081890453 8.997544017709034 694.0 17.890294480691235 0.0 - - - - - - - 0.0 1 0 C9orf114 chromosome 9 open reading frame 114 803 102 C20140401_SF093_03 C20140401_SF093_03 TB482779.[MT7]-VVSSQDPR.2b5_1.heavy 516.284 / 645.369 1228.0 16.444100379943848 41 18 10 5 8 1.3711165370632006 41.74079125298268 0.04120063781738281 4 0.9812451081890453 8.997544017709034 1228.0 21.72765297125727 0.0 - - - - - - - 97.75 2 12 C9orf114 chromosome 9 open reading frame 114 805 102 C20140401_SF093_03 C20140401_SF093_03 TB482779.[MT7]-VVSSQDPR.2y7_1.heavy 516.284 / 788.39 1068.0 16.444100379943848 41 18 10 5 8 1.3711165370632006 41.74079125298268 0.04120063781738281 4 0.9812451081890453 8.997544017709034 1068.0 6.57625 1.0 - - - - - - - 135.8181818181818 8 11 C9orf114 chromosome 9 open reading frame 114 807 103 C20140401_SF093_03 C20140401_SF093_03 TB482778.[MT7]-AASLC[CAM]LPR.2y5_1.heavy 516.293 / 658.37 1029.0 28.778200149536133 44 18 10 6 10 5.617450285087951 17.8016706735188 0.032199859619140625 3 0.9881846101906373 11.34252643439627 1029.0 1.3608761329305135 3.0 - - - - - - - 263.3157894736842 2 19 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 809 103 C20140401_SF093_03 C20140401_SF093_03 TB482778.[MT7]-AASLC[CAM]LPR.2y6_1.heavy 516.293 / 745.403 2279.0 28.778200149536133 44 18 10 6 10 5.617450285087951 17.8016706735188 0.032199859619140625 3 0.9881846101906373 11.34252643439627 2279.0 13.91816326530612 2.0 - - - - - - - 147.2941176470588 4 17 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 811 103 C20140401_SF093_03 C20140401_SF093_03 TB482778.[MT7]-AASLC[CAM]LPR.2b5_1.heavy 516.293 / 647.33 1470.0 28.778200149536133 44 18 10 6 10 5.617450285087951 17.8016706735188 0.032199859619140625 3 0.9881846101906373 11.34252643439627 1470.0 0.6665457842248412 1.0 - - - - - - - 188.6875 2 16 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 813 103 C20140401_SF093_03 C20140401_SF093_03 TB482778.[MT7]-AASLC[CAM]LPR.2y7_1.heavy 516.293 / 816.44 4852.0 28.778200149536133 44 18 10 6 10 5.617450285087951 17.8016706735188 0.032199859619140625 3 0.9881846101906373 11.34252643439627 4852.0 63.34486486486486 0.0 - - - - - - - 180.72727272727272 9 11 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 815 104 C20140401_SF093_03 C20140401_SF093_03 TB144112.[MT7]-FVIDVGVER.2y8_1.heavy 589.339 / 886.499 4752.0 36.390098571777344 42 12 10 10 10 0.8532515748780152 67.29461508363009 0.0 3 0.8816201540412638 3.550937565962784 4752.0 71.352 0.0 - - - - - - - 132.0 9 7 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 817 104 C20140401_SF093_03 C20140401_SF093_03 TB144112.[MT7]-FVIDVGVER.2y5_1.heavy 589.339 / 559.32 4356.0 36.390098571777344 42 12 10 10 10 0.8532515748780152 67.29461508363009 0.0 3 0.8816201540412638 3.550937565962784 4356.0 -0.2969666329625884 2.0 - - - - - - - 352.0 12 3 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 819 104 C20140401_SF093_03 C20140401_SF093_03 TB144112.[MT7]-FVIDVGVER.2b4_1.heavy 589.339 / 619.357 5940.0 36.390098571777344 42 12 10 10 10 0.8532515748780152 67.29461508363009 0.0 3 0.8816201540412638 3.550937565962784 5940.0 57.75 0.0 - - - - - - - 242.0 11 6 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 821 104 C20140401_SF093_03 C20140401_SF093_03 TB144112.[MT7]-FVIDVGVER.2y7_1.heavy 589.339 / 787.431 4092.0 36.390098571777344 42 12 10 10 10 0.8532515748780152 67.29461508363009 0.0 3 0.8816201540412638 3.550937565962784 4092.0 30.628 0.0 - - - - - - - 132.0 8 5 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 823 105 C20140401_SF093_03 C20140401_SF093_03 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 379854.0 21.817399978637695 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 379854.0 719.3613397259769 0.0 - - - - - - - 1228.4285714285713 759 7 825 105 C20140401_SF093_03 C20140401_SF093_03 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 525635.0 21.817399978637695 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 525635.0 1056.3445458941785 0.0 - - - - - - - 718.0 1051 9 827 105 C20140401_SF093_03 C20140401_SF093_03 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 1647260.0 21.817399978637695 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1647260.0 14301.710735330525 0.0 - - - - - - - 375.1666666666667 3294 6 829 106 C20140401_SF093_03 C20140401_SF093_03 TB143807.[MT7]-RDVAVAEEVR.3b4_1.heavy 429.909 / 586.343 67172.0 20.649200439453125 47 17 10 10 10 5.597784017828727 17.86421192412995 0.0 3 0.9797291413089307 8.653462741354264 67172.0 215.3714922947143 0.0 - - - - - - - 736.875 134 8 FBLIM1 filamin binding LIM protein 1 831 106 C20140401_SF093_03 C20140401_SF093_03 TB143807.[MT7]-RDVAVAEEVR.3b3_1.heavy 429.909 / 515.306 15602.0 20.649200439453125 47 17 10 10 10 5.597784017828727 17.86421192412995 0.0 3 0.9797291413089307 8.653462741354264 15602.0 25.484349762813835 0.0 - - - - - - - 752.6363636363636 31 11 FBLIM1 filamin binding LIM protein 1 833 106 C20140401_SF093_03 C20140401_SF093_03 TB143807.[MT7]-RDVAVAEEVR.3y4_1.heavy 429.909 / 532.273 54011.0 20.649200439453125 47 17 10 10 10 5.597784017828727 17.86421192412995 0.0 3 0.9797291413089307 8.653462741354264 54011.0 110.06616511642824 0.0 - - - - - - - 610.25 108 8 FBLIM1 filamin binding LIM protein 1 835 106 C20140401_SF093_03 C20140401_SF093_03 TB143807.[MT7]-RDVAVAEEVR.3y5_1.heavy 429.909 / 603.31 90158.0 20.649200439453125 47 17 10 10 10 5.597784017828727 17.86421192412995 0.0 3 0.9797291413089307 8.653462741354264 90158.0 544.105422310084 0.0 - - - - - - - 211.83333333333334 180 18 FBLIM1 filamin binding LIM protein 1 837 107 C20140401_SF093_03 C20140401_SF093_03 TB143806.[MT7]-ALQLLR.2y4_1.heavy 429.288 / 529.346 15345.0 33.07889938354492 44 14 10 10 10 1.8263115262985687 47.70206890046387 0.0 3 0.9442373601919882 5.201775866977743 15345.0 18.96451271186441 0.0 - - - - - - - 311.85714285714283 30 14 ART5;ZFYVE26;ART3 ADP-ribosyltransferase 5;zinc finger, FYVE domain containing 26;ADP-ribosyltransferase 3 839 107 C20140401_SF093_03 C20140401_SF093_03 TB143806.[MT7]-ALQLLR.2b3_1.heavy 429.288 / 457.289 26440.0 33.07889938354492 44 14 10 10 10 1.8263115262985687 47.70206890046387 0.0 3 0.9442373601919882 5.201775866977743 26440.0 19.510464875589975 0.0 - - - - - - - 236.0 52 10 ART5;ZFYVE26;ART3 ADP-ribosyltransferase 5;zinc finger, FYVE domain containing 26;ADP-ribosyltransferase 3 841 107 C20140401_SF093_03 C20140401_SF093_03 TB143806.[MT7]-ALQLLR.2y5_1.heavy 429.288 / 642.43 35293.0 33.07889938354492 44 14 10 10 10 1.8263115262985687 47.70206890046387 0.0 3 0.9442373601919882 5.201775866977743 35293.0 91.97116525423728 0.0 - - - - - - - 200.6 70 10 ART5;ZFYVE26;ART3 ADP-ribosyltransferase 5;zinc finger, FYVE domain containing 26;ADP-ribosyltransferase 3 843 107 C20140401_SF093_03 C20140401_SF093_03 TB143806.[MT7]-ALQLLR.2b4_1.heavy 429.288 / 570.373 26204.0 33.07889938354492 44 14 10 10 10 1.8263115262985687 47.70206890046387 0.0 3 0.9442373601919882 5.201775866977743 26204.0 21.51129906609152 0.0 - - - - - - - 236.0 52 9 ART5;ZFYVE26;ART3 ADP-ribosyltransferase 5;zinc finger, FYVE domain containing 26;ADP-ribosyltransferase 3 845 108 C20140401_SF093_03 C20140401_SF093_03 TB348684.[MT7]-IIADIFEYTAK[MT7].2y4_1.heavy 786.45 / 626.363 7265.0 46.09294891357422 46 20 10 6 10 7.787701668147578 12.840758963457636 0.0363006591796875 3 0.9955678691523189 18.530858865795807 7265.0 27.483342266690492 0.0 - - - - - - - 354.52941176470586 14 17 MUT methylmalonyl CoA mutase 847 108 C20140401_SF093_03 C20140401_SF093_03 TB348684.[MT7]-IIADIFEYTAK[MT7].2y8_1.heavy 786.45 / 1130.58 4946.0 46.09294891357422 46 20 10 6 10 7.787701668147578 12.840758963457636 0.0363006591796875 3 0.9955678691523189 18.530858865795807 4946.0 11.626770449726592 0.0 - - - - - - - 290.88235294117646 9 17 MUT methylmalonyl CoA mutase 849 108 C20140401_SF093_03 C20140401_SF093_03 TB348684.[MT7]-IIADIFEYTAK[MT7].2y6_1.heavy 786.45 / 902.474 8501.0 46.09294891357422 46 20 10 6 10 7.787701668147578 12.840758963457636 0.0363006591796875 3 0.9955678691523189 18.530858865795807 8501.0 26.20418247061388 0.0 - - - - - - - 259.0 17 20 MUT methylmalonyl CoA mutase 851 108 C20140401_SF093_03 C20140401_SF093_03 TB348684.[MT7]-IIADIFEYTAK[MT7].2y7_1.heavy 786.45 / 1015.56 7265.0 46.09294891357422 46 20 10 6 10 7.787701668147578 12.840758963457636 0.0363006591796875 3 0.9955678691523189 18.530858865795807 7265.0 16.59369399573301 0.0 - - - - - - - 275.375 14 16 MUT methylmalonyl CoA mutase 853 109 C20140401_SF093_03 C20140401_SF093_03 TB144107.[MT7]-VYEDETK[MT7].2y4_1.heavy 586.308 / 636.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 855 109 C20140401_SF093_03 C20140401_SF093_03 TB144107.[MT7]-VYEDETK[MT7].2y5_1.heavy 586.308 / 765.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 857 109 C20140401_SF093_03 C20140401_SF093_03 TB144107.[MT7]-VYEDETK[MT7].2y3_1.heavy 586.308 / 521.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 859 109 C20140401_SF093_03 C20140401_SF093_03 TB144107.[MT7]-VYEDETK[MT7].2y6_1.heavy 586.308 / 928.438 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 861 110 C20140401_SF093_03 C20140401_SF093_03 TB144102.[MT7]-GVAVTNTSK[MT7].2y6_1.heavy 582.845 / 793.454 1113.0 17.928099632263184 40 14 10 6 10 1.5946309531076646 49.6612372648079 0.033199310302734375 3 0.9371735144220474 4.897681818384493 1113.0 32.06949152542373 0.0 - - - - - - - 110.125 2 8 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 863 110 C20140401_SF093_03 C20140401_SF093_03 TB144102.[MT7]-GVAVTNTSK[MT7].2y4_1.heavy 582.845 / 593.338 351.0 17.928099632263184 40 14 10 6 10 1.5946309531076646 49.6612372648079 0.033199310302734375 3 0.9371735144220474 4.897681818384493 351.0 4.8 0.0 - - - - - - - 0.0 0 0 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 865 110 C20140401_SF093_03 C20140401_SF093_03 TB144102.[MT7]-GVAVTNTSK[MT7].2y5_1.heavy 582.845 / 694.385 1288.0 17.928099632263184 40 14 10 6 10 1.5946309531076646 49.6612372648079 0.033199310302734375 3 0.9371735144220474 4.897681818384493 1288.0 31.310919889902937 0.0 - - - - - - - 175.85714285714286 2 7 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 867 110 C20140401_SF093_03 C20140401_SF093_03 TB144102.[MT7]-GVAVTNTSK[MT7].2y7_1.heavy 582.845 / 864.491 527.0 17.928099632263184 40 14 10 6 10 1.5946309531076646 49.6612372648079 0.033199310302734375 3 0.9371735144220474 4.897681818384493 527.0 17.41779661016949 0.0 - - - - - - - 0.0 1 0 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 869 111 C20140401_SF093_03 C20140401_SF093_03 TB483090.[MT7]-EALQNVHEEVALR.3y7_1.heavy 551.301 / 853.453 9896.0 27.473750114440918 43 17 10 6 10 2.7183517545841744 29.325394421131985 0.033000946044921875 3 0.9725769463695708 7.435444941514273 9896.0 94.92092255095332 0.0 - - - - - - - 135.41176470588235 19 17 AS3MT arsenic (+3 oxidation state) methyltransferase 871 111 C20140401_SF093_03 C20140401_SF093_03 TB483090.[MT7]-EALQNVHEEVALR.3y6_1.heavy 551.301 / 716.394 19061.0 27.473750114440918 43 17 10 6 10 2.7183517545841744 29.325394421131985 0.033000946044921875 3 0.9725769463695708 7.435444941514273 19061.0 102.80550768555116 0.0 - - - - - - - 146.61111111111111 38 18 AS3MT arsenic (+3 oxidation state) methyltransferase 873 111 C20140401_SF093_03 C20140401_SF093_03 TB483090.[MT7]-EALQNVHEEVALR.3b4_1.heavy 551.301 / 586.332 10458.0 27.473750114440918 43 17 10 6 10 2.7183517545841744 29.325394421131985 0.033000946044921875 3 0.9725769463695708 7.435444941514273 10458.0 96.42284866468843 0.0 - - - - - - - 155.14285714285714 20 21 AS3MT arsenic (+3 oxidation state) methyltransferase 875 111 C20140401_SF093_03 C20140401_SF093_03 TB483090.[MT7]-EALQNVHEEVALR.3b5_1.heavy 551.301 / 700.375 11639.0 27.473750114440918 43 17 10 6 10 2.7183517545841744 29.325394421131985 0.033000946044921875 3 0.9725769463695708 7.435444941514273 11639.0 194.32973214285715 0.0 - - - - - - - 155.23809523809524 23 21 AS3MT arsenic (+3 oxidation state) methyltransferase 877 112 C20140401_SF093_03 C20140401_SF093_03 TB483094.[MT7]-K[MT7]RPC[CAM]GPGEHGQR.3y7_1.heavy 556.298 / 780.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 879 112 C20140401_SF093_03 C20140401_SF093_03 TB483094.[MT7]-K[MT7]RPC[CAM]GPGEHGQR.3y8_1.heavy 556.298 / 837.396 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 881 112 C20140401_SF093_03 C20140401_SF093_03 TB483094.[MT7]-K[MT7]RPC[CAM]GPGEHGQR.3b8_2.heavy 556.298 / 585.818 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 883 112 C20140401_SF093_03 C20140401_SF093_03 TB483094.[MT7]-K[MT7]RPC[CAM]GPGEHGQR.3y10_1.heavy 556.298 / 1094.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 885 113 C20140401_SF093_03 C20140401_SF093_03 TB482780.[MT7]-EIEVLER.2y5_1.heavy 516.296 / 645.357 9830.0 29.431349754333496 46 20 10 6 10 10.158326168803278 9.844141479440278 0.03330039978027344 3 0.9956008275940562 18.600196768129504 9830.0 26.45946791862285 0.0 - - - - - - - 253.33333333333334 19 18 PALM paralemmin 887 113 C20140401_SF093_03 C20140401_SF093_03 TB482780.[MT7]-EIEVLER.2b4_1.heavy 516.296 / 615.347 12068.0 29.431349754333496 46 20 10 6 10 10.158326168803278 9.844141479440278 0.03330039978027344 3 0.9956008275940562 18.600196768129504 12068.0 26.617138739946377 0.0 - - - - - - - 324.44444444444446 24 18 PALM paralemmin 889 113 C20140401_SF093_03 C20140401_SF093_03 TB482780.[MT7]-EIEVLER.2y6_1.heavy 516.296 / 758.441 16863.0 29.431349754333496 46 20 10 6 10 10.158326168803278 9.844141479440278 0.03330039978027344 3 0.9956008275940562 18.600196768129504 16863.0 38.03171081677705 0.0 - - - - - - - 650.4285714285714 33 7 PALM paralemmin 891 113 C20140401_SF093_03 C20140401_SF093_03 TB482780.[MT7]-EIEVLER.2b5_1.heavy 516.296 / 728.431 3516.0 29.431349754333496 46 20 10 6 10 10.158326168803278 9.844141479440278 0.03330039978027344 3 0.9956008275940562 18.600196768129504 3516.0 21.90175 0.0 - - - - - - - 257.39130434782606 7 23 PALM paralemmin 893 114 C20140401_SF093_03 C20140401_SF093_03 TB144366.[MT7]-LTGTIQNDILK[MT7].3b6_1.heavy 501.971 / 758.453 2832.0 34.87810134887695 50 20 10 10 10 28.08934680317262 3.5600685448728644 0.0 3 0.9969778650777533 22.44378034784891 2832.0 17.080155642023346 0.0 - - - - - - - 228.66666666666666 5 9 MUT methylmalonyl CoA mutase 895 114 C20140401_SF093_03 C20140401_SF093_03 TB144366.[MT7]-LTGTIQNDILK[MT7].3b5_1.heavy 501.971 / 630.394 5534.0 34.87810134887695 50 20 10 10 10 28.08934680317262 3.5600685448728644 0.0 3 0.9969778650777533 22.44378034784891 5534.0 13.142121275012165 1.0 - - - - - - - 273.25 11 8 MUT methylmalonyl CoA mutase 897 114 C20140401_SF093_03 C20140401_SF093_03 TB144366.[MT7]-LTGTIQNDILK[MT7].3y4_1.heavy 501.971 / 632.41 3861.0 34.87810134887695 50 20 10 10 10 28.08934680317262 3.5600685448728644 0.0 3 0.9969778650777533 22.44378034784891 3861.0 27.49272373540856 0.0 - - - - - - - 273.25 7 8 MUT methylmalonyl CoA mutase 899 114 C20140401_SF093_03 C20140401_SF093_03 TB144366.[MT7]-LTGTIQNDILK[MT7].3y5_1.heavy 501.971 / 746.453 5277.0 34.87810134887695 50 20 10 10 10 28.08934680317262 3.5600685448728644 0.0 3 0.9969778650777533 22.44378034784891 5277.0 51.605104952403906 0.0 - - - - - - - 193.125 10 8 MUT methylmalonyl CoA mutase 901 115 C20140401_SF093_03 C20140401_SF093_03 TB483098.[MT7]-ITVNEVELLVMK[MT7].2y4_1.heavy 838.499 / 634.408 3711.0 45.78510093688965 46 20 10 6 10 5.661039015554688 17.6646018028197 0.039600372314453125 3 0.9929794977074579 14.720544311146007 3711.0 15.33390015173468 0.0 - - - - - - - 282.35 7 20 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 903 115 C20140401_SF093_03 C20140401_SF093_03 TB483098.[MT7]-ITVNEVELLVMK[MT7].2y3_1.heavy 838.499 / 521.324 3402.0 45.78510093688965 46 20 10 6 10 5.661039015554688 17.6646018028197 0.039600372314453125 3 0.9929794977074579 14.720544311146007 3402.0 24.864792328938453 0.0 - - - - - - - 279.6923076923077 6 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 905 115 C20140401_SF093_03 C20140401_SF093_03 TB483098.[MT7]-ITVNEVELLVMK[MT7].2b7_1.heavy 838.499 / 929.506 3866.0 45.78510093688965 46 20 10 6 10 5.661039015554688 17.6646018028197 0.039600372314453125 3 0.9929794977074579 14.720544311146007 3866.0 14.99741379310345 0.0 - - - - - - - 232.0 7 16 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 907 115 C20140401_SF093_03 C20140401_SF093_03 TB483098.[MT7]-ITVNEVELLVMK[MT7].2b5_1.heavy 838.499 / 701.395 4485.0 45.78510093688965 46 20 10 6 10 5.661039015554688 17.6646018028197 0.039600372314453125 3 0.9929794977074579 14.720544311146007 4485.0 9.569291102562822 0.0 - - - - - - - 263.0 8 15 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 909 116 C20140401_SF093_03 C20140401_SF093_03 TB144367.[MT7]-GSDVASAQLPNFR.2y4_1.heavy 753.395 / 533.283 6530.0 31.348499298095703 48 18 10 10 10 6.380137596359837 15.673643160463282 0.0 3 0.9842707778003887 9.827381997519788 6530.0 22.244667819684874 0.0 - - - - - - - 703.1428571428571 13 7 C9orf114 chromosome 9 open reading frame 114 911 116 C20140401_SF093_03 C20140401_SF093_03 TB144367.[MT7]-GSDVASAQLPNFR.2b4_1.heavy 753.395 / 503.258 5888.0 31.348499298095703 48 18 10 10 10 6.380137596359837 15.673643160463282 0.0 3 0.9842707778003887 9.827381997519788 5888.0 5.302803738317757 1.0 - - - - - - - 687.8571428571429 11 7 C9orf114 chromosome 9 open reading frame 114 913 116 C20140401_SF093_03 C20140401_SF093_03 TB144367.[MT7]-GSDVASAQLPNFR.2y9_1.heavy 753.395 / 1003.53 9421.0 31.348499298095703 48 18 10 10 10 6.380137596359837 15.673643160463282 0.0 3 0.9842707778003887 9.827381997519788 9421.0 55.02920560747664 0.0 - - - - - - - 263.38461538461536 18 13 C9orf114 chromosome 9 open reading frame 114 915 116 C20140401_SF093_03 C20140401_SF093_03 TB144367.[MT7]-GSDVASAQLPNFR.2y10_1.heavy 753.395 / 1102.6 5995.0 31.348499298095703 48 18 10 10 10 6.380137596359837 15.673643160463282 0.0 3 0.9842707778003887 9.827381997519788 5995.0 26.44861995481154 1.0 - - - - - - - 222.23076923076923 14 13 C9orf114 chromosome 9 open reading frame 114 917 117 C20140401_SF093_03 C20140401_SF093_03 TB482784.[MT7]-GIPEFWFTIFR.3b4_1.heavy 519.618 / 541.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 919 117 C20140401_SF093_03 C20140401_SF093_03 TB482784.[MT7]-GIPEFWFTIFR.3b5_1.heavy 519.618 / 688.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 921 117 C20140401_SF093_03 C20140401_SF093_03 TB482784.[MT7]-GIPEFWFTIFR.3y4_1.heavy 519.618 / 536.319 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 923 117 C20140401_SF093_03 C20140401_SF093_03 TB482784.[MT7]-GIPEFWFTIFR.3y5_1.heavy 519.618 / 683.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 925 118 C20140401_SF093_03 C20140401_SF093_03 TB144664.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].3y6_1.heavy 916.844 / 776.463 4624.0 54.02130126953125 44 14 10 10 10 2.006051145560516 44.954174051123026 0.0 3 0.9383262138863373 4.9437254087267135 4624.0 57.8 0.0 - - - - - - - 108.60714285714286 9 28 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 927 118 C20140401_SF093_03 C20140401_SF093_03 TB144664.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].3b4_1.heavy 916.844 / 555.399 7437.0 54.02130126953125 44 14 10 10 10 2.006051145560516 44.954174051123026 0.0 3 0.9383262138863373 4.9437254087267135 7437.0 0.0 0.0 - - - - - - - 136.19230769230768 14 26 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 929 118 C20140401_SF093_03 C20140401_SF093_03 TB144664.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].3b8_1.heavy 916.844 / 997.605 8189.0 54.02130126953125 44 14 10 10 10 2.006051145560516 44.954174051123026 0.0 3 0.9383262138863373 4.9437254087267135 8189.0 8.398974358974357 0.0 - - - - - - - 121.39285714285714 16 28 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 931 118 C20140401_SF093_03 C20140401_SF093_03 TB144664.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].3b7_1.heavy 916.844 / 884.521 8523.0 54.02130126953125 44 14 10 10 10 2.006051145560516 44.954174051123026 0.0 3 0.9383262138863373 4.9437254087267135 8523.0 0.0 0.0 - - - - - - - 121.95833333333333 17 24 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 933 119 C20140401_SF093_03 C20140401_SF093_03 TB144361.[MT7]-ETLTQGLEFC[CAM]R.2y8_1.heavy 749.378 / 1010.47 16454.0 34.0640983581543 42 12 10 10 10 2.2103926499191995 38.67759693099048 0.0 3 0.8976238172371954 3.8237211604976165 16454.0 59.757872807958734 0.0 - - - - - - - 332.55555555555554 32 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 935 119 C20140401_SF093_03 C20140401_SF093_03 TB144361.[MT7]-ETLTQGLEFC[CAM]R.2y6_1.heavy 749.378 / 781.366 4114.0 34.0640983581543 42 12 10 10 10 2.2103926499191995 38.67759693099048 0.0 3 0.8976238172371954 3.8237211604976165 4114.0 3.1510941941595068 1.0 - - - - - - - 304.77777777777777 10 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 937 119 C20140401_SF093_03 C20140401_SF093_03 TB144361.[MT7]-ETLTQGLEFC[CAM]R.2y10_1.heavy 749.378 / 1224.6 3864.0 34.0640983581543 42 12 10 10 10 2.2103926499191995 38.67759693099048 0.0 3 0.8976238172371954 3.8237211604976165 3864.0 8.92002924206128 1.0 - - - - - - - 311.7857142857143 8 14 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 939 119 C20140401_SF093_03 C20140401_SF093_03 TB144361.[MT7]-ETLTQGLEFC[CAM]R.2y7_1.heavy 749.378 / 909.425 5360.0 34.0640983581543 42 12 10 10 10 2.2103926499191995 38.67759693099048 0.0 3 0.8976238172371954 3.8237211604976165 5360.0 32.84515172991431 0.0 - - - - - - - 301.25 10 12 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 941 120 C20140401_SF093_03 C20140401_SF093_03 TB144360.[MT7]-AAVQVLDDIEK[MT7].3y3_1.heavy 496.955 / 533.341 6898.0 35.751399993896484 43 18 10 5 10 3.5669524048267096 28.035137184528317 0.040802001953125 3 0.9848895331273487 10.027092951676277 6898.0 26.076475409060368 0.0 - - - - - - - 298.5 13 8 MUT methylmalonyl CoA mutase 943 120 C20140401_SF093_03 C20140401_SF093_03 TB144360.[MT7]-AAVQVLDDIEK[MT7].3b4_1.heavy 496.955 / 514.311 40195.0 35.751399993896484 43 18 10 5 10 3.5669524048267096 28.035137184528317 0.040802001953125 3 0.9848895331273487 10.027092951676277 40195.0 71.64195826639477 0.0 - - - - - - - 251.9 80 10 MUT methylmalonyl CoA mutase 945 120 C20140401_SF093_03 C20140401_SF093_03 TB144360.[MT7]-AAVQVLDDIEK[MT7].3b5_1.heavy 496.955 / 613.379 15654.0 35.751399993896484 43 18 10 5 10 3.5669524048267096 28.035137184528317 0.040802001953125 3 0.9848895331273487 10.027092951676277 15654.0 77.72160437121147 0.0 - - - - - - - 215.75 31 8 MUT methylmalonyl CoA mutase 947 120 C20140401_SF093_03 C20140401_SF093_03 TB144360.[MT7]-AAVQVLDDIEK[MT7].3y5_1.heavy 496.955 / 763.395 7031.0 35.751399993896484 43 18 10 5 10 3.5669524048267096 28.035137184528317 0.040802001953125 3 0.9848895331273487 10.027092951676277 7031.0 21.724915850738384 0.0 - - - - - - - 212.4 14 5 MUT methylmalonyl CoA mutase 949 121 C20140401_SF093_03 C20140401_SF093_03 TB483116.[MT7]-SLGAEHVITEEELR.3y7_1.heavy 576.308 / 889.463 15107.0 29.79669952392578 50 20 10 10 10 5.531363850266995 18.078723929031185 0.0 3 0.9922275236030264 13.989460515084987 15107.0 381.6505263157894 0.0 - - - - - - - 220.9090909090909 30 11 MECR mitochondrial trans-2-enoyl-CoA reductase 951 121 C20140401_SF093_03 C20140401_SF093_03 TB483116.[MT7]-SLGAEHVITEEELR.3y6_1.heavy 576.308 / 776.378 13437.0 29.79669952392578 50 20 10 10 10 5.531363850266995 18.078723929031185 0.0 3 0.9922275236030264 13.989460515084987 13437.0 104.31355263157894 0.0 - - - - - - - 152.0 26 12 MECR mitochondrial trans-2-enoyl-CoA reductase 953 121 C20140401_SF093_03 C20140401_SF093_03 TB483116.[MT7]-SLGAEHVITEEELR.3b5_1.heavy 576.308 / 602.327 21180.0 29.79669952392578 50 20 10 10 10 5.531363850266995 18.078723929031185 0.0 3 0.9922275236030264 13.989460515084987 21180.0 222.80802631578948 0.0 - - - - - - - 189.91666666666666 42 12 MECR mitochondrial trans-2-enoyl-CoA reductase 955 121 C20140401_SF093_03 C20140401_SF093_03 TB483116.[MT7]-SLGAEHVITEEELR.3y8_1.heavy 576.308 / 988.531 5314.0 29.79669952392578 50 20 10 10 10 5.531363850266995 18.078723929031185 0.0 3 0.9922275236030264 13.989460515084987 5314.0 80.05960526315789 0.0 - - - - - - - 177.33333333333334 10 9 MECR mitochondrial trans-2-enoyl-CoA reductase 957 122 C20140401_SF093_03 C20140401_SF093_03 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 90153.0 31.61436716715495 23 -3 10 6 10 null 0.0 0.03940010070800781 3 0.0 0.0 90153.0 858.622726310217 0.0 - - - - - - - 157.5 180 12 959 122 C20140401_SF093_03 C20140401_SF093_03 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 80288.0 31.61436716715495 23 -3 10 6 10 null 0.0 0.03940010070800781 3 0.0 0.0 80288.0 730.3517062654059 0.0 - - - - - - - 198.33333333333334 160 9 961 122 C20140401_SF093_03 C20140401_SF093_03 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 190907.0 31.61436716715495 23 -3 10 6 10 null 0.0 0.03940010070800781 3 0.0 0.0 190907.0 870.6309057670561 0.0 - - - - - - - 280.0 381 6 963 123 C20140401_SF093_03 C20140401_SF093_03 TB144100.[MT7]-GQINNSIK[MT7].2y4_1.heavy 581.345 / 605.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 965 123 C20140401_SF093_03 C20140401_SF093_03 TB144100.[MT7]-GQINNSIK[MT7].2y5_1.heavy 581.345 / 719.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 967 123 C20140401_SF093_03 C20140401_SF093_03 TB144100.[MT7]-GQINNSIK[MT7].2b4_1.heavy 581.345 / 557.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 969 123 C20140401_SF093_03 C20140401_SF093_03 TB144100.[MT7]-GQINNSIK[MT7].2b5_1.heavy 581.345 / 671.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 971 124 C20140401_SF093_03 C20140401_SF093_03 TB144260.[MT7]-LTDQVMQNPR.2y8_1.heavy 673.354 / 987.468 1259.0 25.98870086669922 42 20 2 10 10 5.337436970010531 18.735584244248734 0.0 3 0.9914147919289261 13.309929586197057 1259.0 20.60181818181818 0.0 - - - - - - - 117.06666666666666 2 15 NAP1L4 nucleosome assembly protein 1-like 4 973 124 C20140401_SF093_03 C20140401_SF093_03 TB144260.[MT7]-LTDQVMQNPR.2y9_1.heavy 673.354 / 1088.52 2464.0 25.98870086669922 42 20 2 10 10 5.337436970010531 18.735584244248734 0.0 3 0.9914147919289261 13.309929586197057 2464.0 35.18165853658537 0.0 - - - - - - - 144.31578947368422 4 19 NAP1L4 nucleosome assembly protein 1-like 4 975 124 C20140401_SF093_03 C20140401_SF093_03 TB144260.[MT7]-LTDQVMQNPR.2b4_1.heavy 673.354 / 602.327 N/A 25.98870086669922 42 20 2 10 10 5.337436970010531 18.735584244248734 0.0 3 0.9914147919289261 13.309929586197057 1150.0 2.038413058085527 5.0 - - - - - - - 724.1111111111111 10 9 NAP1L4 nucleosome assembly protein 1-like 4 977 124 C20140401_SF093_03 C20140401_SF093_03 TB144260.[MT7]-LTDQVMQNPR.2y7_1.heavy 673.354 / 872.441 1917.0 25.98870086669922 42 20 2 10 10 5.337436970010531 18.735584244248734 0.0 3 0.9914147919289261 13.309929586197057 1917.0 40.08272727272727 0.0 - - - - - - - 124.33333333333333 3 15 NAP1L4 nucleosome assembly protein 1-like 4 979 125 C20140401_SF093_03 C20140401_SF093_03 TB144120.[MT7]-SISIGPISK[MT7].2y4_1.heavy 595.373 / 588.384 2153.0 31.337624549865723 45 20 10 5 10 36.84258142945487 2.7142506339160075 0.043498992919921875 3 0.9998736633299135 109.79765997768696 2153.0 19.026511627906977 0.0 - - - - - - - 269.0 4 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 981 125 C20140401_SF093_03 C20140401_SF093_03 TB144120.[MT7]-SISIGPISK[MT7].2y5_1.heavy 595.373 / 645.405 4845.0 31.337624549865723 45 20 10 5 10 36.84258142945487 2.7142506339160075 0.043498992919921875 3 0.9998736633299135 109.79765997768696 4845.0 21.45 0.0 - - - - - - - 202.0 9 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 983 125 C20140401_SF093_03 C20140401_SF093_03 TB144120.[MT7]-SISIGPISK[MT7].2y6_1.heavy 595.373 / 758.489 969.0 31.337624549865723 45 20 10 5 10 36.84258142945487 2.7142506339160075 0.043498992919921875 3 0.9998736633299135 109.79765997768696 969.0 -0.3183728611221647 2.0 - - - - - - - 204.6 2 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 985 125 C20140401_SF093_03 C20140401_SF093_03 TB144120.[MT7]-SISIGPISK[MT7].2y7_1.heavy 595.373 / 845.521 1830.0 31.337624549865723 45 20 10 5 10 36.84258142945487 2.7142506339160075 0.043498992919921875 3 0.9998736633299135 109.79765997768696 1830.0 20.36485788113695 0.0 - - - - - - - 236.9 3 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 987 126 C20140401_SF093_03 C20140401_SF093_03 TB482742.[MT7]-VVVTEK[MT7].2y4_1.heavy 481.81 / 620.374 13829.0 21.191200256347656 44 20 6 10 8 18.924285132500682 5.284215456480276 0.0 4 0.9990700052837345 40.465831223449634 13829.0 46.93987253730429 0.0 - - - - - - - 233.35 27 20 NAP1L4 nucleosome assembly protein 1-like 4 989 126 C20140401_SF093_03 C20140401_SF093_03 TB482742.[MT7]-VVVTEK[MT7].2y5_1.heavy 481.81 / 719.442 16134.0 21.191200256347656 44 20 6 10 8 18.924285132500682 5.284215456480276 0.0 4 0.9990700052837345 40.465831223449634 16134.0 121.96325796395169 0.0 - - - - - - - 215.7391304347826 32 23 NAP1L4 nucleosome assembly protein 1-like 4 991 126 C20140401_SF093_03 C20140401_SF093_03 TB482742.[MT7]-VVVTEK[MT7].2y3_1.heavy 481.81 / 521.305 18262.0 21.191200256347656 44 20 6 10 8 18.924285132500682 5.284215456480276 0.0 4 0.9990700052837345 40.465831223449634 18262.0 55.82182741116751 1.0 - - - - - - - 315.1666666666667 52 18 NAP1L4 nucleosome assembly protein 1-like 4 993 126 C20140401_SF093_03 C20140401_SF093_03 TB482742.[MT7]-VVVTEK[MT7].2b5_1.heavy 481.81 / 672.405 1477.0 21.191200256347656 44 20 6 10 8 18.924285132500682 5.284215456480276 0.0 4 0.9990700052837345 40.465831223449634 1477.0 0.9542923337238056 0.0 - - - - - - - 222.86363636363637 2 22 NAP1L4 nucleosome assembly protein 1-like 4 995 127 C20140401_SF093_03 C20140401_SF093_03 TB482743.[MT7]-K[MT7]TPEEPSPK[MT7].3y3_1.heavy 482.284 / 475.3 2178.0 16.094200134277344 50 20 10 10 10 18.950774714662842 5.276829127340461 0.0 3 0.9957619735317373 18.95077776926616 2178.0 24.493333333333332 1.0 - - - - - - - 206.05263157894737 4 19 SLC35C1 solute carrier family 35, member C1 997 127 C20140401_SF093_03 C20140401_SF093_03 TB482743.[MT7]-K[MT7]TPEEPSPK[MT7].3b4_1.heavy 482.284 / 744.449 N/A 16.094200134277344 50 20 10 10 10 18.950774714662842 5.276829127340461 0.0 3 0.9957619735317373 18.95077776926616 347.0 2.748053691275168 3.0 - - - - - - - 0.0 0 0 SLC35C1 solute carrier family 35, member C1 999 127 C20140401_SF093_03 C20140401_SF093_03 TB482743.[MT7]-K[MT7]TPEEPSPK[MT7].3b5_1.heavy 482.284 / 873.492 N/A 16.094200134277344 50 20 10 10 10 18.950774714662842 5.276829127340461 0.0 3 0.9957619735317373 18.95077776926616 347.0 9.08255033557047 0.0 - - - - - - - 0.0 0 0 SLC35C1 solute carrier family 35, member C1 1001 127 C20140401_SF093_03 C20140401_SF093_03 TB482743.[MT7]-K[MT7]TPEEPSPK[MT7].3y4_1.heavy 482.284 / 572.352 2376.0 16.094200134277344 50 20 10 10 10 18.950774714662842 5.276829127340461 0.0 3 0.9957619735317373 18.95077776926616 2376.0 8.3616 0.0 - - - - - - - 157.0 4 18 SLC35C1 solute carrier family 35, member C1 1003 128 C20140401_SF093_03 C20140401_SF093_03 TB482847.[MT7]-AC[CAM]DFLLSR.2y5_1.heavy 563.296 / 635.388 3074.0 34.00772476196289 42 17 10 5 10 2.535175270651887 27.100631319439067 0.0438995361328125 3 0.9776103281629699 8.232369397937223 3074.0 45.9850406504065 0.0 - - - - - - - 246.0 6 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1005 128 C20140401_SF093_03 C20140401_SF093_03 TB482847.[MT7]-AC[CAM]DFLLSR.2b4_1.heavy 563.296 / 638.273 2213.0 34.00772476196289 42 17 10 5 10 2.535175270651887 27.100631319439067 0.0438995361328125 3 0.9776103281629699 8.232369397937223 2213.0 25.18861788617886 0.0 - - - - - - - 199.875 4 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1007 128 C20140401_SF093_03 C20140401_SF093_03 TB482847.[MT7]-AC[CAM]DFLLSR.2b5_1.heavy 563.296 / 751.357 1107.0 34.00772476196289 42 17 10 5 10 2.535175270651887 27.100631319439067 0.0438995361328125 3 0.9776103281629699 8.232369397937223 1107.0 17.1 0.0 - - - - - - - 193.28571428571428 2 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1009 128 C20140401_SF093_03 C20140401_SF093_03 TB482847.[MT7]-AC[CAM]DFLLSR.2y7_1.heavy 563.296 / 910.445 3197.0 34.00772476196289 42 17 10 5 10 2.535175270651887 27.100631319439067 0.0438995361328125 3 0.9776103281629699 8.232369397937223 3197.0 15.595121951219515 0.0 - - - - - - - 199.875 6 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1011 129 C20140401_SF093_03 C20140401_SF093_03 TB144403.[MT7]-LNQQQHPDC[CAM]K[MT7].3b4_1.heavy 519.268 / 628.354 1114.0 15.531200408935547 48 18 10 10 10 6.831347458346077 14.638400492691495 0.0 3 0.9844839506550765 9.894837012630386 1114.0 11.508297191610382 0.0 - - - - - - - 109.9090909090909 2 11 C9orf114 chromosome 9 open reading frame 114 1013 129 C20140401_SF093_03 C20140401_SF093_03 TB144403.[MT7]-LNQQQHPDC[CAM]K[MT7].3b5_1.heavy 519.268 / 756.412 824.0 15.531200408935547 48 18 10 10 10 6.831347458346077 14.638400492691495 0.0 3 0.9844839506550765 9.894837012630386 824.0 21.91139175257732 0.0 - - - - - - - 0.0 1 0 C9orf114 chromosome 9 open reading frame 114 1015 129 C20140401_SF093_03 C20140401_SF093_03 TB144403.[MT7]-LNQQQHPDC[CAM]K[MT7].3b3_1.heavy 519.268 / 500.295 1308.0 15.531200408935547 48 18 10 10 10 6.831347458346077 14.638400492691495 0.0 3 0.9844839506550765 9.894837012630386 1308.0 6.314482758620689 0.0 - - - - - - - 132.0 2 11 C9orf114 chromosome 9 open reading frame 114 1017 129 C20140401_SF093_03 C20140401_SF093_03 TB144403.[MT7]-LNQQQHPDC[CAM]K[MT7].3y4_1.heavy 519.268 / 663.325 3827.0 15.531200408935547 48 18 10 10 10 6.831347458346077 14.638400492691495 0.0 3 0.9844839506550765 9.894837012630386 3827.0 54.445979381443294 0.0 - - - - - - - 89.71428571428571 7 14 C9orf114 chromosome 9 open reading frame 114 1019 130 C20140401_SF093_03 C20140401_SF093_03 TB482849.[MT7]-DVAVAEEVR.2y8_1.heavy 566.31 / 872.484 4376.0 24.239299774169922 48 18 10 10 10 4.1220935957625695 19.412439032340565 0.0 3 0.9881058887403928 11.304854248738057 4376.0 88.21460317460317 0.0 - - - - - - - 116.3076923076923 8 13 FBLIM1 filamin binding LIM protein 1 1021 130 C20140401_SF093_03 C20140401_SF093_03 TB482849.[MT7]-DVAVAEEVR.2y5_1.heavy 566.31 / 603.31 5511.0 24.239299774169922 48 18 10 10 10 4.1220935957625695 19.412439032340565 0.0 3 0.9881058887403928 11.304854248738057 5511.0 123.48722222222223 0.0 - - - - - - - 150.42857142857142 11 14 FBLIM1 filamin binding LIM protein 1 1023 130 C20140401_SF093_03 C20140401_SF093_03 TB482849.[MT7]-DVAVAEEVR.2y6_1.heavy 566.31 / 702.378 2917.0 24.239299774169922 48 18 10 10 10 4.1220935957625695 19.412439032340565 0.0 3 0.9881058887403928 11.304854248738057 2917.0 82.64833333333334 0.0 - - - - - - - 115.2 5 15 FBLIM1 filamin binding LIM protein 1 1025 130 C20140401_SF093_03 C20140401_SF093_03 TB482849.[MT7]-DVAVAEEVR.2y7_1.heavy 566.31 / 773.415 5349.0 24.239299774169922 48 18 10 10 10 4.1220935957625695 19.412439032340565 0.0 3 0.9881058887403928 11.304854248738057 5349.0 90.63583333333332 0.0 - - - - - - - 77.14285714285714 10 7 FBLIM1 filamin binding LIM protein 1 1027 131 C20140401_SF093_03 C20140401_SF093_03 TB144404.[MT7]-RAAIELLMVLAGR.3y6_1.heavy 519.652 / 646.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 1029 131 C20140401_SF093_03 C20140401_SF093_03 TB144404.[MT7]-RAAIELLMVLAGR.3b5_1.heavy 519.652 / 685.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 1031 131 C20140401_SF093_03 C20140401_SF093_03 TB144404.[MT7]-RAAIELLMVLAGR.3b7_1.heavy 519.652 / 911.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 1033 131 C20140401_SF093_03 C20140401_SF093_03 TB144404.[MT7]-RAAIELLMVLAGR.3y5_1.heavy 519.652 / 515.33 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBXL8 F-box and leucine-rich repeat protein 8 1035 132 C20140401_SF093_03 C20140401_SF093_03 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 59388.0 25.829500198364258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 59388.0 268.8462686485615 0.0 - - - - - - - 354.125 118 8 1037 132 C20140401_SF093_03 C20140401_SF093_03 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 63825.0 25.829500198364258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 63825.0 238.45725229826354 0.0 - - - - - - - 321.0 127 1 1039 132 C20140401_SF093_03 C20140401_SF093_03 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 84137.0 25.829500198364258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 84137.0 315.10216338557154 0.0 - - - - - - - 124.66666666666667 168 3 1041 133 C20140401_SF093_03 C20140401_SF093_03 TB144408.[MT7]-IPEPFPLPEDK[MT7].3y3_1.heavy 523.964 / 535.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 1043 133 C20140401_SF093_03 C20140401_SF093_03 TB144408.[MT7]-IPEPFPLPEDK[MT7].3b4_1.heavy 523.964 / 581.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 1045 133 C20140401_SF093_03 C20140401_SF093_03 TB144408.[MT7]-IPEPFPLPEDK[MT7].3b5_1.heavy 523.964 / 728.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 1047 133 C20140401_SF093_03 C20140401_SF093_03 TB144408.[MT7]-IPEPFPLPEDK[MT7].3y4_1.heavy 523.964 / 632.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - ART3 ADP-ribosyltransferase 3 1049 134 C20140401_SF093_03 C20140401_SF093_03 TB144342.[MT7]-QLAGQSFYQK[MT7].3y3_1.heavy 486.605 / 582.337 25617.0 26.966699600219727 44 14 10 10 10 1.8673998554818354 46.61073170541362 0.0 3 0.930674064050747 4.659861379493112 25617.0 81.26521219469362 0.0 - - - - - - - 314.94117647058823 51 17 FBLIM1 filamin binding LIM protein 1 1051 134 C20140401_SF093_03 C20140401_SF093_03 TB144342.[MT7]-QLAGQSFYQK[MT7].3b4_1.heavy 486.605 / 514.311 8580.0 26.966699600219727 44 14 10 10 10 1.8673998554818354 46.61073170541362 0.0 3 0.930674064050747 4.659861379493112 8580.0 11.676340495463206 0.0 - - - - - - - 615.875 17 8 FBLIM1 filamin binding LIM protein 1 1053 134 C20140401_SF093_03 C20140401_SF093_03 TB144342.[MT7]-QLAGQSFYQK[MT7].3b5_1.heavy 486.605 / 642.369 9492.0 26.966699600219727 44 14 10 10 10 1.8673998554818354 46.61073170541362 0.0 3 0.930674064050747 4.659861379493112 9492.0 24.10651177135808 0.0 - - - - - - - 743.2142857142857 18 14 FBLIM1 filamin binding LIM protein 1 1055 134 C20140401_SF093_03 C20140401_SF093_03 TB144342.[MT7]-QLAGQSFYQK[MT7].3y5_1.heavy 486.605 / 816.437 1460.0 26.966699600219727 44 14 10 10 10 1.8673998554818354 46.61073170541362 0.0 3 0.930674064050747 4.659861379493112 1460.0 10.55478648046954 0.0 - - - - - - - 145.0 2 21 FBLIM1 filamin binding LIM protein 1 1057 135 C20140401_SF093_03 C20140401_SF093_03 TB144548.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.3y6_1.heavy 639.666 / 709.435 5358.0 38.53670120239258 47 17 10 10 10 4.231397748406043 23.63285277014427 0.0 3 0.9799643598944011 8.704282274389632 5358.0 21.18133333333333 0.0 - - - - - - - 215.33333333333334 10 9 FBLIM1 filamin binding LIM protein 1 1059 135 C20140401_SF093_03 C20140401_SF093_03 TB144548.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.3b4_1.heavy 639.666 / 559.336 7182.0 38.53670120239258 47 17 10 10 10 4.231397748406043 23.63285277014427 0.0 3 0.9799643598944011 8.704282274389632 7182.0 82.467 0.0 - - - - - - - 285.0 14 12 FBLIM1 filamin binding LIM protein 1 1061 135 C20140401_SF093_03 C20140401_SF093_03 TB144548.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.3y8_1.heavy 639.666 / 998.509 7980.0 38.53670120239258 47 17 10 10 10 4.231397748406043 23.63285277014427 0.0 3 0.9799643598944011 8.704282274389632 7980.0 21.51333333333333 1.0 - - - - - - - 260.57142857142856 17 7 FBLIM1 filamin binding LIM protein 1 1063 135 C20140401_SF093_03 C20140401_SF093_03 TB144548.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.3y5_1.heavy 639.666 / 595.393 16074.0 38.53670120239258 47 17 10 10 10 4.231397748406043 23.63285277014427 0.0 3 0.9799643598944011 8.704282274389632 16074.0 48.0575 0.0 - - - - - - - 276.85714285714283 32 7 FBLIM1 filamin binding LIM protein 1 1065 136 C20140401_SF093_03 C20140401_SF093_03 TB348650.[MT7]-IVLPEDLQLK[MT7].2y4_1.heavy 728.455 / 645.442 11869.0 40.019325256347656 44 18 10 6 10 2.4078313562669273 30.621227877475256 0.03790283203125 3 0.9879084542488286 11.211994526307162 11869.0 26.23747070375284 0.0 - - - - - - - 746.0 23 11 FANCL Fanconi anemia, complementation group L 1067 136 C20140401_SF093_03 C20140401_SF093_03 TB348650.[MT7]-IVLPEDLQLK[MT7].2y8_1.heavy 728.455 / 1099.65 17704.0 40.019325256347656 44 18 10 6 10 2.4078313562669273 30.621227877475256 0.03790283203125 3 0.9879084542488286 11.211994526307162 17704.0 83.1551515151515 0.0 - - - - - - - 297.0 35 14 FANCL Fanconi anemia, complementation group L 1069 136 C20140401_SF093_03 C20140401_SF093_03 TB348650.[MT7]-IVLPEDLQLK[MT7].2y3_1.heavy 728.455 / 532.357 4550.0 40.019325256347656 44 18 10 6 10 2.4078313562669273 30.621227877475256 0.03790283203125 3 0.9879084542488286 11.211994526307162 4550.0 12.032514450867051 0.0 - - - - - - - 290.4 9 15 FANCL Fanconi anemia, complementation group L 1071 136 C20140401_SF093_03 C20140401_SF093_03 TB348650.[MT7]-IVLPEDLQLK[MT7].2y7_1.heavy 728.455 / 986.564 78632.0 40.019325256347656 44 18 10 6 10 2.4078313562669273 30.621227877475256 0.03790283203125 3 0.9879084542488286 11.211994526307162 78632.0 227.28885845461014 0.0 - - - - - - - 703.0 157 9 FANCL Fanconi anemia, complementation group L 1073 137 C20140401_SF093_03 C20140401_SF093_03 TB144542.[MT7]-EQTGLEAYALGLDTK[MT7].3b6_1.heavy 633.01 / 802.406 3101.0 37.70159912109375 45 15 10 10 10 1.8150050104690516 38.73333581388442 0.0 3 0.9568169523799329 5.917392218853401 3101.0 14.725418994413406 0.0 - - - - - - - 188.75 6 12 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1075 137 C20140401_SF093_03 C20140401_SF093_03 TB144542.[MT7]-EQTGLEAYALGLDTK[MT7].3b4_1.heavy 633.01 / 560.28 1312.0 37.70159912109375 45 15 10 10 10 1.8150050104690516 38.73333581388442 0.0 3 0.9568169523799329 5.917392218853401 1312.0 10.045857740585774 1.0 - - - - - - - 255.71428571428572 2 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1077 137 C20140401_SF093_03 C20140401_SF093_03 TB144542.[MT7]-EQTGLEAYALGLDTK[MT7].3y5_1.heavy 633.01 / 677.395 4532.0 37.70159912109375 45 15 10 10 10 1.8150050104690516 38.73333581388442 0.0 3 0.9568169523799329 5.917392218853401 4532.0 18.43203354297694 0.0 - - - - - - - 325.54545454545456 9 11 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1079 137 C20140401_SF093_03 C20140401_SF093_03 TB144542.[MT7]-EQTGLEAYALGLDTK[MT7].3b7_1.heavy 633.01 / 873.443 4294.0 37.70159912109375 45 15 10 10 10 1.8150050104690516 38.73333581388442 0.0 3 0.9568169523799329 5.917392218853401 4294.0 70.72470588235294 0.0 - - - - - - - 119.0 8 3 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1081 138 C20140401_SF093_03 C20140401_SF093_03 TB482747.[MT7]-IVLPEDLQLK[MT7].3y3_1.heavy 485.972 / 532.357 30597.0 40.019325256347656 37 11 10 6 10 1.2300637788031508 49.94933206362296 0.03790283203125 3 0.8572106695064918 3.2263086038399162 30597.0 170.56094660194174 0.0 - - - - - - - 206.0 61 14 FANCL Fanconi anemia, complementation group L 1083 138 C20140401_SF093_03 C20140401_SF093_03 TB482747.[MT7]-IVLPEDLQLK[MT7].3b6_1.heavy 485.972 / 811.468 22870.0 40.019325256347656 37 11 10 6 10 1.2300637788031508 49.94933206362296 0.03790283203125 3 0.8572106695064918 3.2263086038399162 22870.0 127.7833495145631 0.0 - - - - - - - 180.25 45 8 FANCL Fanconi anemia, complementation group L 1085 138 C20140401_SF093_03 C20140401_SF093_03 TB482747.[MT7]-IVLPEDLQLK[MT7].3b5_1.heavy 485.972 / 696.441 9787.0 40.019325256347656 37 11 10 6 10 1.2300637788031508 49.94933206362296 0.03790283203125 3 0.8572106695064918 3.2263086038399162 9787.0 123.05014563106796 0.0 - - - - - - - 185.4 19 10 FANCL Fanconi anemia, complementation group L 1087 138 C20140401_SF093_03 C20140401_SF093_03 TB482747.[MT7]-IVLPEDLQLK[MT7].3y4_1.heavy 485.972 / 645.442 7623.0 40.019325256347656 37 11 10 6 10 1.2300637788031508 49.94933206362296 0.03790283203125 3 0.8572106695064918 3.2263086038399162 7623.0 26.550983009708737 0.0 - - - - - - - 236.9 15 10 FANCL Fanconi anemia, complementation group L 1089 139 C20140401_SF093_03 C20140401_SF093_03 TB144540.[MT7]-QMTDPNVALTFLEK[MT7].3y3_1.heavy 632.344 / 533.341 2735.0 41.87695121765137 40 14 10 6 10 1.264401590952773 51.926227368396034 0.03980255126953125 3 0.9365150261261134 4.871941669505032 2735.0 8.710194467109607 0.0 - - - - - - - 191.875 5 16 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1091 139 C20140401_SF093_03 C20140401_SF093_03 TB144540.[MT7]-QMTDPNVALTFLEK[MT7].3b6_1.heavy 632.344 / 831.379 2404.0 41.87695121765137 40 14 10 6 10 1.264401590952773 51.926227368396034 0.03980255126953125 3 0.9365150261261134 4.871941669505032 2404.0 27.032931726907627 0.0 - - - - - - - 166.0 4 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1093 139 C20140401_SF093_03 C20140401_SF093_03 TB144540.[MT7]-QMTDPNVALTFLEK[MT7].3b4_1.heavy 632.344 / 620.283 3315.0 41.87695121765137 40 14 10 6 10 1.264401590952773 51.926227368396034 0.03980255126953125 3 0.9365150261261134 4.871941669505032 3315.0 51.92168674698795 0.0 - - - - - - - 207.33333333333334 6 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1095 139 C20140401_SF093_03 C20140401_SF093_03 TB144540.[MT7]-QMTDPNVALTFLEK[MT7].3y4_1.heavy 632.344 / 680.41 1077.0 41.87695121765137 40 14 10 6 10 1.264401590952773 51.926227368396034 0.03980255126953125 3 0.9365150261261134 4.871941669505032 1077.0 11.872951807228915 0.0 - - - - - - - 189.57142857142858 2 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1097 140 C20140401_SF093_03 C20140401_SF093_03 TB348659.[MT7]-ELILTLC[CAM]DLIR.3y6_1.heavy 501.629 / 789.429 5197.0 51.5546989440918 39 9 10 10 10 2.0822512457154985 37.79352032108185 0.0 3 0.8141384504642805 2.8170809626521853 5197.0 121.83131147540983 0.0 - - - - - - - 122.16666666666667 10 6 MECR mitochondrial trans-2-enoyl-CoA reductase 1099 140 C20140401_SF093_03 C20140401_SF093_03 TB348659.[MT7]-ELILTLC[CAM]DLIR.3y4_1.heavy 501.629 / 516.314 12166.0 51.5546989440918 39 9 10 10 10 2.0822512457154985 37.79352032108185 0.0 3 0.8141384504642805 2.8170809626521853 12166.0 188.4732786885246 0.0 - - - - - - - 128.2 24 10 MECR mitochondrial trans-2-enoyl-CoA reductase 1101 140 C20140401_SF093_03 C20140401_SF093_03 TB348659.[MT7]-ELILTLC[CAM]DLIR.3b3_1.heavy 501.629 / 500.32 11066.0 51.5546989440918 39 9 10 10 10 2.0822512457154985 37.79352032108185 0.0 3 0.8141384504642805 2.8170809626521853 11066.0 253.97377049180326 0.0 - - - - - - - 152.66666666666666 22 6 MECR mitochondrial trans-2-enoyl-CoA reductase 1103 140 C20140401_SF093_03 C20140401_SF093_03 TB348659.[MT7]-ELILTLC[CAM]DLIR.3y5_1.heavy 501.629 / 676.345 2996.0 51.5546989440918 39 9 10 10 10 2.0822512457154985 37.79352032108185 0.0 3 0.8141384504642805 2.8170809626521853 2996.0 -1.0891245077249319 1.0 - - - - - - - 162.66666666666666 6 3 MECR mitochondrial trans-2-enoyl-CoA reductase 1105 141 C20140401_SF093_03 C20140401_SF093_03 TB144029.[MT7]-GDSAPATAK[MT7].2y4_1.heavy 553.308 / 534.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1107 141 C20140401_SF093_03 C20140401_SF093_03 TB144029.[MT7]-GDSAPATAK[MT7].2y5_1.heavy 553.308 / 631.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1109 141 C20140401_SF093_03 C20140401_SF093_03 TB144029.[MT7]-GDSAPATAK[MT7].2y6_1.heavy 553.308 / 702.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1111 141 C20140401_SF093_03 C20140401_SF093_03 TB144029.[MT7]-GDSAPATAK[MT7].2y7_1.heavy 553.308 / 789.459 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1113 142 C20140401_SF093_03 C20140401_SF093_03 TB482945.[MT7]-TDPFC[CAM]PIFR.2y4_1.heavy 648.83 / 532.324 4383.0 38.908599853515625 50 20 10 10 10 2.143731582628434 33.7053728365485 0.0 3 0.991918816572035 13.719301026670285 4383.0 5.489306358381503 0.0 - - - - - - - 192.16666666666666 8 6 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1115 142 C20140401_SF093_03 C20140401_SF093_03 TB482945.[MT7]-TDPFC[CAM]PIFR.2y8_1.heavy 648.83 / 1051.5 6689.0 38.908599853515625 50 20 10 10 10 2.143731582628434 33.7053728365485 0.0 3 0.991918816572035 13.719301026670285 6689.0 83.60305759457933 0.0 - - - - - - - 243.44444444444446 13 9 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1117 142 C20140401_SF093_03 C20140401_SF093_03 TB482945.[MT7]-TDPFC[CAM]PIFR.2b4_1.heavy 648.83 / 605.305 807.0 38.908599853515625 50 20 10 10 10 2.143731582628434 33.7053728365485 0.0 3 0.991918816572035 13.719301026670285 807.0 -0.3109826589595375 8.0 - - - - - - - 263.57142857142856 2 7 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1119 142 C20140401_SF093_03 C20140401_SF093_03 TB482945.[MT7]-TDPFC[CAM]PIFR.2y7_1.heavy 648.83 / 936.476 36676.0 38.908599853515625 50 20 10 10 10 2.143731582628434 33.7053728365485 0.0 3 0.991918816572035 13.719301026670285 36676.0 370.54281739130437 0.0 - - - - - - - 247.14285714285714 73 7 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1121 143 C20140401_SF093_03 C20140401_SF093_03 TB144201.[MT7]-VLYNLFTK[MT7].2b4_1.heavy 643.392 / 634.368 3460.0 41.37874984741211 39 14 10 5 10 2.45403884413499 27.25469329542893 0.0402984619140625 3 0.9359383809602809 4.8497262691067675 3460.0 21.55846153846154 0.0 - - - - - - - 225.2 6 15 PARVB;PARVA parvin, beta;parvin, alpha 1123 143 C20140401_SF093_03 C20140401_SF093_03 TB144201.[MT7]-VLYNLFTK[MT7].2y3_1.heavy 643.392 / 539.331 3114.0 41.37874984741211 39 14 10 5 10 2.45403884413499 27.25469329542893 0.0402984619140625 3 0.9359383809602809 4.8497262691067675 3114.0 22.157307692307693 0.0 - - - - - - - 153.46153846153845 6 13 PARVB;PARVA parvin, beta;parvin, alpha 1125 143 C20140401_SF093_03 C20140401_SF093_03 TB144201.[MT7]-VLYNLFTK[MT7].2y6_1.heavy 643.392 / 929.521 4671.0 41.37874984741211 39 14 10 5 10 2.45403884413499 27.25469329542893 0.0402984619140625 3 0.9359383809602809 4.8497262691067675 4671.0 33.95457692307692 0.0 - - - - - - - 151.83333333333334 9 12 PARVB;PARVA parvin, beta;parvin, alpha 1127 143 C20140401_SF093_03 C20140401_SF093_03 TB144201.[MT7]-VLYNLFTK[MT7].2y7_1.heavy 643.392 / 1042.61 4585.0 41.37874984741211 39 14 10 5 10 2.45403884413499 27.25469329542893 0.0402984619140625 3 0.9359383809602809 4.8497262691067675 4585.0 75.77084911301574 0.0 - - - - - - - 121.5 9 10 PARVB;PARVA parvin, beta;parvin, alpha 1129 144 C20140401_SF093_03 C20140401_SF093_03 TB144131.[MT7]-AVLLLQEK[MT7].3y3_1.heavy 401.263 / 548.316 27898.0 34.29909896850586 44 14 10 10 10 1.8170127271732288 35.38718902953796 0.0 3 0.9365351823339412 4.872723644306763 27898.0 86.20185348627334 0.0 - - - - - - - 234.28571428571428 55 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1131 144 C20140401_SF093_03 C20140401_SF093_03 TB144131.[MT7]-AVLLLQEK[MT7].3b4_1.heavy 401.263 / 541.383 82432.0 34.29909896850586 44 14 10 10 10 1.8170127271732288 35.38718902953796 0.0 3 0.9365351823339412 4.872723644306763 82432.0 843.3770272647317 0.0 - - - - - - - 234.14285714285714 164 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1133 144 C20140401_SF093_03 C20140401_SF093_03 TB144131.[MT7]-AVLLLQEK[MT7].3y4_1.heavy 401.263 / 661.4 5807.0 34.29909896850586 44 14 10 10 10 1.8170127271732288 35.38718902953796 0.0 3 0.9365351823339412 4.872723644306763 5807.0 37.7915873015873 0.0 - - - - - - - 204.75 11 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1135 144 C20140401_SF093_03 C20140401_SF093_03 TB144131.[MT7]-AVLLLQEK[MT7].3b3_1.heavy 401.263 / 428.299 79529.0 34.29909896850586 44 14 10 10 10 1.8170127271732288 35.38718902953796 0.0 3 0.9365351823339412 4.872723644306763 79529.0 378.06691715147593 0.0 - - - - - - - 240.9090909090909 159 11 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1137 145 C20140401_SF093_03 C20140401_SF093_03 TB348744.[MT7]-VNPLSLVEIILHVVR.3y6_1.heavy 615.72 / 736.483 N/A N/A - - - - - - - - - 0.0 - - - - - - - PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1139 145 C20140401_SF093_03 C20140401_SF093_03 TB348744.[MT7]-VNPLSLVEIILHVVR.3y4_1.heavy 615.72 / 510.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1141 145 C20140401_SF093_03 C20140401_SF093_03 TB348744.[MT7]-VNPLSLVEIILHVVR.3y8_1.heavy 615.72 / 978.609 N/A N/A - - - - - - - - - 0.0 - - - - - - - PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1143 145 C20140401_SF093_03 C20140401_SF093_03 TB348744.[MT7]-VNPLSLVEIILHVVR.3y5_1.heavy 615.72 / 623.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1145 146 C20140401_SF093_03 C20140401_SF093_03 TB144606.[MT7]-NIHLWDPENSVLQNLK[MT7].4y3_1.heavy 552.806 / 518.342 2148.0 40.96997547149658 37 11 10 6 10 1.5762877602232523 42.50903691971333 0.038700103759765625 3 0.8532086441227694 3.18090372734804 2148.0 23.321348314606745 0.0 - - - - - - - 178.71428571428572 4 7 FANCL Fanconi anemia, complementation group L 1147 146 C20140401_SF093_03 C20140401_SF093_03 TB144606.[MT7]-NIHLWDPENSVLQNLK[MT7].4b6_1.heavy 552.806 / 923.486 716.0 40.96997547149658 37 11 10 6 10 1.5762877602232523 42.50903691971333 0.038700103759765625 3 0.8532086441227694 3.18090372734804 716.0 16.089887640449437 0.0 - - - - - - - 0.0 1 0 FANCL Fanconi anemia, complementation group L 1149 146 C20140401_SF093_03 C20140401_SF093_03 TB144606.[MT7]-NIHLWDPENSVLQNLK[MT7].4b3_1.heavy 552.806 / 509.295 1700.0 40.96997547149658 37 11 10 6 10 1.5762877602232523 42.50903691971333 0.038700103759765625 3 0.8532086441227694 3.18090372734804 1700.0 8.547486033519554 0.0 - - - - - - - 232.6 3 5 FANCL Fanconi anemia, complementation group L 1151 146 C20140401_SF093_03 C20140401_SF093_03 TB144606.[MT7]-NIHLWDPENSVLQNLK[MT7].4b4_1.heavy 552.806 / 622.379 1163.0 40.96997547149658 37 11 10 6 10 1.5762877602232523 42.50903691971333 0.038700103759765625 3 0.8532086441227694 3.18090372734804 1163.0 18.062964660096668 0.0 - - - - - - - 156.25 2 4 FANCL Fanconi anemia, complementation group L 1153 147 C20140401_SF093_03 C20140401_SF093_03 TB144416.[MT7]-ILVVNAAYFVGK[MT7].3b6_1.heavy 527.992 / 754.494 6538.0 42.48849868774414 46 16 10 10 10 3.7426114800806127 21.3955097630649 0.0 3 0.9624568880497036 6.349346890868317 6538.0 54.84867757210504 0.0 - - - - - - - 152.55555555555554 13 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1155 147 C20140401_SF093_03 C20140401_SF093_03 TB144416.[MT7]-ILVVNAAYFVGK[MT7].3b4_1.heavy 527.992 / 569.414 8072.0 42.48849868774414 46 16 10 10 10 3.7426114800806127 21.3955097630649 0.0 3 0.9624568880497036 6.349346890868317 8072.0 116.47276168635096 0.0 - - - - - - - 210.0 16 10 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1157 147 C20140401_SF093_03 C20140401_SF093_03 TB144416.[MT7]-ILVVNAAYFVGK[MT7].3b5_1.heavy 527.992 / 683.457 6457.0 42.48849868774414 46 16 10 10 10 3.7426114800806127 21.3955097630649 0.0 3 0.9624568880497036 6.349346890868317 6457.0 49.97289102202146 0.0 - - - - - - - 198.0 12 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1159 147 C20140401_SF093_03 C20140401_SF093_03 TB144416.[MT7]-ILVVNAAYFVGK[MT7].3y4_1.heavy 527.992 / 594.373 6861.0 42.48849868774414 46 16 10 10 10 3.7426114800806127 21.3955097630649 0.0 3 0.9624568880497036 6.349346890868317 6861.0 53.86735537190083 0.0 - - - - - - - 156.13333333333333 13 15 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1161 148 C20140401_SF093_03 C20140401_SF093_03 TB144130.[MT7]-TLVPELIK[MT7].2y4_1.heavy 600.894 / 646.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1163 148 C20140401_SF093_03 C20140401_SF093_03 TB144130.[MT7]-TLVPELIK[MT7].2y5_1.heavy 600.894 / 743.478 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1165 148 C20140401_SF093_03 C20140401_SF093_03 TB144130.[MT7]-TLVPELIK[MT7].2y3_1.heavy 600.894 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1167 148 C20140401_SF093_03 C20140401_SF093_03 TB144130.[MT7]-TLVPELIK[MT7].2y6_1.heavy 600.894 / 842.547 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1169 149 C20140401_SF093_03 C20140401_SF093_03 TB482838.[MT7]-STVFGTALNYVSLR.3y6_1.heavy 557.978 / 751.41 4571.0 43.53464984893799 39 13 10 6 10 1.6175033173920226 49.1095890537802 0.032199859619140625 3 0.9223363822643301 4.3994858166990065 4571.0 86.18451026392962 0.0 - - - - - - - 154.66666666666666 9 9 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1171 149 C20140401_SF093_03 C20140401_SF093_03 TB482838.[MT7]-STVFGTALNYVSLR.3b4_1.heavy 557.978 / 579.326 3564.0 43.53464984893799 39 13 10 6 10 1.6175033173920226 49.1095890537802 0.032199859619140625 3 0.9223363822643301 4.3994858166990065 3564.0 24.14322580645161 0.0 - - - - - - - 174.125 7 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1173 149 C20140401_SF093_03 C20140401_SF093_03 TB482838.[MT7]-STVFGTALNYVSLR.3b5_1.heavy 557.978 / 636.347 2402.0 43.53464984893799 39 13 10 6 10 1.6175033173920226 49.1095890537802 0.032199859619140625 3 0.9223363822643301 4.3994858166990065 2402.0 10.697579394848713 0.0 - - - - - - - 220.30769230769232 4 13 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1175 149 C20140401_SF093_03 C20140401_SF093_03 TB482838.[MT7]-STVFGTALNYVSLR.3y5_1.heavy 557.978 / 637.367 6353.0 43.53464984893799 39 13 10 6 10 1.6175033173920226 49.1095890537802 0.032199859619140625 3 0.9223363822643301 4.3994858166990065 6353.0 65.77192352614014 0.0 - - - - - - - 145.0 12 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1177 150 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 104674.0 36.43199920654297 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 104674.0 88.73878066378066 0.0 - - - - - - - 220.0 209 12 1179 150 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 183741.0 36.43199920654297 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 183741.0 97.93247509820426 0.0 - - - - - - - 308.0 367 6 1181 150 C20140401_SF093_03 C20140401_SF093_03 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 226772.0 36.43199920654297 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 226772.0 120.48868807904756 0.0 - - - - - - - 276.0 453 11 1183 151 C20140401_SF093_03 C20140401_SF093_03 TB144600.[MT7]-GDTANEIGQVLHFENVK[MT7].3y6_1.heavy 720.383 / 917.496 9856.0 38.05595016479492 41 16 10 5 10 3.766217727164493 26.551837212897382 0.04630279541015625 3 0.9683068479992846 6.913944931506016 9856.0 21.655953216374265 0.0 - - - - - - - 322.14285714285717 19 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1185 151 C20140401_SF093_03 C20140401_SF093_03 TB144600.[MT7]-GDTANEIGQVLHFENVK[MT7].3b6_1.heavy 720.383 / 732.328 16387.0 38.05595016479492 41 16 10 5 10 3.766217727164493 26.551837212897382 0.04630279541015625 3 0.9683068479992846 6.913944931506016 16387.0 42.880821584647535 0.0 - - - - - - - 306.5 32 12 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1187 151 C20140401_SF093_03 C20140401_SF093_03 TB144600.[MT7]-GDTANEIGQVLHFENVK[MT7].3b5_1.heavy 720.383 / 603.286 7125.0 38.05595016479492 41 16 10 5 10 3.766217727164493 26.551837212897382 0.04630279541015625 3 0.9683068479992846 6.913944931506016 7125.0 18.860030627871364 0.0 - - - - - - - 323.6363636363636 14 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1189 151 C20140401_SF093_03 C20140401_SF093_03 TB144600.[MT7]-GDTANEIGQVLHFENVK[MT7].3y5_1.heavy 720.383 / 780.437 12468.0 38.05595016479492 41 16 10 5 10 3.766217727164493 26.551837212897382 0.04630279541015625 3 0.9683068479992846 6.913944931506016 12468.0 29.305514192785335 0.0 - - - - - - - 342.8888888888889 24 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1191 152 C20140401_SF093_03 C20140401_SF093_03 TB348644.[MT7]-DVFIIQTVSK[MT7].2y4_1.heavy 719.431 / 578.363 21223.0 36.99319839477539 46 16 10 10 10 3.1106438725100127 32.147685205542 0.0 3 0.9633543838094308 6.427115506803411 21223.0 24.828695976154997 0.0 - - - - - - - 271.1111111111111 42 9 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1193 152 C20140401_SF093_03 C20140401_SF093_03 TB348644.[MT7]-DVFIIQTVSK[MT7].2b3_1.heavy 719.431 / 506.273 36348.0 36.99319839477539 46 16 10 10 10 3.1106438725100127 32.147685205542 0.0 3 0.9633543838094308 6.427115506803411 36348.0 112.15103044496486 0.0 - - - - - - - 355.8333333333333 72 12 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1195 152 C20140401_SF093_03 C20140401_SF093_03 TB348644.[MT7]-DVFIIQTVSK[MT7].2b4_1.heavy 719.431 / 619.357 31347.0 36.99319839477539 46 16 10 10 10 3.1106438725100127 32.147685205542 0.0 3 0.9633543838094308 6.427115506803411 31347.0 63.685064402810305 0.0 - - - - - - - 749.4285714285714 62 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1197 152 C20140401_SF093_03 C20140401_SF093_03 TB348644.[MT7]-DVFIIQTVSK[MT7].2y6_1.heavy 719.431 / 819.506 19028.0 36.99319839477539 46 16 10 10 10 3.1106438725100127 32.147685205542 0.0 3 0.9633543838094308 6.427115506803411 19028.0 76.83984699453552 0.0 - - - - - - - 280.6 38 10 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1199 153 C20140401_SF093_03 C20140401_SF093_03 TB144034.[MT7]-RAQSFAER.3y3_1.heavy 370.204 / 375.199 42639.0 16.34119987487793 50 20 10 10 10 168.13404899134935 0.594763527077999 0.0 3 0.997196516160225 23.302999593531673 42639.0 180.7332098765432 0.0 - - - - - - - 232.6153846153846 85 13 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1201 153 C20140401_SF093_03 C20140401_SF093_03 TB144034.[MT7]-RAQSFAER.3b4_1.heavy 370.204 / 587.338 4540.0 16.34119987487793 50 20 10 10 10 168.13404899134935 0.594763527077999 0.0 3 0.997196516160225 23.302999593531673 4540.0 78.30899470899472 0.0 - - - - - - - 174.7058823529412 9 17 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1203 153 C20140401_SF093_03 C20140401_SF093_03 TB144034.[MT7]-RAQSFAER.3y4_1.heavy 370.204 / 522.267 16537.0 16.34119987487793 50 20 10 10 10 168.13404899134935 0.594763527077999 0.0 3 0.997196516160225 23.302999593531673 16537.0 93.77065344291661 0.0 - - - - - - - 182.25 33 16 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1205 153 C20140401_SF093_03 C20140401_SF093_03 TB144034.[MT7]-RAQSFAER.3y5_1.heavy 370.204 / 609.299 10484.0 16.34119987487793 50 20 10 10 10 168.13404899134935 0.594763527077999 0.0 3 0.997196516160225 23.302999593531673 10484.0 191.8183703703704 0.0 - - - - - - - 191.07692307692307 20 13 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1207 154 C20140401_SF093_03 C20140401_SF093_03 TB482832.[MT7]-RAQSFAER.2b7_1.heavy 554.803 / 934.486 770.0 16.34119987487793 46 16 10 10 10 3.4013437476736432 29.400145183325037 0.0 3 0.969111011775107 7.003840274932187 770.0 10.266666666666667 0.0 - - - - - - - 0.0 1 0 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1209 154 C20140401_SF093_03 C20140401_SF093_03 TB482832.[MT7]-RAQSFAER.2b5_1.heavy 554.803 / 734.407 220.0 16.34119987487793 46 16 10 10 10 3.4013437476736432 29.400145183325037 0.0 3 0.969111011775107 7.003840274932187 220.0 4.4 1.0 - - - - - - - 0.0 0 0 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1211 154 C20140401_SF093_03 C20140401_SF093_03 TB482832.[MT7]-RAQSFAER.2b4_1.heavy 554.803 / 587.338 N/A 16.34119987487793 46 16 10 10 10 3.4013437476736432 29.400145183325037 0.0 3 0.969111011775107 7.003840274932187 55.0 1.46 21.0 - - - - - - - 0.0 0 0 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1213 154 C20140401_SF093_03 C20140401_SF093_03 TB482832.[MT7]-RAQSFAER.2y7_1.heavy 554.803 / 808.395 935.0 16.34119987487793 46 16 10 10 10 3.4013437476736432 29.400145183325037 0.0 3 0.969111011775107 7.003840274932187 935.0 33.983000000000004 0.0 - - - - - - - 0.0 1 0 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1215 155 C20140401_SF093_03 C20140401_SF093_03 TB144350.[MT7]-TVYEGFISAQGR.2y8_1.heavy 736.387 / 835.442 44567.0 33.35710144042969 44 14 10 10 10 1.859280854884929 42.94842089105455 0.0 3 0.9332908632187736 4.751441027868256 44567.0 149.8554859746479 0.0 - - - - - - - 322.45454545454544 89 11 FANCL Fanconi anemia, complementation group L 1217 155 C20140401_SF093_03 C20140401_SF093_03 TB144350.[MT7]-TVYEGFISAQGR.2y9_1.heavy 736.387 / 964.485 39366.0 33.35710144042969 44 14 10 10 10 1.859280854884929 42.94842089105455 0.0 3 0.9332908632187736 4.751441027868256 39366.0 143.17584722207317 0.0 - - - - - - - 212.7 78 10 FANCL Fanconi anemia, complementation group L 1219 155 C20140401_SF093_03 C20140401_SF093_03 TB144350.[MT7]-TVYEGFISAQGR.2y10_1.heavy 736.387 / 1127.55 28963.0 33.35710144042969 44 14 10 10 10 1.859280854884929 42.94842089105455 0.0 3 0.9332908632187736 4.751441027868256 28963.0 259.30370132198607 0.0 - - - - - - - 236.42857142857142 57 7 FANCL Fanconi anemia, complementation group L 1221 155 C20140401_SF093_03 C20140401_SF093_03 TB144350.[MT7]-TVYEGFISAQGR.2y11_1.heavy 736.387 / 1226.62 9575.0 33.35710144042969 44 14 10 10 10 1.859280854884929 42.94842089105455 0.0 3 0.9332908632187736 4.751441027868256 9575.0 31.615713105735082 0.0 - - - - - - - 236.26666666666668 19 15 FANCL Fanconi anemia, complementation group L 1223 156 C20140401_SF093_03 C20140401_SF093_03 TB144553.[MT7]-VLWGEC[CAM]LGGALYWK[MT7].3b6_1.heavy 647.35 / 889.436 4023.0 46.29485034942627 44 18 10 6 10 4.03970537905824 24.75428047758092 0.034198760986328125 3 0.9853419236277418 10.181035571339184 4023.0 20.295807682302957 0.0 - - - - - - - 190.0 8 6 AS3MT arsenic (+3 oxidation state) methyltransferase 1225 156 C20140401_SF093_03 C20140401_SF093_03 TB144553.[MT7]-VLWGEC[CAM]LGGALYWK[MT7].3y3_1.heavy 647.35 / 640.357 6908.0 46.29485034942627 44 18 10 6 10 4.03970537905824 24.75428047758092 0.034198760986328125 3 0.9853419236277418 10.181035571339184 6908.0 89.41429561928774 0.0 - - - - - - - 165.8181818181818 13 11 AS3MT arsenic (+3 oxidation state) methyltransferase 1227 156 C20140401_SF093_03 C20140401_SF093_03 TB144553.[MT7]-VLWGEC[CAM]LGGALYWK[MT7].3b4_1.heavy 647.35 / 600.363 2961.0 46.29485034942627 44 18 10 6 10 4.03970537905824 24.75428047758092 0.034198760986328125 3 0.9853419236277418 10.181035571339184 2961.0 36.23328947368421 0.0 - - - - - - - 119.42857142857143 5 14 AS3MT arsenic (+3 oxidation state) methyltransferase 1229 156 C20140401_SF093_03 C20140401_SF093_03 TB144553.[MT7]-VLWGEC[CAM]LGGALYWK[MT7].3b5_1.heavy 647.35 / 729.405 4023.0 46.29485034942627 44 18 10 6 10 4.03970537905824 24.75428047758092 0.034198760986328125 3 0.9853419236277418 10.181035571339184 4023.0 33.8778947368421 0.0 - - - - - - - 218.5 8 8 AS3MT arsenic (+3 oxidation state) methyltransferase 1231 157 C20140401_SF093_03 C20140401_SF093_03 TB144032.[MT7]-VDSIAWK[MT7].2y5_1.heavy 553.826 / 748.447 856.0 31.21619987487793 45 17 10 10 8 6.863655460249415 14.569495887307571 0.0 4 0.9780212800253528 8.30926310547342 856.0 5.12 1.0 - - - - - - - 255.15384615384616 2 13 CD244 CD244 molecule, natural killer cell receptor 2B4 1233 157 C20140401_SF093_03 C20140401_SF093_03 TB144032.[MT7]-VDSIAWK[MT7].2y3_1.heavy 553.826 / 548.331 3212.0 31.21619987487793 45 17 10 10 8 6.863655460249415 14.569495887307571 0.0 4 0.9780212800253528 8.30926310547342 3212.0 5.423476122488424 1.0 - - - - - - - 187.25 6 8 CD244 CD244 molecule, natural killer cell receptor 2B4 1235 157 C20140401_SF093_03 C20140401_SF093_03 TB144032.[MT7]-VDSIAWK[MT7].2y6_1.heavy 553.826 / 863.474 2462.0 31.21619987487793 45 17 10 10 8 6.863655460249415 14.569495887307571 0.0 4 0.9780212800253528 8.30926310547342 2462.0 31.982990654205608 0.0 - - - - - - - 198.71428571428572 4 7 CD244 CD244 molecule, natural killer cell receptor 2B4 1237 157 C20140401_SF093_03 C20140401_SF093_03 TB144032.[MT7]-VDSIAWK[MT7].2b5_1.heavy 553.826 / 630.358 1499.0 31.21619987487793 45 17 10 10 8 6.863655460249415 14.569495887307571 0.0 4 0.9780212800253528 8.30926310547342 1499.0 7.22065031152648 0.0 - - - - - - - 229.28571428571428 2 14 CD244 CD244 molecule, natural killer cell receptor 2B4 1239 158 C20140401_SF093_03 C20140401_SF093_03 TB144602.[MT7]-QWLIDTLYAFNSGNVER.2b3_1.heavy 1085.56 / 572.331 4691.0 49.869049072265625 41 15 10 6 10 2.0161862248834224 40.19479504867085 0.03369903564453125 3 0.9511507929330412 5.560958438283593 4691.0 34.499305961525394 0.0 - - - - - - - 148.0 9 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1241 158 C20140401_SF093_03 C20140401_SF093_03 TB144602.[MT7]-QWLIDTLYAFNSGNVER.2y9_1.heavy 1085.56 / 993.475 1876.0 49.869049072265625 41 15 10 6 10 2.0161862248834224 40.19479504867085 0.03369903564453125 3 0.9511507929330412 5.560958438283593 1876.0 23.087572765957447 0.0 - - - - - - - 120.46153846153847 3 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1243 158 C20140401_SF093_03 C20140401_SF093_03 TB144602.[MT7]-QWLIDTLYAFNSGNVER.2y10_1.heavy 1085.56 / 1156.54 1376.0 49.869049072265625 41 15 10 6 10 2.0161862248834224 40.19479504867085 0.03369903564453125 3 0.9511507929330412 5.560958438283593 1376.0 8.493018829447353 0.0 - - - - - - - 199.0909090909091 2 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1245 158 C20140401_SF093_03 C20140401_SF093_03 TB144602.[MT7]-QWLIDTLYAFNSGNVER.2b5_1.heavy 1085.56 / 800.442 1188.0 49.869049072265625 41 15 10 6 10 2.0161862248834224 40.19479504867085 0.03369903564453125 3 0.9511507929330412 5.560958438283593 1188.0 17.63343465045593 0.0 - - - - - - - 125.28571428571429 2 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1247 159 C20140401_SF093_03 C20140401_SF093_03 TB144552.[MT7]-RLSFTLDDALVLQAAR.3y6_1.heavy 645.038 / 657.404 8720.0 41.84709930419922 47 17 10 10 10 2.6163353012938084 30.500911999058157 0.0 3 0.9733667898155358 7.545395039679683 8720.0 68.02929092113983 1.0 - - - - - - - 670.7142857142857 17 7 FBXL8 F-box and leucine-rich repeat protein 8 1249 159 C20140401_SF093_03 C20140401_SF093_03 TB144552.[MT7]-RLSFTLDDALVLQAAR.3b8_1.heavy 645.038 / 1092.58 7127.0 41.84709930419922 47 17 10 10 10 2.6163353012938084 30.500911999058157 0.0 3 0.9733667898155358 7.545395039679683 7127.0 110.2139642857143 0.0 - - - - - - - 143.92857142857142 14 14 FBXL8 F-box and leucine-rich repeat protein 8 1251 159 C20140401_SF093_03 C20140401_SF093_03 TB144552.[MT7]-RLSFTLDDALVLQAAR.3y5_1.heavy 645.038 / 558.336 12241.0 41.84709930419922 47 17 10 10 10 2.6163353012938084 30.500911999058157 0.0 3 0.9733667898155358 7.545395039679683 12241.0 38.24223282373589 0.0 - - - - - - - 237.66666666666666 24 12 FBXL8 F-box and leucine-rich repeat protein 8 1253 159 C20140401_SF093_03 C20140401_SF093_03 TB144552.[MT7]-RLSFTLDDALVLQAAR.3b8_2.heavy 645.038 / 546.794 9474.0 41.84709930419922 47 17 10 10 10 2.6163353012938084 30.500911999058157 0.0 3 0.9733667898155358 7.545395039679683 9474.0 66.08628011681675 0.0 - - - - - - - 223.66666666666666 18 6 FBXL8 F-box and leucine-rich repeat protein 8 1255 160 C20140401_SF093_03 C20140401_SF093_03 TB144038.[MT7]-DSFESILR.2y5_1.heavy 555.799 / 617.362 1333.0 36.18519973754883 47 17 10 10 10 4.187580719520877 23.880136694163 0.0 3 0.9734245916835459 7.553632993453391 1333.0 12.087203007518797 0.0 - - - - - - - 266.57142857142856 2 7 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1257 160 C20140401_SF093_03 C20140401_SF093_03 TB144038.[MT7]-DSFESILR.2b4_1.heavy 555.799 / 623.279 1333.0 36.18519973754883 47 17 10 10 10 4.187580719520877 23.880136694163 0.0 3 0.9734245916835459 7.553632993453391 1333.0 9.054126879699249 1.0 - - - - - - - 222.0 3 6 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1259 160 C20140401_SF093_03 C20140401_SF093_03 TB144038.[MT7]-DSFESILR.2b5_1.heavy 555.799 / 710.311 2800.0 36.18519973754883 47 17 10 10 10 4.187580719520877 23.880136694163 0.0 3 0.9734245916835459 7.553632993453391 2800.0 16.787415730337077 0.0 - - - - - - - 333.5 5 4 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1261 160 C20140401_SF093_03 C20140401_SF093_03 TB144038.[MT7]-DSFESILR.2y7_1.heavy 555.799 / 851.462 3600.0 36.18519973754883 47 17 10 10 10 4.187580719520877 23.880136694163 0.0 3 0.9734245916835459 7.553632993453391 3600.0 35.70766917293233 0.0 - - - - - - - 239.8 7 5 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1263 161 C20140401_SF093_03 C20140401_SF093_03 TB144356.[MT7]-QTWTYLQDER.2y8_1.heavy 742.369 / 1110.52 5701.0 31.43199920654297 44 14 10 10 10 1.276907526837748 45.638865029623375 0.0 3 0.9368359022164399 4.884434540978693 5701.0 9.470073719989928 0.0 - - - - - - - 258.2 11 15 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1265 161 C20140401_SF093_03 C20140401_SF093_03 TB144356.[MT7]-QTWTYLQDER.2y9_1.heavy 742.369 / 1211.57 5378.0 31.43199920654297 44 14 10 10 10 1.276907526837748 45.638865029623375 0.0 3 0.9368359022164399 4.884434540978693 5378.0 43.77441860465116 0.0 - - - - - - - 179.41666666666666 10 12 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1267 161 C20140401_SF093_03 C20140401_SF093_03 TB144356.[MT7]-QTWTYLQDER.2y6_1.heavy 742.369 / 823.394 4518.0 31.43199920654297 44 14 10 10 10 1.276907526837748 45.638865029623375 0.0 3 0.9368359022164399 4.884434540978693 4518.0 23.72429807761538 0.0 - - - - - - - 201.875 9 16 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1269 161 C20140401_SF093_03 C20140401_SF093_03 TB144356.[MT7]-QTWTYLQDER.2y7_1.heavy 742.369 / 924.442 6777.0 31.43199920654297 44 14 10 10 10 1.276907526837748 45.638865029623375 0.0 3 0.9368359022164399 4.884434540978693 6777.0 43.65648837209302 0.0 - - - - - - - 225.0909090909091 13 11 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1271 162 C20140401_SF093_03 C20140401_SF093_03 TB144216.[MT7]-DK[MT7]LEETK[MT7].2y4_1.heavy 647.883 / 650.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1273 162 C20140401_SF093_03 C20140401_SF093_03 TB144216.[MT7]-DK[MT7]LEETK[MT7].2b4_1.heavy 647.883 / 774.46 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1275 162 C20140401_SF093_03 C20140401_SF093_03 TB144216.[MT7]-DK[MT7]LEETK[MT7].2b5_1.heavy 647.883 / 903.503 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1277 162 C20140401_SF093_03 C20140401_SF093_03 TB144216.[MT7]-DK[MT7]LEETK[MT7].2y6_2.heavy 647.883 / 518.318 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1279 163 C20140401_SF093_03 C20140401_SF093_03 TB144425.[MT7]-LIINSSPHLISK[MT7].3b6_1.heavy 537.334 / 772.469 682.0 32.485300064086914 42 18 10 6 8 5.454813109133925 18.332433760664124 0.036197662353515625 4 0.9875911082435694 11.067403749455785 682.0 0.7017621145374449 2.0 - - - - - - - 215.8 2 10 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1281 163 C20140401_SF093_03 C20140401_SF093_03 TB144425.[MT7]-LIINSSPHLISK[MT7].3b4_1.heavy 537.334 / 598.404 1590.0 32.485300064086914 42 18 10 6 8 5.454813109133925 18.332433760664124 0.036197662353515625 4 0.9875911082435694 11.067403749455785 1590.0 8.030489218641318 0.0 - - - - - - - 227.33333333333334 3 9 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1283 163 C20140401_SF093_03 C20140401_SF093_03 TB144425.[MT7]-LIINSSPHLISK[MT7].3y4_1.heavy 537.334 / 604.415 3180.0 32.485300064086914 42 18 10 6 8 5.454813109133925 18.332433760664124 0.036197662353515625 4 0.9875911082435694 11.067403749455785 3180.0 1.6 1.0 - - - - - - - 227.27272727272728 6 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1285 163 C20140401_SF093_03 C20140401_SF093_03 TB144425.[MT7]-LIINSSPHLISK[MT7].3y5_1.heavy 537.334 / 741.474 454.0 32.485300064086914 42 18 10 6 8 5.454813109133925 18.332433760664124 0.036197662353515625 4 0.9875911082435694 11.067403749455785 454.0 1.4 8.0 - - - - - - - 0.0 1 0 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1287 164 C20140401_SF093_03 C20140401_SF093_03 TB144529.[MT7]-NTQIIIQEESGIPK[MT7].3b6_1.heavy 620.022 / 827.511 2316.0 31.81422472000122 41 15 10 6 10 2.3468955542960503 42.609480348176355 0.03989982604980469 3 0.9563702322808967 5.886797829897761 2316.0 7.669293924466338 0.0 - - - - - - - 232.77777777777777 4 9 MUT methylmalonyl CoA mutase 1289 164 C20140401_SF093_03 C20140401_SF093_03 TB144529.[MT7]-NTQIIIQEESGIPK[MT7].3b4_1.heavy 620.022 / 601.343 6949.0 31.81422472000122 41 15 10 6 10 2.3468955542960503 42.609480348176355 0.03989982604980469 3 0.9563702322808967 5.886797829897761 6949.0 78.90865284262564 0.0 - - - - - - - 200.45454545454547 13 11 MUT methylmalonyl CoA mutase 1291 164 C20140401_SF093_03 C20140401_SF093_03 TB144529.[MT7]-NTQIIIQEESGIPK[MT7].3b5_1.heavy 620.022 / 714.427 6728.0 31.81422472000122 41 15 10 6 10 2.3468955542960503 42.609480348176355 0.03989982604980469 3 0.9563702322808967 5.886797829897761 6728.0 57.23366515837104 0.0 - - - - - - - 151.625 13 8 MUT methylmalonyl CoA mutase 1293 164 C20140401_SF093_03 C20140401_SF093_03 TB144529.[MT7]-NTQIIIQEESGIPK[MT7].3y5_1.heavy 620.022 / 645.405 3199.0 31.81422472000122 41 15 10 6 10 2.3468955542960503 42.609480348176355 0.03989982604980469 3 0.9563702322808967 5.886797829897761 3199.0 43.266113122171944 0.0 - - - - - - - 220.66666666666666 6 6 MUT methylmalonyl CoA mutase 1295 165 C20140401_SF093_03 C20140401_SF093_03 TB144427.[MT7]-YAALYQPLFDK[MT7].3y3_1.heavy 539.636 / 553.31 7994.0 40.293800354003906 48 18 10 10 10 8.053746426720695 12.416581638108237 0.0 3 0.9841039296440514 9.775534205264474 7994.0 99.83855968858131 0.0 - - - - - - - 180.5 15 8 NAP1L4 nucleosome assembly protein 1-like 4 1297 165 C20140401_SF093_03 C20140401_SF093_03 TB144427.[MT7]-YAALYQPLFDK[MT7].3b4_1.heavy 539.636 / 563.331 17817.0 40.293800354003906 48 18 10 10 10 8.053746426720695 12.416581638108237 0.0 3 0.9841039296440514 9.775534205264474 17817.0 117.13598615916955 0.0 - - - - - - - 235.55555555555554 35 9 NAP1L4 nucleosome assembly protein 1-like 4 1299 165 C20140401_SF093_03 C20140401_SF093_03 TB144427.[MT7]-YAALYQPLFDK[MT7].3y4_1.heavy 539.636 / 666.394 1637.0 40.293800354003906 48 18 10 10 10 8.053746426720695 12.416581638108237 0.0 3 0.9841039296440514 9.775534205264474 1637.0 14.376761658031088 0.0 - - - - - - - 270.0 3 10 NAP1L4 nucleosome assembly protein 1-like 4 1301 165 C20140401_SF093_03 C20140401_SF093_03 TB144427.[MT7]-YAALYQPLFDK[MT7].3y5_1.heavy 539.636 / 763.447 6356.0 40.293800354003906 48 18 10 10 10 8.053746426720695 12.416581638108237 0.0 3 0.9841039296440514 9.775534205264474 6356.0 48.16313498395396 0.0 - - - - - - - 160.5 12 6 NAP1L4 nucleosome assembly protein 1-like 4 1303 166 C20140401_SF093_03 C20140401_SF093_03 TB348771.[MT7]-GDIVVFLAC[CAM]EQDIEK[MT7].3b6_1.heavy 675.359 / 775.447 7112.0 42.04180145263672 47 17 10 10 10 4.280711671643497 23.36060161734904 0.0 3 0.9780185413135302 8.308743544193158 7112.0 35.86910987482615 0.0 - - - - - - - 218.66666666666666 14 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1305 166 C20140401_SF093_03 C20140401_SF093_03 TB348771.[MT7]-GDIVVFLAC[CAM]EQDIEK[MT7].3b4_1.heavy 675.359 / 529.31 13025.0 42.04180145263672 47 17 10 10 10 4.280711671643497 23.36060161734904 0.0 3 0.9780185413135302 8.308743544193158 13025.0 40.205899187965066 0.0 - - - - - - - 279.875 26 16 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1307 166 C20140401_SF093_03 C20140401_SF093_03 TB348771.[MT7]-GDIVVFLAC[CAM]EQDIEK[MT7].3b5_1.heavy 675.359 / 628.379 20377.0 42.04180145263672 47 17 10 10 10 4.280711671643497 23.36060161734904 0.0 3 0.9780185413135302 8.308743544193158 20377.0 34.17730602728792 0.0 - - - - - - - 268.90909090909093 40 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1309 166 C20140401_SF093_03 C20140401_SF093_03 TB348771.[MT7]-GDIVVFLAC[CAM]EQDIEK[MT7].3y4_1.heavy 675.359 / 648.369 5753.0 42.04180145263672 47 17 10 10 10 4.280711671643497 23.36060161734904 0.0 3 0.9780185413135302 8.308743544193158 5753.0 9.797367711423178 1.0 - - - - - - - 208.0 11 15 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1311 167 C20140401_SF093_03 C20140401_SF093_03 TB482866.[MT7]-DRPDIQK[MT7].2y5_1.heavy 580.337 / 744.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1313 167 C20140401_SF093_03 C20140401_SF093_03 TB482866.[MT7]-DRPDIQK[MT7].2b4_1.heavy 580.337 / 628.317 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1315 167 C20140401_SF093_03 C20140401_SF093_03 TB482866.[MT7]-DRPDIQK[MT7].2b6_1.heavy 580.337 / 869.46 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1317 167 C20140401_SF093_03 C20140401_SF093_03 TB482866.[MT7]-DRPDIQK[MT7].2y3_1.heavy 580.337 / 532.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1319 168 C20140401_SF093_03 C20140401_SF093_03 TB144421.[MT7]-EDYIYGFQFK[MT7].3b6_1.heavy 533.276 / 885.411 642.0 39.40449905395508 46 16 10 10 10 4.039481726019163 24.755651042033108 0.0 3 0.9672409440766067 6.799921605140641 642.0 11.772 0.0 - - - - - - - 0.0 1 0 ART3 ADP-ribosyltransferase 3 1321 168 C20140401_SF093_03 C20140401_SF093_03 TB144421.[MT7]-EDYIYGFQFK[MT7].3b4_1.heavy 533.276 / 665.326 2460.0 39.40449905395508 46 16 10 10 10 4.039481726019163 24.755651042033108 0.0 3 0.9672409440766067 6.799921605140641 2460.0 42.532710280373834 0.0 - - - - - - - 133.75 4 8 ART3 ADP-ribosyltransferase 3 1323 168 C20140401_SF093_03 C20140401_SF093_03 TB144421.[MT7]-EDYIYGFQFK[MT7].3b3_1.heavy 533.276 / 552.242 3102.0 39.40449905395508 46 16 10 10 10 4.039481726019163 24.755651042033108 0.0 3 0.9672409440766067 6.799921605140641 3102.0 14.398691588785045 0.0 - - - - - - - 261.55555555555554 6 9 ART3 ADP-ribosyltransferase 3 1325 168 C20140401_SF093_03 C20140401_SF093_03 TB144421.[MT7]-EDYIYGFQFK[MT7].3y5_1.heavy 533.276 / 770.432 535.0 39.40449905395508 46 16 10 10 10 4.039481726019163 24.755651042033108 0.0 3 0.9672409440766067 6.799921605140641 535.0 5.0 0.0 - - - - - - - 0.0 1 0 ART3 ADP-ribosyltransferase 3 1327 169 C20140401_SF093_03 C20140401_SF093_03 TB144142.[MT7]-VRLVIAEK[MT7].3y3_1.heavy 405.939 / 491.295 28019.0 28.45835018157959 46 20 10 6 10 6.048325690716349 16.533501189178892 0.03270149230957031 3 0.9902064455970078 12.460547383504487 28019.0 46.037149869823594 0.0 - - - - - - - 686.3333333333334 56 9 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1329 169 C20140401_SF093_03 C20140401_SF093_03 TB144142.[MT7]-VRLVIAEK[MT7].3b4_1.heavy 405.939 / 612.431 10394.0 28.45835018157959 46 20 10 6 10 6.048325690716349 16.533501189178892 0.03270149230957031 3 0.9902064455970078 12.460547383504487 10394.0 25.08509083211745 0.0 - - - - - - - 634.8571428571429 20 7 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1331 169 C20140401_SF093_03 C20140401_SF093_03 TB144142.[MT7]-VRLVIAEK[MT7].3b3_1.heavy 405.939 / 513.363 3992.0 28.45835018157959 46 20 10 6 10 6.048325690716349 16.533501189178892 0.03270149230957031 3 0.9902064455970078 12.460547383504487 3992.0 8.288761390110421 0.0 - - - - - - - 743.875 7 8 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1333 169 C20140401_SF093_03 C20140401_SF093_03 TB144142.[MT7]-VRLVIAEK[MT7].3y4_1.heavy 405.939 / 604.379 6101.0 28.45835018157959 46 20 10 6 10 6.048325690716349 16.533501189178892 0.03270149230957031 3 0.9902064455970078 12.460547383504487 6101.0 19.451887166562386 0.0 - - - - - - - 731.5714285714286 12 7 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1335 170 C20140401_SF093_03 C20140401_SF093_03 TB482867.[MT7]-ELAVLAQK[MT7].2y4_1.heavy 580.368 / 603.395 3812.0 31.128299713134766 47 17 10 10 10 2.9381605019228707 29.103714645030575 0.0 3 0.9754659887019381 7.862961565740952 3812.0 47.557475728155346 0.0 - - - - - - - 161.85714285714286 7 7 AS3MT arsenic (+3 oxidation state) methyltransferase 1337 170 C20140401_SF093_03 C20140401_SF093_03 TB482867.[MT7]-ELAVLAQK[MT7].2y5_1.heavy 580.368 / 702.463 3194.0 31.128299713134766 47 17 10 10 10 2.9381605019228707 29.103714645030575 0.0 3 0.9754659887019381 7.862961565740952 3194.0 45.11912621359223 0.0 - - - - - - - 231.75 6 4 AS3MT arsenic (+3 oxidation state) methyltransferase 1339 170 C20140401_SF093_03 C20140401_SF093_03 TB482867.[MT7]-ELAVLAQK[MT7].2b4_1.heavy 580.368 / 557.341 5255.0 31.128299713134766 47 17 10 10 10 2.9381605019228707 29.103714645030575 0.0 3 0.9754659887019381 7.862961565740952 5255.0 19.217313915857606 0.0 - - - - - - - 236.9 10 10 AS3MT arsenic (+3 oxidation state) methyltransferase 1341 170 C20140401_SF093_03 C20140401_SF093_03 TB482867.[MT7]-ELAVLAQK[MT7].2y6_1.heavy 580.368 / 773.5 2782.0 31.128299713134766 47 17 10 10 10 2.9381605019228707 29.103714645030575 0.0 3 0.9754659887019381 7.862961565740952 2782.0 34.752491909385114 0.0 - - - - - - - 206.0 5 9 AS3MT arsenic (+3 oxidation state) methyltransferase 1343 171 C20140401_SF093_03 C20140401_SF093_03 TB144424.[MT7]-LRGFWLSQWK[MT7].3b6_1.heavy 536.98 / 917.548 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1345 171 C20140401_SF093_03 C20140401_SF093_03 TB144424.[MT7]-LRGFWLSQWK[MT7].3b4_1.heavy 536.98 / 618.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1347 171 C20140401_SF093_03 C20140401_SF093_03 TB144424.[MT7]-LRGFWLSQWK[MT7].3b5_1.heavy 536.98 / 804.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1349 171 C20140401_SF093_03 C20140401_SF093_03 TB144424.[MT7]-LRGFWLSQWK[MT7].3y4_1.heavy 536.98 / 692.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1351 172 C20140401_SF093_03 C20140401_SF093_03 TB482722.[MT7]-QLEDER.2y4_1.heavy 467.242 / 548.231 1367.0 16.593749523162842 37 13 10 6 8 2.3439098369074225 42.663757122987704 0.03899955749511719 4 0.9281449785952751 4.576129812493496 1367.0 3.67000357366211 4.0 - - - - - - - 223.9047619047619 11 21 PALM paralemmin 1353 172 C20140401_SF093_03 C20140401_SF093_03 TB482722.[MT7]-QLEDER.2b3_1.heavy 467.242 / 515.295 2626.0 16.593749523162842 37 13 10 6 8 2.3439098369074225 42.663757122987704 0.03899955749511719 4 0.9281449785952751 4.576129812493496 2626.0 9.568675604910526 0.0 - - - - - - - 294.2857142857143 5 21 PALM paralemmin 1355 172 C20140401_SF093_03 C20140401_SF093_03 TB482722.[MT7]-QLEDER.2y5_1.heavy 467.242 / 661.315 2680.0 16.593749523162842 37 13 10 6 8 2.3439098369074225 42.663757122987704 0.03899955749511719 4 0.9281449785952751 4.576129812493496 2680.0 14.446332529259358 1.0 - - - - - - - 270.5263157894737 11 19 PALM paralemmin 1357 172 C20140401_SF093_03 C20140401_SF093_03 TB482722.[MT7]-QLEDER.2b4_1.heavy 467.242 / 630.321 12964.0 16.593749523162842 37 13 10 6 8 2.3439098369074225 42.663757122987704 0.03899955749511719 4 0.9281449785952751 4.576129812493496 12964.0 123.8588521637133 0.0 - - - - - - - 228.47058823529412 25 17 PALM paralemmin 1359 173 C20140401_SF093_03 C20140401_SF093_03 TB348635.[MT7]-TVEGEFTGVGK[MT7].2y8_1.heavy 706.387 / 938.506 4208.0 28.43382453918457 43 17 10 6 10 3.22160109431649 25.422697441052623 0.0326995849609375 3 0.9762609934789116 7.99407452769975 4208.0 17.279227053140097 0.0 - - - - - - - 213.27272727272728 8 22 C9orf114 chromosome 9 open reading frame 114 1361 173 C20140401_SF093_03 C20140401_SF093_03 TB348635.[MT7]-TVEGEFTGVGK[MT7].2y9_1.heavy 706.387 / 1067.55 4345.0 28.43382453918457 43 17 10 6 10 3.22160109431649 25.422697441052623 0.0326995849609375 3 0.9762609934789116 7.99407452769975 4345.0 11.964492753623189 0.0 - - - - - - - 207.0 8 22 C9orf114 chromosome 9 open reading frame 114 1363 173 C20140401_SF093_03 C20140401_SF093_03 TB348635.[MT7]-TVEGEFTGVGK[MT7].2y6_1.heavy 706.387 / 752.442 3587.0 28.43382453918457 43 17 10 6 10 3.22160109431649 25.422697441052623 0.0326995849609375 3 0.9762609934789116 7.99407452769975 3587.0 23.53210628019324 0.0 - - - - - - - 167.57142857142858 7 21 C9orf114 chromosome 9 open reading frame 114 1365 173 C20140401_SF093_03 C20140401_SF093_03 TB348635.[MT7]-TVEGEFTGVGK[MT7].2b5_1.heavy 706.387 / 660.332 2897.0 28.43382453918457 43 17 10 6 10 3.22160109431649 25.422697441052623 0.0326995849609375 3 0.9762609934789116 7.99407452769975 2897.0 8.587944664031621 0.0 - - - - - - - 318.7142857142857 5 21 C9orf114 chromosome 9 open reading frame 114 1367 174 C20140401_SF093_03 C20140401_SF093_03 TB144000.[MT7]-AVAEGIPK[MT7].2y6_1.heavy 536.834 / 758.453 594.0 23.607749938964844 44 18 10 6 10 5.262223557533748 19.003373556190592 0.03910064697265625 3 0.9888872876949014 11.696322374733477 594.0 13.713333333333331 1.0 - - - - - - - 0.0 1 0 MUT methylmalonyl CoA mutase 1369 174 C20140401_SF093_03 C20140401_SF093_03 TB144000.[MT7]-AVAEGIPK[MT7].2b5_1.heavy 536.834 / 572.316 1837.0 23.607749938964844 44 18 10 6 10 5.262223557533748 19.003373556190592 0.03910064697265625 3 0.9888872876949014 11.696322374733477 1837.0 6.706507936507936 0.0 - - - - - - - 189.0 3 14 MUT methylmalonyl CoA mutase 1371 174 C20140401_SF093_03 C20140401_SF093_03 TB144000.[MT7]-AVAEGIPK[MT7].2y5_1.heavy 536.834 / 687.416 486.0 23.607749938964844 44 18 10 6 10 5.262223557533748 19.003373556190592 0.03910064697265625 3 0.9888872876949014 11.696322374733477 486.0 2.25 2.0 - - - - - - - 0.0 0 0 MUT methylmalonyl CoA mutase 1373 174 C20140401_SF093_03 C20140401_SF093_03 TB144000.[MT7]-AVAEGIPK[MT7].2b4_1.heavy 536.834 / 515.295 1081.0 23.607749938964844 44 18 10 6 10 5.262223557533748 19.003373556190592 0.03910064697265625 3 0.9888872876949014 11.696322374733477 1081.0 4.654305555555555 3.0 - - - - - - - 142.94117647058823 2 17 MUT methylmalonyl CoA mutase 1375 175 C20140401_SF093_03 C20140401_SF093_03 TB482864.[MT7]-TLHELLER.2y4_1.heavy 577.836 / 530.33 N/A N/A - - - - - - - - - 0.0 - - - - - - - SASH3 SAM and SH3 domain containing 3 1377 175 C20140401_SF093_03 C20140401_SF093_03 TB482864.[MT7]-TLHELLER.2y5_1.heavy 577.836 / 659.372 N/A N/A - - - - - - - - - 0.0 - - - - - - - SASH3 SAM and SH3 domain containing 3 1379 175 C20140401_SF093_03 C20140401_SF093_03 TB482864.[MT7]-TLHELLER.2y6_1.heavy 577.836 / 796.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - SASH3 SAM and SH3 domain containing 3 1381 175 C20140401_SF093_03 C20140401_SF093_03 TB482864.[MT7]-TLHELLER.2y7_1.heavy 577.836 / 909.515 N/A N/A - - - - - - - - - 0.0 - - - - - - - SASH3 SAM and SH3 domain containing 3 1383 176 C20140401_SF093_03 C20140401_SF093_03 TB144002.[MT7]-ALSVGLVK[MT7].2y4_1.heavy 537.86 / 560.389 9967.0 31.548599243164062 50 20 10 10 10 6.367506634581962 15.704734323620407 0.0 3 0.9916920868281379 13.530544154493255 9967.0 57.25723404255318 0.0 - - - - - - - 252.92307692307693 19 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1385 176 C20140401_SF093_03 C20140401_SF093_03 TB144002.[MT7]-ALSVGLVK[MT7].2y6_1.heavy 537.86 / 746.489 4819.0 31.548599243164062 50 20 10 10 10 6.367506634581962 15.704734323620407 0.0 3 0.9916920868281379 13.530544154493255 4819.0 51.30664674138647 0.0 - - - - - - - 219.375 9 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1387 176 C20140401_SF093_03 C20140401_SF093_03 TB144002.[MT7]-ALSVGLVK[MT7].2b5_1.heavy 537.86 / 572.352 4162.0 31.548599243164062 50 20 10 10 10 6.367506634581962 15.704734323620407 0.0 3 0.9916920868281379 13.530544154493255 4162.0 25.846210045662104 0.0 - - - - - - - 219.28571428571428 8 14 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1389 176 C20140401_SF093_03 C20140401_SF093_03 TB144002.[MT7]-ALSVGLVK[MT7].2y7_1.heavy 537.86 / 859.573 4819.0 31.548599243164062 50 20 10 10 10 6.367506634581962 15.704734323620407 0.0 3 0.9916920868281379 13.530544154493255 4819.0 50.557555125725344 0.0 - - - - - - - 197.6 9 5 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1391 177 C20140401_SF093_03 C20140401_SF093_03 TB144523.[MT7]-FFC[CAM]LYTEEFASK[MT7].2y4_1.heavy 915.455 / 596.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1393 177 C20140401_SF093_03 C20140401_SF093_03 TB144523.[MT7]-FFC[CAM]LYTEEFASK[MT7].2b3_1.heavy 915.455 / 599.277 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1395 177 C20140401_SF093_03 C20140401_SF093_03 TB144523.[MT7]-FFC[CAM]LYTEEFASK[MT7].2b4_1.heavy 915.455 / 712.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1397 177 C20140401_SF093_03 C20140401_SF093_03 TB144523.[MT7]-FFC[CAM]LYTEEFASK[MT7].2y7_1.heavy 915.455 / 955.485 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1399 178 C20140401_SF093_03 C20140401_SF093_03 TB348458.[MT7]-EFLTIYEDVK[MT7].3y3_1.heavy 515.62 / 505.31 12611.0 40.38002586364746 33 11 8 6 8 0.852505649851576 69.45839611909298 0.03929901123046875 4 0.8724087077519133 3.4176075371150376 12611.0 198.07494565217394 0.0 - - - - - - - 130.33333333333334 25 12 CD244 CD244 molecule, natural killer cell receptor 2B4 1401 178 C20140401_SF093_03 C20140401_SF093_03 TB348458.[MT7]-EFLTIYEDVK[MT7].3y7_2.heavy 515.62 / 506.278 3314.0 40.38002586364746 33 11 8 6 8 0.852505649851576 69.45839611909298 0.03929901123046875 4 0.8724087077519133 3.4176075371150376 3314.0 4.928531831854227 0.0 - - - - - - - 165.6 6 10 CD244 CD244 molecule, natural killer cell receptor 2B4 1403 178 C20140401_SF093_03 C20140401_SF093_03 TB348458.[MT7]-EFLTIYEDVK[MT7].3b3_1.heavy 515.62 / 534.304 8837.0 40.38002586364746 33 11 8 6 8 0.852505649851576 69.45839611909298 0.03929901123046875 4 0.8724087077519133 3.4176075371150376 8837.0 90.29108695652172 0.0 - - - - - - - 149.5 17 8 CD244 CD244 molecule, natural killer cell receptor 2B4 1405 178 C20140401_SF093_03 C20140401_SF093_03 TB348458.[MT7]-EFLTIYEDVK[MT7].3y4_1.heavy 515.62 / 634.353 4511.0 40.38002586364746 33 11 8 6 8 0.852505649851576 69.45839611909298 0.03929901123046875 4 0.8724087077519133 3.4176075371150376 4511.0 67.66499999999999 1.0 - - - - - - - 163.55555555555554 32 9 CD244 CD244 molecule, natural killer cell receptor 2B4 1407 179 C20140401_SF093_03 C20140401_SF093_03 TB144525.[MT7]-RNILPNITTTYLK[MT7].3y3_1.heavy 612.371 / 567.362 3313.0 35.99002647399902 38 13 10 5 10 1.1659111786043317 50.39242271200557 0.04290008544921875 3 0.9202080658680866 4.339622072546934 3313.0 7.097602094538832 0.0 - - - - - - - 586.8571428571429 6 7 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1409 179 C20140401_SF093_03 C20140401_SF093_03 TB144525.[MT7]-RNILPNITTTYLK[MT7].3b6_1.heavy 612.371 / 852.517 3048.0 35.99002647399902 38 13 10 5 10 1.1659111786043317 50.39242271200557 0.04290008544921875 3 0.9202080658680866 4.339622072546934 3048.0 34.41918002553554 0.0 - - - - - - - 238.8 6 5 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1411 179 C20140401_SF093_03 C20140401_SF093_03 TB144525.[MT7]-RNILPNITTTYLK[MT7].3b4_1.heavy 612.371 / 641.422 4506.0 35.99002647399902 38 13 10 5 10 1.1659111786043317 50.39242271200557 0.04290008544921875 3 0.9202080658680866 4.339622072546934 4506.0 22.725556219585073 0.0 - - - - - - - 246.42857142857142 9 7 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1413 179 C20140401_SF093_03 C20140401_SF093_03 TB144525.[MT7]-RNILPNITTTYLK[MT7].3y5_1.heavy 612.371 / 769.458 2651.0 35.99002647399902 38 13 10 5 10 1.1659111786043317 50.39242271200557 0.04290008544921875 3 0.9202080658680866 4.339622072546934 2651.0 7.8125050339324345 1.0 - - - - - - - 215.625 5 8 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1415 180 C20140401_SF093_03 C20140401_SF093_03 TB144632.[MT7]-TFLHPEGDHFTLISIYK[MT7].4y4_1.heavy 577.316 / 654.394 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1417 180 C20140401_SF093_03 C20140401_SF093_03 TB144632.[MT7]-TFLHPEGDHFTLISIYK[MT7].4b4_1.heavy 577.316 / 643.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1419 180 C20140401_SF093_03 C20140401_SF093_03 TB144632.[MT7]-TFLHPEGDHFTLISIYK[MT7].4b9_2.heavy 577.316 / 589.789 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1421 180 C20140401_SF093_03 C20140401_SF093_03 TB144632.[MT7]-TFLHPEGDHFTLISIYK[MT7].4b3_1.heavy 577.316 / 506.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1423 181 C20140401_SF093_03 C20140401_SF093_03 TB482729.[MT7]-NLEPGLR.2b3_1.heavy 471.778 / 501.279 45245.0 24.013500213623047 47 17 10 10 10 3.9008734047162954 25.635284620899625 0.0 3 0.976234725868415 7.989637762788387 45245.0 98.51324354657689 0.0 - - - - - - - 712.8 90 10 C9orf114 chromosome 9 open reading frame 114 1425 181 C20140401_SF093_03 C20140401_SF093_03 TB482729.[MT7]-NLEPGLR.2y5_1.heavy 471.778 / 571.32 12094.0 24.013500213623047 47 17 10 10 10 3.9008734047162954 25.635284620899625 0.0 3 0.976234725868415 7.989637762788387 12094.0 38.322551440329214 0.0 - - - - - - - 313.2 24 15 C9orf114 chromosome 9 open reading frame 114 1427 181 C20140401_SF093_03 C20140401_SF093_03 TB482729.[MT7]-NLEPGLR.2y6_1.heavy 471.778 / 684.404 21435.0 24.013500213623047 47 17 10 10 10 3.9008734047162954 25.635284620899625 0.0 3 0.976234725868415 7.989637762788387 21435.0 151.50046296296296 0.0 - - - - - - - 198.94736842105263 42 19 C9orf114 chromosome 9 open reading frame 114 1429 181 C20140401_SF093_03 C20140401_SF093_03 TB482729.[MT7]-NLEPGLR.2b5_1.heavy 471.778 / 655.353 11338.0 24.013500213623047 47 17 10 10 10 3.9008734047162954 25.635284620899625 0.0 3 0.976234725868415 7.989637762788387 11338.0 56.19008818342152 0.0 - - - - - - - 298.42105263157896 22 19 C9orf114 chromosome 9 open reading frame 114 1431 182 C20140401_SF093_03 C20140401_SF093_03 TB144320.[MT7]-K[MT7]GQAC[CAM]VQLAR.3y7_1.heavy 473.61 / 817.435 693.0 19.48979949951172 44 14 10 10 10 2.367766167433999 42.23390019478664 0.0 3 0.9310712126406367 4.673425217217699 693.0 4.803473205510486 0.0 - - - - - - - 0.0 1 0 C9orf114 chromosome 9 open reading frame 114 1433 182 C20140401_SF093_03 C20140401_SF093_03 TB144320.[MT7]-K[MT7]GQAC[CAM]VQLAR.3y6_1.heavy 473.61 / 746.398 2484.0 19.48979949951172 44 14 10 10 10 2.367766167433999 42.23390019478664 0.0 3 0.9310712126406367 4.673425217217699 2484.0 22.135814369472328 0.0 - - - - - - - 146.35294117647058 4 17 C9orf114 chromosome 9 open reading frame 114 1435 182 C20140401_SF093_03 C20140401_SF093_03 TB144320.[MT7]-K[MT7]GQAC[CAM]VQLAR.3y4_1.heavy 473.61 / 487.299 5776.0 19.48979949951172 44 14 10 10 10 2.367766167433999 42.23390019478664 0.0 3 0.9310712126406367 4.673425217217699 5776.0 18.31328751939703 0.0 - - - - - - - 252.47368421052633 11 19 C9orf114 chromosome 9 open reading frame 114 1437 182 C20140401_SF093_03 C20140401_SF093_03 TB144320.[MT7]-K[MT7]GQAC[CAM]VQLAR.3y5_1.heavy 473.61 / 586.367 3812.0 19.48979949951172 44 14 10 10 10 2.367766167433999 42.23390019478664 0.0 3 0.9310712126406367 4.673425217217699 3812.0 25.844139617607826 0.0 - - - - - - - 606.625 7 8 C9orf114 chromosome 9 open reading frame 114 1439 183 C20140401_SF093_03 C20140401_SF093_03 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 531977.0 39.89953358968099 23 -3 10 6 10 null 0.0 0.039501190185546875 3 0.0 0.0 531977.0 193.81929972576302 0.0 - - - - - - - 251.6 1063 5 1441 183 C20140401_SF093_03 C20140401_SF093_03 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 845377.0 39.89953358968099 23 -3 10 6 10 null 0.0 0.039501190185546875 3 0.0 0.0 845377.0 531.1898174871391 0.0 - - - - - - - 314.3333333333333 1690 3 1443 183 C20140401_SF093_03 C20140401_SF093_03 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 919142.0 39.89953358968099 23 -3 10 6 10 null 0.0 0.039501190185546875 3 0.0 0.0 919142.0 194.75608711472205 0.0 - - - - - - - 335.2 1838 5 1445 184 C20140401_SF093_03 C20140401_SF093_03 TB144325.[MT7]-ILFDGIPLEK[MT7].2y4_1.heavy 716.936 / 630.394 27939.0 42.45209884643555 48 20 10 10 8 8.008370746124639 12.486934380303433 0.0 4 0.991138353511578 13.100380902404885 27939.0 77.36195767195767 0.0 - - - - - - - 659.5714285714286 55 7 MUT methylmalonyl CoA mutase 1447 184 C20140401_SF093_03 C20140401_SF093_03 TB144325.[MT7]-ILFDGIPLEK[MT7].2b4_1.heavy 716.936 / 633.373 9556.0 42.45209884643555 48 20 10 10 8 8.008370746124639 12.486934380303433 0.0 4 0.991138353511578 13.100380902404885 9556.0 15.832286419753085 0.0 - - - - - - - 293.625 19 16 MUT methylmalonyl CoA mutase 1449 184 C20140401_SF093_03 C20140401_SF093_03 TB144325.[MT7]-ILFDGIPLEK[MT7].2y6_1.heavy 716.936 / 800.5 6641.0 42.45209884643555 48 20 10 10 8 8.008370746124639 12.486934380303433 0.0 4 0.991138353511578 13.100380902404885 6641.0 36.62115226337448 2.0 - - - - - - - 274.5 13 18 MUT methylmalonyl CoA mutase 1451 184 C20140401_SF093_03 C20140401_SF093_03 TB144325.[MT7]-ILFDGIPLEK[MT7].2b5_1.heavy 716.936 / 690.394 6560.0 42.45209884643555 48 20 10 10 8 8.008370746124639 12.486934380303433 0.0 4 0.991138353511578 13.100380902404885 6560.0 13.791721132897603 0.0 - - - - - - - 705.8571428571429 13 7 MUT methylmalonyl CoA mutase 1453 185 C20140401_SF093_03 C20140401_SF093_03 TB144009.[MT7]-RVSNTPLR.3y3_1.heavy 362.888 / 385.256 28542.0 17.239999771118164 46 16 10 10 10 5.042737304660262 19.830499579580454 0.0 3 0.9658841485686878 6.662569813177234 28542.0 108.17643401092732 0.0 - - - - - - - 242.33333333333334 57 12 PALM paralemmin 1455 185 C20140401_SF093_03 C20140401_SF093_03 TB144009.[MT7]-RVSNTPLR.3b4_1.heavy 362.888 / 601.354 5813.0 17.239999771118164 46 16 10 10 10 5.042737304660262 19.830499579580454 0.0 3 0.9658841485686878 6.662569813177234 5813.0 142.31827586206896 0.0 - - - - - - - 111.92857142857143 11 14 PALM paralemmin 1457 185 C20140401_SF093_03 C20140401_SF093_03 TB144009.[MT7]-RVSNTPLR.3b5_1.heavy 362.888 / 702.401 1337.0 17.239999771118164 46 16 10 10 10 5.042737304660262 19.830499579580454 0.0 3 0.9658841485686878 6.662569813177234 1337.0 31.926637931034485 0.0 - - - - - - - 98.23076923076923 2 13 PALM paralemmin 1459 185 C20140401_SF093_03 C20140401_SF093_03 TB144009.[MT7]-RVSNTPLR.3b3_1.heavy 362.888 / 487.311 1860.0 17.239999771118164 46 16 10 10 10 5.042737304660262 19.830499579580454 0.0 3 0.9658841485686878 6.662569813177234 1860.0 14.624182329436142 0.0 - - - - - - - 188.9 3 20 PALM paralemmin 1461 186 C20140401_SF093_03 C20140401_SF093_03 TB144329.[MT7]-C[CAM]QVALSC[CAM]LVSR.2b3_1.heavy 718.877 / 532.267 4084.0 33.51789855957031 48 18 10 10 10 6.3535430373561015 15.739249645755603 0.0 3 0.9859786113099758 10.410176550305135 4084.0 18.803416666666664 0.0 - - - - - - - 280.0 8 15 CD244 CD244 molecule, natural killer cell receptor 2B4 1463 186 C20140401_SF093_03 C20140401_SF093_03 TB144329.[MT7]-C[CAM]QVALSC[CAM]LVSR.2y8_1.heavy 718.877 / 905.487 6366.0 33.51789855957031 48 18 10 10 10 6.3535430373561015 15.739249645755603 0.0 3 0.9859786113099758 10.410176550305135 6366.0 28.470166666666668 0.0 - - - - - - - 229.0909090909091 12 11 CD244 CD244 molecule, natural killer cell receptor 2B4 1465 186 C20140401_SF093_03 C20140401_SF093_03 TB144329.[MT7]-C[CAM]QVALSC[CAM]LVSR.2y9_1.heavy 718.877 / 1004.56 4564.0 33.51789855957031 48 18 10 10 10 6.3535430373561015 15.739249645755603 0.0 3 0.9859786113099758 10.410176550305135 4564.0 15.924322518025512 0.0 - - - - - - - 291.42857142857144 9 14 CD244 CD244 molecule, natural killer cell receptor 2B4 1467 186 C20140401_SF093_03 C20140401_SF093_03 TB144329.[MT7]-C[CAM]QVALSC[CAM]LVSR.2y10_1.heavy 718.877 / 1132.61 3723.0 33.51789855957031 48 18 10 10 10 6.3535430373561015 15.739249645755603 0.0 3 0.9859786113099758 10.410176550305135 3723.0 19.132083333333334 0.0 - - - - - - - 252.0 7 10 CD244 CD244 molecule, natural killer cell receptor 2B4 1469 187 C20140401_SF093_03 C20140401_SF093_03 TB482927.[MT7]-RQAEIENK[MT7].3y3_1.heavy 425.913 / 534.3 29884.0 15.38129997253418 48 18 10 10 10 5.976688004209695 16.731674788706513 0.0 3 0.9802354674254312 8.763976158453962 29884.0 84.04698430705237 0.0 - - - - - - - 260.9375 59 16 PALM paralemmin 1471 187 C20140401_SF093_03 C20140401_SF093_03 TB482927.[MT7]-RQAEIENK[MT7].3b4_1.heavy 425.913 / 629.349 34763.0 15.38129997253418 48 18 10 10 10 5.976688004209695 16.731674788706513 0.0 3 0.9802354674254312 8.763976158453962 34763.0 133.4343732623169 0.0 - - - - - - - 214.0625 69 16 PALM paralemmin 1473 187 C20140401_SF093_03 C20140401_SF093_03 TB482927.[MT7]-RQAEIENK[MT7].3y4_1.heavy 425.913 / 647.385 8022.0 15.38129997253418 48 18 10 10 10 5.976688004209695 16.731674788706513 0.0 3 0.9802354674254312 8.763976158453962 8022.0 42.23046043420819 0.0 - - - - - - - 623.2857142857143 16 7 PALM paralemmin 1475 187 C20140401_SF093_03 C20140401_SF093_03 TB482927.[MT7]-RQAEIENK[MT7].3b3_1.heavy 425.913 / 500.306 4879.0 15.38129997253418 48 18 10 10 10 5.976688004209695 16.731674788706513 0.0 3 0.9802354674254312 8.763976158453962 4879.0 8.747588111935418 0.0 - - - - - - - 243.95 9 20 PALM paralemmin 1477 188 C20140401_SF093_03 C20140401_SF093_03 TB143994.[MT7]-GYDSDNPR.2b5_1.heavy 534.247 / 682.28 936.0 15.016700029373169 46 20 10 6 10 23.95351938109098 4.174751877126685 0.032799720764160156 3 0.999218984333728 44.157474529921714 936.0 10.931868796291631 0.0 - - - - - - - 0.0 1 0 MUT methylmalonyl CoA mutase 1479 188 C20140401_SF093_03 C20140401_SF093_03 TB143994.[MT7]-GYDSDNPR.2y5_1.heavy 534.247 / 588.274 1070.0 15.016700029373169 46 20 10 6 10 23.95351938109098 4.174751877126685 0.032799720764160156 3 0.999218984333728 44.157474529921714 1070.0 7.985074626865671 1.0 - - - - - - - 122.75 2 8 MUT methylmalonyl CoA mutase 1481 188 C20140401_SF093_03 C20140401_SF093_03 TB143994.[MT7]-GYDSDNPR.2b6_1.heavy 534.247 / 796.323 312.0 15.016700029373169 46 20 10 6 10 23.95351938109098 4.174751877126685 0.032799720764160156 3 0.999218984333728 44.157474529921714 312.0 6.2633707865168535 0.0 - - - - - - - 0.0 0 0 MUT methylmalonyl CoA mutase 1483 188 C20140401_SF093_03 C20140401_SF093_03 TB143994.[MT7]-GYDSDNPR.2y7_1.heavy 534.247 / 866.364 401.0 15.016700029373169 46 20 10 6 10 23.95351938109098 4.174751877126685 0.032799720764160156 3 0.999218984333728 44.157474529921714 401.0 8.05003745318352 0.0 - - - - - - - 0.0 0 0 MUT methylmalonyl CoA mutase 1485 189 C20140401_SF093_03 C20140401_SF093_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 87384.0 34.83259963989258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 87384.0 270.50689655172414 0.0 - - - - - - - 637.7142857142857 174 7 1487 189 C20140401_SF093_03 C20140401_SF093_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 20028.0 34.83259963989258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 20028.0 168.8717606707317 1.0 - - - - - - - 219.0 40 7 1489 189 C20140401_SF093_03 C20140401_SF093_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 14925.0 34.83259963989258 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 14925.0 43.64045922835007 0.0 - - - - - - - 237.28571428571428 29 7 1491 190 C20140401_SF093_03 C20140401_SF093_03 TB144148.[MT7]-LALNC[CAM]VGGK[MT7].3b4_1.heavy 407.241 / 556.357 50384.0 28.221099853515625 48 18 10 10 10 4.701409920834259 15.88681799498987 0.0 3 0.9829463952706581 9.437025838494057 50384.0 158.01232142857143 0.0 - - - - - - - 769.4615384615385 100 13 MECR mitochondrial trans-2-enoyl-CoA reductase 1493 190 C20140401_SF093_03 C20140401_SF093_03 TB144148.[MT7]-LALNC[CAM]VGGK[MT7].3b5_1.heavy 407.241 / 716.388 10599.0 28.221099853515625 48 18 10 10 10 4.701409920834259 15.88681799498987 0.0 3 0.9829463952706581 9.437025838494057 10599.0 57.93558737458193 0.0 - - - - - - - 181.35714285714286 21 14 MECR mitochondrial trans-2-enoyl-CoA reductase 1495 190 C20140401_SF093_03 C20140401_SF093_03 TB144148.[MT7]-LALNC[CAM]VGGK[MT7].3y4_1.heavy 407.241 / 504.326 10749.0 28.221099853515625 48 18 10 10 10 4.701409920834259 15.88681799498987 0.0 3 0.9829463952706581 9.437025838494057 10749.0 14.877857703697057 0.0 - - - - - - - 734.9230769230769 21 13 MECR mitochondrial trans-2-enoyl-CoA reductase 1497 190 C20140401_SF093_03 C20140401_SF093_03 TB144148.[MT7]-LALNC[CAM]VGGK[MT7].3b3_1.heavy 407.241 / 442.315 36501.0 28.221099853515625 48 18 10 10 10 4.701409920834259 15.88681799498987 0.0 3 0.9829463952706581 9.437025838494057 36501.0 55.89945814753516 0.0 - - - - - - - 796.0 73 9 MECR mitochondrial trans-2-enoyl-CoA reductase 1499 191 C20140401_SF093_03 C20140401_SF093_03 TB144226.[MT7]-AC[CAM]LENLGLK[MT7].2y8_1.heavy 653.376 / 1090.6 2406.0 32.6150016784668 40 10 10 10 10 0.7995051634554067 75.85058575011055 0.0 3 0.8373638667819637 3.017755431230759 2406.0 21.999802544142774 0.0 - - - - - - - 160.7 4 10 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1501 191 C20140401_SF093_03 C20140401_SF093_03 TB144226.[MT7]-AC[CAM]LENLGLK[MT7].2b4_1.heavy 653.376 / 618.304 N/A 32.6150016784668 40 10 10 10 10 0.7995051634554067 75.85058575011055 0.0 3 0.8373638667819637 3.017755431230759 4239.0 14.937102916108607 0.0 - - - - - - - 764.0 8 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1503 191 C20140401_SF093_03 C20140401_SF093_03 TB144226.[MT7]-AC[CAM]LENLGLK[MT7].2y6_1.heavy 653.376 / 817.49 1375.0 32.6150016784668 40 10 10 10 10 0.7995051634554067 75.85058575011055 0.0 3 0.8373638667819637 3.017755431230759 1375.0 1.5988372093023258 0.0 - - - - - - - 212.92857142857142 2 14 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1505 191 C20140401_SF093_03 C20140401_SF093_03 TB144226.[MT7]-AC[CAM]LENLGLK[MT7].2b5_1.heavy 653.376 / 732.347 1031.0 32.6150016784668 40 10 10 10 10 0.7995051634554067 75.85058575011055 0.0 3 0.8373638667819637 3.017755431230759 1031.0 5.161851148661477 0.0 - - - - - - - 239.72727272727272 2 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1507 192 C20140401_SF093_03 C20140401_SF093_03 TB144151.[MT7]-NNIWYPK[MT7].2y4_1.heavy 611.845 / 737.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1509 192 C20140401_SF093_03 C20140401_SF093_03 TB144151.[MT7]-NNIWYPK[MT7].2b4_1.heavy 611.845 / 672.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1511 192 C20140401_SF093_03 C20140401_SF093_03 TB144151.[MT7]-NNIWYPK[MT7].2y3_1.heavy 611.845 / 551.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1513 192 C20140401_SF093_03 C20140401_SF093_03 TB144151.[MT7]-NNIWYPK[MT7].2b5_1.heavy 611.845 / 835.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1515 193 C20140401_SF093_03 C20140401_SF093_03 TB144155.[MT7]-VLSSTTLLPR.2y8_1.heavy 615.881 / 874.499 4017.0 35.002949714660645 42 17 10 5 10 4.272225951790919 23.40700167276498 0.046199798583984375 3 0.9727161222738122 7.454472369510181 4017.0 14.78576232228406 2.0 - - - - - - - 259.3333333333333 8 6 PALM paralemmin 1517 193 C20140401_SF093_03 C20140401_SF093_03 TB144155.[MT7]-VLSSTTLLPR.2y9_1.heavy 615.881 / 987.583 11402.0 35.002949714660645 42 17 10 5 10 4.272225951790919 23.40700167276498 0.046199798583984375 3 0.9727161222738122 7.454472369510181 11402.0 97.7645831566449 0.0 - - - - - - - 207.6 22 5 PALM paralemmin 1519 193 C20140401_SF093_03 C20140401_SF093_03 TB144155.[MT7]-VLSSTTLLPR.2y6_1.heavy 615.881 / 700.435 1555.0 35.002949714660645 42 17 10 5 10 4.272225951790919 23.40700167276498 0.046199798583984375 3 0.9727161222738122 7.454472369510181 1555.0 9.681495965300593 1.0 - - - - - - - 272.2 3 10 PALM paralemmin 1521 193 C20140401_SF093_03 C20140401_SF093_03 TB144155.[MT7]-VLSSTTLLPR.2y7_1.heavy 615.881 / 787.467 1943.0 35.002949714660645 42 17 10 5 10 4.272225951790919 23.40700167276498 0.046199798583984375 3 0.9727161222738122 7.454472369510181 1943.0 4.995012774128027 0.0 - - - - - - - 216.11111111111111 3 9 PALM paralemmin 1523 194 C20140401_SF093_03 C20140401_SF093_03 TB144433.[MT7]-LPTSGGC[CAM]SALELK[MT7].3b9_1.heavy 540.967 / 975.469 1363.0 32.349549293518066 44 18 10 6 10 3.929344583480246 25.44953690761052 0.035396575927734375 3 0.985783871607208 10.33846010355566 1363.0 8.369298245614035 0.0 - - - - - - - 162.42857142857142 2 7 AS3MT arsenic (+3 oxidation state) methyltransferase 1525 194 C20140401_SF093_03 C20140401_SF093_03 TB144433.[MT7]-LPTSGGC[CAM]SALELK[MT7].3b6_1.heavy 540.967 / 657.369 2272.0 32.349549293518066 44 18 10 6 10 3.929344583480246 25.44953690761052 0.035396575927734375 3 0.985783871607208 10.33846010355566 2272.0 17.004969162995593 0.0 - - - - - - - 241.5 4 8 AS3MT arsenic (+3 oxidation state) methyltransferase 1527 194 C20140401_SF093_03 C20140401_SF093_03 TB144433.[MT7]-LPTSGGC[CAM]SALELK[MT7].3y3_1.heavy 540.967 / 533.341 4543.0 32.349549293518066 44 18 10 6 10 3.929344583480246 25.44953690761052 0.035396575927734375 3 0.985783871607208 10.33846010355566 4543.0 26.21731277533039 0.0 - - - - - - - 246.08333333333334 9 12 AS3MT arsenic (+3 oxidation state) methyltransferase 1529 194 C20140401_SF093_03 C20140401_SF093_03 TB144433.[MT7]-LPTSGGC[CAM]SALELK[MT7].3y4_1.heavy 540.967 / 646.426 4203.0 32.349549293518066 44 18 10 6 10 3.929344583480246 25.44953690761052 0.035396575927734375 3 0.985783871607208 10.33846010355566 4203.0 11.269598632852835 0.0 - - - - - - - 261.4 8 10 AS3MT arsenic (+3 oxidation state) methyltransferase 1531 195 C20140401_SF093_03 C20140401_SF093_03 TB144012.[MT7]-NLSLLIK[MT7].2y4_1.heavy 544.868 / 630.467 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 1533 195 C20140401_SF093_03 C20140401_SF093_03 TB144012.[MT7]-NLSLLIK[MT7].2y5_1.heavy 544.868 / 717.499 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 1535 195 C20140401_SF093_03 C20140401_SF093_03 TB144012.[MT7]-NLSLLIK[MT7].2b4_1.heavy 544.868 / 572.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 1537 195 C20140401_SF093_03 C20140401_SF093_03 TB144012.[MT7]-NLSLLIK[MT7].2y3_1.heavy 544.868 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - CD244 CD244 molecule, natural killer cell receptor 2B4 1539 196 C20140401_SF093_03 C20140401_SF093_03 TB348827.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].4b8_1.heavy 687.884 / 997.605 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1541 196 C20140401_SF093_03 C20140401_SF093_03 TB348827.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].4b7_1.heavy 687.884 / 884.521 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1543 196 C20140401_SF093_03 C20140401_SF093_03 TB348827.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].4b4_1.heavy 687.884 / 555.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1545 196 C20140401_SF093_03 C20140401_SF093_03 TB348827.[MT7]-IAIIVDDIIDDVDSFLAAAETLK[MT7].4y6_1.heavy 687.884 / 776.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1547 197 C20140401_SF093_03 C20140401_SF093_03 TB482852.[MT7]-EK[MT7]PPITVVGDVGGR.3y7_1.heavy 571.336 / 659.347 8185.0 28.515474796295166 46 20 10 6 10 9.030326399711612 11.073796845614966 0.03270149230957031 3 0.9959048953985047 19.27886898004157 8185.0 122.3650025682977 0.0 - - - - - - - 192.1818181818182 16 11 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 1549 197 C20140401_SF093_03 C20140401_SF093_03 TB482852.[MT7]-EK[MT7]PPITVVGDVGGR.3y6_1.heavy 571.336 / 560.279 7912.0 28.515474796295166 46 20 10 6 10 9.030326399711612 11.073796845614966 0.03270149230957031 3 0.9959048953985047 19.27886898004157 7912.0 47.14660124454616 0.0 - - - - - - - 220.30769230769232 15 13 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 1551 197 C20140401_SF093_03 C20140401_SF093_03 TB482852.[MT7]-EK[MT7]PPITVVGDVGGR.3b7_2.heavy 571.336 / 527.331 4911.0 28.515474796295166 46 20 10 6 10 9.030326399711612 11.073796845614966 0.03270149230957031 3 0.9959048953985047 19.27886898004157 4911.0 8.140449763051048 0.0 - - - - - - - 259.2 9 20 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 1553 197 C20140401_SF093_03 C20140401_SF093_03 TB482852.[MT7]-EK[MT7]PPITVVGDVGGR.3y9_1.heavy 571.336 / 859.463 5184.0 28.515474796295166 46 20 10 6 10 9.030326399711612 11.073796845614966 0.03270149230957031 3 0.9959048953985047 19.27886898004157 5184.0 74.19407549338953 0.0 - - - - - - - 120.46153846153847 10 13 PRPSAP1;PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 1;phosphoribosyl pyrophosphate synthetase-associated protein 2 1555 198 C20140401_SF093_03 C20140401_SF093_03 TB482908.[MT7]-DIITDPFK[MT7].2y5_1.heavy 618.858 / 751.411 2000.0 36.517601013183594 50 20 10 10 10 5.43862380042748 18.387004446260825 0.0 3 0.9967202435788882 21.54382459450886 2000.0 -0.3237740762249015 2.0 - - - - - - - 244.5 5 6 AS3MT arsenic (+3 oxidation state) methyltransferase 1557 198 C20140401_SF093_03 C20140401_SF093_03 TB482908.[MT7]-DIITDPFK[MT7].2y3_1.heavy 618.858 / 535.336 33208.0 36.517601013183594 50 20 10 10 10 5.43862380042748 18.387004446260825 0.0 3 0.9967202435788882 21.54382459450886 33208.0 72.53992070345984 0.0 - - - - - - - 647.7142857142857 66 7 AS3MT arsenic (+3 oxidation state) methyltransferase 1559 198 C20140401_SF093_03 C20140401_SF093_03 TB482908.[MT7]-DIITDPFK[MT7].2y6_1.heavy 618.858 / 864.495 1600.0 36.517601013183594 50 20 10 10 10 5.43862380042748 18.387004446260825 0.0 3 0.9967202435788882 21.54382459450886 1600.0 7.697805232721985 0.0 - - - - - - - 233.25 3 8 AS3MT arsenic (+3 oxidation state) methyltransferase 1561 198 C20140401_SF093_03 C20140401_SF093_03 TB482908.[MT7]-DIITDPFK[MT7].2b5_1.heavy 618.858 / 702.379 9736.0 36.517601013183594 50 20 10 10 10 5.43862380042748 18.387004446260825 0.0 3 0.9967202435788882 21.54382459450886 9736.0 145.08836090225566 0.0 - - - - - - - 199.875 19 8 AS3MT arsenic (+3 oxidation state) methyltransferase 1563 199 C20140401_SF093_03 C20140401_SF093_03 TB482718.[MT7]-AAENFTLLVK[MT7].3y3_1.heavy 465.281 / 503.367 N/A 37.321800231933594 44 14 10 10 10 1.7547751017399211 48.74054697511964 0.0 3 0.9345593414440251 4.797789885651343 41645.0 0.8020823990321271 2.0 - - - - - - - 264.5 92 2 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1565 199 C20140401_SF093_03 C20140401_SF093_03 TB482718.[MT7]-AAENFTLLVK[MT7].3b4_1.heavy 465.281 / 530.269 46273.0 37.321800231933594 44 14 10 10 10 1.7547751017399211 48.74054697511964 0.0 3 0.9345593414440251 4.797789885651343 46273.0 63.74023973721613 0.0 - - - - - - - 198.0 92 8 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1567 199 C20140401_SF093_03 C20140401_SF093_03 TB482718.[MT7]-AAENFTLLVK[MT7].3b5_1.heavy 465.281 / 677.338 26441.0 37.321800231933594 44 14 10 10 10 1.7547751017399211 48.74054697511964 0.0 3 0.9345593414440251 4.797789885651343 26441.0 218.7055161701044 0.0 - - - - - - - 220.33333333333334 52 3 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1569 199 C20140401_SF093_03 C20140401_SF093_03 TB482718.[MT7]-AAENFTLLVK[MT7].3y4_1.heavy 465.281 / 616.451 29614.0 37.321800231933594 44 14 10 10 10 1.7547751017399211 48.74054697511964 0.0 3 0.9345593414440251 4.797789885651343 29614.0 18.835899624558454 0.0 - - - - - - - 264.25 59 4 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1571 200 C20140401_SF093_03 C20140401_SF093_03 TB348626.[MT7]-AAENFTLLVK[MT7].2y5_1.heavy 697.418 / 717.499 3870.0 37.29784965515137 33 10 8 5 10 2.013886198676422 33.839285322788804 0.047901153564453125 3 0.8219465757487256 2.880195187200244 3870.0 15.511983471074378 0.0 - - - - - - - 297.84615384615387 7 13 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1573 200 C20140401_SF093_03 C20140401_SF093_03 TB348626.[MT7]-AAENFTLLVK[MT7].2b4_1.heavy 697.418 / 530.269 2540.0 37.29784965515137 33 10 8 5 10 2.013886198676422 33.839285322788804 0.047901153564453125 3 0.8219465757487256 2.880195187200244 2540.0 8.942479338842976 0.0 - - - - - - - 282.3333333333333 5 9 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1575 200 C20140401_SF093_03 C20140401_SF093_03 TB348626.[MT7]-AAENFTLLVK[MT7].2b7_1.heavy 697.418 / 891.469 4474.0 37.29784965515137 33 10 8 5 10 2.013886198676422 33.839285322788804 0.047901153564453125 3 0.8219465757487256 2.880195187200244 4474.0 11.074189885220857 0.0 - - - - - - - 254.1 8 10 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1577 200 C20140401_SF093_03 C20140401_SF093_03 TB348626.[MT7]-AAENFTLLVK[MT7].2b5_1.heavy 697.418 / 677.338 3265.0 37.29784965515137 33 10 8 5 10 2.013886198676422 33.839285322788804 0.047901153564453125 3 0.8219465757487256 2.880195187200244 3265.0 8.328898071625344 0.0 - - - - - - - 352.0 12 11 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1579 201 C20140401_SF093_03 C20140401_SF093_03 TB144016.[MT7]-AQEEQAK[MT7].2y4_1.heavy 546.3 / 619.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 1581 201 C20140401_SF093_03 C20140401_SF093_03 TB144016.[MT7]-AQEEQAK[MT7].2y5_1.heavy 546.3 / 748.396 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 1583 201 C20140401_SF093_03 C20140401_SF093_03 TB144016.[MT7]-AQEEQAK[MT7].2b4_1.heavy 546.3 / 602.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 1585 201 C20140401_SF093_03 C20140401_SF093_03 TB144016.[MT7]-AQEEQAK[MT7].2b5_1.heavy 546.3 / 730.349 N/A N/A - - - - - - - - - 0.0 - - - - - - - C9orf114 chromosome 9 open reading frame 114 1587 202 C20140401_SF093_03 C20140401_SF093_03 TB144158.[MT7]-LSSFYSLK[MT7].2y4_1.heavy 616.86 / 654.394 667.0 36.22639846801758 41 11 10 10 10 0.8517170477964456 74.53389336479513 0.0 3 0.8659185005241676 3.3319730060492794 667.0 2.231452247191011 1.0 - - - - - - - 0.0 1 0 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1589 202 C20140401_SF093_03 C20140401_SF093_03 TB144158.[MT7]-LSSFYSLK[MT7].2y5_1.heavy 616.86 / 801.463 400.0 36.22639846801758 41 11 10 10 10 0.8517170477964456 74.53389336479513 0.0 3 0.8659185005241676 3.3319730060492794 400.0 3.1834586466165415 7.0 - - - - - - - 209.28571428571428 2 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1591 202 C20140401_SF093_03 C20140401_SF093_03 TB144158.[MT7]-LSSFYSLK[MT7].2y6_1.heavy 616.86 / 888.495 1333.0 36.22639846801758 41 11 10 10 10 0.8517170477964456 74.53389336479513 0.0 3 0.8659185005241676 3.3319730060492794 1333.0 9.319373834586466 0.0 - - - - - - - 228.42857142857142 2 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1593 202 C20140401_SF093_03 C20140401_SF093_03 TB144158.[MT7]-LSSFYSLK[MT7].2y7_1.heavy 616.86 / 975.527 3866.0 36.22639846801758 41 11 10 10 10 0.8517170477964456 74.53389336479513 0.0 3 0.8659185005241676 3.3319730060492794 3866.0 29.024122103010335 0.0 - - - - - - - 159.8 7 5 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1595 203 C20140401_SF093_03 C20140401_SF093_03 TB144238.[MT7]-TRLLEDSVSR.2y8_1.heavy 660.374 / 918.489 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1597 203 C20140401_SF093_03 C20140401_SF093_03 TB144238.[MT7]-TRLLEDSVSR.2b6_1.heavy 660.374 / 872.496 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1599 203 C20140401_SF093_03 C20140401_SF093_03 TB144238.[MT7]-TRLLEDSVSR.2b7_1.heavy 660.374 / 959.528 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1601 203 C20140401_SF093_03 C20140401_SF093_03 TB144238.[MT7]-TRLLEDSVSR.2y7_1.heavy 660.374 / 805.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 1603 204 C20140401_SF093_03 C20140401_SF093_03 TB144237.[MT7]-DVLEIDFPAR.2y8_1.heavy 659.86 / 960.515 5756.0 39.32789993286133 42 20 6 10 6 14.961518260688742 6.683813651636488 0.0 6 0.9988136575732903 35.82732589165838 5756.0 0.15001303101381283 2.0 - - - - - - - 279.625 15 8 FANCL Fanconi anemia, complementation group L 1605 204 C20140401_SF093_03 C20140401_SF093_03 TB144237.[MT7]-DVLEIDFPAR.2b4_1.heavy 659.86 / 601.331 6182.0 39.32789993286133 42 20 6 10 6 14.961518260688742 6.683813651636488 0.0 6 0.9988136575732903 35.82732589165838 6182.0 6.681471504590431 2.0 - - - - - - - 200.0 13 8 FANCL Fanconi anemia, complementation group L 1607 204 C20140401_SF093_03 C20140401_SF093_03 TB144237.[MT7]-DVLEIDFPAR.2b6_1.heavy 659.86 / 829.442 N/A 39.32789993286133 42 20 6 10 6 14.961518260688742 6.683813651636488 0.0 6 0.9988136575732903 35.82732589165838 0.0 0.0 31.0 - - - - - - - 213.375 18 8 FANCL Fanconi anemia, complementation group L 1609 204 C20140401_SF093_03 C20140401_SF093_03 TB144237.[MT7]-DVLEIDFPAR.2y7_1.heavy 659.86 / 847.431 5756.0 39.32789993286133 42 20 6 10 6 14.961518260688742 6.683813651636488 0.0 6 0.9988136575732903 35.82732589165838 5756.0 -0.18949794238683124 1.0 - - - - - - - 266.6666666666667 12 6 FANCL Fanconi anemia, complementation group L 1611 205 C20140401_SF093_03 C20140401_SF093_03 TB348374.[MT7]-AEDASGR.2b3_1.heavy 425.213 / 460.216 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1613 205 C20140401_SF093_03 C20140401_SF093_03 TB348374.[MT7]-AEDASGR.2y5_1.heavy 425.213 / 505.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1615 205 C20140401_SF093_03 C20140401_SF093_03 TB348374.[MT7]-AEDASGR.2b4_1.heavy 425.213 / 531.253 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1617 205 C20140401_SF093_03 C20140401_SF093_03 TB348374.[MT7]-AEDASGR.2y6_1.heavy 425.213 / 634.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1619 206 C20140401_SF093_03 C20140401_SF093_03 TB144065.[MT7]-TYLAGQIAR.2b3_1.heavy 568.831 / 522.304 4506.0 27.301624298095703 28 16 0 6 6 1.9173816492726323 41.42297646747937 0.0345001220703125 5 0.9663342553968955 6.707215542421764 4506.0 30.593353574558655 0.0 - - - - - - - 163.25 9 16 C9orf114 chromosome 9 open reading frame 114 1621 206 C20140401_SF093_03 C20140401_SF093_03 TB144065.[MT7]-TYLAGQIAR.2y5_1.heavy 568.831 / 544.32 6465.0 27.301624298095703 28 16 0 6 6 1.9173816492726323 41.42297646747937 0.0345001220703125 5 0.9663342553968955 6.707215542421764 6465.0 30.1285479709125 1.0 - - - - - - - 191.46666666666667 90 15 C9orf114 chromosome 9 open reading frame 114 1623 206 C20140401_SF093_03 C20140401_SF093_03 TB144065.[MT7]-TYLAGQIAR.2y6_1.heavy 568.831 / 615.357 7379.0 27.301624298095703 28 16 0 6 6 1.9173816492726323 41.42297646747937 0.0345001220703125 5 0.9663342553968955 6.707215542421764 7379.0 67.68021994092013 1.0 - - - - - - - 163.21428571428572 42 14 C9orf114 chromosome 9 open reading frame 114 1625 206 C20140401_SF093_03 C20140401_SF093_03 TB144065.[MT7]-TYLAGQIAR.2y7_1.heavy 568.831 / 728.441 4702.0 27.301624298095703 28 16 0 6 6 1.9173816492726323 41.42297646747937 0.0345001220703125 5 0.9663342553968955 6.707215542421764 4702.0 57.3931145038168 0.0 - - - - - - - 121.5 9 14 C9orf114 chromosome 9 open reading frame 114 1627 207 C20140401_SF093_03 C20140401_SF093_03 TB483039.[MT7]-ELILTLC[CAM]DLIR.2y8_1.heavy 751.94 / 1003.56 113807.0 51.5546989440918 43 13 10 10 10 3.0406505674122304 32.88769879437537 0.0 3 0.9152201491811702 4.208224729493091 113807.0 708.4357320077563 0.0 - - - - - - - 193.23076923076923 227 13 MECR mitochondrial trans-2-enoyl-CoA reductase 1629 207 C20140401_SF093_03 C20140401_SF093_03 TB483039.[MT7]-ELILTLC[CAM]DLIR.2y9_1.heavy 751.94 / 1116.64 33570.0 51.5546989440918 43 13 10 10 10 3.0406505674122304 32.88769879437537 0.0 3 0.9152201491811702 4.208224729493091 33570.0 160.0107364186116 0.0 - - - - - - - 251.52941176470588 67 17 MECR mitochondrial trans-2-enoyl-CoA reductase 1631 207 C20140401_SF093_03 C20140401_SF093_03 TB483039.[MT7]-ELILTLC[CAM]DLIR.2y10_1.heavy 751.94 / 1229.73 13792.0 51.5546989440918 43 13 10 10 10 3.0406505674122304 32.88769879437537 0.0 3 0.9152201491811702 4.208224729493091 13792.0 180.45607476635513 0.0 - - - - - - - 142.46666666666667 27 15 MECR mitochondrial trans-2-enoyl-CoA reductase 1633 207 C20140401_SF093_03 C20140401_SF093_03 TB483039.[MT7]-ELILTLC[CAM]DLIR.2y7_1.heavy 751.94 / 890.476 63719.0 51.5546989440918 43 13 10 10 10 3.0406505674122304 32.88769879437537 0.0 3 0.9152201491811702 4.208224729493091 63719.0 233.48908194399516 0.0 - - - - - - - 203.0 127 15 MECR mitochondrial trans-2-enoyl-CoA reductase 1635 208 C20140401_SF093_03 C20140401_SF093_03 TB144167.[MT7]-FLGC[CAM]VDIK[MT7].2y3_1.heavy 620.354 / 519.326 1711.0 35.39820098876953 47 17 10 10 10 4.658449919390982 21.466367940062216 0.0 3 0.9787297019457402 8.447005260021726 1711.0 2.9877946768060832 3.0 - - - - - - - 239.27272727272728 3 11 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1637 208 C20140401_SF093_03 C20140401_SF093_03 TB144167.[MT7]-FLGC[CAM]VDIK[MT7].2b6_1.heavy 620.354 / 836.409 5527.0 35.39820098876953 47 17 10 10 10 4.658449919390982 21.466367940062216 0.0 3 0.9787297019457402 8.447005260021726 5527.0 39.088288973384024 0.0 - - - - - - - 197.5 11 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1639 208 C20140401_SF093_03 C20140401_SF093_03 TB144167.[MT7]-FLGC[CAM]VDIK[MT7].2y6_1.heavy 620.354 / 835.446 3290.0 35.39820098876953 47 17 10 10 10 4.658449919390982 21.466367940062216 0.0 3 0.9787297019457402 8.447005260021726 3290.0 24.943196220762765 0.0 - - - - - - - 190.22222222222223 6 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1641 208 C20140401_SF093_03 C20140401_SF093_03 TB144167.[MT7]-FLGC[CAM]VDIK[MT7].2y7_1.heavy 620.354 / 948.531 5264.0 35.39820098876953 47 17 10 10 10 4.658449919390982 21.466367940062216 0.0 3 0.9787297019457402 8.447005260021726 5264.0 58.6961170641779 0.0 - - - - - - - 204.88888888888889 10 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1643 209 C20140401_SF093_03 C20140401_SF093_03 TB144449.[MT7]-IPLPAGYREEIVR.3y10_2.heavy 552.99 / 595.32 4332.0 33.38695049285889 46 20 10 6 10 6.379545100343754 15.675098839666738 0.039798736572265625 3 0.9923567659288446 14.107393602354769 4332.0 7.108923076923077 0.0 - - - - - - - 248.625 8 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1645 209 C20140401_SF093_03 C20140401_SF093_03 TB144449.[MT7]-IPLPAGYREEIVR.3y12_2.heavy 552.99 / 700.388 26459.0 33.38695049285889 46 20 10 6 10 6.379545100343754 15.675098839666738 0.039798736572265625 3 0.9923567659288446 14.107393602354769 26459.0 220.21975740422522 0.0 - - - - - - - 136.5 52 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1647 209 C20140401_SF093_03 C20140401_SF093_03 TB144449.[MT7]-IPLPAGYREEIVR.3y5_1.heavy 552.99 / 645.357 1873.0 33.38695049285889 46 20 10 6 10 6.379545100343754 15.675098839666738 0.039798736572265625 3 0.9923567659288446 14.107393602354769 1873.0 1.921025641025641 0.0 - - - - - - - 269.1 3 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1649 209 C20140401_SF093_03 C20140401_SF093_03 TB144449.[MT7]-IPLPAGYREEIVR.3y4_1.heavy 552.99 / 516.314 1639.0 33.38695049285889 46 20 10 6 10 6.379545100343754 15.675098839666738 0.039798736572265625 3 0.9923567659288446 14.107393602354769 1639.0 13.027948717948718 0.0 - - - - - - - 259.07142857142856 3 14 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1651 210 C20140401_SF093_03 C20140401_SF093_03 TB143978.[MT7]-EITSAIK[MT7].2y4_1.heavy 525.326 / 562.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1653 210 C20140401_SF093_03 C20140401_SF093_03 TB143978.[MT7]-EITSAIK[MT7].2y5_1.heavy 525.326 / 663.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1655 210 C20140401_SF093_03 C20140401_SF093_03 TB143978.[MT7]-EITSAIK[MT7].2y6_1.heavy 525.326 / 776.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1657 210 C20140401_SF093_03 C20140401_SF093_03 TB143978.[MT7]-EITSAIK[MT7].2b5_1.heavy 525.326 / 646.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - MUT methylmalonyl CoA mutase 1659 211 C20140401_SF093_03 C20140401_SF093_03 TB482980.[MT7]-LNLSGDTVGPVR.2y9_1.heavy 686.389 / 887.458 12388.0 31.390899658203125 47 17 10 10 10 2.8646740678860922 27.96402828580146 0.0 3 0.9791042059933296 8.52263271313923 12388.0 54.6881954523464 0.0 - - - - - - - 302.85714285714283 24 7 FBXL8 F-box and leucine-rich repeat protein 8 1661 211 C20140401_SF093_03 C20140401_SF093_03 TB482980.[MT7]-LNLSGDTVGPVR.2y6_1.heavy 686.389 / 628.378 11223.0 31.390899658203125 47 17 10 10 10 2.8646740678860922 27.96402828580146 0.0 3 0.9791042059933296 8.52263271313923 11223.0 14.495279799370573 0.0 - - - - - - - 212.0 22 8 FBXL8 F-box and leucine-rich repeat protein 8 1663 211 C20140401_SF093_03 C20140401_SF093_03 TB482980.[MT7]-LNLSGDTVGPVR.2y10_1.heavy 686.389 / 1000.54 7306.0 31.390899658203125 47 17 10 10 10 2.8646740678860922 27.96402828580146 0.0 3 0.9791042059933296 8.52263271313923 7306.0 48.93641509433962 0.0 - - - - - - - 212.0 14 12 FBXL8 F-box and leucine-rich repeat protein 8 1665 211 C20140401_SF093_03 C20140401_SF093_03 TB482980.[MT7]-LNLSGDTVGPVR.2y11_1.heavy 686.389 / 1114.59 10270.0 31.390899658203125 47 17 10 10 10 2.8646740678860922 27.96402828580146 0.0 3 0.9791042059933296 8.52263271313923 10270.0 55.75834905660377 0.0 - - - - - - - 185.5 20 12 FBXL8 F-box and leucine-rich repeat protein 8 1667 212 C20140401_SF093_03 C20140401_SF093_03 TB144441.[MT7]-TWVLEPEK[MT7]PPR.3y6_1.heavy 547.319 / 867.517 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1669 212 C20140401_SF093_03 C20140401_SF093_03 TB144441.[MT7]-TWVLEPEK[MT7]PPR.3y4_1.heavy 547.319 / 641.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1671 212 C20140401_SF093_03 C20140401_SF093_03 TB144441.[MT7]-TWVLEPEK[MT7]PPR.3b3_1.heavy 547.319 / 531.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1673 212 C20140401_SF093_03 C20140401_SF093_03 TB144441.[MT7]-TWVLEPEK[MT7]PPR.3y8_1.heavy 547.319 / 1109.64 N/A N/A - - - - - - - - - 0.0 - - - - - - - FANCL Fanconi anemia, complementation group L 1675 213 C20140401_SF093_03 C20140401_SF093_03 TB483172.[MT7]-TPEAGLAGRPSPWTTPGR.4y5_1.heavy 499.519 / 531.289 6448.0 29.283724784851074 34 13 10 3 8 1.8683481484681037 53.523215189841366 0.0662994384765625 4 0.9225026064712252 4.404264319840055 6448.0 22.68599280727734 0.0 - - - - - - - 673.8 12 10 FBLIM1 filamin binding LIM protein 1 1677 213 C20140401_SF093_03 C20140401_SF093_03 TB483172.[MT7]-TPEAGLAGRPSPWTTPGR.4y12_2.heavy 499.519 / 641.836 5506.0 29.283724784851074 34 13 10 3 8 1.8683481484681037 53.523215189841366 0.0662994384765625 4 0.9225026064712252 4.404264319840055 5506.0 22.833217060599125 0.0 - - - - - - - 191.28571428571428 11 14 FBLIM1 filamin binding LIM protein 1 1679 213 C20140401_SF093_03 C20140401_SF093_03 TB483172.[MT7]-TPEAGLAGRPSPWTTPGR.4y9_1.heavy 499.519 / 998.505 652.0 29.283724784851074 34 13 10 3 8 1.8683481484681037 53.523215189841366 0.0662994384765625 4 0.9225026064712252 4.404264319840055 652.0 2.9977011494252874 0.0 - - - - - - - 0.0 1 0 FBLIM1 filamin binding LIM protein 1 1681 213 C20140401_SF093_03 C20140401_SF093_03 TB483172.[MT7]-TPEAGLAGRPSPWTTPGR.4b5_1.heavy 499.519 / 600.311 5579.0 29.283724784851074 34 13 10 3 8 1.8683481484681037 53.523215189841366 0.0662994384765625 4 0.9225026064712252 4.404264319840055 5579.0 18.890737604570496 1.0 - - - - - - - 208.125 13 16 FBLIM1 filamin binding LIM protein 1 1683 214 C20140401_SF093_03 C20140401_SF093_03 TB143973.[MT7]-VLAALQER.2y4_1.heavy 522.32 / 545.304 5840.0 32.01330089569092 44 18 10 6 10 5.3439467935568805 18.71276116007902 0.039600372314453125 3 0.9811293107541745 8.969808271488773 5840.0 13.607420380271357 0.0 - - - - - - - 294.8125 11 16 NAP1L4 nucleosome assembly protein 1-like 4 1685 214 C20140401_SF093_03 C20140401_SF093_03 TB143973.[MT7]-VLAALQER.2y5_1.heavy 522.32 / 616.341 11006.0 32.01330089569092 44 18 10 6 10 5.3439467935568805 18.71276116007902 0.039600372314453125 3 0.9811293107541745 8.969808271488773 11006.0 42.871575347351566 0.0 - - - - - - - 256.85714285714283 22 14 NAP1L4 nucleosome assembly protein 1-like 4 1687 214 C20140401_SF093_03 C20140401_SF093_03 TB143973.[MT7]-VLAALQER.2y6_1.heavy 522.32 / 687.378 21563.0 32.01330089569092 44 18 10 6 10 5.3439467935568805 18.71276116007902 0.039600372314453125 3 0.9811293107541745 8.969808271488773 21563.0 282.60792956349206 0.0 - - - - - - - 207.23076923076923 43 13 NAP1L4 nucleosome assembly protein 1-like 4 1689 214 C20140401_SF093_03 C20140401_SF093_03 TB143973.[MT7]-VLAALQER.2y7_1.heavy 522.32 / 800.463 27852.0 32.01330089569092 44 18 10 6 10 5.3439467935568805 18.71276116007902 0.039600372314453125 3 0.9811293107541745 8.969808271488773 27852.0 31.391603053435112 1.0 - - - - - - - 285.0769230769231 55 13 NAP1L4 nucleosome assembly protein 1-like 4 1691 215 C20140401_SF093_03 C20140401_SF093_03 TB143976.[MT7]-IIADIFEYTAK[MT7].3b5_1.heavy 524.636 / 670.426 11056.0 46.10202407836914 44 18 10 6 10 5.757641520092868 17.368222674340284 0.0363006591796875 3 0.9853656165030692 10.189293946470126 11056.0 160.15274757815473 0.0 - - - - - - - 107.8 22 5 MUT methylmalonyl CoA mutase 1693 215 C20140401_SF093_03 C20140401_SF093_03 TB143976.[MT7]-IIADIFEYTAK[MT7].3y4_1.heavy 524.636 / 626.363 8138.0 46.10202407836914 44 18 10 6 10 5.757641520092868 17.368222674340284 0.0363006591796875 3 0.9853656165030692 10.189293946470126 8138.0 147.96363636363637 0.0 - - - - - - - 128.16666666666666 16 6 MUT methylmalonyl CoA mutase 1695 215 C20140401_SF093_03 C20140401_SF093_03 TB143976.[MT7]-IIADIFEYTAK[MT7].3b7_1.heavy 524.636 / 946.537 998.0 46.10202407836914 44 18 10 6 10 5.757641520092868 17.368222674340284 0.0363006591796875 3 0.9853656165030692 10.189293946470126 998.0 25.85727272727273 0.0 - - - - - - - 0.0 1 0 MUT methylmalonyl CoA mutase 1697 215 C20140401_SF093_03 C20140401_SF093_03 TB143976.[MT7]-IIADIFEYTAK[MT7].3y5_1.heavy 524.636 / 755.406 2457.0 46.10202407836914 44 18 10 6 10 5.757641520092868 17.368222674340284 0.0363006591796875 3 0.9853656165030692 10.189293946470126 2457.0 62.22272727272727 0.0 - - - - - - - 77.0 4 4 MUT methylmalonyl CoA mutase 1699 216 C20140401_SF093_03 C20140401_SF093_03 TB483030.[MT7]-EREDLPIWK[MT7].3y3_1.heavy 491.948 / 590.378 15038.0 31.94409942626953 47 17 10 10 10 3.969694706339202 25.19085405744429 0.0 3 0.9706328675331913 7.183944982347167 15038.0 39.05493934618801 0.0 - - - - - - - 720.5 30 10 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1701 216 C20140401_SF093_03 C20140401_SF093_03 TB483030.[MT7]-EREDLPIWK[MT7].3b4_1.heavy 491.948 / 674.323 28824.0 31.94409942626953 47 17 10 10 10 3.969694706339202 25.19085405744429 0.0 3 0.9706328675331913 7.183944982347167 28824.0 78.9505502567865 0.0 - - - - - - - 290.0 57 9 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1703 216 C20140401_SF093_03 C20140401_SF093_03 TB483030.[MT7]-EREDLPIWK[MT7].3b5_1.heavy 491.948 / 787.407 17545.0 31.94409942626953 47 17 10 10 10 3.969694706339202 25.19085405744429 0.0 3 0.9706328675331913 7.183944982347167 17545.0 114.19736842105263 0.0 - - - - - - - 162.11111111111111 35 9 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1705 216 C20140401_SF093_03 C20140401_SF093_03 TB483030.[MT7]-EREDLPIWK[MT7].3y4_1.heavy 491.948 / 687.431 14412.0 31.94409942626953 47 17 10 10 10 3.969694706339202 25.19085405744429 0.0 3 0.9706328675331913 7.183944982347167 14412.0 78.33882660470519 0.0 - - - - - - - 216.6153846153846 28 13 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1707 217 C20140401_SF093_03 C20140401_SF093_03 TB144310.[MT7]-DYFLNC[CAM]SALR.2b3_1.heavy 701.849 / 570.268 2402.0 35.95785140991211 41 16 10 5 10 1.9785749210919978 34.41201671237549 0.04290008544921875 3 0.9675499155087216 6.832395471340198 2402.0 5.428239700374532 0.0 - - - - - - - 300.125 4 8 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1709 217 C20140401_SF093_03 C20140401_SF093_03 TB144310.[MT7]-DYFLNC[CAM]SALR.2y8_1.heavy 701.849 / 980.498 3603.0 35.95785140991211 41 16 10 5 10 1.9785749210919978 34.41201671237549 0.04290008544921875 3 0.9675499155087216 6.832395471340198 3603.0 11.9985297752809 0.0 - - - - - - - 629.0 7 7 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1711 217 C20140401_SF093_03 C20140401_SF093_03 TB144310.[MT7]-DYFLNC[CAM]SALR.2y9_1.heavy 701.849 / 1143.56 2802.0 35.95785140991211 41 16 10 5 10 1.9785749210919978 34.41201671237549 0.04290008544921875 3 0.9675499155087216 6.832395471340198 2802.0 17.135226966292134 0.0 - - - - - - - 254.54545454545453 5 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1713 217 C20140401_SF093_03 C20140401_SF093_03 TB144310.[MT7]-DYFLNC[CAM]SALR.2y7_1.heavy 701.849 / 833.43 3736.0 35.95785140991211 41 16 10 5 10 1.9785749210919978 34.41201671237549 0.04290008544921875 3 0.9675499155087216 6.832395471340198 3736.0 13.805942571785268 0.0 - - - - - - - 225.6153846153846 7 13 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1715 218 C20140401_SF093_03 C20140401_SF093_03 TB144075.[MT7]-SC[CAM]IYDAK[MT7].2b3_1.heavy 572.799 / 505.256 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1717 218 C20140401_SF093_03 C20140401_SF093_03 TB144075.[MT7]-SC[CAM]IYDAK[MT7].2y4_1.heavy 572.799 / 640.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1719 218 C20140401_SF093_03 C20140401_SF093_03 TB144075.[MT7]-SC[CAM]IYDAK[MT7].2y6_1.heavy 572.799 / 913.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1721 218 C20140401_SF093_03 C20140401_SF093_03 TB144075.[MT7]-SC[CAM]IYDAK[MT7].2b5_1.heavy 572.799 / 783.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1723 219 C20140401_SF093_03 C20140401_SF093_03 TB483166.[MT7]-DVPFGFQTVTSDVNK[MT7].3b4_1.heavy 648.01 / 603.326 4089.0 37.41780090332031 48 18 10 10 10 5.529110382823072 18.08609216966684 0.0 3 0.9866117203923432 10.654038237566121 4089.0 14.209274999999998 0.0 - - - - - - - 442.85714285714283 8 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1725 219 C20140401_SF093_03 C20140401_SF093_03 TB483166.[MT7]-DVPFGFQTVTSDVNK[MT7].3b5_1.heavy 648.01 / 660.347 25898.0 37.41780090332031 48 18 10 10 10 5.529110382823072 18.08609216966684 0.0 3 0.9866117203923432 10.654038237566121 25898.0 96.90190013766417 0.0 - - - - - - - 265.7142857142857 51 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1727 219 C20140401_SF093_03 C20140401_SF093_03 TB483166.[MT7]-DVPFGFQTVTSDVNK[MT7].3y4_1.heavy 648.01 / 619.353 6320.0 37.41780090332031 48 18 10 10 10 5.529110382823072 18.08609216966684 0.0 3 0.9866117203923432 10.654038237566121 6320.0 17.13545087483176 0.0 - - - - - - - 301.14285714285717 12 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1729 219 C20140401_SF093_03 C20140401_SF093_03 TB483166.[MT7]-DVPFGFQTVTSDVNK[MT7].3y5_1.heavy 648.01 / 706.385 6939.0 37.41780090332031 48 18 10 10 10 5.529110382823072 18.08609216966684 0.0 3 0.9866117203923432 10.654038237566121 6939.0 65.09975806451612 0.0 - - - - - - - 248.0 13 8 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1731 220 C20140401_SF093_03 C20140401_SF093_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 101334.0 43.93190002441406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 101334.0 567.5797383957655 0.0 - - - - - - - 230.15384615384616 202 13 1733 220 C20140401_SF093_03 C20140401_SF093_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 97192.0 43.93190002441406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 97192.0 322.5495792161787 0.0 - - - - - - - 253.3 194 10 1735 220 C20140401_SF093_03 C20140401_SF093_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 104096.0 43.93190002441406 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 104096.0 204.4892356354411 0.0 - - - - - - - 199.4 208 10 1737 221 C20140401_SF093_03 C20140401_SF093_03 TB143980.[MT7]-NASNTEK[MT7].2y4_1.heavy 526.285 / 635.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 1739 221 C20140401_SF093_03 C20140401_SF093_03 TB143980.[MT7]-NASNTEK[MT7].2y5_1.heavy 526.285 / 722.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 1741 221 C20140401_SF093_03 C20140401_SF093_03 TB143980.[MT7]-NASNTEK[MT7].2y3_1.heavy 526.285 / 521.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 1743 221 C20140401_SF093_03 C20140401_SF093_03 TB143980.[MT7]-NASNTEK[MT7].2y6_1.heavy 526.285 / 793.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - NAP1L4 nucleosome assembly protein 1-like 4 1745 222 C20140401_SF093_03 C20140401_SF093_03 TB144078.[MT7]-FYDLSSK[MT7].2y4_1.heavy 574.315 / 578.363 4468.0 29.41469955444336 50 20 10 10 10 5.38901219015394 18.55627645131444 0.0 3 0.9917155768689383 13.549739749398308 4468.0 27.795116279069767 0.0 - - - - - - - 211.69230769230768 8 13 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1747 222 C20140401_SF093_03 C20140401_SF093_03 TB144078.[MT7]-FYDLSSK[MT7].2b3_1.heavy 574.315 / 570.268 4726.0 29.41469955444336 50 20 10 10 10 5.38901219015394 18.55627645131444 0.0 3 0.9917155768689383 13.549739749398308 4726.0 35.0328488372093 0.0 - - - - - - - 186.33333333333334 9 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1749 222 C20140401_SF093_03 C20140401_SF093_03 TB144078.[MT7]-FYDLSSK[MT7].2y5_1.heavy 574.315 / 693.39 2062.0 29.41469955444336 50 20 10 10 10 5.38901219015394 18.55627645131444 0.0 3 0.9917155768689383 13.549739749398308 2062.0 19.18139534883721 0.0 - - - - - - - 154.8 4 15 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1751 222 C20140401_SF093_03 C20140401_SF093_03 TB144078.[MT7]-FYDLSSK[MT7].2y6_1.heavy 574.315 / 856.453 4296.0 29.41469955444336 50 20 10 10 10 5.38901219015394 18.55627645131444 0.0 3 0.9917155768689383 13.549739749398308 4296.0 57.94604651162791 0.0 - - - - - - - 161.25 8 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1753 223 C20140401_SF093_03 C20140401_SF093_03 TB144598.[MT7]-TAWGQQPDLAANEAQLLR.3y7_1.heavy 709.375 / 843.468 4884.0 37.808024406433105 45 20 10 5 10 3.721529984003717 18.20654280202282 0.046901702880859375 3 0.9908286745769997 12.876974542133695 4884.0 7.091525078860435 0.0 - - - - - - - 193.375 9 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1755 223 C20140401_SF093_03 C20140401_SF093_03 TB144598.[MT7]-TAWGQQPDLAANEAQLLR.3b4_1.heavy 709.375 / 560.295 5956.0 37.808024406433105 45 20 10 5 10 3.721529984003717 18.20654280202282 0.046901702880859375 3 0.9908286745769997 12.876974542133695 5956.0 9.24735680775983 0.0 - - - - - - - 337.1666666666667 11 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1757 223 C20140401_SF093_03 C20140401_SF093_03 TB144598.[MT7]-TAWGQQPDLAANEAQLLR.3b5_1.heavy 709.375 / 688.354 5598.0 37.808024406433105 45 20 10 5 10 3.721529984003717 18.20654280202282 0.046901702880859375 3 0.9908286745769997 12.876974542133695 5598.0 8.926096070176675 0.0 - - - - - - - 249.9 11 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1759 223 C20140401_SF093_03 C20140401_SF093_03 TB144598.[MT7]-TAWGQQPDLAANEAQLLR.3y8_1.heavy 709.375 / 914.505 7504.0 37.808024406433105 45 20 10 5 10 3.721529984003717 18.20654280202282 0.046901702880859375 3 0.9908286745769997 12.876974542133695 7504.0 39.39765364047717 0.0 - - - - - - - 178.5 15 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1761 224 C20140401_SF093_03 C20140401_SF093_03 TB144456.[MT7]-STVFGTALNYVSLR.2y8_1.heavy 836.463 / 935.531 9932.0 43.5265998840332 43 13 10 10 10 1.824045539396777 43.88510836034108 0.0 3 0.9263570364727266 4.519545691087928 9932.0 24.876066790352507 0.0 - - - - - - - 264.6875 19 16 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1763 224 C20140401_SF093_03 C20140401_SF093_03 TB144456.[MT7]-STVFGTALNYVSLR.2y9_1.heavy 836.463 / 1036.58 12088.0 43.5265998840332 43 13 10 10 10 1.824045539396777 43.88510836034108 0.0 3 0.9263570364727266 4.519545691087928 12088.0 33.98893424036281 0.0 - - - - - - - 231.0 24 20 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1765 224 C20140401_SF093_03 C20140401_SF093_03 TB144456.[MT7]-STVFGTALNYVSLR.2y10_1.heavy 836.463 / 1093.6 37572.0 43.5265998840332 43 13 10 10 10 1.824045539396777 43.88510836034108 0.0 3 0.9263570364727266 4.519545691087928 37572.0 136.21883116883117 0.0 - - - - - - - 283.5 75 22 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1767 224 C20140401_SF093_03 C20140401_SF093_03 TB144456.[MT7]-STVFGTALNYVSLR.2y11_1.heavy 836.463 / 1240.67 21558.0 43.5265998840332 43 13 10 10 10 1.824045539396777 43.88510836034108 0.0 3 0.9263570364727266 4.519545691087928 21558.0 109.18987012987013 0.0 - - - - - - - 283.9375 43 16 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1769 225 C20140401_SF093_03 C20140401_SF093_03 TB143888.[MT7]-SSTELLR.2y5_1.heavy 475.275 / 631.377 5508.0 23.948200225830078 48 18 10 10 10 3.974200288853256 25.16229498560444 0.0 3 0.9845243046297609 9.907762867377457 5508.0 5.831208791208792 2.0 - - - - - - - 785.4545454545455 11 11 MECR mitochondrial trans-2-enoyl-CoA reductase 1771 225 C20140401_SF093_03 C20140401_SF093_03 TB143888.[MT7]-SSTELLR.2b4_1.heavy 475.275 / 549.264 23380.0 23.948200225830078 48 18 10 10 10 3.974200288853256 25.16229498560444 0.0 3 0.9845243046297609 9.907762867377457 23380.0 52.574074074074076 0.0 - - - - - - - 702.0 46 10 MECR mitochondrial trans-2-enoyl-CoA reductase 1773 225 C20140401_SF093_03 C20140401_SF093_03 TB143888.[MT7]-SSTELLR.2y6_1.heavy 475.275 / 718.409 16955.0 23.948200225830078 48 18 10 10 10 3.974200288853256 25.16229498560444 0.0 3 0.9845243046297609 9.907762867377457 16955.0 66.98271604938273 0.0 - - - - - - - 208.8 33 15 MECR mitochondrial trans-2-enoyl-CoA reductase 1775 225 C20140401_SF093_03 C20140401_SF093_03 TB143888.[MT7]-SSTELLR.2b5_1.heavy 475.275 / 662.348 16901.0 23.948200225830078 48 18 10 10 10 3.974200288853256 25.16229498560444 0.0 3 0.9845243046297609 9.907762867377457 16901.0 59.225295170972934 0.0 - - - - - - - 702.0 33 7 MECR mitochondrial trans-2-enoyl-CoA reductase 1777 226 C20140401_SF093_03 C20140401_SF093_03 TB144454.[MT7]-VQVYQEPNRETR.3y10_2.heavy 554.961 / 646.323 1488.0 20.675225734710693 46 20 10 6 10 6.2688723135374875 15.951832323024393 0.03470039367675781 3 0.9913067581824004 13.226848159326748 1488.0 7.502521008403361 0.0 - - - - - - - 173.27272727272728 2 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1779 226 C20140401_SF093_03 C20140401_SF093_03 TB144454.[MT7]-VQVYQEPNRETR.3b4_1.heavy 554.961 / 634.368 1250.0 20.675225734710693 46 20 10 6 10 6.2688723135374875 15.951832323024393 0.03470039367675781 3 0.9913067581824004 13.226848159326748 1250.0 18.897058823529413 0.0 - - - - - - - 163.75 2 8 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1781 226 C20140401_SF093_03 C20140401_SF093_03 TB144454.[MT7]-VQVYQEPNRETR.3y11_2.heavy 554.961 / 710.352 4225.0 20.675225734710693 46 20 10 6 10 6.2688723135374875 15.951832323024393 0.03470039367675781 3 0.9913067581824004 13.226848159326748 4225.0 43.25363832683911 0.0 - - - - - - - 143.1 8 10 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1783 226 C20140401_SF093_03 C20140401_SF093_03 TB144454.[MT7]-VQVYQEPNRETR.3y9_2.heavy 554.961 / 596.789 1666.0 20.675225734710693 46 20 10 6 10 6.2688723135374875 15.951832323024393 0.03470039367675781 3 0.9913067581824004 13.226848159326748 1666.0 28.33690827740492 0.0 - - - - - - - 139.33333333333334 3 3 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1785 227 C20140401_SF093_03 C20140401_SF093_03 TB144174.[MT7]-VLDLQQIK[MT7].2y5_1.heavy 622.894 / 773.5 5681.0 34.29909896850586 48 18 10 10 10 6.268947126124366 15.951641956473594 0.0 3 0.9884067139327806 11.450873684134367 5681.0 48.68142404346842 0.0 - - - - - - - 144.0 11 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1787 227 C20140401_SF093_03 C20140401_SF093_03 TB144174.[MT7]-VLDLQQIK[MT7].2b4_1.heavy 622.894 / 585.373 3787.0 34.29909896850586 48 18 10 10 10 6.268947126124366 15.951641956473594 0.0 3 0.9884067139327806 11.450873684134367 3787.0 23.719305189094108 0.0 - - - - - - - 252.125 7 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1789 227 C20140401_SF093_03 C20140401_SF093_03 TB144174.[MT7]-VLDLQQIK[MT7].2y6_1.heavy 622.894 / 888.527 4671.0 34.29909896850586 48 18 10 10 10 6.268947126124366 15.951641956473594 0.0 3 0.9884067139327806 11.450873684134367 4671.0 33.92035714285714 0.0 - - - - - - - 252.14285714285714 9 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1791 227 C20140401_SF093_03 C20140401_SF093_03 TB144174.[MT7]-VLDLQQIK[MT7].2y7_1.heavy 622.894 / 1001.61 8837.0 34.29909896850586 48 18 10 10 10 6.268947126124366 15.951641956473594 0.0 3 0.9884067139327806 11.450873684134367 8837.0 75.37073550212165 0.0 - - - - - - - 231.16666666666666 17 6 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1793 228 C20140401_SF093_03 C20140401_SF093_03 TB144070.[MT7]-EHLITLK[MT7].3y3_1.heavy 381.244 / 505.347 46790.0 27.678600311279297 50 20 10 10 10 12.531146807641917 7.980115589980688 0.0 3 0.9979078445895279 26.976751546385895 46790.0 199.67525100219837 0.0 - - - - - - - 262.5 93 22 FANCL Fanconi anemia, complementation group L 1795 228 C20140401_SF093_03 C20140401_SF093_03 TB144070.[MT7]-EHLITLK[MT7].3b4_1.heavy 381.244 / 637.379 2377.0 27.678600311279297 50 20 10 10 10 12.531146807641917 7.980115589980688 0.0 3 0.9979078445895279 26.976751546385895 2377.0 20.099632352941175 0.0 - - - - - - - 153.8421052631579 4 19 FANCL Fanconi anemia, complementation group L 1797 228 C20140401_SF093_03 C20140401_SF093_03 TB144070.[MT7]-EHLITLK[MT7].3y4_1.heavy 381.244 / 618.431 7470.0 27.678600311279297 50 20 10 10 10 12.531146807641917 7.980115589980688 0.0 3 0.9979078445895279 26.976751546385895 7470.0 15.898764751485915 0.0 - - - - - - - 197.05 14 20 FANCL Fanconi anemia, complementation group L 1799 228 C20140401_SF093_03 C20140401_SF093_03 TB144070.[MT7]-EHLITLK[MT7].3b3_1.heavy 381.244 / 524.295 31918.0 27.678600311279297 50 20 10 10 10 12.531146807641917 7.980115589980688 0.0 3 0.9979078445895279 26.976751546385895 31918.0 133.40340557275542 0.0 - - - - - - - 199.94117647058823 63 17 FANCL Fanconi anemia, complementation group L 1801 229 C20140401_SF093_03 C20140401_SF093_03 TB143884.[MT7]-DQALAER.2y5_1.heavy 473.757 / 559.32 5006.0 17.396850109100342 41 18 9 6 8 5.946617142507463 16.816283544669865 0.03700065612792969 4 0.9847475048674549 9.980179810258026 5006.0 22.559227467811155 1.0 - - - - - - - 199.10526315789474 20 19 MUT methylmalonyl CoA mutase 1803 229 C20140401_SF093_03 C20140401_SF093_03 TB143884.[MT7]-DQALAER.2b4_1.heavy 473.757 / 572.316 5297.0 17.396850109100342 41 18 9 6 8 5.946617142507463 16.816283544669865 0.03700065612792969 4 0.9847475048674549 9.980179810258026 5297.0 22.757786150178262 0.0 - - - - - - - 227.45454545454547 10 22 MUT methylmalonyl CoA mutase 1805 229 C20140401_SF093_03 C20140401_SF093_03 TB143884.[MT7]-DQALAER.2y6_1.heavy 473.757 / 687.378 9139.0 17.396850109100342 41 18 9 6 8 5.946617142507463 16.816283544669865 0.03700065612792969 4 0.9847475048674549 9.980179810258026 9139.0 40.22890646245963 0.0 - - - - - - - 218.1875 18 16 MUT methylmalonyl CoA mutase 1807 229 C20140401_SF093_03 C20140401_SF093_03 TB143884.[MT7]-DQALAER.2b5_1.heavy 473.757 / 643.353 4424.0 17.396850109100342 41 18 9 6 8 5.946617142507463 16.816283544669865 0.03700065612792969 4 0.9847475048674549 9.980179810258026 4424.0 46.49549254026283 0.0 - - - - - - - 151.13333333333333 8 15 MUT methylmalonyl CoA mutase 1809 230 C20140401_SF093_03 C20140401_SF093_03 TB144459.[MT7]-ITVNEVELLVMK[MT7].3y3_1.heavy 559.335 / 521.324 6197.0 45.78510093688965 39 13 10 6 10 1.5702409831083317 50.75625211635597 0.039600372314453125 3 0.9220130529393442 4.3902345581337885 6197.0 16.649996230607467 0.0 - - - - - - - 278.8 12 5 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1811 230 C20140401_SF093_03 C20140401_SF093_03 TB144459.[MT7]-ITVNEVELLVMK[MT7].3b4_1.heavy 559.335 / 572.352 2324.0 45.78510093688965 39 13 10 6 10 1.5702409831083317 50.75625211635597 0.039600372314453125 3 0.9220130529393442 4.3902345581337885 2324.0 40.65782991202346 0.0 - - - - - - - 121.42857142857143 4 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1813 230 C20140401_SF093_03 C20140401_SF093_03 TB144459.[MT7]-ITVNEVELLVMK[MT7].3b5_1.heavy 559.335 / 701.395 4338.0 45.78510093688965 39 13 10 6 10 1.5702409831083317 50.75625211635597 0.039600372314453125 3 0.9220130529393442 4.3902345581337885 4338.0 34.591810344827586 0.0 - - - - - - - 131.4 8 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1815 230 C20140401_SF093_03 C20140401_SF093_03 TB144459.[MT7]-ITVNEVELLVMK[MT7].3b7_1.heavy 559.335 / 929.506 3563.0 45.78510093688965 39 13 10 6 10 1.5702409831083317 50.75625211635597 0.039600372314453125 3 0.9220130529393442 4.3902345581337885 3563.0 66.96111436950147 0.0 - - - - - - - 125.5 7 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1817 231 C20140401_SF093_03 C20140401_SF093_03 TB144171.[MT7]-LLASMMC[CAM]K[MT7].2y5_1.heavy 621.337 / 800.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1819 231 C20140401_SF093_03 C20140401_SF093_03 TB144171.[MT7]-LLASMMC[CAM]K[MT7].2y3_1.heavy 621.337 / 582.286 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1821 231 C20140401_SF093_03 C20140401_SF093_03 TB144171.[MT7]-LLASMMC[CAM]K[MT7].2y6_1.heavy 621.337 / 871.396 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1823 231 C20140401_SF093_03 C20140401_SF093_03 TB144171.[MT7]-LLASMMC[CAM]K[MT7].2y7_1.heavy 621.337 / 984.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1825 232 C20140401_SF093_03 C20140401_SF093_03 TB144452.[MT7]-RVASSVFITLAPPR.3y7_1.heavy 553.334 / 767.477 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 1827 232 C20140401_SF093_03 C20140401_SF093_03 TB144452.[MT7]-RVASSVFITLAPPR.3y6_1.heavy 553.334 / 654.393 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 1829 232 C20140401_SF093_03 C20140401_SF093_03 TB144452.[MT7]-RVASSVFITLAPPR.3y8_1.heavy 553.334 / 914.546 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 1831 232 C20140401_SF093_03 C20140401_SF093_03 TB144452.[MT7]-RVASSVFITLAPPR.3b7_1.heavy 553.334 / 891.517 N/A N/A - - - - - - - - - 0.0 - - - - - - - FBLIM1 filamin binding LIM protein 1 1833 233 C20140401_SF093_03 C20140401_SF093_03 TB144453.[MT7]-ELILTLC[CAM]DLIRR.3y11_2.heavy 553.663 / 693.419 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1835 233 C20140401_SF093_03 C20140401_SF093_03 TB144453.[MT7]-ELILTLC[CAM]DLIRR.3b4_1.heavy 553.663 / 613.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1837 233 C20140401_SF093_03 C20140401_SF093_03 TB144453.[MT7]-ELILTLC[CAM]DLIRR.3y4_1.heavy 553.663 / 557.388 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1839 233 C20140401_SF093_03 C20140401_SF093_03 TB144453.[MT7]-ELILTLC[CAM]DLIRR.3b3_1.heavy 553.663 / 500.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 1841 234 C20140401_SF093_03 C20140401_SF093_03 TB144591.[MT7]-SVAAIHPSLEIPMLIPK[MT7].4b11_2.heavy 526.817 / 631.865 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1843 234 C20140401_SF093_03 C20140401_SF093_03 TB144591.[MT7]-SVAAIHPSLEIPMLIPK[MT7].4b5_1.heavy 526.817 / 586.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1845 234 C20140401_SF093_03 C20140401_SF093_03 TB144591.[MT7]-SVAAIHPSLEIPMLIPK[MT7].4b6_1.heavy 526.817 / 723.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1847 234 C20140401_SF093_03 C20140401_SF093_03 TB144591.[MT7]-SVAAIHPSLEIPMLIPK[MT7].4b10_2.heavy 526.817 / 575.323 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1849 235 C20140401_SF093_03 C20140401_SF093_03 TB143988.[MT7]-LLEDSVSR.2y6_1.heavy 531.799 / 692.321 2552.0 27.3966007232666 44 14 10 10 10 2.6673051707482247 37.491023185752795 0.0 3 0.9490300357621795 5.44305919066998 2552.0 10.109371980676329 0.0 - - - - - - - 178.25 5 12 PALM paralemmin 1851 235 C20140401_SF093_03 C20140401_SF093_03 TB143988.[MT7]-LLEDSVSR.2y5_1.heavy 531.799 / 563.278 1311.0 27.3966007232666 44 14 10 10 10 2.6673051707482247 37.491023185752795 0.0 3 0.9490300357621795 5.44305919066998 1311.0 3.6944444444444446 0.0 - - - - - - - 203.16666666666666 2 18 PALM paralemmin 1853 235 C20140401_SF093_03 C20140401_SF093_03 TB143988.[MT7]-LLEDSVSR.2b4_1.heavy 531.799 / 615.347 1517.0 27.3966007232666 44 14 10 10 10 2.6673051707482247 37.491023185752795 0.0 3 0.9490300357621795 5.44305919066998 1517.0 1.758840579710145 1.0 - - - - - - - 190.76470588235293 3 17 PALM paralemmin 1855 235 C20140401_SF093_03 C20140401_SF093_03 TB143988.[MT7]-LLEDSVSR.2y7_1.heavy 531.799 / 805.405 2621.0 27.3966007232666 44 14 10 10 10 2.6673051707482247 37.491023185752795 0.0 3 0.9490300357621795 5.44305919066998 2621.0 20.57548309178744 0.0 - - - - - - - 184.0 5 15 PALM paralemmin 1857 236 C20140401_SF093_03 C20140401_SF093_03 TB483162.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.2y8_1.heavy 958.996 / 998.509 4683.0 38.52552604675293 41 16 10 5 10 3.8711800855745606 25.831916312195535 0.04470062255859375 3 0.9644870103369695 6.529426590396082 4683.0 51.89991452991453 0.0 - - - - - - - 221.0 9 9 FBLIM1 filamin binding LIM protein 1 1859 236 C20140401_SF093_03 C20140401_SF093_03 TB483162.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.2y5_1.heavy 958.996 / 595.393 2927.0 38.52552604675293 41 16 10 5 10 3.8711800855745606 25.831916312195535 0.04470062255859375 3 0.9644870103369695 6.529426590396082 2927.0 19.80519943019943 0.0 - - - - - - - 253.5 5 6 FBLIM1 filamin binding LIM protein 1 1861 236 C20140401_SF093_03 C20140401_SF093_03 TB483162.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.2y6_1.heavy 958.996 / 709.435 2693.0 38.52552604675293 41 16 10 5 10 3.8711800855745606 25.831916312195535 0.04470062255859375 3 0.9644870103369695 6.529426590396082 2693.0 31.76358974358974 0.0 - - - - - - - 140.4 5 10 FBLIM1 filamin binding LIM protein 1 1863 236 C20140401_SF093_03 C20140401_SF093_03 TB483162.[MT7]-FAPVC[CAM]SIC[CAM]ENPIIPR.2y10_1.heavy 958.996 / 1198.62 2459.0 38.52552604675293 41 16 10 5 10 3.8711800855745606 25.831916312195535 0.04470062255859375 3 0.9644870103369695 6.529426590396082 2459.0 9.807977207977208 0.0 - - - - - - - 212.72727272727272 4 11 FBLIM1 filamin binding LIM protein 1 1865 237 C20140401_SF093_03 C20140401_SF093_03 TB482977.[MT7]-QLTFEEIAK[MT7].3b6_1.heavy 456.266 / 892.453 14866.0 34.0640983581543 39 9 10 10 10 0.8298559384679792 73.61715373575898 0.0 3 0.802792947273449 2.7320644945384296 14866.0 61.210634698032614 1.0 - - - - - - - 155.57142857142858 37 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1867 237 C20140401_SF093_03 C20140401_SF093_03 TB482977.[MT7]-QLTFEEIAK[MT7].3y3_1.heavy 456.266 / 475.336 78561.0 34.0640983581543 39 9 10 10 10 0.8298559384679792 73.61715373575898 0.0 3 0.802792947273449 2.7320644945384296 78561.0 201.88095375880891 0.0 - - - - - - - 712.9 157 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1869 237 C20140401_SF093_03 C20140401_SF093_03 TB482977.[MT7]-QLTFEEIAK[MT7].3b4_1.heavy 456.266 / 634.368 29491.0 34.0640983581543 39 9 10 10 10 0.8298559384679792 73.61715373575898 0.0 3 0.802792947273449 2.7320644945384296 29491.0 125.19403772827614 0.0 - - - - - - - 217.8 58 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1871 237 C20140401_SF093_03 C20140401_SF093_03 TB482977.[MT7]-QLTFEEIAK[MT7].3b5_1.heavy 456.266 / 763.411 22722.0 34.0640983581543 39 9 10 10 10 0.8298559384679792 73.61715373575898 0.0 3 0.802792947273449 2.7320644945384296 22722.0 361.4863636363636 0.0 - - - - - - - 169.4 45 5 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1873 238 C20140401_SF093_03 C20140401_SF093_03 TB483018.[MT7]-DVLLARPELK[MT7].3b4_1.heavy 481.304 / 585.373 23674.0 31.08300018310547 43 13 10 10 10 1.5298043518789983 42.176753016043435 0.0 3 0.9257573135661908 4.5010232776357055 23674.0 65.48127659574467 0.0 - - - - - - - 267.53846153846155 47 13 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1875 238 C20140401_SF093_03 C20140401_SF093_03 TB483018.[MT7]-DVLLARPELK[MT7].3y4_1.heavy 481.304 / 630.394 47630.0 31.08300018310547 43 13 10 10 10 1.5298043518789983 42.176753016043435 0.0 3 0.9257573135661908 4.5010232776357055 47630.0 98.52620416769352 0.0 - - - - - - - 297.6666666666667 95 12 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1877 238 C20140401_SF093_03 C20140401_SF093_03 TB483018.[MT7]-DVLLARPELK[MT7].3y8_2.heavy 481.304 / 542.354 27808.0 31.08300018310547 43 13 10 10 10 1.5298043518789983 42.176753016043435 0.0 3 0.9257573135661908 4.5010232776357055 27808.0 44.24052251494466 0.0 - - - - - - - 270.25 55 8 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1879 238 C20140401_SF093_03 C20140401_SF093_03 TB483018.[MT7]-DVLLARPELK[MT7].3y9_2.heavy 481.304 / 591.888 48006.0 31.08300018310547 43 13 10 10 10 1.5298043518789983 42.176753016043435 0.0 3 0.9257573135661908 4.5010232776357055 48006.0 195.55635638297872 0.0 - - - - - - - 239.27272727272728 96 11 DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1881 239 C20140401_SF093_03 C20140401_SF093_03 TB483016.[MT7]-DVFIIQTVSK[MT7].3b4_1.heavy 479.957 / 619.357 108807.0 36.99319839477539 41 11 10 10 10 1.5065596706141282 51.191618934252176 0.0 3 0.8670988475323071 3.347082842307199 108807.0 375.669629254994 0.0 - - - - - - - 294.77777777777777 217 9 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1883 239 C20140401_SF093_03 C20140401_SF093_03 TB483016.[MT7]-DVFIIQTVSK[MT7].3b5_1.heavy 479.957 / 732.441 10881.0 36.99319839477539 41 11 10 10 10 1.5065596706141282 51.191618934252176 0.0 3 0.8670988475323071 3.347082842307199 10881.0 39.6378720314267 1.0 - - - - - - - 265.2 22 5 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1885 239 C20140401_SF093_03 C20140401_SF093_03 TB483016.[MT7]-DVFIIQTVSK[MT7].3y4_1.heavy 479.957 / 578.363 39277.0 36.99319839477539 41 11 10 10 10 1.5065596706141282 51.191618934252176 0.0 3 0.8670988475323071 3.347082842307199 39277.0 70.06701005025126 0.0 - - - - - - - 701.2857142857143 78 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1887 239 C20140401_SF093_03 C20140401_SF093_03 TB483016.[MT7]-DVFIIQTVSK[MT7].3b3_1.heavy 479.957 / 506.273 66744.0 36.99319839477539 41 11 10 10 10 1.5065596706141282 51.191618934252176 0.0 3 0.8670988475323071 3.347082842307199 66744.0 157.63658291457284 0.0 - - - - - - - 265.0 133 5 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1889 240 C20140401_SF093_03 C20140401_SF093_03 TB144566.[MT7]-TPEAGLAGRPSPWTTPGR.3y7_1.heavy 665.689 / 814.421 1800.0 29.275624752044678 37 13 10 6 8 2.4562473146583033 40.712512703107556 0.03389930725097656 4 0.9099507388979498 4.0813902514070834 1800.0 20.853658536585368 0.0 - - - - - - - 222.77777777777777 3 18 FBLIM1 filamin binding LIM protein 1 1891 240 C20140401_SF093_03 C20140401_SF093_03 TB144566.[MT7]-TPEAGLAGRPSPWTTPGR.3y15_2.heavy 665.689 / 762.407 3437.0 29.275624752044678 37 13 10 6 8 2.4562473146583033 40.712512703107556 0.03389930725097656 4 0.9099507388979498 4.0813902514070834 3437.0 7.983251833740831 1.0 - - - - - - - 207.4 7 15 FBLIM1 filamin binding LIM protein 1 1893 240 C20140401_SF093_03 C20140401_SF093_03 TB144566.[MT7]-TPEAGLAGRPSPWTTPGR.3y17_2.heavy 665.689 / 875.455 17184.0 29.275624752044678 37 13 10 6 8 2.4562473146583033 40.712512703107556 0.03389930725097656 4 0.9099507388979498 4.0813902514070834 17184.0 220.50898225003192 0.0 - - - - - - - 272.5833333333333 34 12 FBLIM1 filamin binding LIM protein 1 1895 240 C20140401_SF093_03 C20140401_SF093_03 TB144566.[MT7]-TPEAGLAGRPSPWTTPGR.3y9_1.heavy 665.689 / 998.505 6628.0 29.275624752044678 37 13 10 6 8 2.4562473146583033 40.712512703107556 0.03389930725097656 4 0.9099507388979498 4.0813902514070834 6628.0 115.99 0.0 - - - - - - - 214.75 13 8 FBLIM1 filamin binding LIM protein 1 1897 241 C20140401_SF093_03 C20140401_SF093_03 TB483199.[MT7]-ASPFLLQYIQEEIPDYR.3b6_1.heavy 742.724 / 773.468 28383.0 49.160301208496094 48 18 10 10 10 5.61638069956921 17.80506082995233 0.0 3 0.9876266801408735 11.083334104458961 28383.0 164.8172188938639 0.0 - - - - - - - 180.9375 56 16 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1899 241 C20140401_SF093_03 C20140401_SF093_03 TB483199.[MT7]-ASPFLLQYIQEEIPDYR.3b4_1.heavy 742.724 / 547.3 48761.0 49.160301208496094 48 18 10 10 10 5.61638069956921 17.80506082995233 0.0 3 0.9876266801408735 11.083334104458961 48761.0 198.64961113769368 0.0 - - - - - - - 318.1818181818182 97 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1901 241 C20140401_SF093_03 C20140401_SF093_03 TB483199.[MT7]-ASPFLLQYIQEEIPDYR.3b5_1.heavy 742.724 / 660.384 85887.0 49.160301208496094 48 18 10 10 10 5.61638069956921 17.80506082995233 0.0 3 0.9876266801408735 11.083334104458961 85887.0 195.8609174724774 0.0 - - - - - - - 306.44444444444446 171 9 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1903 241 C20140401_SF093_03 C20140401_SF093_03 TB483199.[MT7]-ASPFLLQYIQEEIPDYR.3b7_1.heavy 742.724 / 901.526 29055.0 49.160301208496094 48 18 10 10 10 5.61638069956921 17.80506082995233 0.0 3 0.9876266801408735 11.083334104458961 29055.0 132.6994158258099 0.0 - - - - - - - 242.26666666666668 58 15 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1905 242 C20140401_SF093_03 C20140401_SF093_03 TB482827.[MT7]-VQIQESVR.2y5_1.heavy 551.82 / 618.321 6164.0 23.63705015182495 46 20 10 6 10 7.411986607126149 13.491659564502779 0.03899955749511719 3 0.9951939537142492 17.794848919961336 6164.0 162.66111111111113 0.0 - - - - - - - 157.27272727272728 12 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1907 242 C20140401_SF093_03 C20140401_SF093_03 TB482827.[MT7]-VQIQESVR.2b4_1.heavy 551.82 / 613.379 1352.0 23.63705015182495 46 20 10 6 10 7.411986607126149 13.491659564502779 0.03899955749511719 3 0.9951939537142492 17.794848919961336 1352.0 36.053333333333335 0.0 - - - - - - - 146.57142857142858 2 7 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1909 242 C20140401_SF093_03 C20140401_SF093_03 TB482827.[MT7]-VQIQESVR.2y6_1.heavy 551.82 / 731.405 6921.0 23.63705015182495 46 20 10 6 10 7.411986607126149 13.491659564502779 0.03899955749511719 3 0.9951939537142492 17.794848919961336 6921.0 178.79249999999996 0.0 - - - - - - - 147.27272727272728 13 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1911 242 C20140401_SF093_03 C20140401_SF093_03 TB482827.[MT7]-VQIQESVR.2y7_1.heavy 551.82 / 859.463 15247.0 23.63705015182495 46 20 10 6 10 7.411986607126149 13.491659564502779 0.03899955749511719 3 0.9951939537142492 17.794848919961336 15247.0 166.58759259259259 0.0 - - - - - - - 122.72727272727273 30 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 1913 243 C20140401_SF093_03 C20140401_SF093_03 TB482828.[MT7]-TEPATDLGR.2y8_1.heavy 552.294 / 858.432 1348.0 20.373274326324463 36 12 10 6 8 1.4175518656475177 59.69709720011656 0.03750038146972656 4 0.8881743971757197 3.6556029278700537 1348.0 0.8183087664856479 2.0 - - - - - - - 146.5 2 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1915 243 C20140401_SF093_03 C20140401_SF093_03 TB482828.[MT7]-TEPATDLGR.2b4_1.heavy 552.294 / 543.289 3516.0 20.373274326324463 36 12 10 6 8 1.4175518656475177 59.69709720011656 0.03750038146972656 4 0.8881743971757197 3.6556029278700537 3516.0 0.7271975180972079 0.0 - - - - - - - 251.7058823529412 7 17 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1917 243 C20140401_SF093_03 C20140401_SF093_03 TB482828.[MT7]-TEPATDLGR.2b6_1.heavy 552.294 / 759.364 1641.0 20.373274326324463 36 12 10 6 8 1.4175518656475177 59.69709720011656 0.03750038146972656 4 0.8881743971757197 3.6556029278700537 1641.0 0.4149178255372946 2.0 - - - - - - - 78.5 3 6 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1919 243 C20140401_SF093_03 C20140401_SF093_03 TB482828.[MT7]-TEPATDLGR.2y7_1.heavy 552.294 / 729.389 4220.0 20.373274326324463 36 12 10 6 8 1.4175518656475177 59.69709720011656 0.03750038146972656 4 0.8881743971757197 3.6556029278700537 4220.0 36.4117698380497 1.0 - - - - - - - 175.8 8 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1921 244 C20140401_SF093_03 C20140401_SF093_03 TB144187.[MT7]-ELETVDFK[MT7].2b3_1.heavy 634.852 / 516.279 4186.0 31.369699478149414 37 12 10 5 10 2.6615196973990227 37.57251922566092 0.042400360107421875 3 0.8892626226187794 3.67386837398881 4186.0 17.944545454545455 0.0 - - - - - - - 238.33333333333334 8 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1923 244 C20140401_SF093_03 C20140401_SF093_03 TB144187.[MT7]-ELETVDFK[MT7].2y5_1.heavy 634.852 / 753.426 1395.0 31.369699478149414 37 12 10 5 10 2.6615196973990227 37.57251922566092 0.042400360107421875 3 0.8892626226187794 3.67386837398881 1395.0 5.143551248438934 0.0 - - - - - - - 259.5 2 12 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1925 244 C20140401_SF093_03 C20140401_SF093_03 TB144187.[MT7]-ELETVDFK[MT7].2b6_1.heavy 634.852 / 831.422 3005.0 31.369699478149414 37 12 10 5 10 2.6615196973990227 37.57251922566092 0.042400360107421875 3 0.8892626226187794 3.67386837398881 3005.0 30.882703744853277 0.0 - - - - - - - 202.55555555555554 6 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1927 244 C20140401_SF093_03 C20140401_SF093_03 TB144187.[MT7]-ELETVDFK[MT7].2y3_1.heavy 634.852 / 553.31 859.0 31.369699478149414 37 12 10 5 10 2.6615196973990227 37.57251922566092 0.042400360107421875 3 0.8892626226187794 3.67386837398881 859.0 1.2958423964734391 6.0 - - - - - - - 243.72727272727272 4 11 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 1929 245 C20140401_SF093_03 C20140401_SF093_03 TB143758.[MT7]-GLLTSR.2y4_1.heavy 395.749 / 476.283 12578.0 23.803724765777588 46 20 10 6 10 6.952306827977711 14.383714999110307 0.03629875183105469 3 0.9952472310446749 17.89438841692738 12578.0 26.204166666666666 0.0 - - - - - - - 708.0 25 9 FANCL Fanconi anemia, complementation group L 1931 245 C20140401_SF093_03 C20140401_SF093_03 TB143758.[MT7]-GLLTSR.2b3_1.heavy 395.749 / 428.299 13928.0 23.803724765777588 46 20 10 6 10 6.952306827977711 14.383714999110307 0.03629875183105469 3 0.9952472310446749 17.89438841692738 13928.0 26.299519359975143 0.0 - - - - - - - 654.75 27 8 FANCL Fanconi anemia, complementation group L 1933 245 C20140401_SF093_03 C20140401_SF093_03 TB143758.[MT7]-GLLTSR.2y5_1.heavy 395.749 / 589.367 11715.0 23.803724765777588 46 20 10 6 10 6.952306827977711 14.383714999110307 0.03629875183105469 3 0.9952472310446749 17.89438841692738 11715.0 32.61302997076024 0.0 - - - - - - - 226.125 23 16 FANCL Fanconi anemia, complementation group L 1935 245 C20140401_SF093_03 C20140401_SF093_03 TB143758.[MT7]-GLLTSR.2b4_1.heavy 395.749 / 529.347 3077.0 23.803724765777588 46 20 10 6 10 6.952306827977711 14.383714999110307 0.03629875183105469 3 0.9952472310446749 17.89438841692738 3077.0 7.336778171845847 1.0 - - - - - - - 702.0 6 9 FANCL Fanconi anemia, complementation group L 1937 246 C20140401_SF093_03 C20140401_SF093_03 TB143897.[MT7]-LVIAEK[MT7].2y4_1.heavy 480.82 / 604.379 35727.0 28.04145050048828 43 20 9 6 8 11.291886687347908 8.855916001357492 0.03099822998046875 4 0.9966335740907833 21.264536904487088 35727.0 46.753948672920615 0.0 - - - - - - - 654.5 71 10 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1939 246 C20140401_SF093_03 C20140401_SF093_03 TB143897.[MT7]-LVIAEK[MT7].2y5_1.heavy 480.82 / 703.447 27788.0 28.04145050048828 43 20 9 6 8 11.291886687347908 8.855916001357492 0.03099822998046875 4 0.9966335740907833 21.264536904487088 27788.0 92.27591716774705 1.0 - - - - - - - 606.6666666666666 96 12 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1941 246 C20140401_SF093_03 C20140401_SF093_03 TB143897.[MT7]-LVIAEK[MT7].2b4_1.heavy 480.82 / 541.383 7057.0 28.04145050048828 43 20 9 6 8 11.291886687347908 8.855916001357492 0.03099822998046875 4 0.9966335740907833 21.264536904487088 7057.0 13.646114442073662 1.0 - - - - - - - 796.5833333333334 15 12 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1943 246 C20140401_SF093_03 C20140401_SF093_03 TB143897.[MT7]-LVIAEK[MT7].2y3_1.heavy 480.82 / 491.295 39844.0 28.04145050048828 43 20 9 6 8 11.291886687347908 8.855916001357492 0.03099822998046875 4 0.9966335740907833 21.264536904487088 39844.0 43.59843428796711 0.0 - - - - - - - 786.7 79 10 GDAP1;GDAP1L1 ganglioside-induced differentiation-associated protein 1;ganglioside-induced differentiation-associated protein 1-like 1 1945 247 C20140401_SF093_03 C20140401_SF093_03 TB348732.[MT7]-LSFTLDDALVLQAAR.3y7_1.heavy 593.004 / 770.488 1162.0 46.019649505615234 44 18 10 6 10 4.067335193879413 24.58612217416492 0.03749847412109375 3 0.9877939232811732 11.159161876713707 1162.0 10.25135400444939 0.0 - - - - - - - 170.2 2 5 FBXL8 F-box and leucine-rich repeat protein 8 1947 247 C20140401_SF093_03 C20140401_SF093_03 TB348732.[MT7]-LSFTLDDALVLQAAR.3y6_1.heavy 593.004 / 657.404 3331.0 46.019649505615234 44 18 10 6 10 4.067335193879413 24.58612217416492 0.03749847412109375 3 0.9877939232811732 11.159161876713707 3331.0 43.490956112852665 0.0 - - - - - - - 143.57142857142858 6 7 FBXL8 F-box and leucine-rich repeat protein 8 1949 247 C20140401_SF093_03 C20140401_SF093_03 TB348732.[MT7]-LSFTLDDALVLQAAR.3b7_1.heavy 593.004 / 936.479 1394.0 46.019649505615234 44 18 10 6 10 4.067335193879413 24.58612217416492 0.03749847412109375 3 0.9877939232811732 11.159161876713707 1394.0 26.196921658986177 0.0 - - - - - - - 163.22222222222223 2 9 FBXL8 F-box and leucine-rich repeat protein 8 1951 247 C20140401_SF093_03 C20140401_SF093_03 TB348732.[MT7]-LSFTLDDALVLQAAR.3y5_1.heavy 593.004 / 558.336 3563.0 46.019649505615234 44 18 10 6 10 4.067335193879413 24.58612217416492 0.03749847412109375 3 0.9877939232811732 11.159161876713707 3563.0 48.556510263929624 0.0 - - - - - - - 224.4 7 10 FBXL8 F-box and leucine-rich repeat protein 8 1953 248 C20140401_SF093_03 C20140401_SF093_03 TB143899.[MT7]-TAIGALK[MT7].2y4_1.heavy 481.318 / 532.357 48271.0 25.760900497436523 45 18 10 7 10 5.007642543540991 19.969476481300173 0.0279998779296875 3 0.9873252875313765 10.950489396530811 48271.0 86.60779189939035 0.0 - - - - - - - 708.9 96 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1955 248 C20140401_SF093_03 C20140401_SF093_03 TB143899.[MT7]-TAIGALK[MT7].2y5_1.heavy 481.318 / 645.442 16613.0 25.760900497436523 45 18 10 7 10 5.007642543540991 19.969476481300173 0.0279998779296875 3 0.9873252875313765 10.950489396530811 16613.0 46.58224176908968 0.0 - - - - - - - 703.625 33 8 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1957 248 C20140401_SF093_03 C20140401_SF093_03 TB143899.[MT7]-TAIGALK[MT7].2y6_1.heavy 481.318 / 716.479 17263.0 25.760900497436523 45 18 10 7 10 5.007642543540991 19.969476481300173 0.0279998779296875 3 0.9873252875313765 10.950489396530811 17263.0 49.999190635451505 0.0 - - - - - - - 186.9090909090909 34 22 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1959 248 C20140401_SF093_03 C20140401_SF093_03 TB143899.[MT7]-TAIGALK[MT7].2b5_1.heavy 481.318 / 558.337 10553.0 25.760900497436523 45 18 10 7 10 5.007642543540991 19.969476481300173 0.0279998779296875 3 0.9873252875313765 10.950489396530811 10553.0 13.227663049108203 0.0 - - - - - - - 684.2142857142857 21 14 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1961 249 C20140401_SF093_03 C20140401_SF093_03 TB482961.[MT7]-NIFPIWALGR.2b3_1.heavy 665.891 / 519.305 9682.0 47.29439926147461 42 16 10 6 10 2.4059005024620608 41.56447862148319 0.0355987548828125 3 0.960368112857519 6.178671855026898 9682.0 101.83545045045045 0.0 - - - - - - - 177.53333333333333 19 15 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1963 249 C20140401_SF093_03 C20140401_SF093_03 TB482961.[MT7]-NIFPIWALGR.2y8_1.heavy 665.891 / 959.546 12860.0 47.29439926147461 42 16 10 6 10 2.4059005024620608 41.56447862148319 0.0355987548828125 3 0.960368112857519 6.178671855026898 12860.0 122.08310810810809 0.0 - - - - - - - 170.2 25 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1965 249 C20140401_SF093_03 C20140401_SF093_03 TB482961.[MT7]-NIFPIWALGR.2y9_1.heavy 665.891 / 1072.63 6134.0 47.29439926147461 42 16 10 6 10 2.4059005024620608 41.56447862148319 0.0355987548828125 3 0.960368112857519 6.178671855026898 6134.0 38.13027027027027 1.0 - - - - - - - 140.6 12 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1967 249 C20140401_SF093_03 C20140401_SF093_03 TB482961.[MT7]-NIFPIWALGR.2y7_1.heavy 665.891 / 812.478 18181.0 47.29439926147461 42 16 10 6 10 2.4059005024620608 41.56447862148319 0.0355987548828125 3 0.960368112857519 6.178671855026898 18181.0 144.39124548406272 0.0 - - - - - - - 147.9 36 10 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 1969 250 C20140401_SF093_03 C20140401_SF093_03 TB144460.[MT7]-DVEHNVSPGYNFR.3y7_1.heavy 559.942 / 840.4 2554.0 25.40404987335205 47 20 10 7 10 16.394477150521098 6.099615076582147 0.026700973510742188 3 0.9992692512827199 45.65116748632598 2554.0 21.4448680663924 1.0 - - - - - - - 124.0 5 12 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1971 250 C20140401_SF093_03 C20140401_SF093_03 TB144460.[MT7]-DVEHNVSPGYNFR.3y6_1.heavy 559.942 / 753.368 4469.0 25.40404987335205 47 20 10 7 10 16.394477150521098 6.099615076582147 0.026700973510742188 3 0.9992692512827199 45.65116748632598 4469.0 99.41931614846311 0.0 - - - - - - - 111.94736842105263 8 19 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1973 250 C20140401_SF093_03 C20140401_SF093_03 TB144460.[MT7]-DVEHNVSPGYNFR.3b4_1.heavy 559.942 / 625.306 1649.0 25.40404987335205 47 20 10 7 10 16.394477150521098 6.099615076582147 0.026700973510742188 3 0.9992692512827199 45.65116748632598 1649.0 18.66792452830189 0.0 - - - - - - - 156.2941176470588 3 17 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1975 250 C20140401_SF093_03 C20140401_SF093_03 TB144460.[MT7]-DVEHNVSPGYNFR.3y5_1.heavy 559.942 / 656.315 1383.0 25.40404987335205 47 20 10 7 10 16.394477150521098 6.099615076582147 0.026700973510742188 3 0.9992692512827199 45.65116748632598 1383.0 17.78090353441403 0.0 - - - - - - - 169.375 2 16 P2RX4 purinergic receptor P2X, ligand-gated ion channel, 4 1977 251 C20140401_SF093_03 C20140401_SF093_03 TB483195.[MT7]-QWLIDTLYAFNSGNVER.3y7_1.heavy 724.04 / 775.369 17973.0 49.87747383117676 46 20 10 6 10 8.346474614703206 11.98110634924107 0.03369903564453125 3 0.9968477076359158 21.975308140264485 17973.0 71.26611105929479 0.0 - - - - - - - 216.88888888888889 35 18 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1979 251 C20140401_SF093_03 C20140401_SF093_03 TB483195.[MT7]-QWLIDTLYAFNSGNVER.3b5_1.heavy 724.04 / 800.442 18103.0 49.87747383117676 46 20 10 6 10 8.346474614703206 11.98110634924107 0.03369903564453125 3 0.9968477076359158 21.975308140264485 18103.0 57.887370834171946 0.0 - - - - - - - 260.4736842105263 36 19 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1981 251 C20140401_SF093_03 C20140401_SF093_03 TB483195.[MT7]-QWLIDTLYAFNSGNVER.3b3_1.heavy 724.04 / 572.331 25591.0 49.87747383117676 46 20 10 6 10 8.346474614703206 11.98110634924107 0.03369903564453125 3 0.9968477076359158 21.975308140264485 25591.0 215.8320076371939 0.0 - - - - - - - 669.7142857142857 51 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1983 251 C20140401_SF093_03 C20140401_SF093_03 TB483195.[MT7]-QWLIDTLYAFNSGNVER.3y8_1.heavy 724.04 / 922.438 17907.0 49.87747383117676 46 20 10 6 10 8.346474614703206 11.98110634924107 0.03369903564453125 3 0.9968477076359158 21.975308140264485 17907.0 121.12267086366319 0.0 - - - - - - - 211.5 35 12 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 1985 252 C20140401_SF093_03 C20140401_SF093_03 TB143955.[MT7]-NLELAAVR.2b3_1.heavy 515.312 / 501.279 22915.0 29.616500854492188 50 20 10 10 10 7.787791331467677 12.84061112371306 0.0 3 0.992780195236339 14.51570063543341 22915.0 62.50569298820446 0.0 - - - - - - - 688.3 45 10 MECR mitochondrial trans-2-enoyl-CoA reductase 1987 252 C20140401_SF093_03 C20140401_SF093_03 TB143955.[MT7]-NLELAAVR.2y5_1.heavy 515.312 / 529.346 29711.0 29.616500854492188 50 20 10 10 10 7.787791331467677 12.84061112371306 0.0 3 0.992780195236339 14.51570063543341 29711.0 96.79995108593897 0.0 - - - - - - - 670.9 59 10 MECR mitochondrial trans-2-enoyl-CoA reductase 1989 252 C20140401_SF093_03 C20140401_SF093_03 TB143955.[MT7]-NLELAAVR.2y6_1.heavy 515.312 / 658.388 24048.0 29.616500854492188 50 20 10 10 10 7.787791331467677 12.84061112371306 0.0 3 0.992780195236339 14.51570063543341 24048.0 188.468269933801 0.0 - - - - - - - 189.41176470588235 48 17 MECR mitochondrial trans-2-enoyl-CoA reductase 1991 252 C20140401_SF093_03 C20140401_SF093_03 TB143955.[MT7]-NLELAAVR.2y7_1.heavy 515.312 / 771.472 29276.0 29.616500854492188 50 20 10 10 10 7.787791331467677 12.84061112371306 0.0 3 0.992780195236339 14.51570063543341 29276.0 182.0473593957558 0.0 - - - - - - - 199.7058823529412 58 17 MECR mitochondrial trans-2-enoyl-CoA reductase 1993 253 C20140401_SF093_03 C20140401_SF093_03 TB144048.[MT7]-ENTLNIK[MT7].2y5_1.heavy 560.334 / 732.474 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1995 253 C20140401_SF093_03 C20140401_SF093_03 TB144048.[MT7]-ENTLNIK[MT7].2y3_1.heavy 560.334 / 518.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1997 253 C20140401_SF093_03 C20140401_SF093_03 TB144048.[MT7]-ENTLNIK[MT7].2y6_1.heavy 560.334 / 846.516 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 1999 253 C20140401_SF093_03 C20140401_SF093_03 TB144048.[MT7]-ENTLNIK[MT7].2b5_1.heavy 560.334 / 716.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - DHX32 DEAH (Asp-Glu-Ala-His) box polypeptide 32 2001 254 C20140401_SF093_03 C20140401_SF093_03 TB483193.[MT7]-GDTANEIGQVLHFENVK[MT7].4y5_1.heavy 540.539 / 780.437 1017.0 38.032798767089844 41 11 10 10 10 1.6669234141068565 46.71502816736269 0.0 3 0.8593709944045118 3.251612863679392 1017.0 2.2824409448818894 1.0 - - - - - - - 279.4 2 5 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2003 254 C20140401_SF093_03 C20140401_SF093_03 TB483193.[MT7]-GDTANEIGQVLHFENVK[MT7].4b5_1.heavy 540.539 / 603.286 2542.0 38.032798767089844 41 11 10 10 10 1.6669234141068565 46.71502816736269 0.0 3 0.8593709944045118 3.251612863679392 2542.0 23.578551181102362 0.0 - - - - - - - 127.0 5 4 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2005 254 C20140401_SF093_03 C20140401_SF093_03 TB483193.[MT7]-GDTANEIGQVLHFENVK[MT7].4y6_1.heavy 540.539 / 917.496 1271.0 38.032798767089844 41 11 10 10 10 1.6669234141068565 46.71502816736269 0.0 3 0.8593709944045118 3.251612863679392 1271.0 16.93332283464567 0.0 - - - - - - - 190.5 2 4 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2007 254 C20140401_SF093_03 C20140401_SF093_03 TB483193.[MT7]-GDTANEIGQVLHFENVK[MT7].4b6_1.heavy 540.539 / 732.328 4194.0 38.032798767089844 41 11 10 10 10 1.6669234141068565 46.71502816736269 0.0 3 0.8593709944045118 3.251612863679392 4194.0 66.01422047244094 0.0 - - - - - - - 148.16666666666666 8 6 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2009 255 C20140401_SF093_03 C20140401_SF093_03 TB483006.[MT7]-TVEGEFTGVGK[MT7].3b4_1.heavy 471.261 / 531.289 21583.0 28.441999435424805 48 18 10 10 10 5.3464647660608815 18.70394819298081 0.0 3 0.9805879033860816 8.843437009356945 21583.0 40.561010249993785 0.0 - - - - - - - 668.6363636363636 43 11 C9orf114 chromosome 9 open reading frame 114 2011 255 C20140401_SF093_03 C20140401_SF093_03 TB483006.[MT7]-TVEGEFTGVGK[MT7].3b5_1.heavy 471.261 / 660.332 73618.0 28.441999435424805 48 18 10 10 10 5.3464647660608815 18.70394819298081 0.0 3 0.9805879033860816 8.843437009356945 73618.0 252.5874118271888 0.0 - - - - - - - 628.4285714285714 147 7 C9orf114 chromosome 9 open reading frame 114 2013 255 C20140401_SF093_03 C20140401_SF093_03 TB483006.[MT7]-TVEGEFTGVGK[MT7].3b3_1.heavy 471.261 / 474.268 36912.0 28.441999435424805 48 18 10 10 10 5.3464647660608815 18.70394819298081 0.0 3 0.9805879033860816 8.843437009356945 36912.0 51.55840705306623 0.0 - - - - - - - 1125.5 73 8 C9orf114 chromosome 9 open reading frame 114 2015 255 C20140401_SF093_03 C20140401_SF093_03 TB483006.[MT7]-TVEGEFTGVGK[MT7].3y4_1.heavy 471.261 / 504.326 68668.0 28.441999435424805 48 18 10 10 10 5.3464647660608815 18.70394819298081 0.0 3 0.9805879033860816 8.843437009356945 68668.0 171.19658425301043 0.0 - - - - - - - 743.8181818181819 137 11 C9orf114 chromosome 9 open reading frame 114 2017 256 C20140401_SF093_03 C20140401_SF093_03 TB143766.[MT7]-VTGETR.2b3_1.heavy 403.728 / 402.247 9815.0 13.97790002822876 42 16 10 6 10 3.900806047457114 25.635727278773253 0.03560066223144531 3 0.9635907943829972 6.448076628493419 9815.0 22.16297471212463 0.0 - - - - - - - 657.5294117647059 19 17 PALM paralemmin 2019 256 C20140401_SF093_03 C20140401_SF093_03 TB143766.[MT7]-VTGETR.2y4_1.heavy 403.728 / 462.231 3546.0 13.97790002822876 42 16 10 6 10 3.900806047457114 25.635727278773253 0.03560066223144531 3 0.9635907943829972 6.448076628493419 3546.0 14.427539087599056 2.0 - - - - - - - 245.8181818181818 7 22 PALM paralemmin 2021 256 C20140401_SF093_03 C20140401_SF093_03 TB143766.[MT7]-VTGETR.2y5_1.heavy 403.728 / 563.278 26616.0 13.97790002822876 42 16 10 6 10 3.900806047457114 25.635727278773253 0.03560066223144531 3 0.9635907943829972 6.448076628493419 26616.0 102.4531208741179 0.0 - - - - - - - 210.88888888888889 53 18 PALM paralemmin 2023 256 C20140401_SF093_03 C20140401_SF093_03 TB143766.[MT7]-VTGETR.2b4_1.heavy 403.728 / 531.289 17123.0 13.97790002822876 42 16 10 6 10 3.900806047457114 25.635727278773253 0.03560066223144531 3 0.9635907943829972 6.448076628493419 17123.0 16.280955003191064 0.0 - - - - - - - 653.625 34 8 PALM paralemmin 2025 257 C20140401_SF093_03 C20140401_SF093_03 TB144054.[MT7]-C[CAM]AC[CAM]PEDAR.2b3_1.heavy 561.743 / 536.208 374.0 14.704400062561035 42 12 10 10 10 2.1438530982926913 46.6449870467512 0.0 3 0.8899582205649549 3.685684442762522 374.0 12.787452667814115 0.0 - - - - - - - 0.0 0 0 FBXL8 F-box and leucine-rich repeat protein 8 2027 257 C20140401_SF093_03 C20140401_SF093_03 TB144054.[MT7]-C[CAM]AC[CAM]PEDAR.2y5_1.heavy 561.743 / 587.278 416.0 14.704400062561035 42 12 10 10 10 2.1438530982926913 46.6449870467512 0.0 3 0.8899582205649549 3.685684442762522 416.0 19.51238095238095 0.0 - - - - - - - 0.0 0 0 FBXL8 F-box and leucine-rich repeat protein 8 2029 257 C20140401_SF093_03 C20140401_SF093_03 TB144054.[MT7]-C[CAM]AC[CAM]PEDAR.2b6_1.heavy 561.743 / 877.33 1455.0 14.704400062561035 42 12 10 10 10 2.1438530982926913 46.6449870467512 0.0 3 0.8899582205649549 3.685684442762522 1455.0 20.78571428571429 0.0 - - - - - - - 148.57142857142858 2 7 FBXL8 F-box and leucine-rich repeat protein 8 2031 257 C20140401_SF093_03 C20140401_SF093_03 TB144054.[MT7]-C[CAM]AC[CAM]PEDAR.2y7_1.heavy 561.743 / 818.346 416.0 14.704400062561035 42 12 10 10 10 2.1438530982926913 46.6449870467512 0.0 3 0.8899582205649549 3.685684442762522 416.0 10.954905335628228 0.0 - - - - - - - 0.0 0 0 FBXL8 F-box and leucine-rich repeat protein 8 2033 258 C20140401_SF093_03 C20140401_SF093_03 TB483003.[MT7]-SSDEAVILC[CAM]K[MT7].3b6_1.heavy 470.59 / 733.349 43788.0 27.8794002532959 50 20 10 10 10 3.8548729835638866 20.394569704544367 0.0 3 0.9912678798156899 13.1973272048308 43788.0 81.57347035573122 0.0 - - - - - - - 689.6666666666666 87 9 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 2035 258 C20140401_SF093_03 C20140401_SF093_03 TB483003.[MT7]-SSDEAVILC[CAM]K[MT7].3y3_1.heavy 470.59 / 564.33 64063.0 27.8794002532959 50 20 10 10 10 3.8548729835638866 20.394569704544367 0.0 3 0.9912678798156899 13.1973272048308 64063.0 38.151694213597324 0.0 - - - - - - - 1217.2857142857142 128 7 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 2037 258 C20140401_SF093_03 C20140401_SF093_03 TB483003.[MT7]-SSDEAVILC[CAM]K[MT7].3b4_1.heavy 470.59 / 563.243 44844.0 27.8794002532959 50 20 10 10 10 3.8548729835638866 20.394569704544367 0.0 3 0.9912678798156899 13.1973272048308 44844.0 50.3828864757057 0.0 - - - - - - - 745.3571428571429 89 14 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 2039 258 C20140401_SF093_03 C20140401_SF093_03 TB483003.[MT7]-SSDEAVILC[CAM]K[MT7].3b5_1.heavy 470.59 / 634.28 103426.0 27.8794002532959 50 20 10 10 10 3.8548729835638866 20.394569704544367 0.0 3 0.9912678798156899 13.1973272048308 103426.0 63.03096062981719 0.0 - - - - - - - 739.7 206 10 PSMD13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 2041 259 C20140401_SF093_03 C20140401_SF093_03 TB483189.[MT7]-QVPNESFFNFFNPLK[MT7].3b6_1.heavy 706.042 / 799.407 3180.0 49.6505012512207 48 18 10 10 10 2.528813379475051 30.48611429965275 0.0 3 0.9815929943985177 9.082436417511714 3180.0 17.900502512562813 0.0 - - - - - - - 157.76923076923077 6 13 NAP1L4 nucleosome assembly protein 1-like 4 2043 259 C20140401_SF093_03 C20140401_SF093_03 TB483189.[MT7]-QVPNESFFNFFNPLK[MT7].3y3_1.heavy 706.042 / 501.352 11593.0 49.6505012512207 48 18 10 10 10 2.528813379475051 30.48611429965275 0.0 3 0.9815929943985177 9.082436417511714 11593.0 58.041942258462115 0.0 - - - - - - - 637.625 23 8 NAP1L4 nucleosome assembly protein 1-like 4 2045 259 C20140401_SF093_03 C20140401_SF093_03 TB483189.[MT7]-QVPNESFFNFFNPLK[MT7].3b5_1.heavy 706.042 / 712.375 2451.0 49.6505012512207 48 18 10 10 10 2.528813379475051 30.48611429965275 0.0 3 0.9815929943985177 9.082436417511714 2451.0 11.24062482222433 0.0 - - - - - - - 136.5 4 16 NAP1L4 nucleosome assembly protein 1-like 4 2047 259 C20140401_SF093_03 C20140401_SF093_03 TB483189.[MT7]-QVPNESFFNFFNPLK[MT7].3y4_1.heavy 706.042 / 615.395 5830.0 49.6505012512207 48 18 10 10 10 2.528813379475051 30.48611429965275 0.0 3 0.9815929943985177 9.082436417511714 5830.0 44.037658078914205 0.0 - - - - - - - 275.94444444444446 11 18 NAP1L4 nucleosome assembly protein 1-like 4 2049 260 C20140401_SF093_03 C20140401_SF093_03 TB144579.[MT7]-SVQLPDGGWGLHIEDK[MT7].3y3_1.heavy 680.365 / 535.284 3546.0 36.863924980163574 32 18 4 2 8 2.7026455096908166 25.57693524148503 0.08549880981445312 4 0.9827743297712472 9.389639302363612 3546.0 11.197894736842105 0.0 - - - - - - - 217.28571428571428 7 7 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 2051 260 C20140401_SF093_03 C20140401_SF093_03 TB144579.[MT7]-SVQLPDGGWGLHIEDK[MT7].3y5_1.heavy 680.365 / 785.427 2912.0 36.863924980163574 32 18 4 2 8 2.7026455096908166 25.57693524148503 0.08549880981445312 4 0.9827743297712472 9.389639302363612 2912.0 20.372490118577076 0.0 - - - - - - - 221.625 5 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 2053 260 C20140401_SF093_03 C20140401_SF093_03 TB144579.[MT7]-SVQLPDGGWGLHIEDK[MT7].3b4_1.heavy 680.365 / 572.352 4305.0 36.863924980163574 32 18 4 2 8 2.7026455096908166 25.57693524148503 0.08549880981445312 4 0.9827743297712472 9.389639302363612 4305.0 20.392469151223693 1.0 - - - - - - - 206.0 14 8 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 2055 260 C20140401_SF093_03 C20140401_SF093_03 TB144579.[MT7]-SVQLPDGGWGLHIEDK[MT7].3y4_1.heavy 680.365 / 648.369 3419.0 36.863924980163574 32 18 4 2 8 2.7026455096908166 25.57693524148503 0.08549880981445312 4 0.9827743297712472 9.389639302363612 3419.0 10.526921052631577 0.0 - - - - - - - 299.27272727272725 6 11 LSS lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 2057 261 C20140401_SF093_03 C20140401_SF093_03 TB482818.[MT7]-QLEDERR.2y4_1.heavy 545.292 / 575.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2059 261 C20140401_SF093_03 C20140401_SF093_03 TB482818.[MT7]-QLEDERR.2b3_1.heavy 545.292 / 515.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2061 261 C20140401_SF093_03 C20140401_SF093_03 TB482818.[MT7]-QLEDERR.2b4_1.heavy 545.292 / 630.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2063 261 C20140401_SF093_03 C20140401_SF093_03 TB482818.[MT7]-QLEDERR.2b6_1.heavy 545.292 / 915.465 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2065 262 C20140401_SF093_03 C20140401_SF093_03 TB144193.[MT7]-VQVYQEPNR.2y8_1.heavy 638.842 / 1033.51 3014.0 22.076499938964844 46 20 10 6 10 6.31152818309836 15.844023364704286 0.036998748779296875 3 0.9945831242715083 16.76068234932923 3014.0 27.80560430168791 0.0 - - - - - - - 95.0 6 9 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2067 262 C20140401_SF093_03 C20140401_SF093_03 TB144193.[MT7]-VQVYQEPNR.2y5_1.heavy 638.842 / 643.316 455.0 22.076499938964844 46 20 10 6 10 6.31152818309836 15.844023364704286 0.036998748779296875 3 0.9945831242715083 16.76068234932923 455.0 7.982456140350878 2.0 - - - - - - - 0.0 0 0 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2069 262 C20140401_SF093_03 C20140401_SF093_03 TB144193.[MT7]-VQVYQEPNR.2y6_1.heavy 638.842 / 806.379 2331.0 22.076499938964844 46 20 10 6 10 6.31152818309836 15.844023364704286 0.036998748779296875 3 0.9945831242715083 16.76068234932923 2331.0 55.2078947368421 0.0 - - - - - - - 95.0 4 6 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2071 262 C20140401_SF093_03 C20140401_SF093_03 TB144193.[MT7]-VQVYQEPNR.2y7_1.heavy 638.842 / 905.448 1251.0 22.076499938964844 46 20 10 6 10 6.31152818309836 15.844023364704286 0.036998748779296875 3 0.9945831242715083 16.76068234932923 1251.0 37.74947368421053 0.0 - - - - - - - 144.72727272727272 2 11 PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2073 263 C20140401_SF093_03 C20140401_SF093_03 TB482813.[MT7]-RVSNTPLR.2b4_1.heavy 543.829 / 601.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2075 263 C20140401_SF093_03 C20140401_SF093_03 TB482813.[MT7]-RVSNTPLR.2y6_1.heavy 543.829 / 687.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2077 263 C20140401_SF093_03 C20140401_SF093_03 TB482813.[MT7]-RVSNTPLR.2b7_1.heavy 543.829 / 912.538 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2079 263 C20140401_SF093_03 C20140401_SF093_03 TB482813.[MT7]-RVSNTPLR.2y7_1.heavy 543.829 / 786.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - PALM paralemmin 2081 264 C20140401_SF093_03 C20140401_SF093_03 TB348722.[MT7]-SLNLSTEFISSTK[MT7].2b8_1.heavy 857.977 / 1036.54 1995.0 36.550299644470215 41 16 10 5 10 2.72344828075995 28.959722197574926 0.043598175048828125 3 0.9696214831947032 7.062744189764518 1995.0 4.923076923076923 1.0 - - - - - - - 228.0 3 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2083 264 C20140401_SF093_03 C20140401_SF093_03 TB348722.[MT7]-SLNLSTEFISSTK[MT7].2y4_1.heavy 857.977 / 566.327 3324.0 36.550299644470215 41 16 10 5 10 2.72344828075995 28.959722197574926 0.043598175048828125 3 0.9696214831947032 7.062744189764518 3324.0 14.245714285714286 0.0 - - - - - - - 206.88888888888889 6 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2085 264 C20140401_SF093_03 C20140401_SF093_03 TB348722.[MT7]-SLNLSTEFISSTK[MT7].2y6_1.heavy 857.977 / 826.479 3590.0 36.550299644470215 41 16 10 5 10 2.72344828075995 28.959722197574926 0.043598175048828125 3 0.9696214831947032 7.062744189764518 3590.0 15.17577276524645 0.0 - - - - - - - 226.1 7 10 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2087 264 C20140401_SF093_03 C20140401_SF093_03 TB348722.[MT7]-SLNLSTEFISSTK[MT7].2b5_1.heavy 857.977 / 659.385 2128.0 36.550299644470215 41 16 10 5 10 2.72344828075995 28.959722197574926 0.043598175048828125 3 0.9696214831947032 7.062744189764518 2128.0 3.4773333333333336 0.0 - - - - - - - 681.625 4 8 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2089 265 C20140401_SF093_03 C20140401_SF093_03 TB482811.[MT7]-RLYVDK[MT7].2y4_1.heavy 541.334 / 668.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2091 265 C20140401_SF093_03 C20140401_SF093_03 TB482811.[MT7]-RLYVDK[MT7].2y5_1.heavy 541.334 / 781.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2093 265 C20140401_SF093_03 C20140401_SF093_03 TB482811.[MT7]-RLYVDK[MT7].2y3_1.heavy 541.334 / 505.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2095 265 C20140401_SF093_03 C20140401_SF093_03 TB482811.[MT7]-RLYVDK[MT7].2b5_1.heavy 541.334 / 791.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2097 266 C20140401_SF093_03 C20140401_SF093_03 TB348727.[MT7]-TVDISMILSEAIRR.3y6_1.heavy 583.333 / 731.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2099 266 C20140401_SF093_03 C20140401_SF093_03 TB348727.[MT7]-TVDISMILSEAIRR.3b4_1.heavy 583.333 / 573.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2101 266 C20140401_SF093_03 C20140401_SF093_03 TB348727.[MT7]-TVDISMILSEAIRR.3b5_1.heavy 583.333 / 660.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2103 266 C20140401_SF093_03 C20140401_SF093_03 TB348727.[MT7]-TVDISMILSEAIRR.3y13_2.heavy 583.333 / 751.922 N/A N/A - - - - - - - - - 0.0 - - - - - - - PRPSAP2 phosphoribosyl pyrophosphate synthetase-associated protein 2 2105 267 C20140401_SF093_03 C20140401_SF093_03 TB143965.[MT7]-ALVYGHHGDPAK[MT7].3y3_1.heavy 518.287 / 459.305 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 2107 267 C20140401_SF093_03 C20140401_SF093_03 TB143965.[MT7]-ALVYGHHGDPAK[MT7].3y6_1.heavy 518.287 / 768.412 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 2109 267 C20140401_SF093_03 C20140401_SF093_03 TB143965.[MT7]-ALVYGHHGDPAK[MT7].3b5_1.heavy 518.287 / 648.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 2111 267 C20140401_SF093_03 C20140401_SF093_03 TB143965.[MT7]-ALVYGHHGDPAK[MT7].3y5_1.heavy 518.287 / 631.353 N/A N/A - - - - - - - - - 0.0 - - - - - - - MECR mitochondrial trans-2-enoyl-CoA reductase 2113 268 C20140401_SF093_03 C20140401_SF093_03 TB483182.[MT7]-EGEIVEVDEETAAILK[MT7].3b6_1.heavy 678.368 / 801.411 8370.0 40.6362247467041 44 18 10 6 10 16.347025898180917 6.117320705482452 0.03949737548828125 3 0.9826426153842464 9.353842069021008 8370.0 40.29976615774546 0.0 - - - - - - - 336.27272727272725 16 11 AS3MT arsenic (+3 oxidation state) methyltransferase 2115 268 C20140401_SF093_03 C20140401_SF093_03 TB483182.[MT7]-EGEIVEVDEETAAILK[MT7].3b4_1.heavy 678.368 / 573.3 9829.0 40.6362247467041 44 18 10 6 10 16.347025898180917 6.117320705482452 0.03949737548828125 3 0.9826426153842464 9.353842069021008 9829.0 38.43754209936242 0.0 - - - - - - - 243.5 19 10 AS3MT arsenic (+3 oxidation state) methyltransferase 2117 268 C20140401_SF093_03 C20140401_SF093_03 TB483182.[MT7]-EGEIVEVDEETAAILK[MT7].3b5_1.heavy 678.368 / 672.369 7494.0 40.6362247467041 44 18 10 6 10 16.347025898180917 6.117320705482452 0.03949737548828125 3 0.9826426153842464 9.353842069021008 7494.0 21.612401838222347 0.0 - - - - - - - 284.38461538461536 14 13 AS3MT arsenic (+3 oxidation state) methyltransferase 2119 268 C20140401_SF093_03 C20140401_SF093_03 TB483182.[MT7]-EGEIVEVDEETAAILK[MT7].3b8_1.heavy 678.368 / 1015.51 6715.0 40.6362247467041 44 18 10 6 10 16.347025898180917 6.117320705482452 0.03949737548828125 3 0.9826426153842464 9.353842069021008 6715.0 31.85025684931507 0.0 - - - - - - - 221.27272727272728 13 11 AS3MT arsenic (+3 oxidation state) methyltransferase 2121 269 C20140401_SF093_03 C20140401_SF093_03 TB144058.[MT7]-QPVVASVSLLIFK[MT7].3b6_1.heavy 563.69 / 726.427 1232.0 47.44047451019287 43 17 10 6 10 2.692047530355503 31.28809589821808 0.036899566650390625 3 0.9730797254157177 7.504875731649917 1232.0 22.417921146953404 0.0 - - - - - - - 134.14285714285714 2 7 MECR mitochondrial trans-2-enoyl-CoA reductase 2123 269 C20140401_SF093_03 C20140401_SF093_03 TB144058.[MT7]-QPVVASVSLLIFK[MT7].3y3_1.heavy 563.69 / 551.367 3697.0 47.44047451019287 43 17 10 6 10 2.692047530355503 31.28809589821808 0.036899566650390625 3 0.9730797254157177 7.504875731649917 3697.0 15.844285714285713 1.0 - - - - - - - 181.0 7 8 MECR mitochondrial trans-2-enoyl-CoA reductase 2125 269 C20140401_SF093_03 C20140401_SF093_03 TB144058.[MT7]-QPVVASVSLLIFK[MT7].3b4_1.heavy 563.69 / 568.357 2465.0 47.44047451019287 43 17 10 6 10 2.692047530355503 31.28809589821808 0.036899566650390625 3 0.9730797254157177 7.504875731649917 2465.0 16.15 1.0 - - - - - - - 144.83333333333334 4 6 MECR mitochondrial trans-2-enoyl-CoA reductase 2127 269 C20140401_SF093_03 C20140401_SF093_03 TB144058.[MT7]-QPVVASVSLLIFK[MT7].3b5_1.heavy 563.69 / 639.395 1740.0 47.44047451019287 43 17 10 6 10 2.692047530355503 31.28809589821808 0.036899566650390625 3 0.9730797254157177 7.504875731649917 1740.0 18.497695852534562 0.0 - - - - - - - 193.0 3 6 MECR mitochondrial trans-2-enoyl-CoA reductase 2129 270 C20140401_SF093_03 C20140401_SF093_03 TB482959.[MT7]-GVALSNVIHK[MT7].3y3_1.heavy 442.61 / 541.358 27742.0 28.858600616455078 44 14 10 10 10 1.766911836370082 50.58082303782357 0.0 3 0.9414555918224526 5.0754873712176485 27742.0 42.16989907796865 0.0 - - - - - - - 1233.4285714285713 55 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2131 270 C20140401_SF093_03 C20140401_SF093_03 TB482959.[MT7]-GVALSNVIHK[MT7].3b6_1.heavy 442.61 / 686.395 29299.0 28.858600616455078 44 14 10 10 10 1.766911836370082 50.58082303782357 0.0 3 0.9414555918224526 5.0754873712176485 29299.0 110.68511111111111 0.0 - - - - - - - 216.38888888888889 58 18 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2133 270 C20140401_SF093_03 C20140401_SF093_03 TB482959.[MT7]-GVALSNVIHK[MT7].3b4_1.heavy 442.61 / 485.32 29582.0 28.858600616455078 44 14 10 10 10 1.766911836370082 50.58082303782357 0.0 3 0.9414555918224526 5.0754873712176485 29582.0 59.07018356331254 0.0 - - - - - - - 1242.5555555555557 59 9 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2135 270 C20140401_SF093_03 C20140401_SF093_03 TB482959.[MT7]-GVALSNVIHK[MT7].3b5_1.heavy 442.61 / 572.352 12880.0 28.858600616455078 44 14 10 10 10 1.766911836370082 50.58082303782357 0.0 3 0.9414555918224526 5.0754873712176485 12880.0 43.89874718920655 0.0 - - - - - - - 667.1428571428571 25 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2137 271 C20140401_SF093_03 C20140401_SF093_03 TB144059.[MT7]-NIIFFGK[MT7].2y4_1.heavy 563.847 / 642.373 7667.0 38.582298278808594 50 20 10 10 10 5.751591745693206 17.386491326488887 0.0 3 0.9913800486163697 13.283040625763592 7667.0 72.11836421578289 0.0 - - - - - - - 114.0 15 3 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2139 271 C20140401_SF093_03 C20140401_SF093_03 TB144059.[MT7]-NIIFFGK[MT7].2y5_1.heavy 563.847 / 755.457 2403.0 38.582298278808594 50 20 10 10 10 5.751591745693206 17.386491326488887 0.0 3 0.9913800486163697 13.283040625763592 2403.0 39.62842105263158 0.0 - - - - - - - 130.42857142857142 4 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2141 271 C20140401_SF093_03 C20140401_SF093_03 TB144059.[MT7]-NIIFFGK[MT7].2b4_1.heavy 563.847 / 632.389 687.0 38.582298278808594 50 20 10 10 10 5.751591745693206 17.386491326488887 0.0 3 0.9913800486163697 13.283040625763592 687.0 1.2686427580741033 4.0 - - - - - - - 212.28571428571428 2 7 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2143 271 C20140401_SF093_03 C20140401_SF093_03 TB144059.[MT7]-NIIFFGK[MT7].2y6_1.heavy 563.847 / 868.541 1602.0 38.582298278808594 50 20 10 10 10 5.751591745693206 17.386491326488887 0.0 3 0.9913800486163697 13.283040625763592 1602.0 11.129379352489593 0.0 - - - - - - - 286.0 3 6 SERPINB5 serpin peptidase inhibitor, clade B (ovalbumin), member 5 2145 272 C20140401_SF093_03 C20140401_SF093_03 TB144572.[MT7]-ILQYLEC[CAM]PQYLRK[MT7].3y7_1.heavy 671.38 / 1108.61 1526.0 40.21739959716797 44 14 10 10 10 1.7734460463905257 47.16542965981914 0.0 3 0.9380055020445907 4.930786463260561 1526.0 1.4997542997542999 1.0 - - - - - - - 166.72727272727272 3 11 C9orf114 chromosome 9 open reading frame 114 2147 272 C20140401_SF093_03 C20140401_SF093_03 TB144572.[MT7]-ILQYLEC[CAM]PQYLRK[MT7].3y6_1.heavy 671.38 / 948.575 2239.0 40.21739959716797 44 14 10 10 10 1.7734460463905257 47.16542965981914 0.0 3 0.9380055020445907 4.930786463260561 2239.0 1.1002457002457005 1.0 - - - - - - - 203.75 6 8 C9orf114 chromosome 9 open reading frame 114 2149 272 C20140401_SF093_03 C20140401_SF093_03 TB144572.[MT7]-ILQYLEC[CAM]PQYLRK[MT7].3b4_1.heavy 671.38 / 662.399 2035.0 40.21739959716797 44 14 10 10 10 1.7734460463905257 47.16542965981914 0.0 3 0.9380055020445907 4.930786463260561 2035.0 2.5723314606741576 2.0 - - - - - - - 266.2307692307692 4 13 C9orf114 chromosome 9 open reading frame 114 2151 272 C20140401_SF093_03 C20140401_SF093_03 TB144572.[MT7]-ILQYLEC[CAM]PQYLRK[MT7].3y8_1.heavy 671.38 / 1237.65 814.0 40.21739959716797 44 14 10 10 10 1.7734460463905257 47.16542965981914 0.0 3 0.9380055020445907 4.930786463260561 814.0 10.773529411764706 1.0 - - - - - - - 0.0 1 0 C9orf114 chromosome 9 open reading frame 114